Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of the Universal Scientific Education and Research Network (USERN). Prof. Rezaei supervised more than two hundred research projects and designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He edited more than one hundred international books, presented more than a thousand lectures in congresses/meetings, and published more than 1,500 scientific papers in the international journals.
June 2005 Division of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
June 2005 Division of Immunopathology, Medical University of Vienna, Vienna, Austria
May 2007 Department of Immunology, 2nd Medical School Charles Univesity and University Hospital Motol, Prague, Csech Republic
May 2011 The Laboratory of Host Defenses, and the Genetic Immunotherapy Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
May 2011 Division of Immunology, and the Jeffrey Modell Endowed Chair of Immunology, Children's Hospital of Philadelphia, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
May 2011 Division of Immunology, and the Jeffrey Modell Immunology Center at Harvard, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
June 2011 St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, USA
June 2011 Center for Immunity and Immunotherapies, and the Jeffrey Modell Chair of Pediatric Immunology Research, Seattle Children's Research Institute, University of Washington, Seattle, WA, USA
June 2011 Type I Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA
January 2012 The Pediatric Department, Children’s University Hospital Bratislava, Comenius University Medical Faculty, Bratislava, Slovak Republic
January 2012 Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
January 2012 Department of Pathophysiology and Allergy Research Center for Pathophysiology, Infectology and Immunology, Medical University of Vienna, Vienna, Austria
June 2012 Department of Pathology and Immunology, Geneva Medical Faculty, University of Geneva; and the Department of Genetic and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
June 2012 The San Raffaele Telethon Institute for Gene Therapy HSR-TIGET, Milan, Italy
June 2012 The Children's Memorial Health Institute, Warsaw, Poland
June 2012 Department of Immunology-Histocompatibility, and Specific Center & Referral Center for Primary Immunodeficiencies – Paediatric Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece
May 2013 Pediatric Infectious Diseases, and Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon
February 2014 Gene Therapy Laboratory, Universidad Austral, Buenos Aires, Argentina
February 2014 Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, and Jeffrey Modell Diagnostic and Research Center in São Paulo, São Paulo,Brazil
February 2014 Center of Human Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
February 2014 Immunology, Allergy & Rheumatology, and The Center for Human Immunobiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA
March 2014 Department of Pediatrics, and Emory Vaccine Center, School of Medicine, Emory University, Atlanta, GA, USA
December 2014 The Laboratory of Research, and Department of Immunology, Institut Pasteur de Tunis, Tunis
December 2014 Al-Bashir Hamzeh Children’s Hospital, Faculty of Medicine, University of Tunis, Tunis
December 2014 Casablanca Children’s Hospital, and Faculty of Medicine, Universite Hassan II Casablanca, Casablanca, Morocco
February 2015 Division of Pediatric Allergy/Immunology, Marmara University Hospital, Marmara University, Istanbul, Turkey
April 2015 Belarusian State Medical University, Minsk Region, Belarus
April 2015 The Belarusian National Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
October 2015 State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, China
January 2016 Tajikistan National Medical Center, Dushanbe, Tajikistan
August 2016 Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
August 2016 Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
August 2016 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
August 2016 Massachusetts Institute of Technology (MIT), Boston, MA, USA
August 2016 Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA
August 2016 Brigham and Women's Hospital, Boston, MA, USA
August 2016 National Institute of Health (NIH), Bethesda, MD, USA
August 2016 Stanford University School of Medicine, Stanford, CA, USA
August 2016 Stanford Medical Center, Stanford, CA, USA
September 2016 Semmelweis University, Budapest, Hungary
December 2016 Kyiv's Municipal Children's Hospital, Kiev, Ukraine
December 2016 Kharkiv National Medical University, Kharkiv, Ukraine
February 2017 University of Maribor, Maribor, Slovenia
February 2017 Alma Mater Europaea, Maribor, Slovenia
March 2017 University of Ljubljana, Maribor, Slovenia
August 2017 Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
August 2017 Faculty of Medicine, Mahidol University, Bangkok, Thailand
September 2017 Section for Immunology and Rheumatology, The Queen Silvia Children's, Hospital, University of Gothenburg, Gothenburg, Sweden
October 2017 National Institute of Pediatrics, Mexico City, Mexico
November 2017 Kharkiv National Medical University, Kharkiv, Ukraine
November 2017 V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
October 2018 Russian-Armenian University, Yerevan, Armenia
November 2018 The Queen Silvia Children's, Hospital, University of Gothenburg, Gothenburg, Sweden
November 2018 Ce–M–M– Research Center for Molecular Medicine, Vienna, Austria
November 2018 University Mediterranea of Reggio Calabria, Reggio Calabria, Italy
November 2018 University of Turin, Turin, Italy
February 2019 Panjab University, Chandigarh, India
February 2019 Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
February 2019 Mehr Chand Mahajan DAV College for Women, Chandigarh, India
March 2019 Karolinska Institutet, Stockholm, Sweden
May 2019 Azerbaijan Medical University, Baku, Azerbaijan
November 2019 Semmelweis University, Budapest, Hungary
December 2019 Selçuk Üniversitesi, Konya, Turkey
November 2021 Marmara University, Yerevan, Armenia
May 2022 Yerevan Medical State University, Yerevan, Armenia
May 2022 National Institute of Health, Yerevan, Armenia
May 2022 Pediatric Cancer and Blood Disorders Center of Armenia, Yerevan, Armenia
July 2022 Akkon University of Human Sciences, Berlin, Germany
August 2022 University of Lithuania, Vilnius, Lithuania
August 2022 Imagine Institute of Genetic Diseases, Paris, France
August 2022 University of Toronto, Toronto, Canada
August 2022 The Hospital for Sick Children (SickKids), Toronto, Canada
November 2022 Sultan Qaboos University, Muscat, Oman
May 2023 Sidra Medical and Research Center, Doha, Qatar
May 2023 Qatar University, Doha, Qatar
1995 - 1998 Students’ Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1998 - 2002 Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran (In collaboration with Department of Clinical Immunology and Allergy)
2002 - 2009 Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2005 - 2009 Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, UK
2009 - 2010 Growth and Development Research Center; and Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2009 - 2018 Honorary Associate Staff: Department of Infection & Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, UK
2010 - 2018 Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran
2010 - now Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2010 - now Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2015 - now Universal Scientific Education and Research Network (USERN)
2016 – now Karolinska Institutet, Stockholm, Sweden
2019 – now University of Southampton, Southampton, UK
2016 - 2025 Association for Cancer Immunotherapy (CIMT)
2018 - 2025 European Academy of Sciences and Arts
2002 - 2025 European Academy of Allergy and Clinical Immunology (EAACI)
2004 - 2025 European Society of Immunodeficiency (ESID)
2004 - 2025 International Society for Infectious Diseases (ISID)
2010 - 2025 American Academy of Allergy, Asthma & Immunology (AAAAI)
2010 - 2025 European Respiratory Society (ERS)
2012 - 2025 World Allergy Organization (WAO)
2011 - 2025 The New York Academy of Sciences
2013 - 2025 Clinical Immunology Society (CIS)
2016 - 2025 Federation of Clinical Immunology Societies (FOCIS)
2010 - 2025 Human Variome Project Consortoium
2010 - 2025 Geneva Foundation for Medical Education and Research
2007 - 2025 Medical Protection Society (MPS, UK)
2004 - 2025 Iranian Society of Immunology and Allergy (ISIA)
2003 - 2025 Iranian Primary Immunodeficiency Association (IPiA)
2007 - 2025 National Foundation Elite
2007 - 2025 Iranian Cochrane Informal Network (ICInet)
2007 - 2025 Iranian Molecular Medicine Network
2007 - 2025 Iranian Genetic Society
2009 - 2025 Iranian Clinical Genetics
European Hematological Association (EHA, 2004)
The Biochemical Society (2006)
British Society for Cell Biology (BSCB, 2008)
2001 Honor student, Tehran University of Medical Sciences
2003 The best research project "Iranian PID Registry" in the 4th Avicenna Festival
2004 Travel grant from the European Hematology Association (EHA) for the presented article, based on the scientific quality of the article
2004 W.B. Educational grant from the European Society for Immunodeficiencies (ESID)
2005 Travel grant from the European Academy of Allergology and Clinical Immunology (EAACI) for the presented articles
2006 The IBC Leading Health Professionals of the World 2006
2006 Distinctive Researcher in Basic Sciences in the 12th Razi Research Festival on Medical Sciences
2007 Distinctive Researcher; Tehran University of Medical Sciences
2007 The best national Journal of the year "Iranian Journal of Allergy, Asthma and Immunology" in the 8th Avicenna Festival
2007 Distinctive, National Youth Talent, National Foundation Elite
2007 Distinctive Student in M.Sc. Molecular and Genetic Medicine; Division of Genomic Medicine, School of Medicine and Biomedical Sciences, the University of Sheffield, UK
2008 Honor Fellow Travel award from the British Society of Cell Biology (BSCB)
2009 The best book of the year "Primary Immunodeficiency Diseases" in the 10th Avicenna Festival
2009 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) grant, 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
2009 Short-term fellowship award from the European Society for Immunodeficiencies (ESID) in Paediatric Immunology and Infectious Diseases & Bone Marrow Transplant Unit in Newcastle General Hospital, UK
2010 The best lecture award during the 10th International Congress of Immunology and Allergy
2010 Travel Bursary from the International Union of Immunological Societies (IUIS)
2010 ESID (European Society for Immunodeficiencies) Juniors Award 2010 for the activities in the ESID Juniors Working Party
2010 Junior Scientist in Clinical Medicine Award Winner 2010 International Professor Dr. Alireza Yalda Foundation
2011 AAAAI (American Academy of Allergy, Asthma and Immunology) In-Training Member International Travel Grant Scholarship
2011 CIS (Clinical Immunology Society) Travel Grant for the Advanced School in Primary Immune Deficiency
2012 The Best Junior Scientist in Basic Sciences in the 13th Avicenna Festival
2012 The 3rd Rank of the Best Article in Basic Sciences in the 2012 Festival of the National Academy of Medical Sciences
2012 One of the Best 10 Scientists of the Country in the Last Decade (2002-2011) in the 2012 Festival of the National Academy of Medical Sciences
2013 Distinctive Researcher in Basic Sciences in the 18th Razi Research Festival on Medical Sciences
2013 AAAAI (American Academy of Allergy, Asthma and Immunology) International Young Investigator Award
2014 The Best Ranking Newly Established Research Center (Research Center for Immunodeficiencies) in the 19th Razi Research Festival on Medical Sciences
2014 The 2nd Rank of the Best Article in Clinical Sciences in the 2014 Festival of the National Academy of Medical Sciences
2014 One of the Best 10 Scientists of the Country in the Last Decade (2004-2013) in the 2014 Festival of the National Academy of Medical Sciences
2014 WinMD Grant, by World Immunodeficiency Network, Jeffrey Modell Foundation
2014 Iran Young Scientist Scopus Award 2014, by Elsevier
2015 The Best Ranking Research Center (Research Center for Immunodeficiencies) in the 20th Razi Research Festival on Medical Sciences
2015 The best book of the year "Immunology of Aging" in the 16th Avicenna Festival
2016 The best book of the year "Cancer Immunology" in the 17th Avicenna Festival
2017 The best researcher in basic sciences of the year in the 18th Avicenna Festival
2017 The best researcher, 1st Research Festival of Children's Medical Center
2017 The best scientist of last decade of the country in medical sciences, Iranian Academy of Medical Sciences
2017 Distinguished Researcher, University of Tehran Science and Technology Festival
2019 The best National Researcher, 20th Abu Reyhan Biruni Research Festival
2021 The Best Ranking Research Center (Research Center for Immunodeficiencies) in the 27th Razi Research Festival on Medical Sciences
2021 The Best Scientist in the 60th Alborz Foundation Festival
2022 The Best Ranking Research Center (Research Center for Immunodeficiencies) in the 28th Razi Research Festival on Medical Sciences
1995 – 1998 Student Scientific Research Center, affiliated to Tehran University of Medical Sciences
Director of research Consultant ward
2004 - 2012 Instructor and Board member of Iranian Primary Immunodeficiency Association
2004 - 2006 Executive Director of UNESCO Chair in Health Education, Tehran University of Medical Sciences
2002 – 2012 Instructor and Manager of Research and methodology workshops, Priority setting in medical research, Problem oriented research methodology workshops, Scientific writings, and Editing an academic book
2004 - 2009 Executive Manager of Iranian Journal of Allergy, Asthma and Immunology
2010 - 2015 Deputy Head of the Children's Medical Center Hospital, Pediatrics Center of Excellence in Iran
2010 - 2015 Chief Executive Director of the Children's Medical Center Hospital, Tehran University of Medical Sciences
2013 - 2015 Committee Member, Deputy of Culture and Talent Affairs, National Foundation Elite
2015 - 2017 Director of Global Academic Program (GAP), Tehran University of Medical Sciences
2015 - 2017 Chief Consultant of International Affairs, Vice Minister of Education, Ministry of Health and Medical Education
2010 - 2019 Co-Founder and Deputy President of Research Center for Immunodeficiencies, Tehran University of Medical Sciences
2019 - now Head of Research Center for Immunodeficiencies, Tehran University of Medical Sciences
2012 - now Founder and Leader of J Persia Daughter Project
2014 - now Co-Founder and Board Member of Charity for Patients with Primary Immunodeficiency Diseases
2014 - 2019 Member of the Committee of Innovation and Inventions in Basic Sciences, Deputy of Research and Technology, Ministry of Health and Medical Education
2014 - 2022 Founding President of Universal Scientific Education and Research Network (USERN)
2014 - now Founder and President of the Health and Art (HEART) Network
2015 - 2022 Associate Dean of International Affairs, School of Medicine, Tehran University of Medical Sciences
2021 - 2022 Vice Dean of Research, School of Medicine, Tehran University of Medical Sciences
2015 - 2019 Faculty Member of the Higher Council of The Students’ Disciplinary Committee, Ministry of Health and Medical Education
2015 - 2021 Member of the Committee of Communicable Diseases and Immunological Disorders, National Institute of Medical Research Development (NIMAD), Deputy of Research and Technology, Ministry of Health and Medical Education
2015 - now Member of the Higher Council of TUMS Research Diploma (TUMS-RD), Tehran University of Medical Sciences
2016 - now Mentor of J PID Juniors, J Juniors, Eastern Europe and Central Asia
2016 - 2022 Member of Commission for Supporting Talent Students, Tehran University of Medical Sciences
2021 - now Scientific Secretary of National Committee of Students’ Scientific Research and Technology Committees, Ministry of Health and Medical Education
2000 Collaborator and Member of Executive Managing Committee in 12th International Congress of Pediatrics, Tehran, Iran
2002 - 2003 Collaborator and Member of Executive Managing Committee in First and Second Symposium of "Pouyandegan Elm and Danesh" in Research week, Tehran, Iran
2004 - 2005 Executive Manager and member of national scientific committee of the First International Congress on Immunodeficiency Disorders, Tehran, Iran
2004 - 2005 Member of executive committee of The 2nd Iranian Asthma Meeting & The 5th Biennial Seminar of Iranian Society of Asthma and Allergy, Tehran, Iran
2009 Member of organizing committee of 21st International Congress of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
2010 Executive Director of the 22nd International Congress of Pediatrics, Tehran, Iran
2010 Scientific and Executive Director of the 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies, Tehran, Iran
2010 Executive Committee Member of 2nd Symposium of Metabolic Diseases, Tehran, Iran
2010 Executive Director of the 3rd Congress of Laboratory and Clinics (Pediatrics), Tehran, Iran
2011 Executive Director of the 23rd International Congress of Pediatrics, Tehran, Iran
2011 Scientific and Executive Director of the 4th Meeting on Clinical Immunology and Immunodeficiencies, Tehran, Iran
2011 Director of “Chalenges and Opportunitis in the Health System” and “The Role of Talents in the Health System” Panles in the 5th Congress of Naional Foundation Elite, Tehran, Iran
2011 Congress Manager of the 2nd International Congress of International Prof. Dr. Alireza Yalda Academic Foundation in Medical Sciences, Tehran, Iran
2012 Scientific and Executive Director of the World PI Week in Tehran, Iran
2012 Scientific Board Member of 11th International Congress of Immunology and Allergy of Iran, Tehran, Iran
2012 Faculty member of the 31st Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI), Geneva, Switzerland
2012 Scientific and Executive Director of the 5th Meeting on Clinical Immunology and Immunodeficiencies, Tehran, Iran
2012 Executive Director of the 24th International Congress of Pediatrics, Tehran, Iran
2013 Scientific Director of the 1st MENA Immunodeficiency Meeting, Dubai, UAE
2013 Scientific and Executive Director of the 6th Meeting on Clinical Immunology and Immunodeficiencies, Tehran, Iran
2013 Executive Director of the 25th International Congress of Pediatrics, Tehran, Iran
2014 Scientific Committee Member of 100th J Meeting on Primary Immunodeficiencies, Antalya, Turkey
2014 Scientific Committee Member of 12th International Congress of Immunology and Allergy, Tehran, Iran
2014 Scientific Committee Member of the 2nd MENA Immunodeficiency Meeting, Marrakesh, Morocco
2015 Scientific Committee Member of 1st International and 5th National Congress on Stem Cells, Tehran, Iran
2015 President of 1st International Festival of Pediatric Patients’ Paintings (IFPPP), Tehran, Iran
2015 Scientific Committee Member of the 3rd Middle East Asia Asthma Allergy Immunology Cogress (MEAAIC), Abu Dhabi, UAE
2016 Artistic Director of 4th National Congress of Medical Ethics, Tehran, Iran
2016 Scientific Committee Member of the 8th International Iranian Congress of Laboratory and Clinic, Tehran, Iran
2016 Executive Director and Scientific Committee Member of 1st Seminar of Stem Cell Therapy in Neurological Disorders, Tehran, Iran
2016 Scientific Committee Member of 2nd J Project Congress, Antalya, Turkey
2016 Scientific Committee Member of the 9th International & 14th National Congress on Quality Improvement in Clinical Laboratories, Tehran, Iran
2016 Vice-President and Chair of the PID Spring School, Tehran, Iran
2016 Vice-President and Chair of the Scientific Committee of 8th International Conference on Immunodeficiency Diseases, Tehran, Iran
2016 Scientific Committee Member of the Asia Pacific Society for Immunodeficiencies (APSID) Congress, Hong Kong SAR, China
2016 President and Scientific Secretary of 1st USERN Congress and Festival
2017 Vice-President and Chair of the Scientific Committee of 9th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2017 Chair of the 2nd PID Spring School, Tehran, Iran
2017 President and Scientific Secretary of 2nd USERN Congress and Festival, Kharkiv, Ukraine
2018 Vice-President and Chair of the Scientific Committee of 10th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2018 Chair of the 3rd PID Spring School, Tehran, Iran
2018 President and Scientific Secretary of 3rd USERN Congress and Festival, Reggio Calabria, Italy
2018 Scientific Chair of Primary Immunodeficiency Diseases Course, Reggio Calabria, Italy
2019 Vice-President and Chair of the Scientific Committee of 11th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2019 Chair of the 4th PID Spring School, Tehran, Iran
2020 President and Chair of the Scientific Committee of 12th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2020 President and Scientific Secretary of 5th USERN Congress and Festival
2021 President and Chair of the Scientific Committee of 13th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2021 President and Scientific Secretary of 6th USERN Congress and Festival
2022 President and Chair of the Scientific Committee of 14th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2022 President and Scientific Secretary of 7th USERN Congress and Festival
2023 President and Chair of the Scientific Committee of 15th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2023 President and Scientific Secretary of 8th USERN Congress and Festival
2024 President and Chair of the Scientific Committee of 16th International Conference on Primary Immunodeficiency Diseases, Tehran, Iran
2024 President and Scientific Secretary of 9th USERN Congress and Festival
* Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom
* Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at the Karolinska University Hospital Huddinge, Stockholm, Sweden
* Division of Rheumatology and Clinical Immunology, Medical Center, Freiburg University Hospital, Freiburg, Germany
* Department of Immunology and Molecular Pathology, Royal Free Hospital & University College Medical School, London, UK
* Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
* Clinica Pediatrica e Istituto di Medicina Molecolare Angelo Nocivelli, University of Brescia, Brescia, Italy
* Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
* Department of Immunology and Immunodeficiencies, Hospital Vall d´Hebron, School of Medicine, Barcelona, Spain
* Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, USA
* Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany
* National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
* Type I Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA
* St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, USA
* Division of Immunology, and the Jeffrey Modell Immunology Center at Harvard, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
* Division of Immunology, Children's Hospital of Philadelphia, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
* Center for Immunity and Immunotherapies, and the Jeffrey Modell Chair of Pediatric Immunology Research, Seattle Children's Research Institute, University of Washington, Seattle, WA, USA
* The Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria
* The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
* The Pediatric Department, Children’s University Hospital Bratislava, Comenius University Medical Faculty, Bratislava, Slovak Republic
* The Department of Infectious and Pediatric Immunology, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary
* Department of Pathology and Immunology, Geneva Medical Faculty, University of Geneva; and the Department of Genetic and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
* The Children's Memorial Health Institute, Warsaw, Poland
* Department of Immunology-Histocompatibility, and Specific Center & Referral Center for Primary Immunodeficiencies – Paediatric Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece
* The European Laboratory for the Investigation of Food-Induced Diseases (ELFID), Università degli Studi di Napoli Federico II, Naples, Italy
* Department of Immunology, Azerbaijan Medical School, Baku, Azerbaijan
* The Belarusian National Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus
* The Jeffrey Modell Diagnostic and Research Center in São Paulo, Brazil
* Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, and Jeffrey Modell Diagnostic and Research Center in São Paulo, Brazil
* Emory Vaccine Center, School of Medicine, Emory University, Atlanta, Georgia, USA
* Department of Immunology, INSERM, Laboratory of Excellence (LabEx) Transplantex, Strasbourg Federation for Translational Medicine (FMTS), Strasbourg School of Medicine and University Teaching Hospitals, University of Strasbourg, Strasbourg, France
* The Laboratory of Research, and Department of Immunology, Institut Pasteur de Tunis, Tunis
* The Clinical Immunology Unit, Casablanca Children’s Hospital, Universite Hassan II Casablanca, Casablanca, Morocco
* Division of Pediatric Allergy/Immunology, Marmara University Hospital, Marmara University, Istanbul, Turkey
* Belarusian State Medical University, Minsk, Belarus
* Tajikistan National Medical Center, Dushanbe, Tajikistan
* University of Santiago de Compostella, Spain
* Hannover Medical School, Germany
* Laboratory of Nonamedicine and Biomaterials, Brighham and Women's hospital, Harvard Medical School, Boston, MA, USA
* Malaysian Society of Allergy and Immunology (MSAI), Malaysia
* Jimma University, Ethiopia
* Semmelweis University, Budapest, Hungary
* Shupyk National Medical Academy of Postgraduate Education, Ukraine
* Rare Immune Diseases, Ukraine
* Ukrainian Association of Pediatric Immunology
* University of Maribor, Maribor, Slovenia
* Alma Mater Europaea, Maribor, Slovenia
* University of Ljubljana, Maribor, Slovenia
* European School of Genetics in Medicine, Bertinoro, Italy
* Institute of Neurogenetics and Neuropharmacology at Institute of Genetic and Biomedical Research (IRGB), Sardinia, Italy
* Division of Allergy and Immunology, Children’s hospital Philadelphia, Philadelphia,USA
* STEM Fellowship, Vancouver, Canada
* Department of Pediatric Allergy and Immunology, the University of South Florida and University of South Florida Board of Trustees, South Florida, USA
* Division of Allergy and Clinical Immunology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
* Instituto de Pesquisa Pele Pequeno Principle, Curitiba, Brazil
* Latin America Society for Immunodeficiencies (LASID)
* Clinical Operations & Program Management, Rocket Pharmaceuticals, New York, USA
* University of South Florida at Johns Hopkins All Children’s Hospital, South Florida, USA
* Departamento de Imunologia Institute of Biomedical Sciences, University of São Paulo, Sao Paulo, Brazil
* Brazilian Group for Immunodeficiency (BRAGID), Universidade Federal de Sao Paulo, Sao Paulo, Brazil
* Division of Pediatric Allergology and Clinical Immunology, Sister María Ludovica Children's Hospital, La Plata, Aegentina
* Serviço de Alergia e Imunologia do IPPMG, Departamento de Pediatria da Faculdade de Medicina da, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
* Allergy and Clinical Immunology Unit, Department of Pediatrics, Al-Sabah Hospital, Kuwait City, Kuwait
* University College London, Great Ormond Street Institute of Child Health, London, UK
* Mexican Foundation for Girls and Boys with Immunodeficiencies, Mexico City, Mexico
* Section of Allergy and Clinical Immunology, Department of Pediatrics, Medical Collegen of Wisconsin, Milwaukee, WI, USA
* The United States of America | * The United Kingdom | * Germany |
* Switzerland | * France | * Italy |
* Sweden | * Denmark | * Finland |
* Norway | * Hungary | * Austria |
* The Netherlands | * Scotland | * Wales |
* Portugal | * Czech Republic | * Slovakia |
* Spain | * Belgium | * Russia |
* Poland | * Greece | * Luxembourg |
* Slovenia | * Serbia | * Croatia |
* Lichtenstein | * Monaco | * Vatican |
* Belarus | * Ukraine | * Argentina |
* Brazil | * Mexico | * Chile |
* Ecuador | * China | * Japan |
* South Korea | * Malaysia | * Singapore |
* Thailand | * Hong Kong | * Lebanon |
* Turkey | * Saudi Arabia | * UAE |
* Canada | * Bulgaria | * Azerbaijan |
* Turkmenistan | * Armenia | * Tunis |
* Kazakhstan | * Uzbekistan | * Tajikistan |
* Morocco | * Qatar | * Oman |
* Bosnia and Herzegovina | * Iceland | * North Macedonia |
* Estonia | * Lithuania | * Latvia |
| Title of Presentation | Name of Congress | Date | Place |
1 | Primary immunodeficiency in Iran; First report of Iranian primary immunodeficiency registry | 12th International Congress of Pediatrics | October 2000 | Tehran , Iran |
2 | X-linked agammaglobulinemia; clinical and immunological analysis of 27 patients | 12th International Congress of Pediatrics | October 2000 | Tehran , Iran |
3 | Clinical and immunologic analysis of 52 patients with common variable immunodeficiency | 12th International Congress of Pediatrics | October 2000 | Tehran , Iran |
4 | Primary immunodeficiency in Iran (328 patients) | 11th International Congress of Immunology | July 2001 | Stockholm, Sweden |
5 | The clinical spectrum of respiratory diseases in patients with primary humoral immunodeficiency disorders; a survey of patients from Iranian primary immunodeficiency registry | 11th European Respiratory Congress | September 2001 | Berlin , Germany |
6 | Lung manifestations of chronic granulomatous disease; a survey of patients from Iranian primary immunodeficiency registry | 11th European Respiratory Congress | September 2001 | Berlin , Germany |
7 | Frequency of primary immunodeficiency in Iran | 13th International Congress of Pediatrics | October 2001 | Tehran , Iran |
8 | A single center 20 year survey of infectious complications in patients with common variable immunodeficiency | 13th International Congress of Pediatrics | October 2001 | Tehran , Iran |
9 | Clinical manifestations of chronic granulomatous disease, a clinical survey of patients of the Iranian primary immunodeficiency registry | 13th International Congress of Pediatrics | October 2001 | Tehran , Iran |
10 | Respiratory diseases in patients with primary humoral immunodeficiency disorders | 13th International Congress of Pediatrics | October 2001 | Tehran , Iran |
11 | The clinical spectrum of gastrointestinal involvement in patients with primary humoral immunodeficiency; A clinical survey of patients from Iranian primary immunodeficiency registry | British Society of Gastroenterology Annual Meeting | March 2002 | London , UK |
12 | The clinical spectrum of infections in patients with primary humoral immunodeficiency; a clinical survey of patients from Iranian Primary ImmunoDeficiency Registry | 12th European Congress of Clinical Microbiology and Infectious Diseases | April 2002 | Milan , Italy |
13 | The clinical spectrum of infections in patients with primary phagocytic disorders; a clinical survey of patients from Iranian Primary ImmunoDeficiency Registry | 12th European Congress of Clinical Microbiology and Infectious Diseases | April 2002 | Milan , Italy |
14 | Primary immunodeficiencies in Children’s Medical Center | 6th Iranian Congress of Immunology and Allergy | May 2002 | Tehran , Iran |
15 | The clinical spectrum of infections in patients with primary antibody immunodeficiency | 6th Iranian Congress of Immunology and Allergy | May 2002 | Tehran , Iran |
16 | Consanguinity in primary immunodeficient patients | 6th Iranian Congress of Immunology and Allergy | May 2002 | Tehran , Iran |
17 | Primary immunodeficiency diseases in Iran: the report of the national registry in children and adults (440 patients) | 21st Congress of the European Academy of Allergology and Clinical Immunology | June 2002 | Naples, Italy |
18 | X-linked Agammaglobulinemia in Iran: Clinical and immunologic analysis of 29 patients | 21st Congress of the European Academy of Allergology and Clinical Immunology | June 2002 | Naples, Italy |
19 | The frequency of consanguinity in primary immunodeficient patients, registered in Iranian Primary Immunodeficiency Registry | 21st Congress of the European Academy of Allergology and Clinical Immunology | June 2002 | Naples, Italy |
20 | A survey of infectious complication in 64 Iranian patients with common variable immunodeficiency | 21st Congress of the European Academy of Allergology and Clinical Immunology | June 2002 | Naples, Italy |
21 | Clinical manifestations of chronic granulomatous disease in Iran | 21st Congress of the European Academy of Allergology and Clinical Immunology | June 2002 | Naples, Italy |
22 | Efficacy of intravenous immunoglobulin in patients with agammaglobulinemia | 14th International Congress of Pediatrics | October 2002 | Tehran , Iran |
23 | The study of liver enzyme abnormality in pediatrics with brucellosis in Emam hospital | 14th International Congress of Pediatrics | October 2002 | Tehran , Iran |
24 | Frequency of primary immunodeficiencies in Children’s Medical Center | 10th Meeting of European Society for Immunodeficiencies | October 2002 | Weimar, Germany |
25 | Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with X-linked agammaglobulinemia | 10th Meeting of European Society for Immunodeficiencies | October 2002 | Weimar, Germany |
26 | Adverse reactions of intravenous immunoglobulin therapy | 4th Iranian Congress of Asthma and Allergy | May 2003 | Shiraz, Iran |
27 | Human leukocyte antigen class I and II, in Iranian patients with common variable immunodeficiency | 17th European Histocompatibility Conference- 11th Annual Meeting German Society of Immunogenetics | May 2003 | Baden-Baden, Germany |
28 | Adverse reactions of 955 prophylactic intravenous immunoglobulin therapy in patients with antibody deficiencies | 22nd Congress of the European Academy of Allergology and Clinical Immunology | June 2003 | Paris, France |
29 | Ear, Nose, and Throat manifestations in patients with primary antibody deficiencies | World Allergy Organization Congress- XVIII ICACI | September 2003 | Vancouver, Canada |
30 | Molecular diagnosis of antibody deficiencies patients | 15th International Congress of Pediatrics | October 2003 | Tehran, Iran |
31 | Iranian children with atopic dermatitis: severity scoring of atopic dermatitis, total serum IgE and eosinophil count in different age groups | 15th International Congress of Pediatrics | October 2003 | Tehran, Iran |
32 | Prevalence of common allergens in patients with allergic disorders in the Southeast of Iran | The Week of Allergy (ISBAAR-meeting, EAACI-ENT section meeting, SERIN meeting) | November 2003 | Ghent, Belgium |
33 | Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with Common variable immunodeficiency | The First International Congress on Pulmonary Diseases, Intensive Care and Tuberculosis | December 2003 | Tehran, Iran |
34 | The common allergens spectrum in South-east of Iran | 33rd Annual Scientific Meeting of the Australasian Society for Immunology | December 2003 | Perth, Australia |
35 | Pneumonia in Iranian pediatric patients with agammaglobulinemia | 6th International Congress on Pediatric Pulmonology | February 2004 | Lisbon, Portugal |
36 | Brucellosis and liver enzyme complications; A six-year study on 188 patients in Tehran | 15th Congress of Iranian Internal Medicine | May 2004 | Tehran, Iran |
37 | Survey of primary immunodeficiency patients with congenital neutropenia | The 7th Iranian Congress of Immunology and Allergy | May 2004 | Mashhad, Iran |
38 | Primary immunodeficiency disorders and adverse effects of intravenous immunoglobulin therapy | The 7th Iranian Congress of Immunology and Allergy | May 2004 | Mashhad, Iran |
39 | X-linked agammaglobulinemia in Iran | The 7th Iranian Congress of Immunology and Allergy | May 2004 | Mashhad, Iran |
40 | Gastrointestinal manifestations of cow's milk allergy | The 7th Iranian Congress of Immunology and Allergy | May 2004 | Mashhad, Iran |
41 | The prevalence of type I allergy among Zahedan Population | The 7th Iranian Congress of Immunology and Allergy | May 2004 | Mashhad, Iran |
42 | Infections in Iranian pediatrics with Common Variable Immunodeficiency | 22nd Annual Meeting of the European Society for Paediatric Infectious Diseases | May 2004 | Tampere, Finland |
43 | Evaluation of the immune system in Iranian children with atopic dermatitis | II World Congress on Immunopathology & Respiratory Allergy | May 2004 | Moscow, Russia |
44 | Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients | 9th Congress of the European Haematology Association | June 2004 | Geneva, Switzerland |
45 | The comparative study between the incidence of adverse reactions following intravenous immunoglobulin infusion in various immunodeficiency disorders | 23rd Congress of the European Academy of Allergology and Clinical Immunology | June 2004 | Amsterdam, Netherlands |
46 | Human leukocyte antigen profile in the Baloch ethnic group living in the South-East region of Iran | 23rd Congress of the European Academy of Allergology and Clinical Immunology | June 2004 | Amsterdam, Netherlands |
47 | Comparision of the severity scoring of atopic dermatiiis, total serum IgE and eosinophil count based on different age group in Iranian children with atopic dermatitis | 23rd Congress of the European Academy of Allergology and Clinical Immunology | June 2004 | Amsterdam, Netherlands |
48 | Clinical manifestations of Iranian patients with Cyclic neutropenia | July 2004 | Montreal, Canada | |
49 | A 22-year survey of infectious complications in Iranian patients with X-linked agammaglobulinemia | July 2004 | Montreal, Canada | |
50 | Common variable immunodeficiency: Clinical and immunological features of 61 patients | July 2004 | Montreal, Canada | |
51 | Major histocompatibility complex class I and II antigens frequencies in Zaboli ethnic group living in the South-East region of Iran | July 2004 | Montreal, Canada | |
52 | Involvement of gastrointestinal system in patients with cow's milk allergy | July 2004 | Montreal, Canada | |
53 | Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency | 14th European Respiratory Congress | September 2004 | Glasgow, Scotland |
54 | Prevalence of allergic rhinitis, eczema and asthma among school children in Tehran, Iran | October 2004 | Tbilisi, Republic of Georgia | |
55 | Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a four-year follow up study | 1st International Congress on Basic and Clinical Immunogenomics | October 2004 | Budapest, Hungary |
56 | Neutropenia in pediatric patients with primary humoral immunodeficiencies | 16th International Congress of Pediatrics | October 2004 | Tehran, Iran |
57 | Prevalence of allergic rhinitis in school-age children in Tehran | 16th International Congress of Pediatrics | October 2004 | Tehran, Iran |
58 | The clinical manifestations of 68 children with cow’s milk allergy | 16th International Congress of Pediatrics | October 2004 | Tehran, Iran |
59 | The Iranian national registry | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
60 | Neutropenia in Iranian patients with predominant antibody deficiency disorders | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
61 | Gastrointestinal complications in Common Variable Immunodeficiency: Endoscopic and pathologic findings | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
62 | Hodgkin’s lymphoma in two siblings with Common Variable Immunodeficiency | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
63 | An asymptomatic adult case with primary complement deficiency | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
64 | Complement deficiency in a patient with hyper IgM syndrome | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
65 | Recurrent and persistant neutropenia in patient with X-Linked Hyper IgM syndrome | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
66 | Mortality in primary immunodeficient patients, registered in Iranian primary Immunodeficiency Registry | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
67 | Congenital ophthalmic defects in a patient with X-linked agammaglobulinemia | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
68 | Distribution of T-cell immunodeficiency disorders diagnosed in Children's Medical Center in Iran | XIth Meeting for the European Society for Immunodeficiencies | October 2004 | Versailles, France |
69 | The prevalence of asthma in Iranian school-aged children in the city of Tehran during 2002-2003 | ACAAI Annual Scientific Meeting | November 2004 | Boston, MA, USA |
70 | Prevalence of allergic rhinitis in school-aged children in Tehran, Iran | November 2004 | Mumbai, India | |
71 | The Registry of Primary Immunodeficiency Disorders in Iran | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
72 | Iranian Primary Immunodeficiency Registry (IPIDR): From the Past to the Future | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
73 | Mortality in Iranian Patients with Primary Immunodeficiency Disorders | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
74 | The Frequency of Consanguinity in Primary Immunodeficient Patients; the Report from Iranian Primary Immunodeficiency Registry | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
75 | Distribution of Primary Immunodeficiency Disorders Diagnosed in Children's Medical Center in Iran | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
76 | Pulmonary Complications in Patients with Primary Hypogammaglobulinemia: A Survey by High Resolution CT Scan and Pulmonary Function Test | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
77 | Ear, Nose and Throat Manifestations in Patients with Primary Antibody Deficiencies | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
78 | Gastrointestinal Problems in Iranian Patients with Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
79 | The Clinical and Laboratory Findings of Patients with Antibody Deficiency Disorders Associated Neutropenia | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
80 | Human Leukocyte Antigens Class I and II, in Iranian Patients with Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
81 | Clinical and Immunological Features of 65 Iranian Patients with Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
82 | Common Variable Immunodeficiency: Clinical and Immunological Features of 39 Iranian Pediatrics | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
83 | Classification of Common Variable Immunodeficiency Based on Numbers of Switched Memory B–Cells | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
84 | X-Linked Agammaglobulinemia: Clinical and Laboratory Findings of Patients in Children’s Medical Center | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
85 | Identification of the Bruton Tyrosine Kinase Gene Mutations in 13 Iranian Patients with Presumed X-Linked Agammaglobulinemia | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
86 | Lymphoma of Mucosa Associated Lymphoid Tissue in a Patient with Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
87 | Hodgkin’s Lymphoma in Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
88 | Gastrointestinal Complications in Two Patients with Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
89 | Ataxia-Telangiectasia: Immunological and Clinical Features of 79 Iranian Patients | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
90 | The Report of Iranian Patients with Chronic Granulomatous Disease (CGD) from Two Referral Centers of Tehran | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
91 | Primary Complement Deficiency in Patients with Recurrent Infections, Immune Complex Diseases or Angioedema | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
92 | Clinical Manifestations of Iranian Patients with Primary Complement Deficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
93 | Primary Complement Deficiency in an Asymptomatic Adult Case | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
94 | Hyper IgM Syndrome or Complement Deficiency? (A Case Report) | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
95 | The Report of Acquired Immune Deficiency Syndrome (AIDS) in Zabol | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
96 | Cytokine Gene Polymorphism in Iranian Patients with Chronic Myelogenous Leukemia | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
97 | Efficacy of Intravenous Immunoglobulin on the Prevention of Pneumonia in Patients with Agammaglobulinemia | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
98 | The Effect of Intravenous Immunoglobulin Therapy on Prevention of Pneumonia in Patients with Common Variable Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
99 | Adverse Reactions of Prophylactic Intravenous Immunoglobulin Infusions in Iranian Patients with Primary Immunodeficiency | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
100 | Successful Management of Neutropenia in Hyper IgM Syndrome by Regular Intravenous Immunoglobulin Infusion | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
101 | Scientific Output of Iran at the Threshold of the 21st Century | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
102 | Major Histocompatibility Complex Class I and II Antigens Frequencies in Baloch Ethnic Group Living in the Southeast Region of Iran | First International Congress on Immunodeficiency Disorders | February-March 2005 | Tehran, Iran |
103 | Clinical and laboratory manifestations of patients with primary immunodeficiency disorders associated neutropenia; the report from Iranian Primary Immunodeficiency Registry | 10th Congress of the European Hematology Association | June 2005 | Stockholm, Sweden |
104 | Primary immunodeficiency disorders in Iran | The University of Vienna | June 2005 | Vienna, Austria |
105 | Primary immunodeficiency disorders in Iran: Incidence, diagnostic and treatment options | The University of Freiburg | June 2005 | Freiburg, Germany |
106 | Frequency of primary immunodeficiency disorders in Iran; the second report from Iranian Primary Immunodeficiency Registry | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
107 | Relative marriage in Iranian patients with primary immunodeficiency disorders | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
108 | The clinical manifestations of cow’s milk allergy in Iranian children | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
109 | The clinical manifestations of Iranian patients with primary complement deficiency | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
110 | Primary complement deficiency in Iranian patients with recurrent infections, immune complex diseases or angioedema | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
111 | Ear, nose and throat manifestations in patients with primary antibody deficiencies | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
112 | Ataxia-Telangiectasia: immunological and clinical features of 79 Iranian patients | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
113 | One year survey of infection in primary immunodeficient patients receiving intravenous immunoglobulin | The World Allergy Congress- 24th Congress of the European Academy of Allergology and Clinical Immunology | June-July 2005 | Munich, Germany |
114 | The prevalence of asthma in Iranian school-aged children in the city of Tehran during 2002-2003 | November 2005 | Tehran , Iran | |
115 | Gastrointestinal (GI) Involvement in Iranian Patients with Chronic Granulomatous Disease (CGD) | March 2006 | Miami Beach, FL, USA | |
116 | The Clinical and Laboratory Survey of Patients with Severe Congenital Neutropenia (Kostman Syndrome) | The 8th Iranian Congress of Immunology and Allergy | May 2006 | Tehran , Iran |
117 | The Clinical and Laboratory Survey of Patients with Hyper IgE Syndrome | The 8th Iranian Congress of Immunology and Allergy | May 2006 | Tehran , Iran |
118 | The Comparison of Human Leukocyte Antigen antigens frequencies in Zaboli and Balochi ethnic groups | The 8th Iranian Congress of Immunology and Allergy | May 2006 | Tehran , Iran |
119 | Hereditary and acquired angioedema | The 8th Iranian Congress of Immunology and Allergy | May 2006 | Tehran , Iran |
120 | The clinical and laboratory survey of hyper IgE syndrome | 25th Congress of the European Academy of Allergology and Clinical Immunology | June 2006 | Vienna , Austria |
121 | Severe combined immunodeficiency in Iran | 25th Congress of the European Academy of Allergology and Clinical Immunology | June 2006 | Vienna , Austria |
122 | Hereditary and acquired angioedema: serologic screening tests for diagnosis and classification | 25th Congress of the European Academy of Allergology and Clinical Immunology | June 2006 | Vienna , Austria |
123 | Human Leukocyte Antigen profile of two ethnic groups living in the southeastern Iran | 25th Congress of the European Academy of Allergology and Clinical Immunology | June 2006 | Vienna , Austria |
124 | Chromosomal radiosensitivity in Ataxia-Telangiectasia as a diagnostic test | 25th Congress of the European Academy of Allergology and Clinical Immunology | June 2006 | Vienna , Austria |
125 | Clinical and Laboratory Features of Iranian Patients with Kostman Syndrome | XIIth Meeting for the European Society for Immunodeficiencies | October 2006 | Budapest, Hungary |
126 | The Spectrum of Primary Immunodeficiency Diseases in Iran | ESID Spring meeting | May 2007 | Prague, Czech Republic |
127 | Severe Congenital Neutropenia in Iran | ESID Spring meeting | May 2007 | Prague, Czech Republic |
128 | The study of antibody response in patients with primary antibody deficiencies to plain polysaccharide meningococcal c vaccine by serum bactericidal assay | 26th Congress of the European Academy of Allergology and Clinical Immunology | June 2007 | Goteborg , Sweden |
129 | High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency | 26th Congress of the European Academy of Allergology and Clinical Immunology | June 2007 | Goteborg , Sweden |
130 | Serum Bactericidal Antibody Response to Serogroup C Polysaccharide Meningococcal Vaccination in Children with Primary Antibody Deficiencies | Research Day, The University of Sheffield | June 2007 | Sheffield, UK |
131 | The Clinical And Laboratory Spectrum of Iranian Patients With Severe Congenital Neutropenia | 19th International Congress of Pediatrics | November 2007 | Tehran, Iran |
132 | Intravenous immunoglobulin therapy panel (Co-chair) | 19th International Congress of Pediatrics | November 2007 | Tehran, Iran |
133 | Mutation analysis in Iranian Patients with Hyper IgE syndrome | The 1st International Congress on Health Genomics and Biotechnology | November 2007 | Tehran, Iran |
134 | Congenital Neutropenia due to Mutation of CD40 Ligand in Hyper IgM Syndrome | The 1st International Congress on Health Genomics and Biotechnology | November 2007 | Tehran, Iran |
135 | Serum bactericidal antibody response to polysaccharide meningococcal vaccination in common variable immunodeficiency and its clinical implications | 18th European Congress of Clinical Microbiology and Infectious Diseases | April 2008 | Barcelona, Spain |
136 | Novel vaccine antigens and host response (Co-chair) | 18th European Congress of Clinical Microbiology and Infectious Diseases | April 2008 | Barcelona, Spain |
137 | Western immunoblotting assay of Btk deficiency | 27th Congress of the European Academy of Allergology and Clinical Immunology | June 2008 | Barcelona, Spain |
138 | Response to polysaccharide vaccination amongst patients with common variable immunodeficiency correlates with clinical disease | Research Day, The University of Sheffield | June 2008 | Sheffield, UK |
139 | Serum cytokine assay in patients with common variable immunodeficiency | The 9th Iranian Congress of Immunology and Allergy | June 2008 | Tehran, Iran |
140 | Th1 and Th2 cytokine gene polymorphisms in asthma | The 9th Iranian Congress of Immunology and Allergy | June 2008 | Tehran, Iran |
141 | Selective IgA deficiency: association between clinical and immunological findings | The 9th Iranian Congress of Immunology and Allergy | June 2008 | Tehran, Iran |
142 | A 10-year single center survey of pediatric patients with histiocytosis in Iran | 24th Annual Meeting of the Histiocyte Society | September- October 2008 | Berlin, Germany |
143 | Abnormal immunoglobulin levels in Iranian patients with hematologic malignancies | 8th Iranian Congress in Hematology and Oncology | October 2008 | Urmia, Iran |
144 | Severe congenital neutropenia: definition, diagnosis and management | 20th International Congress of Pediatrics | October 2008 | Tehran, Iran |
145 | Primary antibody deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings | 13th Meeting of the European Society for Immunodeficiencies | October 2008 | 's-Hertogenbosch, The Netherlands |
146 | Evaluation of humoral immune function in the patients with bronchiectasis | 13th Meeting of the European Society for Immunodeficiencies | October 2008 | 's-Hertogenbosch, The Netherlands |
147 | IgA Deficiency: correlation between clinical and immunological manifestations | 13th Meeting of the European Society for Immunodeficiencies | October 2008 | 's-Hertogenbosch, The Netherlands |
148 | A novel clinical syndrome associating severe congenital neutropenia and complex developmental aberrations caused by deficiency of G6PC3 | 13th Meeting of the European Society for Immunodeficiencies | October 2008 | 's-Hertogenbosch, The Netherlands |
149 | Chronic mucocutaneous candidiasis is associated with a homozygous mutation in CARD9 | 13th Meeting of the European Society for Immunodeficiencies | October 2008 | 's-Hertogenbosch, The Netherlands |
150 | Emerging infections: can we cope with them? (Co-chair) | 19th European Congress of Clinical Microbiology and Infectious Diseases | May 2009 | Helsinki, Finland |
151 | Approach to primary immunodeficiency in children and adults: Clinical manifestations (Invited speaker) | 19th European Congress of Clinical Microbiology and Infectious Diseases | May 2009 | Helsinki, Finland |
152 | Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency | 14th Annual Meeting of the European-Hematology-Association | June 2009 | Berlin, Germany |
153 | Increased susceptibility to fungal infections/chronic mucocutaneous candidiasis due to a homozygous loss of function mutation in CARD9 | 2nd European Congress of Immunology | September 2009 | Berlin, Germany |
154 | Primary immunodeficiency diseases associated with neutropenia | 21st International Congress of Pediatrics | October 2009 | Tehran, Iran |
155 | Immunology, rheumatology and infectious diseases poster session (Co-chair) | 21st International Congress of Pediatrics | October 2009 | Tehran, Iran |
156 | Clinical characteristics of Iranian children with inflammatory bowel disease | 21st International Congress of Pediatrics | October 2009 | Tehran, Iran |
157 | Antibody deficiency to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease
| 21st International Congress of Pediatrics | October 2009 | Tehran, Iran |
158 | Genetic defects in primary immunodeficiency diseases | Iranian Clinical Genetics Meeting | October 2009 | Tehran, Iran |
159 | Susceptibility to fungal infections due to a homozygous mutation in CARD9 | UKPIN Immunology Forum | November 2009 | Bath, UK |
160 | Comparison of pulmonary diseases in common variable immunodeficiency and x-linked agammaglobulinemia. | ACAAI Annual Scientific Meeting | November 2009 | Miami Beach, FL, US |
161 | Infectious and non-infectious complications among undiagnosed patients with common variable immunodeficiency compared with early diagnosed and well-treated patients | ACAAI Annual Scientific Meeting | November 2009 | Miami Beach, FL, US |
162 | Different clinical phenotypes of 93 patients with common variable immunodeficiency | ACAAI Annual Scientific Meeting | November 2009 | Miami Beach, FL, US |
163 | New advances in immunology and mechanisms of immunologic injury | CME Meeting for Pathologists | March 2010 | Tehran, Iran |
164 | Novel insights on histocompatibility antigens and transplantation | CME Meeting for Pathologists | March 2010 | Tehran, Iran |
165 | Approach to a patient with neutropenia and primary immunodeficiency | Annual Congress of Iranian Society of Pediatrics | May 2010 | Tehran, Iran |
166 | Clinical characteristics of patients with primary immunodeficiency diseases | 10th International Congress of Immunology and Allergy | May 2010 | Tehran, Iran |
167 | Molecular studies in patients with severe congenital neutropenia associated with primary immunodeficiencies | 10th International Congress of Immunology and Allergy | May 2010 | Tehran, Iran |
168 | Evaluation of antibody response to polysaccharide vaccination in common variable immunodeficiency | 10th International Congress of Immunology and Allergy | May 2010 | Tehran, Iran |
169 | IL-4 and IL-10 gene polymorphisms in irritable bowel syndrome | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
170 | Cytokine gene polymorphisms in common variable immunodeficiency | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
171 | Behaviour abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
172 | Antibody responses to pneumococcal polysaccharide vaccine in splenectomised patients | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
173 | In vitro cytotoxic effects of high dose of oxLDL on peripheral blood mononuclear cells of patients with atherosclerosis | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
175 | Physicians awareness on primary immunodeficiency diseases in Iran | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
176 | Measurement of soluble CD30 in common variable immunodeficiency | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
177 | B- and T-cells cognate interaction assay in common variable immunodeficiency | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
178 | Cutaneous granulomas in common variable immunodeficiency | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
179 | Renal amyloidosis in common variable immunodeficiency | 29th Congress of the European Academy of Allergology and Clinical Immunology | June 2010 | London, UK |
180 | Effect of vitamin A supplementation on reducing cytotoxic effect of oxLDL in patients with atherosclerosis | 14th International Congress of Immunology | August 2010 | Kobe, Japan |
181 | Switched memory B-cells in patients with IgA deficiency | 14th International Congress of Immunology | August 2010 | Kobe, Japan |
182 | Malignancy phenotype in 7 patients with common variable immunodeficiency | 14th International Congress of Immunology | August 2010 | Kobe, Japan |
183 | Evaluation of B- and T- cells activation and proliferation in common variable immunodeficiency | 14th International Congress of Immunology | August 2010 | Kobe, Japan |
184 | Defective interleukin-2 and interleukin-4 production in a subgroup of patients with common variable immunodeficiency | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
185 | Poor proliferative response to mitogen and defective IL-2 production in patients with coronary artery disease | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
186 | International survey of post-vaccinal BCG infection in patients with severe combined immunodeficiency (SCID): First report from BCG infection in SCID Patients Interest Group | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
187 | Evaluation of naïve CD4+ T cells according to sex in CVID patients and healthy controls | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
188 | Decreased switched memory B cells in IgA deficient patients | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
189 | Physicians awareness on primary immunodeficiency disorders in Iran | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
190 | Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene | 14th Meeting of the European Society for Immunodeficiencies | October 2010 | Istanbul, Turkey |
191 | Immunodeficiency diseases oral presenting session (Co-chair) | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
192 | Clinical phenotypes of primary immunodeficiencies | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
193 | Oral and dental health in Iranian patients with primary antibody deficiency disorders | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
194 | Ataxia-Telangiectasia in three patients presenting with hyper-immunoglobulin M syndrome | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
195 | Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
196 | X-linked lymphoproliferative syndrome: A genetic condition typified by the triad of infection, immunodeficiency and lymphoma | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
197 | Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
198 | Health policy making for common variable immunodeficiency: the burden of the disease | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
199 | Cutaneous granulomas in common variable immunodeficiency | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
200 | Antibody responses to vaccination with pneumococcal polysaccharide vaccine in Splenectomized Patients with Idiopathic Thrombocytopenic Purpura or Trauma | 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies | October 2010 | Tehran, Iran |
201 | Infectious diseases poster presenting session (Co-chair) | 22nd International Congress of Pediatrics | October 2010 | Tehran, Iran |
202 | Approach to a patient with congenital neutropenia | 22nd International Congress of Pediatrics | October 2010 | Tehran, Iran |
203 | Challenges in diagnosis of Immunodeficiencies session (Co-chair) | 3rd Congress of Laboratory and Clinics (Pediatrics) | November 2010 | Tehran, Iran |
204 | In vitro effect of oxLDL and PHA on lymphocyte proliferation/cytotoxicity and interleukin-2 production in patients with atherosclerosis | AAAAI Annual Meeting | March 2011 | San Francisco, CA, USA |
205 | B-cells and T-cells cognate interaction assay in common variable immunodeficiency | AAAAI Annual Meeting | March 2011 | San Francisco, CA, USA |
206 | Primary immunodeficiency diseases in Iran : a decade of progress in molecular diagnosis of immunodeficient patients | 2nd CIS Annual Meeting | May 2011 | Chicago, IL, USA |
207 | Soluble CD30 as a marker of disease severity in common variable immunodeficiency | 2nd CIS Annual Meeting | May 2011 | Chicago, IL, USA |
208 | T-helper (Th)1 and Th2 cytokines in atherosclerosis and effects of vitamin A supplementation on Th1/Th2 balance | 2nd CIS Annual Meeting | May 2011 | Chicago, IL, USA |
209 | Congenital neutropenias and primary immunodeficiencies | National Institute of Health | May 2011 | Bethesda, MD, USA |
210 | Primary immunodeficiencies in Iran | Children's Hospital of Philadelphia, University of Pennsylvania | May 2011 | Philadelphia, PA, USA |
211 | Recent advances on primary immunodeficiency diseases in Iran | Children's Hospital Boston, Harvard Medical School | May 2011 | Boston, MA, USA |
212 | Primary immunodeficiency diseases in Iran | Seattle Children's Research Institute, University of Washington | June 2011 | Seattle, WA, USA |
213 | The molecular basis of congenital neutropenia | Seattle Children's Research Institute, University of Washington | June 2011 | Seattle, WA, USA |
214 | T-helper 1 and 2 cytokine assay in patients with atherosclerosis | 30th Congress of the European Academy of Allergy and Clinical Immunology | June 2011 | Istanbul, Turkey |
215 | In vitro soluble CD30 levels in patients with chronic stable coronary artery disease | 30th Congress of the European Academy of Allergy and Clinical Immunology | June 2011 | Istanbul, Turkey |
216 | Polymorphisms in IL-4 and IL-4 RA genes confer susceptibility to asthma | 30th Congress of the European Academy of Allergy and Clinical Immunology | June 2011 | Istanbul, Turkey |
217 | Increased soluble CD26 in common variable immunodeficiency and its clinical implications | 30th Congress of the European Academy of Allergy and Clinical Immunology | June 2011 | Istanbul, Turkey |
218 | J Project meetings in non-ECE countries | 2nd Steering J Project Committee Meeting | January 2012 | Budapest, Hungary |
219 | Approach to congenital neutropenias | Children’s University Hospital Bratislava, Comenius University Medical Faculty | January 2012 | Bratislava, Slovakia |
220 | Primary immunodeficiencies in Iran | Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences | January 2012 | Vienna, Austria |
221 | Scientific output related to primary immunodeficiencies in Iran | World PI Week Seminar | April 2012 | Tehran, Iran |
222 | Approach to patients with phagocyte defects | Annual Congress of Iranian Society of Pediatrics, 33rd Memorial Congress of Prof. M. Gharib | April 2012 | Tehran, Iran |
223 | Laboratory evaluation in patients with immunodeficiedncies | ICIA 2012 Advanced Course in Immunology | April 2012 | Tehran, Iran |
224 | Recent update on genetic defects associated with congenital defects of phagocyte | 11th International Congress of Immunology and Allergy of Iran | April 2012 | Tehran, Iran |
225 | Scientific research from studentship to professorship | 11th International Congress of Immunology and Allergy of Iran | April 2012 | Tehran, Iran |
226 | Classification of CVID patients based on naïve CD4+ T cell levels and clinical features | 11th International Congress of Immunology and Allergy of Iran | April 2012 | Tehran, Iran |
227 | Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease | 11th International Congress of Immunology and Allergy of Iran | April 2012 | Tehran, Iran |
228 | Interleukin-10 and TGF-β1 Anti-Inflammatory Cytokine Gene Polymorphisms are Involved in the Pathophysiology of Irritable Bowel Syndrome: A Meta-Analysis | Digestive Disease Week | May 2012 | San Diego, US |
229 | Carriage rate of Hemophilus influenza and Streptococcus pneumonia among under 6 years old children in Tehran, Iran | 31st Annual Meeting of the European Society for Paediatric Infectious Diseases | May 2012 | Athens, Greece |
230 | Prevalence of Heemophilus influenza and Streptococcus pneumonia carriers in nasopharyngeal in children under 6 years old in Tehran | EKMUD Congress (Infectious Diseases & and Clinical Microbiology) | May 2012 | Istanbul, Turkey |
231 | Evaluation of regulatory T-cells and autoimmunity in IgA deficiency | Conference on Excellence in Rheumatology | June 2012 | Madrid, Spain |
232 | Approach to clinical cases with immunodeficiencies | Geneva Medical Faculty, University of Geneva | June 2012 | Geneva, Switzerland |
233 | Phagocyte defects. In: Workshop of primary immunodeficiency diseases: new insights | 31st Congress of the European Academy of Allergy and Clinical Immunology | June 2012 | Geneva, Switzerland |
234 | Autoimmunity and immunodeficiency session (Co-chair) | 31st Congress of the European Academy of Allergy and Clinical Immunology | June 2012 | Geneva, Switzerland |
235 | Phagocyte defects: new insights | 31st Congress of the European Academy of Allergy and Clinical Immunology | June 2012 | Geneva, Switzerland |
236 | Ataxia-telangiectasia presenting as hyper-immunoglobulin M syndrome | 31st Congress of the European Academy of Allergy and Clinical Immunology | June 2012 | Geneva, Switzerland |
237 | Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease | 31st Congress of the European Academy of Allergy and Clinical Immunology | June 2012 | Geneva, Switzerland |
238 | Progress on immunodeficiencies in Iran | The San Raffaele Telethon Institute for Gene Therapy HSR-TIGET | June 2012 | Milan, Italy |
239 | BCG complications associated with primary immunodeficiency diseases | Meeting on BCG Complications | June 2012 | Warsaw, Poland |
240 | Chronic mucocutaneous candidiasis | Middle East Workshop for Primary Immunodeficiency | June 2012 | Athens, Greece |
241 | Carrier Evaluation of Nasopharyngeal Neisseria spp on children up to 5 years old in Tehran, Iran | 13th Iranian and the 2nd International Congress of Microbiology | July 2012 | Ardabil, Iran |
242 | Clinical Presentations and Long-Term Outcome of DOCK8 Deficiency – A Survey of 134 Patients | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
243 | Dramatic effect of live vaccines (OPV and BCG) administred in the first year of life in a patient with severe immunodeficiency | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
244 | Long term Observation of Children Suffered from Common Variable Immunodeficiency | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
245 | Evaluation of Natural Regulatory T Cells in Subjects with Selective IgA Deficiency: From Senior Idea to Novel Opportunities | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
246 | Mortality and Morbidity in Patients with X-linked Agammaglobulinemia | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
247 | Autoimmune manifestations in patients with common variable immune deficiency | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
248 | Otologic Investigation in Primary Immunodeficiency Patients | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
249 | Deleterious LRBA mutations in a novel syndrome of immune deficiency and autoimmunity | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
250 | Novel Activation-Induced Cytidine Deaminase (AICDA) Gene Mutation in Two Siblings of a Family with Hyper IgM Syndrome | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
251 | Identification of a Novel CD40 Ligand Mutation in a Patient with Hyper IgM Phenotype and Neutropenia | 15th Biennial Meeting of the European Society for Immunodeficiencies (ESID) | October 2012 | Florence, Italy |
252 | Primary Immunodeficiency Diseases Session (Co-chair) | 24th International Congress of Pediatrics & 5th Meeting on Clinical Immunology and Immunodeficiencies | October 2012 | Tehran, Iran |
253 | Approach to a child with congenital neutropenia | 24th International Congress of Pediatrics & 5th Meeting on Clinical Immunology and Immunodeficiencies | October 2012 | Tehran, Iran |
254 | Recent Advances on Diagnosis of Primary Immunodeficiencies in Iran | 24th International Congress of Pediatrics & 5th Meeting on Clinical Immunology and Immunodeficiencies | October 2012 | Tehran, Iran |
255 | TNF-alpha single nucleotide polymorphisms in atopic dermatitis | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
256 | Gene polymorphisms of tumor necrosis factor and interleukin-1 gene complex in allergic rhinitis | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
257 | Serum level of zinc in asthmatic patients; A case-control study | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
258 | Multiple cancers in a patient with common variable immunodeficiency | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
259 | Scientific Research during Studentship: From Selecting a Topic to Future Career | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
260 | Interleukin 6 single nucleotide polymorphisms in allergic rhinitis | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
261 | Maturity Onset Diabetes of the Young, Type 2 in an asymptomatic child | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
262 | Effect of nebulized L-epinephrine on the treatment of croup | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
263 | Study of in vitro chromosomal sensitivity to gamma irradiation in lymphocytes of children with acute lymphoblastic leukemia | 24th International Congress of Pediatrics | October 2012 | Tehran, Iran |
263 | How to publish an academic book with international publisher | 1st Tabari Festival | December 2012 | Sari, Mazandaran |
264 | Opportunistic infections (Co-chair) | 5th Congress of Laboratory and Clinics | December 2012 | Tehran, Iran |
265 | Primary hemophagocytic lymphohistiocytosis and hematopoeitic stem cell transplantation in Iran | BMT Tandem Meetings | February 2013 | Salt Lake City, UT, USA |
266 | Congenital neutropenias | 1st MENA Immunodeiciency Meeting | February 2013 | Dubai, UAE |
267 | Proinflammatory cytokine gene polymorphisms in ischemic heart failure | 2013 CIS Annual Meeting: Regulation & Dysregulation of Immunity | April 2013 | Miami, FL, USA |
268 | Congenital neutropenia in primary immunodeficiencies | 46th Middle East Medical Assembly | May 2013 | Beirut, Lebanon |
269 | Interleukin-2 single nucleotide polymorphisms in autoimmune hepatitis | The 5th International Tehran Hepatitis Congress | May 2013 | Tehran, Iran |
270 | Association of interleukin 4 single nucleotide polymorphism with chronic urticaria | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
271 | Single nucleotide polymorphisms of proinflammatory cytokines in allergic rhinitis | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
272 | Normal alleles of rs2237060 of RAD50 in Iranian patients with common variable immunodeficiency and IgA deficiency | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
273 | Cytokine single nucleotide polymorphisms in patients with ischemic heart failure | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
274 | TNF-alpha single nucleotide polymorphisms in atopic dermatitis | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
275 | Gene polymorphisms of Th2 cytokines in allergic rhinitis | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
276 | IL-17F mutation in recurrent aphthous stomatitis | 32nd Congress of the European Academy of Allergy and Clinical Immunology | June 2013 | Milan, Italy |
277 | Update on diagnosis and treatment of PI patients in Iran | Primary Immunodeficiencies JMF Summit | July 2013 | Berlin, Germany |
278 | Immunologic Alterations in Long-Term Divers | 15th International Congress of Immunology | August 2013 | Milan, Italy |
279 | Clinical immunology and Immunodeficiencies (Co-chair) | 6th Meeting on Clinical Immunology and Immunodeficiencies | October 2013 | Tehran, Iran |
280 | Update on classification of primary immunodeficiencies | 6th Meeting on Clinical Immunology and Immunodeficiencies | October 2013 | Tehran, Iran |
281 | IL-17F mutation in recurrent aphthous stomatitis | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
282 | Cohort of 173 Iranian common variable immunodeficiency patients | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
283 | Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
284 | Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
285 | Does oral administration of immunoglobulin could reduce diarrheal severity in common variable immunodeficiency | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
286 | In vitro comparison of chromosomal radiosensitivity in common variable immunodeficiency and acute lymphocytic leukemia patients | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
287 | Association of Interleukin 10(IL-10) and transforming growth factor β(TGF-β) gene polymorphisms with chronic idiopathic urticaria | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
288 | Interleukin-1 family and interleukin-6 gene polymorphisms in recurrent aphthous stomatitis | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
289 | Cutaneous reactivity pattern and nasal smear cytology in patients with chronic rhinosinusitis with nasal polyps; is it associated with the course of the disease? | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
290 | The role of cytokines in pathogenesis of asthma | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
291 | Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
292 | Proinflammatory cytokine gene polymorphisms in autoimmune hepatitis | 25th International Congress of Pediatrics | October 2013 | Tehran, Iran |
293 | Co-chair: Primary immunodeficiency and auto inflammatory disorders | 9th Biennial Congress of Immunology, Asthma and Allergy | November 2013 | Tehran, Iran |
294 | Key lecture: Scientific reseasch | Research Week Meeting, Alborz Univ Med Sci | December 2013 | Karaj, Iran |
295 | Principles of autommunity in primary immunodeficiency diseases | Meeting of Iranian Society of Asthma and Allergy | December 2013 | Tehran, Iran |
296 | Genetic diagnosis of primary immunodeficiency diseases | PID Meeting | January 2014 | Tehran, Iran |
297 | Congenital neutropenia associated with primary immunodeficiency diseases: Future directions and potential gene therapy | Gene Therapy Laboratory, Universidad Austral
| February 2014 | Buenos Aires, Argentina |
298 | Congenital neutropenia and primary immunodeficiency diseases: From bedside to bench and back again! | Texas Children’s Hospital, Baylor College of Medicine | February 2014 | Houston, TX, USA |
299 | Interleukin-4 and transforming growth factor-beta single nucleotide genes polymorphisms confer susceptibility to atopic dermatitis | AAAAI Annual Meeting | February-March 2014 | San Diego, CA, USA |
300 | Polymorphisms of genes encoding interleukin-4 and its receptor are associated with chronic idiopathic urticaria | AAAAI Annual Meeting | February-March 2014 | San Diego, CA, USA |
301 | Association of interleukin-23 receptor single nucleotide polymorphisms with ulcerative colitis | AAAAI Annual Meeting | February-March 2014 | San Diego, CA, USA |
302 | Novel insights in congenital neutropenia | Emory Vaccine Center, Emory University School of Medicine | March 2014 | Atlanta, GA, USA |
303 | Aspirin hypersensitivity in Iranian patients with chronic rhinosinusitis and nasal polyposis: prevalence and comorbid factors | 6th Drug Hypersensitivity Meeting | April 2014 | Bern, Switzerland |
304 | Update on classification of primary immunodeficiency diseases | Advanced Course of ICIA | April 2014 | Tehran, Iran |
305 | Humoral immunodeficiency: Co-chair | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
306 | A case series of patients with Hyper IgM syndromes (13 cases) from Mofid hospital during 2005- 2013 | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
307 | Defects in B-cell development | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
308 | Association of IL9 gene polymorphisms with asthma in pediatric patients | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
309 | The assessment of IL-1 gene family polymorphisms in Iranian children affected by febrile seizure | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
310 | Interleukin 4 single nucleotide polymorphisms in febrile seizures | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
311 | Association between RAD50 single nucleotide polymorphism and common variable immunodeficiency | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
312 | Association of IL-23 receptor gene polymorphisms with juvenile idiopathic arthritis | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
313 | Association of a proliferation -inducing ligand (APRIL) polymorphism with juvenile systemic lupus erythematous | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
314 | Association between IRF5 polymorphisms and the risk of systemic lupus Erythematous in children | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
315 | Evaluation of proinflammatory cytokine gene polymorphisms in autoimmune hepatitis | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
316 | Update on classification of predominantly antibody deficiency | 12th International Congress of Immunology and Allergy | April-May 2014 | Tehran, Iran |
317 | Pharmaceutical cost of primary immunodeficiency diseases during hospital admission | 5th Iranian Clinical Pharmacy Congress | May 2014 | Tehran, Iran |
318 | Update on classification of primary immunodeficiency disease | 5th International Congress on the Latest Molecular and Clinical Medical Research Achievements | October 2014 | Tehran, Iran |
319 | Co-chair: Primary immunodeficiency diseases | 7th Meeting on Clinical Immunology and Immunodeficiencies | October 2014 | Tehran, Iran |
320 | Approach to patients with phagocyte defects | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
321 | Co-chair: Immunology session | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
322 | Late-onset familial hemophagocytic lymphohistiocytosis with STXBP2 mutations | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
323 | Nonhodgkins lymphoma in a patient with leukocyte adhesion deficiency syndrome | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
324 | Vitamin D deficiency in chronic idiopathic urticaria | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
325 | Phenotyping and follow up of forty seven Iranian common variable immune deficiency patients | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
326 | APRIL gene polymorphism and serum sAPRIL and Th1/Th2 cytokines level in children with SLE | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
327 | Interleukin-1 gene cluster polymorphisms in inflammatory bowel disease | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
328 | Association of interleukin 4 single nucleotide polymorphisms with febrile seizures | 26th International Congress of Pediatrics | October 2014 | Tehran, Iran |
329 | Novel insights into phagocyte defects | 2nd MENAID Meeting | December 2014 | Marrakesh, Morocco |
330 | Congenital neutropenia: approach from clinical phenotypes to molecular diagnosis and HSCT opportunities | 1st International and 5th National Congress on Stem Cells | January 2015 | Tehran, Iran |
331 | Co-chair: Chain values in hospitals | 1st Seminar on Health Technology and Innovations in Hospitals | February 2015 | Tehran, Iran |
332 | Co-chair: Applications of technologies in hospital management | 1st Seminar on Health Technology and Innovations in Hospitals | February 2015 | Tehran, Iran |
333 | Recent advances on diagnosis and treatment of immunodeficient patients in Iran | Marmara University Hospital | February 2015 | Istanbul, Turkey |
334 | Current approaches to primary immune deficiencies | 2nd Congress of Marmara Pediatrics | February 2015 | Istanbul, Turkey |
335 | Primary immunodeficiency diseases in Iran: past, present, and future | The Belarusian National Research Center for Pediatric Oncology, Hematology and Immunology | April 2015 | Minsk Region, Belarus |
336 | Primary immunodeficiency diseases associated with congenital neutropenia: from diagnostic approach to treatment opportunities | 4th International Conference of Primary Immune Deficiencies | April 2015 | Minsk, Belarus |
337 | Update on pediatric phagocyte defects | 27th International Congress of Pediatrics | October 2015 | Tehran, Iran |
338 | Evaluation of hematologic parameter of Kawasaki patients in Children’s Medical Center hospital from 2008 to 2013 | 27th International Congress of Pediatrics | October 2015 | Tehran, Iran |
339 | In vitro comparison of chromosomal radiosensitivity in common variable immunodeficiency and acute lymphocytic leukemia patients | 27th International Congress of Pediatrics | October 2015 | Tehran, Iran |
340 | Clinical and laboratory screening of primary immunodeficiency diseases: international effects | XXIV World Allergy Congress | October 2015 | Seoul, South Korea |
341 | Interleukin-9 and interleukin-33 levels in children with asthma | XXIV World Allergy Congress | October 2015 | Seoul, South Korea |
342 | Interleukin-22 gene variation in inflammatory bowel disease | XXIV World Allergy Congress | October 2015 | Seoul, South Korea |
343 | Molecular approach to primary immunodeficiencies | State Key Laboratory of Agrobiotechnology | October 2015 | Beijing, China |
344 | Co-chair: Panel of immunodeficiency | The 10th Biennial Congress of Iranian Society of Asthma and Allergy | October 2015 | Shiraz, Iran |
345 | Immunodeficiency in Iran | The 10th Biennial Congress of Iranian Society of Asthma and Allergy | October 2015 | Shiraz, Iran |
346 | Updates on approach to antibody deficiency | The 10th Biennial Congress of Iranian Society of Asthma and Allergy | October 2015 | Shiraz, Iran |
347 | Primary immunodeficiency diseases: definition, classification, diagnosis, and treatment | Scientific Meeting on Primary and Acquired Immunodeficiency | November 2015 | Tehran, Iran |
348 | Evaluation of patients with congenital neutropenia | 6th International Congress on the Newest Research Achievement in Molecular, Cellular and Clinical Medicine | November 2015 | Tehran, Iran |
349 | Primary immunodeficiency diseases in Iran | Iran Day in Spain | November 2015 | Santiago de Compostella, Spain |
350 | Co-chair: Diagnosis of immunodeficiency | 3rd Middle East- Asia Allergy Asthma Immunology Congress | December 2015 | Abu Dhabi, UAE |
351 | How to assess the outcomes of screening tests in the clinic | 3rd Middle East- Asia Allergy Asthma Immunology Congress | December 2015 | Abu Dhabi, UAE |
352 | Chair: EAACI symposium | 3rd Middle East- Asia Allergy Asthma Immunology Congress | December 2015 | Abu Dhabi, UAE |
353 | Immunodeficiency the way forward | 3rd Middle East- Asia Allergy Asthma Immunology Congress | December 2015 | Abu Dhabi, UAE |
354 | Immunodeficiency state-of-the-art: case senarios | 3rd Middle East- Asia Allergy Asthma Immunology Congress | December 2015 | Abu Dhabi, UAE |
355 | Chair of Panel Discussion on immune defects associated with heart disease in children | The 8th International Iranian Congress of Laboratory and Clinic | February 2016 | Tehran, Iran |
356 | Co-chair: Cell therapy in cerebral palsy, neurometabolic diseases, stroke, ALS | 1st Seminar of Stem Cell Therapy in Neurological Disorders | February 2016 | Tehran, Iran |
357 | Diagnostic approach to phagocytic cell deficiencies | 2nd J Project Congress | March 2016 | Antalya, Turkey |
358 | Co-chair: Defects of neutrophils and complement | 2nd J Project Congress | March 2016 | Antalya, Turkey |
359 | Step by step diagnosis of patients with primary immunodeficiency diseases: case scenarios | The 9th International & 14th National Congress on Quality Improvement in Clinical Laboratories | April 2016 | Tehran, Iran |
360 | Co-chair: The clinical laboratory and immunodeficiency disorders | The 9th International & 14th National Congress on Quality Improvement in Clinical Laboratories | April 2016 | Tehran, Iran |
361 | Cases with primary immunodeficiencies | PID Spring School | April 2016 | Tehran, Iran |
362 | Approach to patients with phagocyte defects | 8th International Conference on Immunodeficiency Diseases | April 2016 | Tehran, Iran |
363 | Co-chair: Defects of innate immunity and immunedysregulation | 8th International Conference on Immunodeficiency Diseases | April 2016 | Tehran, Iran |
364 | Impact of high consanguinity on PID care in Iran and surrounding regions – data from the Iranian PID Registry | Asia Pacific Society for Immunodeficiencies (APSID) Congress | April-May 2016 | Hong Kong SAR, China |
365 | Association of tumor necrosis factor-alpha G/A -238 and G/A -308 single nucleotide polymorphisms with juvenile idiopathic arthritis | European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016 | June 2016 | Vienna, Austria |
366 | Lack of association between PDCD-1 single nucleotide polymorphisms and susceptibility to juvenile idiopathic arthritis | European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016 | June 2016 | Vienna, Austria |
367 | Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis | European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016 | June 2016 | Vienna, Austria |
368 | Interleukin-10 and transforming growth factor-beta 1 gene polymorphisms in juvenile idiopathic arthritis | European Academy of Allergy and Clinical Immunology (EAACI) Congress 2016 | June 2016 | Vienna, Austria |
369 | Effect of vitamin A supplementation on Th-1 to Th-2 balance in patients with atherosclerosis | Federation of Clinical Immunology Societies (FOCIS) Congress | June 2016 | Boston, USA |
370 | Effect of vitamin A supplementation on Th-1 to Th-2 balance in patients with atherosclerosis | Federation of Clinical Immunology Societies (FOCIS) Congress | June 2016 | Boston, USA |
371 | How to diagnose primary immunodeficiency diseases? | Federation of Clinical Immunology Societies (FOCIS) Congress | June 2016 | Boston, USA |
372 | Approach to patients with immunodeficiencies and congenital neutropenia | Boston Children’s Hospital, Harvard Medical School | August 2016 | Boston, USA |
373 | Primary immunodeficiency diseases in Iran | National Institute of Health (NIH) | August 2016 | Bethesda, USA |
374 | Approach to pediatric patients with phagocyte defects | APAAACI and APAPARI 2016 | October 2016 | Kuala Lampur |
375 | Common variable immunodeficiency | APAAACI and APAPARI 2016 | October 2016 | Kuala Lampur |
376 | Chair: SEAPID-APSID: PIDs with atopic manifestations symposium | APAAACI and APAPARI 2016 | October 2016 | Kuala Lampur |
377 | Challenges in diagnosis of patients with primary immunodeficiency diseases | 28th International Congress of Pediatrics | October 2016 | Tehran, Iran |
378 | Co-chair: Immunodeficiency session | 28th International Congress of Pediatrics | October 2016 | Tehran, Iran |
379 | Progress of internationalization of medical education in Iran | 1st Congress of Internationalization of Medical Education | November 2016 | Isfahan, Iran |
380 | USERN: a model of international network of education and research | 1st Congress of Internationalization of Medical Education | November 2016 | Isfahan, Iran |
381 | Primary immunodeficiency diseases in Iran | Kyiv's Municipal Children's Hospital | December 2016 | Kiev, Ukraine |
382 | Approaches to cases with immunodeficiencies | Kharkiv National Medical University | December 2016 | Kharkiv, Ukraine |
383 | Current status of primary immunodeficiencies in Iran | University of Ljubljana | February 2017 | Ljubljana, Slovenia |
384 | Approach to pediatric patients with congenital neutropenia | University of Ljubljana | March 2017 | Ljubljana, Slovenia |
385 | Primary immunodeficiency diseases in Iran (1977-2017) | 9th International Conference on Primary Immunodeficiency Diseases | April 2017 | Tehran, Iran |
386 | Co-chair: Head and neck manifestations of primary immunodeficiencies | 9th International Conference on Primary Immunodeficiency Diseases | April 2017 | Tehran, Iran |
387 | Approach to patients with phagocytosis defect | 9th International Conference on Primary Immunodeficiency Diseases | April 2017 | Tehran, Iran |
388 | Co-chair of panel: National PID network | 9th International Conference on Primary Immunodeficiency Diseases | April 2017 | Tehran, Iran |
389 | Co-chair: International research collaboration | Internationalization of Higher Education | April 2017 | Tehran, Iran |
390 | Co-chair of panel: Scientific reference: action plans | 18th National Medical Education Congress | April 2017 | Tehran, Iran |
391 | Co-chair of panel: Benefits of internarional collaboration for students | 18th National Medical Education Congress | April 2017 | Tehran, Iran |
392 | Approach to patients with phagocyte defects | Faculty of Medicine, Chulalongkorn University | August 2017 | Bangkok, Thailand |
393 | Approach to pediatric patients with phagocyte defects | Faculty of Medicine, Mahidol University | August 2017 | Bangkok, Thailand |
394 | Primary immunodeficiencies: From bench to bedside and back again | 6th Singapore and Pediatric and Perinatal Annual Congress (SiPPAC) | August 2017 | Singapore, Singapore |
395 | PID: lessons from high consanguinity population | Latin American Society for Immunodeficiencies (LASID) 2017 | October 2017 | Sao Paulo, Brazil |
396 | Challenges to diagnosis and access to treatment for patients with Primary Immunodeficiencies | 38th Reunion de Actualizacion en Pediatria | October 2017 | Mexico City, Mexico |
397 | Co-chair: Primary Immunodeficiencies | 29th International Congress of Pediatrics | October 2017 | Tehran, Iran |
398 | Translational approach to primary immunodeficiencies for pediatricians | 29th International Congress of Pediatrics | October 2017 | Tehran, Iran |
399 | Evolution in diagnosis of immunological disorders | II International USERN Congress | November 2017 | Kharkiv, Ukraine |
400 | Immuno-oncology: a new way in treatment of cancer | 2nd International Clinical Oncology Congress | December 2017 | Tehran, Iran |
401 | Co-Chair: Updates in Inborn Errors of Immunity | 10th International Conference on Immunodeficiency Diseases | April 2018 | Tehran, Iran |
402 | Co-Chair: National PID network | 10th International Conference on Immunodeficiency Diseases | April 2018 | Tehran, Iran |
403 | Inborn Errors of Immunity; from Bench to Bedside | 10th International Conference on Immunodeficiency Diseases | April 2018 | Tehran, Iran |
404 | Co-Chair: Primary Immunodeficiencies: Principles and Complications | The 3rd PID Spring School | April 2018 | Tehran, Iran |
405 | Approach to Primary Immunodeficiencies in a Practical Tests | The 3rd PID Spring School | April 2018 | Tehran, Iran |
406 | Respiratory Manifestations in Patients with Hyper IgM Syndrome | The 3rd PID Spring School | April 2018 | Tehran, Iran |
407 | Toll like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA) | The 3rd PID Spring School | April 2018 | Tehran, Iran |
408 | Evaluation of the TLR Negative Regulatory Network in CVID Patients | The 3rd PID Spring School | April 2018 | Tehran, Iran |
409 | Non-pathogenic Heterozygous Polymorphism in RAB27A Gene in a Case Suspicious to Griscelli Syndrome, Type II | The 3rd PID Spring School | April 2018 | Tehran, Iran |
410 | A Novel Mutation in Interferon-γ Receptor 1 is Associated with Mycobacterial Bone Marrow Involvement and Hemophagocytic Lymphohistiocytosis Manifestations | The 3rd PID Spring School | April 2018 | Tehran, Iran |
411 | The Unsuccessful Outcome of Bone Marrow Transplantation in a Child with Wiskott-Aldrich syndrome | The 3rd PID Spring School | April 2018 | Tehran, Iran |
412 | Screening of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia | The 3rd PID Spring School | April 2018 | Tehran, Iran |
413 | Approach to Immunodeficiency Diseases | Annual Congress of Pediatrics and 39th Memorial Conference of Dr. Gharib | April 2018 | Tehran, Iran |
414 | Co-Chair: Diagnosis of Primary Immunodeficiencies | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
415 | Updates in PIDs | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
416 | Evaluation of early and late apoptosis in patients with CVID | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
417 | Toll like Receptors Pathway in Common Variable Immune Deficiency and X-linked Agammaglobulinemia | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
418 | Differentiation Classification of CVID Patients Based on B cell Subpopulation | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
419 | The Potent Suppressive Effect of β-D-mannuronic Acid (M2000) on Molecular Expression of the TLR/ NF-kB Signaling Pathway in Ankylosing Spondylitis Patients | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
420 | Wharton’s Jelly-Derived Mesenchymal Stem Cell’s Conditioned Media Increase Neutrophils Viability and Function | 14th International Congress of Immunology and Allergy (ICIA) | April 2018 | Tehran, Iran |
421 | Bench to Bedside Approach to Inborn Errors of Immunity | 30th International Congress of Pediatrics | October 2018 | Tehran, Iran |
422 | Scientific Collaboration in Pediatrics | 30th International Congress of Pediatrics | October 2018 | Tehran, Iran |
423 | Primary Immunodeficiency Diseases in Iran | 1st PID Meeting in Armenia | October 2018 | Yerevan, Armenia |
424 | Primary Immunodeficiency Diseases: From Bench to Bedside | 1st PID Meeting in Armenia | October 2018 | Yerevan, Armenia |
425 | Primary Immunodeficiency Diseases Case Scenarios | Ce–M–M– Research Center for Molecular Medicine | November 2018 | Vienna, Austria |
426 | Bench to Bedside Approach to PIDs | USERN 2018 Congress | November 2018 | Reggio Calabria, Italy |
427 | Obesity Caused Cancer Progression by Affecting Immunity and Inflammation | USERN 2018 Congress | November 2018 | Reggio Calabria, Italy |
428 | Genetics of Primary Immunodeficiency Diseases | University of Turin | November 2018 | Reggio Calabria, Italy |
429 | Introduction on the Immune System and Immune Diseases | 14th GIAN Course | February 2019 | Chandigarh, India |
430 | Predominantly Antibody Deficiencies | 14th GIAN Course | February 2019 | Chandigarh, India |
431 | Congenital Neutropenias | 14th GIAN Course | February 2019 | Chandigarh, India |
432 | Combined Immunodeficiencies | 14th GIAN Course | February 2019 | Chandigarh, India |
433 | Syndromic Immunodeficiencies | 14th GIAN Course | February 2019 | Chandigarh, India |
434 | Immunological Screening Tests | 14th GIAN Course | February 2019 | Chandigarh, India |
435 | Treatment of Immunodeficiency Diseases | 14th GIAN Course | February 2019 | Chandigarh, India |
436 | TLR Signaling Defects in Primary Immunodeficiencies | 14th GIAN Course | February 2019 | Chandigarh, India |
437 | Bench to Bedside Approach to Primary Immunodeficiency Diseases | Dr. Lata Kumar Lecture, PGIMER | February 2019 | Chandigarh, India |
438 | Clinical Immunology and Primary Immunodeficiencies | Mehr Chand Mahajan DAV College for Women | February 2019 | Chandigarh, India |
439 | Identification of Novel Primary Immunodeficiency Diseases Using Advanced Technology | 4th International Student Biotechnology Congress | February 2019 | Tehran, Iran |
440 | Approach to Inborn Errors of Immunity | 31st International Congress of Pediatrics | October 2019 | Tehran, Iran |
441 | Approach to Congenital Neutropenias | 32nd International Congress of Pediatrics | October 2020 | Tehran, Iran |
442 | Primary Immunodeficiency Diseases | 32nd International Congress of Pediatrics | October 2020 | Tehran, Iran |
443 | COVID-19 and Immunity | ISIC 2020 | October 2020 | Kharkiv, Ukraine |
444 | Diagnostic Approach to Patients with Inborn Errors of Immunity | 15th International Congress of Immunology and Allergy | January 2021 | Ahwaz, Iran |
445 | Approach to Inborn Errors of Immunity | AID Allergy and Immunology Meeting | February 2021 | Istanbul, Turkey |
446 | Therapeutic Approach to Inborn Errors of Immunity | The 6th International Symposium on Pharmaceutical and Biomedical Sciences | May 2022 | Gaziantep, Turkey |
447 | Approach to Patients with Primary Immunodeficiency Diseases | 1st Tajik Symposium on Otalaryngology, Allergology, and Immunology | May 2022 | Dushanbe, Tajikistan |
448 | Inborn errors of immune system | Annual meeting of AAMIA 2022 | May 2022 | Yerevan, Armenia |
449 | Dermatologic manifestation of inborn errors of immune system | Annual meeting of AAMIA 2022 | May 2022 | Yerevan, Armenia |
450 | Endothelial Dysfunction and Toll Like Receptors | World Allergy Congress 2022 | October 2022 | Istanbul, Turkey |
451 | Application of flow cytometry and genetic tools in the diagnosis of PID: Real Case Scenarios | 8th Annual Clinical Immunology Society Meeting | October 2022 | Antalya, Turkey |
452 | Approach to Pediatric Patients with | 34th International Congress of Pediatrics | October 2022 | Tehran, Iran |
453 | Social Responsibility of Immunologists | 16th International Congress of Immunology & Allergy of Iran (ICIA2023) | April 2023 | Tehran, Iran |
454 | Inborn errors of immunity and cancer: from clinics to genetics | The First International Congress of Cancer Genomics (CGC2023) | May 2023 | Tehran, Iran |
455 | The Application of Biomedical Technologies in Diagnosis of Inborn Errors of Immunity | Biomaterial, Biosensor and Microfluidics Technologies for Medical Applications | May 2023 | Doha, Qatar |
456 | Approach to Congenital Neutropenias | SIOP Asia XV Congress | May 2023 | Yerevan, Armenia |
1. Najaf Khosravi H.; Razi S.; Rezaei N. The role of interleukin-2 in graft-versus-host disease pathogenesis, prevention and therapy 2024 Cytokine
2. Bayati B.; Keshavarz F.; Rezaei N.; Zendehboudi S.; Barbiellini B. New insight into impact of humidity on direct air capture performance by SIFSIX-3-Cu MOF 2024 Physical Chemistry Chemical Physics
3. Zamani R.; Zoghi S.; Shahkarami S.; Seyedpour S.; Heredia R.J.; Boztug K.; Rezaei N. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report 2024 Endocrine, Metabolic and Immune Disorders - Drug Targets
4. Zamani R.; Rezaei N. Immune-scoring in head and neck squamous cell carcinoma: a scoping review 2024 Expert Review of Clinical Immunology
5. Nasab M.G.; Heidari A.; Sedighi M.; Shakerian N.; Mirbeyk M.; Saghazadeh A.; Rezaei N. Dietary inflammatory index and neuropsychiatric disorders 2024 Reviews in the Neurosciences
6. Steinmetz J.D.; et al. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study 2024 The Lancet Regional Health - Southeast Asia
7. Masrour M.; Khanmohammadi S.; Fallahtafti P.; Hashemi S.M.; Rezaei N. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis 2024 Journal of Cellular and Molecular Medicine
8. Yazdanpanah N.; Rezaei N. The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations 2024 Expert Review of Clinical Immunology
9. Rahimi Darehbagh R.; Khanmohammadi S.; Rezaei N. The role of mitochondrial DNA variants and dysfunction in the pathogenesis and progression of multiple sclerosis 2025 Mitochondrion
10. Seyedmirzaei H.; Salabat D.; KamaliZonouzi S.; Teixeira A.L.; Rezaei N. Risk of MS relapse and deterioration after COVID-19: A systematic review and meta-analysis 2024 Multiple Sclerosis and Related Disorders
11. Mokhtarpour K.; Razi S.; Rezaei N. Ferroptosis as a promising targeted therapy for triple negative breast cancer 2024 Breast Cancer Research and Treatment
12. Dadkhah M.; Baziar M.; Rezaei N. The regulatory role of BDNF in neuroimmune axis function and neuroinflammation induced by chronic stress: A new therapeutic strategies for neurodegenerative disorders 2024 Cytokine
13. Pa M.; Uddin M.N.; Rezaei N. An Adaptive Neuro-Fuzzy Model-Based Algorithm for Fault Detection in PV Systems 2024 IEEE Transactions on Industry Applications
14. Rayzan E.; Mirbeyk M.; Pezeshki P.S.; Mohammadpour M.; Yaghmaie B.; Hassani S.A.; Sharifzadeh M.; Tahernia L.; Rezaei N. Whole-exome sequencing to identify undiagnosed primary immunodeficiency disorders in children with community-acquired sepsis, admitted in the pediatric intensive care unit 2023 Pediatric Allergy and Immunology
15. Firuzpour F.; Saleki K.; Aram C.; Rezaei N. Nanocarriers in glioblastoma treatment: a neuroimmunological perspective 2024 Reviews in the Neurosciences
16. Nejadghaderi S.A.; Balibegloo M.; Rezaei N. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons 2024 Health Science Reports
17. Mokhtarpour K.; Akbarzadehmoallemkolaei M.; Rezaei N. A viral attack on brain tumors: the potential of oncolytic virus therapy 2024 Journal of NeuroVirology
18. Fekrvand S.; Abolhassani H.; Esfahani Z.H.; Fard N.N.G.; Amiri M.; Salehi H.; Almasi-Hashiani A.; Saeedi-Boroujeni A.; Fathi N.; Mohtashami M.; Razavi A.; Heidari A.; Azizi G.; Khanmohammadi S.; Ahangarzadeh M.; Saleki K.; Hassanpour G.; Rezaei N.; Yazdani R. Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis 2025 Journal of Clinical Immunology
19. Avan A.; et al. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019 2024 The Lancet Global Health
20. Roosta A.; Zendehboudi S.; Rezaei N. Estimating contact angle of pure and mixed liquids on smooth solid surfaces using dispersive-to-attractive surface energy ratio from PCP-SAFT model 2024 Chemical Engineering Science
21. Mahmoudi M.; Taghavi-Farahabadi M.; Hashemi S.M.; Mousavizadeh K.; Rezaei N.; Mojtabavi N. Reprogramming tumor-associated macrophages using exosomes from M1 macrophages 2024 Biochemical and Biophysical Research Communications
22. Daneshpour A.; Rezvanimehr A.; Niktalab P.; Sharif H.; Yazdanpanah N.; Saleki K.; Rezaei N. Exploring the role of vault complex in the nervous system: A literature review 2024 Reviews in the Neurosciences
23. Pashangzadeh S.; Delavari S.; Moeini Shad T.; Salami F.; Rasouli S.E.; Yazdani R.; Mahdaviani S.A.; Nabavi M.; Aleyasin S.; Ahanchian H.; Jabbari-Azad F.; Chavoshzadeh Z.; Nazari F.; Momen T.; Sherkat R.; Abolnezhadian F.; Esmaeilzadeh H.; Fallahpour M.; Arshi S.; Bemanian M.H.; Shokri S.; Ebrahimi S.S.; Abolmolouki M.; Farid A.S.; Rezaei A.; Esmaeili M.; Kalantari A.; Sadeghi-Shabestari M.; Shirkani A.; Behniafard N.; Khalili A.; Eslamian M.H.; Cheraghi T.; Shafie A.; Tavakol M.; Khoshkhui M.; Iranparast S.; Shamshiri M.; Shahri M.A.; Khazaei R.; Asadi M.; Babaha F.; Aghamohammadi A.; Rezaei N.; Abolhassani H. Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency 2024 Journal of Investigational Allergology and Clinical Immunology
24. Sadeghi P.; Karimi H.; Lavafian A.; Rashedi R.; Samieefar N.; Shafiekhani S.; Rezaei N. Machine learning and artificial intelligence within pediatric autoimmune diseases: applications, challenges, future perspective 2024 Expert Review of Clinical Immunology
25. Khazaei S.; Varela-Calviño R.; Rad-Malekshahi M.; Quattrini F.; Jokar S.; Rezaei N.; Balalaie S.; Haririan I.; Csaba N.; Garcia-Fuentes M. Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapies 2024 Drug Delivery and Translational Research
26. Shaker F.; Razi S.; Rezaei N. Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer 2024 Clinical Biochemistry
27. Bordbar S.; Alijanzadeh D.; Samieefar N.; Khazeei Tabari M.A.; Pourbakhtyaran E.; Rezaei N. The Role of Alpha-Synuclein in Neurodevelopmental Diseases 2024 Molecular Neurobiology
28. Daneshpour A.; Shaka Z.; Rezaei N. Interplay of cell death pathways and immune responses in ischemic stroke: insights into novel biomarkers 2024 Reviews in the Neurosciences
29. Rezaei N. Preface 2024 Advances in Experimental Medicine and Biology
30. Tavakoli G.M.; Yazdanpanah N.; Rezaei N. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments 2024 Advances in Rheumatology
31. Rajabi D.; Khanmohammadi S.; Rezaei N. The role of long noncoding RNAs in amyotrophic lateral sclerosis 2024 Reviews in the Neurosciences
32. Sharif H.; Ziaei H.; Rezaei N. Stem Cell-Based Regenerative Approaches for the Treatment of Cleft Lip and Palate: A Comprehensive Review 2024 Stem Cell Reviews and Reports
33. Pourbagheri-Sigaroodi A.; Momeny M.; Rezaei N.; Fallah F.; Bashash D. Unveiling the predictive power of bacterial response-related genes signature in hepatocellular carcinoma: with bioinformatics analyses and experimental approaches 2024 Biocell
34. Rahavi-Ezabadi S.; Zhou S.; Lee S.E.; Ference E.; Magit A.; Leuin S.; Mohamed K.; Rezaei N.; Patel V.A. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review 2024 Otolaryngology - Head and Neck Surgery (United States)
35. Fekrvand S.; Abolhassani H.; Rezaei N. An overview of early genetic predictors of IgA deficiency 2024 Expert Review of Molecular Diagnostics
36. Jin Y.; et al. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 2024 Med
37. Sabahi M.; Fathi Jouzdani A.; Sadeghian Z.; Dabbagh Ohadi M.A.; Sultan H.; Salehipour A.; Maniakhina L.; Rezaei N.; Adada B.; Mansouri A.; Borghei-Razavi H. CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws 2024 Journal of Neuro-Oncology
38. Hamedi H.; Zendehboudi S.; Rezaei N.; Saady N.M.C.; Zhang B. Modeling and optimization of oil adsorption capacity on functionalized magnetic nanoparticles using machine learning approach 2023 Journal of Molecular Liquids
39. Nikkhah Bahrami S.; Momtazmanesh S.; Rezaei N. Music therapy for Alzheimer’s disease management: a narrative review 2024 Egyptian Journal of Neurology, Psychiatry and Neurosurgery
40. Bayegi S.N.; Hamidieh A.A.; Behfar M.; Saghazadeh A.; Bozorgmehr M.; Tajik N.; Delbandi A.-A.; Delavari S.; Shekarabi M.; Rezaei N. The Reconstitution of T-cells after Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Congenital Amegakaryocytic Thrombocytopenia (CAMT) 2024 Endocrine, Metabolic and Immune Disorders - Drug Targets
41. Behnoush A.H.; Khalaji A.; Khanmohammadi S.; Alehossein P.; Saeedian B.; Shobeiri P.; Teixeira A.L.; Rezaei N. Brain-derived neurotrophic factor in fibromyalgia: A systematic review and meta-analysis of its role as a potential biomarker 2023 PLoS ONE
42. Rostami M.; Kolahi Azar H.; Salehi M.; Abedin Dargoush S.; Rostamani H.; Jahed-Khaniki G.; Alikord M.; Aghabeigi R.; Ahmadi A.; Beheshtizadeh N.; Webster T.J.; Rezaei N. The food and biomedical applications of curcumin-loaded electrospun nanofibers: A comprehensive review 2024 Critical Reviews in Food Science and Nutrition
43. Bazzazan M.A.; fattollazadeh P.; Keshavarz Shahbaz S.; Rezaei N. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives 2024 International Journal of Pharmaceutics
44. Kolahi Azar H.; Imanpour A.; Rezaee H.; Ezzatifar F.; Zarei-Behjani Z.; Rostami M.; Azami M.; Behestizadeh N.; Rezaei N. Mesenchymal stromal cells and CAR-T cells in regenerative medicine: The homing procedure and their effective parameters 2024 European Journal of Haematology
45. Afshar Y.; Sharifi N.; Kamroo A.; Yazdanpanah N.; Saleki K.; Rezaei N. Implications of glioblastoma-derived exosomes in modifying the immune system: State-of-The-Art and challenges 2024 Reviews in the Neurosciences
46. Nikpour F.; Salimi A.; Saghazadeh A.; Rezaei N. Blood and CSF levels of brain-derived neurotrophic factor in patients with encephalopathy/encephalitis: a systematic review and meta-analysis 2024 Acta Neurologica Belgica
47. Heidari-Foroozan M.; Rezalotfi A.; Rezaei N. The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies 2024 International Reviews of Immunology
48. Lashgari N.-A.; Roudsari N.M.; Niknejad A.; Shamsnia H.S.; Shayan M.; Shalmani L.M.; Momtaz S.; Rezaei N.; Abdolghaffari A.H. LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping 2024 CNS and Neurological Disorders - Drug Targets
49. Sarkar Lotfabadi A.; Abadi B.; Rezaei N. Biomimetic nanotechnology for cancer immunotherapy: State of the art and future perspective 2024 International Journal of Pharmaceutics
50. Sirota S.B.; et al; Kyu H.H. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 2025 The Lancet Infectious Diseases
51. Rezaei N. Preface 2024 Advances in Experimental Medicine and Biology
52. Hamedi H.; Rezaei N.; Zendehboudi S. Investigation of Emulsified Oil Adsorption onto Functionalized Magnetic Nanoparticles—Kinetic and Isotherm Models 2023 Energies
53. Shabani M.; Shobeiri P.; Nouri S.; Moradi Z.; Amenu R.A.; Mehrabi Nejad M.-M.; Rezaei N. Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis 2024 European Journal of Medical Research
54. Koolivand Z.; Bahreini F.; Rayzan E.; Rezaei N. Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations 2025 Heliyon
55. Zarei D.; Saghazadeh A.; Rezaei N. Subtyping irritable bowel syndrome using cluster analysis: a systematic review 2023 BMC Bioinformatics
56. Yazdanpanah N.; Parnianpour M.; Behniafard M.; Sahraian M.A.; Mehdizadeh M.; Ramezanzadeh F.; Behnaz M.; Motamed A.; Fekrazad R.; Esnaashari M.; Motevalli S.; Ranjbar A.; Mahboudi F.; Rezaei N. USERN and Companions House and Museum: An Initiative by USERNversity for the Integration of Science and Art 2024 Acta Medica Iranica
57. Shahrokhi Nejad S.; Razi S.; Rezaei N. The role of AMPK in pancreatic cancer: from carcinogenesis to treatment 2024 Clinical and Translational Oncology
58. Taghavi-Farahabadi M.; Mahmoudi M.; Mojtabavi N.; Noorbakhsh F.; Ghanbarian H.; Koochaki A.; Hashemi S.M.; Rezaei N. Enhancing the anti-tumor activity and reprogramming M2 macrophages by delivering siRNAs against SIRPα and STAT6 via M1 exosomes and combining with anti-PD-L1 2025 Life Sciences
59. Kolahi Azar H.; Gharibshahian M.; Rostami M.; Mansouri V.; Sabouri L.; Beheshtizadeh N.; Rezaei N. The progressive trend of modeling and drug screening systems of breast cancer bone metastasis 2024 Journal of Biological Engineering
60. Badar M.S.; Rezaei N.; Imtiyaz H.; Ahmed J.; Alam A. Diagnosis and Analysis of COVID-19 USING ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING-BASED TECHNIQUES 2024 Diagnosis and Analysis of COVID-19 Using Artificial Intelligence and Machine Learning-Based Techniques
61. Karimi Jirandehi A.; Asgari R.; Keshavarz Shahbaz S.; Rezaei N. Nanomedicine marvels: crafting the future of cancer therapy with innovative statin nano-formulation strategies 2024 Nanoscale Advances
62. Faegh A.; Moeinafshar A.; Rezaei N. Nephrectomy and IVC thrombectomy in renal cancer: a narrative review 2024 Clinical and Translational Oncology
63. Ildarabadi A.; Ali S.N.M.M.; Rahmani F.; Mosavari N.; Pourbakhtyaran E.; Rezaei N. Inflammation and oxidative stress in epileptic children: from molecular mechanisms to clinical application of ketogenic diet 2024 Reviews in the Neurosciences
64. Tabatabaei F.S.; Shafeghat M.; Azimi A.; Akrami A.; Rezaei N. Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system 2024 Expert Review of Clinical Immunology
65. Khanmohammadi S.; Habibzadeh A.; Fallahtafti P.; Rezaei A.; Sadr M.; Ziaee V.; Rezaei N. Association of NLRP3 single nucleotide polymorphisms with juvenile idiopathic arthritis: a case–control study 2024 Clinical Rheumatology
66. Hanaei S.; Mojtahedi H.; Namvar M.; Iranmehr A.; Safaei R.; Razavi A.; Esmaeili M.; Sadr M.; Rezaei A.; Edalatfar M.; Kashani H.K.; Sadeghi-Naini M.; Darbeheshti F.; Gharehdaghi J.; Forouzesh M.; Ebrahimi A.; Rezaei N. VEGF gene polymorphisms in Iranian patients with intracranial glioblastoma 2024 Journal of Neurosurgical Sciences
67. Schumacher A.E.; Kyu H.H.; Antony C.M.; Aravkin A.Y.; Azhar G.S.; Bisignano C.; Burkart K.; Cercy K.M.; Chung E.; Coberly K.; Comfort H.; Cousin E.; Culbreth G.T.; Cunningham M.; Weaver N.D.; Degenhardt L.; Deitesfeld L.; et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 2024 The Lancet
68. Shobeiri P.; Arabzadeh Bahri R.; Khadembashiri M.M.; Khadembashiri M.A.; Maleki S.; Eslami M.; Khalili Dehkordi M.; Behnoush A.H.; Rezaei N. Role of long non-coding RNAs in cholangiocarcinoma: A systematic review and meta-analysis 2024 Cancer Reports
69. Neehus A.-L.; Carey B.; Landekic M.; Panikulam P.; Deutsch G.; Ogishi M.; Arango-Franco C.A.; Philippot Q.; Modaresi M.; Mohammadzadeh I.; Corcini Berndt M.; Rinchai D.; Le Voyer T.; Rosain J.; Momenilandi M.; Martin-Fernandez M.; Khan T.; Bohlen J.; Han J.E.; Deslys A.; Bernard M.; Gajardo-Carrasco T.; Soudée C.; Le Floc'h C.; Migaud M.; Seeleuthner Y.; Jang M.-S.; Nikolouli E.; Seyedpour S.; Begueret H.; Emile J.-F.; Le Guen P.; Tavazzi G.; Colombo C.N.J.; Marzani F.C.; Angelini M.; Trespidi F.; Ghirardello S.; Alipour N.; Molitor A.; Carapito R.; Mazloomrezaei M.; Rokni-Zadeh H.; Changi-Ashtiani M.; Brouzes C.; Vargas P.; Borghesi A.; Lachmann N.; Bahram S.; Crestani B.; Pahari S.; Schlesinger L.S.; Marr N.; Bugonovic D.; Boisson-Dupuis S.; Béziat V.; Abel L.; Borie R.; Young L.R.; Deterding R.; Shahrooei M.; Rezaei N.; Parvaneh N.; Craven D.; Gros P.; Malo D.; Sepulveda F.E.; Nogee L.M.; Aladjidi N.; Trapnell B.C.; Casanova J.-L.; Bustamante J. Human inherited CCR2 deficiency underlies progressive polycystic lung disease 2024 Cell
70. Ghajarzadeh M.; Rezaei N.; Hanaei S. Systematic Review and Meta-Analysis: Stepwise Approach for Medical and Biomedical Researchers 2024 Systematic Review and Meta-Analysis: Stepwise Approach for Medical and Biomedical Researchers
71. Marcotte H.; Cao Y.; Zuo F.; Simonelli L.; Sammartino J.C.; Pedotti M.; Sun R.; Cassaniti I.; Hagbom M.; Piralla A.; Yang J.; Du L.; Percivalle E.; Bertoglio F.; Schubert M.; Abolhassani H.; Sherina N.; Guerra C.; Borte S.; Rezaei N.; Kumagai-Braesch M.; Xue Y.; Su C.; Yan Q.; He P.; Grönwall C.; Klareskog L.; Calzolai L.; Cavalli A.; Wang Q.; Robbiani D.F.; Hust M.; Shi Z.; Feng L.; Svensson L.; Chen L.; Bao L.; Baldanti F.; Xiao J.; Qin C.; Hammarström L.; Yang X.; Varani L.; Xie X.S.; Pan-Hammarström Q. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages 2024 Proceedings of the National Academy of Sciences of the United States of America
72. Roosta A.; Rezaei N. Modification of e-CPA for estimating phase equilibria and development of predictive models for electrical conductivity in aqueous electrolyte solutions 2024 Chemical Engineering Science
73. Yazdanpanah N.; Sedikides C.; Ochs H.D.; Camargo C.A.; Darmstadt G.L.; Cerda A.; Cauda V.; Peters G.J.; Sellke F.; Wong N.D.; Comini E.; Jimeno A.R.; Glover V.; Hatziargyriou N.; Vincenot C.E.; Bordas S.P.A.; Rao I.M.; Abolhassani H.; Gharehpetian G.B.; Weiskirchen R.; Gupta M.; Chandel S.S.; Olusanya B.O.; Cheson B.; Pomponio A.; Tanzer M.; Myles P.S.; Ma W.-X.; Bella F.; Ghavami S.; Moein Moghimi S.; Pratico D.; Hernandez A.M.; Martinez-Urbistondo M.; Urbistondo D.M.; Fereshtehnejad S.-M.; Ali I.; Kimura S.; Wallace Hayes A.; Cai W.; Ernest C.K.J.; Thomas S.; Rahimi K.; Sorooshian A.; Schreiber M.; Kato K.; Luong J.H.T.; Pluchino S.; Lozano A.M.; Seymour J.F.; Kosik K.S.; Hofmann S.G.; McIntyre R.S.; Perc M.; Leemans A.; Klein R.S.; Ogino S.; Wlezien C.; Perry G.; Nieto J.J.; Levin L.; Klionsky D.J.; Mobasher B.; Dorigo T.; Rezaei N. Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic 2024 Advances in Experimental Medicine and Biology
74. Rahimi Darehbagh R.; Seyedoshohadaei S.A.; Ramezani R.; Rezaei N. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives 2024 European journal of medical research
75. Fekrazad S.; Mohebbi E.; Mehravar S.; Mortaja M.; Teymouri F.; Hadji M.; Rashidian H.; Naghibzadeh-Tahami A.; Rezaei N.; Zendehdel K.; Shirkhoda M. Allergies and risk of head and neck cancer: a case–control study 2024 Scientific Reports
76. Pourbagheri-Sigaroodi A.; Momeny M.; Rezaei N.; Fallah F.; Bashash D. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies 2024 Cell Biochemistry and Function
77. Kyu H.H.; et al. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021 2025 The Lancet Infectious Diseases
78. Delavari S.; Rasouli S.E.; Fekrvand S.; Chavoshzade Z.; Mahdaviani S.A.; Shirmast P.; Sharafian S.; Sherkat R.; Momen T.; Aleyasin S.; Ahanchian H.; Sadeghi-Shabestari M.; Esmaeilzadeh H.; Barzamini S.; Tarighatmonfared F.; Salehi H.; Esmaeili M.; Marzani Z.; Fathi N.; Abolnezhadian F.; Rad M.K.; Saeedi-Boroujeni A.; Shirkani A.; Bagheri Z.; Salami F.; Shad T.M.; Marzbali M.Y.; Mojtahedi H.; Razavi A.; Tavakolinia N.; Cheraghi T.; Tavakol M.; Shafiei A.; Behniafard N.; Ebrahimi S.S.; Sepahi N.; Ghaneimoghadam A.; Rezaei A.; Kalantari A.; Abolhassani H.; Rezaei N. Clinical heterogeneity in families with multiple cases of inborn errors of immunity 2024 Clinical Immunology
79. Amin P.; Memarian A.; Repo E.; Andersson M.; Mansouri S.S.; Zendehboudi S.; Rezaei N. Mathematical modeling of dispersed CO2 dissolution in ionic liquids: Application to carbon capture 2024 Journal of Molecular Liquids
80. Roosta A.; Zendehboudi S.; Rezaei N. Improving the estimation accuracy of confined vapor-liquid equilibria by fine-tuning the pure component parameter in the PC-SAFT equation of state 2024 Physical Chemistry Chemical Physics
81. Fathi N.; Nirouei M.; Salimian Rizi Z.; Fekrvand S.; Abolhassani H.; Salami F.; Ketabforoush A.H.M.E.; Azizi G.; Saghazadeh A.; Esmaeili M.; Almasi-Hashiani A.; Rezaei N. Clinical, Immunological, and Genetic Features in Patients with NFKB1 and NFKB2 Mutations: a Systematic Review 2024 Journal of Clinical Immunology
82. Aleebrahim-Dehkordi E.; Soveyzi F.; Deravi N.; Saghazadeh A.; Rezaei N. Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action 2024 Advances in Experimental Medicine and Biology
83. Khojasteh-Kaffash S.; Parhizkar Roudsari P.; Ghaffari Jolfayi A.; Samieefar N.; Rezaei N. Pediatric asthma exacerbation and COVID-19 pandemic: Impacts, challenges, and future considerations 2024 Journal of Asthma
84. Pourbagheri-Sigaroodi A.; Momeny M.; Rezaei N.; Fallah F.; Bashash D. A Novel Prognostic Immune-related Gene Signature in Hepatocellular Carcinoma Through Bioinformatics and Experimental Approaches 2024 Iranian Journal of Allergy, Asthma and Immunology
85. Agah E.; Mojtabavi H.; Behkar A.; Heidari A.; Ajdari A.; Shaka Z.; Mousavi S.V.; Firoozeh N.; Tafakhori A.; Rezaei N. CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: a systematic review and meta-analysis 2024 Journal of Translational Medicine
86. Valizadeh P.; Momtazmanesh S.; Plazzi G.; Rezaei N. Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches 2024 Sleep Medicine
87. Aghakhani A.; Pezeshki P.S.; Rezaei N. The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy 2024 Expert Opinion on Investigational Drugs
88. Erabi G.; Faridzadeh A.; Parvin A.; Deravi N.; Rahmanian M.; Fathi M.; Aleebrahim-Dehkordi E.; Rezaei N. SARS-CoV-2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID-19 pandemic 2024 Health Science Reports
89. Ghaffaripour Jahromi G.; Razi S.; Rezaei N. NLRP3 inflammatory pathway. Can we unlock depression? 2024 Brain Research
90. Saleki K.; Alijanizadeh P.; Javanmehr N.; Rezaei N. The role of Toll-like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management 2024 Medicinal Research Reviews
91. Sepehrinia M.; Khanmohammadi S.; Rezaei N.; Kuchay M.S. Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review 2025 Clinical Nutrition ESPEN
92. Rezaei N. Preface 2024 Advances in Experimental Medicine and Biology
93. Mennati M.; Moeinafshar A.; Rezaei N. Enhancing breast cancer surgery outcomes: A comprehensive review of oncoplastic techniques, surgical planning, and aesthetic considerations 2025 Critical Reviews in Oncology/Hematology
94. Mortaheb S.; Pezeshki P.S.; Rezaei N. Bispecific therapeutics: a state-of-the-art review on the combination of immune checkpoint inhibition with costimulatory and non-checkpoint targeted therapy 2024 Expert Opinion on Biological Therapy
95. Mokhtarpour K.; Razi S.; Rezaei N. Correction to: Ferroptosis as a promising targeted therapy for triple negative breast cancer (Breast Cancer Research and Treatment, (2024), 207, 3, (497-513), 10.1007/s10549-024-07387-7) 2024 Breast Cancer Research and Treatment
96. Ferrari A.J.; et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 2024 The Lancet
97. Ebrahimi S.; Habibzadeh A.; Khojasteh-Kaffash S.; Valizadeh P.; Samieefar N.; Rezaei N. Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape 2024 Critical Reviews in Oncology/Hematology
98. Rahmati S.; Moeinafshar A.; Rezaei N. The multifaceted role of extracellular vesicles (EVs) in colorectal cancer: metastasis, immune suppression, therapy resistance, and autophagy crosstalk 2024 Journal of Translational Medicine
99. Hosseinzadeh S.; Afshari S.; Molaei S.; Rezaei N.; Dadkhah M. The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape 2023 Journal of Neuroimmunology
100. Adami A.; Rezaei N. Understanding the Security Environment of the Islamic Republic of Iran based on a Systemic Approach 2023 Geopolitics Quarterly
101. Varzandeh M.; Sabouri L.; Mansouri V.; Gharibshahian M.; Beheshtizadeh N.; Hamblin M.R.; Rezaei N. Application of nano-radiosensitizers in combination cancer therapy 2023 Bioengineering and Translational Medicine
102. Da Cunha A.R.; Compton K.; Xu R.; Mishra R.; Drangsholt M.T.; Antunes J.L.F.; Kerr A.R.; Acheson A.R.; Lu D.; Wallace L.E.; Kocarnik J.M.; Fu W.; Dean F.E.; Pennini A.; Henrikson H.J.; Alam T.; Ababneh E.; Abd-Elsalam S.; Abdoun M.; Abidi H.; Abubaker Ali H.; Abu-Gharbieh E.; Adane T.D.; Addo I.Y.; Ahmad A.; Ahmad S.; Ahmed Rashid T.; Akonde M.; Al Hamad H.; Alahdab F.; Alimohamadi Y.; Alipour V.; Al-Maweri S.A.; Alsharif U.; Ansari-Moghaddam A.; Anwar S.L.; Anyasodor A.E.; Arabloo J.; Aravkin A.Y.; Aruleba R.T.; Asaad M.; Ashraf T.; Athari S.S.; Attia S.; Azadnajafabad S.; Azangou-Khyavy M.; Badar M.; Baghcheghi N.; Banach M.; Bardhan M.; Barqawi H.J.; Bashir N.Z.; Bashiri A.; Benzian H.; Bernabe E.; Bhagat D.S.; Bhojaraja V.S.; Bjørge T.; Bouaoud S.; Braithwaite D.; Briko N.I.; Calina D.; Carreras G.; Chakraborty P.A.; Chattu V.K.; Chaurasia A.; Chen M.X.; Cho W.C.S.; Chu D.-T.; Chukwu I.S.; Chung E.; Cruz-Martins N.; Dadras O.; Dai X.; Dandona L.; Dandona R.; Daneshpajouhnejad P.; Darvishi Cheshmeh Soltani R.; Darwesh A.M.; Debela S.A.; Derbew Molla M.; Dessalegn F.N.; Dianati-Nasab M.; Digesa L.E.; Dixit S.G.; Dixit A.; Djalalinia S.; El Sayed I.; El Tantawi M.; Enyew D.B.; Erku D.A.; Ezzeddini R.; Fagbamigbe A.F.; Falzone L.; Fetensa G.; Fukumoto T.; Gaewkhiew P.; Gallus S.; Gebrehiwot M.; Ghashghaee A.; Gill P.S.; Golechha M.; Goleij P.; Gomez R.S.; Gorini G.; Guimaraes A.L.S.; Gupta B.; Gupta S.; Gupta V.B.; Gupta V.K.; Haj-Mirzaian A.; Halboub E.S.; Halwani R.; Hanif A.; Hariyani N.; Harorani M.; Hasani H.; Hassan A.M.; Hassanipour S.; Hassen M.B.; Hay S.I.; Hayat K.; Herrera-Serna B.Y.; Holla R.; Horita N.; Hosseinzadeh M.; Hussain S.; Ilesanmi O.S.; Ilic I.M.; Ilic M.D.; Isola G.; Jaiswal A.; Jani C.T.; Javaheri T.; Jayarajah U.; Jayaram S.; Joseph N.; Kadashetti V.; Kandaswamy E.; Karanth S.D.; Karaye I.M.; Kauppila J.H.; Kaur H.; Keykhaei M.; Khader Y.S.; Khajuria H.; Khanali J.; Khatib M.N.; Khayat Kashani H.R.; Khazeei Tabari M.A.; Kim M.S.; Kompani F.; Koohestani H.R.; Kumar G.A.; Kurmi O.P.; La Vecchia C.; Lal D.K.; Landires I.; Lasrado S.; Ledda C.; Lee Y.H.; Libra M.; Lim S.S.; Listl S.; Lopukhov P.D.; Mafi A.R.; Mahumud R.A.; Malik A.A.; Mathur M.R.; Maulud S.Q.; Meena J.K.; Mehrabi Nasab E.; Mestrovic T.; Mirfakhraie R.; Misganaw A.; Misra S.; Mithra P.; Mohammad Y.; Mohammadi M.; Mohammadi E.; Mokdad A.H.; Moni M.A.; Moraga P.; Morrison S.D.; Mozaffari H.R.; Mubarik S.; Murray C.J.L.; Nair T.S.; Narasimha Swamy S.; Narayana A.I.; Nassereldine H.; Natto Z.S.; Nayak B.P.; Negru S.M.; Nggada H.A.; Nouraei H.; Nuñez-Samudio V.; Oancea B.; Olagunju A.T.; Omar Bali A.; Padron-Monedero A.; Padubidri J.R.; Pandey A.; Pardhan S.; Patel J.; Pezzani R.; Piracha Z.Z.; Rabiee N.; Radhakrishnan V.; Radhakrishnan R.A.; Rahmani A.M.; Rahmanian V.; Rao C.R.; Rao S.J.; Rath G.K.; Rawaf D.L.; Rawaf S.; Rawassizadeh R.; Razeghinia M.S.; Rezaei N.; Rezaei N.; Rezaei N.; Rezapour A.; Riad A.; Roberts T.J.; Romero-Rodríguez E.; Roshandel G.; Manjula S.; Chandan S.N.; Saddik B.; Saeb M.R.; Saeed U.; Safaei M.; Sahebazzamani M.; Sahebkar A.; Salek Farrokhi A.; Samy A.M.; Santric-Milicevic M.M.; Sathian B.; Satpathy M.; Šekerija M.; Senthilkumaran S.; Seylani A.; Shafaat O.; Shahsavari H.R.; Shamsoddin E.; Sharew M.M.; Sharifi-Rad J.; Shetty J.K.; Shivakumar K.M.; Shobeiri P.; Shorofi S.A.; Shrestha S.; Siddappa Malleshappa S.K.; Singh P.; Singh J.A.; Singh G.; Sinha D.N.; Solomon Y.; Suleman M.; Suliankatchi Abdulkader R.; Taheri Abkenar Y.; Talaat I.M.; Tan K.-K.; Tbakhi A.; Thiyagarajan A.; Tiyuri A.; Tovani-Palone M.R.; Unnikrishnan B.; Vo B.; Volovat S.R.; Wang C.; Westerman R.; Wickramasinghe N.D.; Xiao H.; Yu C.; Yuce D.; Yunusa I.; Zadnik V.; Zare I.; Zhang Z.-J.; Zoladl M.; Force L.M.; Hugo F.N. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019 2023 JAMA Oncology
103. Bohlen J.; Zhou Q.; Philippot Q.; Ogishi M.; Rinchai D.; Nieminen T.; Seyedpour S.; Parvaneh N.; Rezaei N.; Yazdanpanah N.; Momenilandi M.; Conil C.; Neehus A.-L.; Schmidt C.; Arango-Franco C.A.; Voyer T.L.; Khan T.; Yang R.; Puchan J.; Erazo L.; Roiuk M.; Vatovec T.; Janda Z.; Bagarić I.; Materna M.; Gervais A.; Li H.; Rosain J.; Peel J.N.; Seeleuthner Y.; Han J.E.; L'Honneur A.-S.; Moncada-Vélez M.; Martin-Fernandez M.; Horesh M.E.; Kochetkov T.; Schmidt M.; AlShehri M.A.; Salo E.; Saxen H.; ElGhazali G.; Yatim A.; Soudée C.; Sallusto F.; Ensser A.; Marr N.; Zhang P.; Bogunovic D.; Cobat A.; Shahrooei M.; Béziat V.; Abel L.; Wang X.; Boisson-Dupuis S.; Teleman A.A.; Bustamante J.; Zhang Q.; Casanova J.-L. Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria 2023 Cell
104. Yazdanpanah N.; Rezaei N. Introduction on neuroinflammation 2023 Translational Neuroimmunology: Neuroinflammation: Volume 7
105. Shin Y.H.; et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 2023 Allergy: European Journal of Allergy and Clinical Immunology
106. Linder M.I.; Mizoguchi Y.; Hesse S.; Csaba G.; Tatematsu M.; Łyszkiewicz M.; Ziȩtara N.; Jeske T.; Hastreiter M.; Rohlfs M.; Liu Y.; Grabowski P.; Ahomaa K.; Maier-Begandt D.; Schwestka M.; Pazhakh V.; Isiaku A.I.; Briones Miranda B.; Blombery P.; Saito M.K.; Rusha E.; Alizadeh Z.; Pourpak Z.; Kobayashi M.; Rezaei N.; Unal E.; Hauck F.; Drukker M.; Walzog B.; Rappsilber J.; Zimmer R.; Lieschke G.J.; Klein C. Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes 2023 Blood
107. Darbeheshti F.; Mansoori Y.; Azizi-Tabesh G.; Zolfaghari F.; Kadkhoda S.; Rasti A.; Rezaei N.; Shakoori A. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors 2023 Biochemical Genetics
108. Noori M.; Fayyaz F.; Rezaei N. Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysis 2023 Immunotherapy
109. Saghazadeh A.; Rezaei N. Inborn errors of immunity and worries during the monkeypox outbreak 2023 Journal of Medical Virology
110. Rayzan E.; Sadeghalvad M.; Shahkarami S.; Zoghi S.; Aryan Z.; Mahdaviani S.A.; Boztug K.; Rezaei N. A novel X-linked mutation in IL2RG associated with early-onset inflammatory bowel disease: a case report of twin brothers 2023 Journal of Medical Case Reports
111. Shobeiri P.; Alilou S.; Jaberinezhad M.; Zare F.; Karimi N.; Maleki S.; Teixeira A.L.; Perry G.; Rezaei N. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis 2023 PLoS ONE
112. Jabbari P.; Ardakany M.R.; Ebrahimi S.; Rezaei N. Nicotinamide N-methyl transferase and cancer-associated thrombosis: insights to prevention and management 2023 Epigenomics
113. Asna Ashari K.; Aslani N.; Parvaneh N.; Assari R.; Heidari M.; Fathi M.; Tahghighi Sharabian F.; Ronagh A.; Shahrooei M.; Moafi A.; Rezaei N.; Ziaee V. A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran 2023 Pediatric Rheumatology
114. Arifin M.S.; Uddin M.N.; Yeo I.A.; Rezaei N. A Neuro-Fuzzy Based Power Control of a Type-3 based Wind Energy Conversion Systems with LVRT Capability 2023 2023 IEEE Industry Applications Society Annual Meeting, IAS 2023
115. Azadnajafabad S.; Moghaddam S.S.; Mohammadi E.; Rezaei N.; Rashidi M.-M.; Rezaei N.; Mokdad A.H.; Naghavi M.; Murray C.J.L.; Larijani B.; Farzadfar F.; Abbasi-Kangevari M.; Abbasi-Kangevari Z.; Abbastabar H.; Abidi H.; Abolhassani H.; Abubaker Ali H.; Abu-Gharbieh E.; Acuna J.M.; Afrashteh S.; Afzal M.S.; Ahmad S.; Ahmadi A.; Ahmadi S.; Ahmed H.; Ahmed L.A.; Rashid T.A.; Ajami M.; Akbarzadeh-Khiavi M.; Hamad H.A.; Al-Hanawi M.K.; Ali B.A.; Alimohamadi Y.; Alipour S.; Aljunid S.M.; Almustanyir S.; Al-Raddadi R.M.; Alvand S.; Arabloo J.; Arab-Zozani M.; Aryannejad A.; Ashraf T.; Athari S.S.; Jafari A.A.; Bagheri N.; Bagherieh S.; Bahadory S.; Behnammoghadam M.; Bhagavathula A.S.; Bohlouli S.; Wolfram Brück W.M.; Darwesh A.M.; Dianatinasab M.; Dorostkar F.; Eini E.; Elbarazi I.; Elhadi M.; Sayed I.E.; Zaki M.E.S.; Eskandarieh S.; Fadhil I.; Farahmand F.; Faris P.S.; Galehdar N.; Ghafourifard M.; Ghamari S.-H.; Ghamari A.; Ghashghaee A.; Gholamalizadeh M.; Gohari K.; Goleij P.; Golitaleb M.; Gubari M.I.M.; Hafezi-Nejad N.; Halwani R.; Hamadeh R.R.; Hamidi S.; Hanif A.; Haque S.; Hassanipour S.; Hayat K.; Heidari M.; Heidarymeybodi Z.; Hosseini M.-S.; Hosseinzadeh M.; Hsairi M.; Jamshidi E.; Mamaghani A.J.; Javaheri T.; Kabir A.; Kalankesh L.R.; Keikavoosi-Arani L.; Khader Y.S.; Khan E.A.; Khan G.; Khayamzadeh M.; Kiani B.; Koohestani H.R.; Lee S.-W.; Letafat-Nezhad M.; Livani S.; Madadizadeh F.; Mafi A.R.; Mahjoub S.; Mahmoodpoor A.; Mahmoudimanesh M.; Malekpour M.-R.; Malik A.A.; Mansour-Ghanaei F.; Mansournia M.A.; Masoumi S.Z.; Nasab E.M.; Mirmoeeni S.; Mohammad Y.; Mohammad K.A.; Mohammadi M.; Mohammed A.; Momtazmanesh S.; Moradi A.; Moraga P.; Mosapour A.; Naqvi A.A.; Natto Z.S.; Nejadghaderi S.A.; Nojomi M.; Noori M.; Okati-Aliabad H.; Pakzad R.; Toroudi H.P.; Piracha Z.Z.; Pourtaheri N.; Rabiee N.; Rafiei A.; Rahim F.; Rahimi-Dehgolan S.; Rahmani A.M.; Rahmanian V.; Rashidi M.; Rashidi A.; Rawassizadeh R.; Razeghinia M.S.; Rezaei N.; Sabour S.; Saddik B.; Saeed U.; Sahebazzamani M.; Sahebkar A.; Samy A.M.; Nadeem Saqib M.A.; Sathian B.; Shafiee S.M.; Shahabi S.; Shahraki-Sanavi F.; Shaikh M.A.; Sheidaei A.; Alisheikhi R.; Shirkoohi R.; Shobeiri P.; Soltani-Zangbar M.S.; Tabibian E.; Taheri M.; Soodejani M.T.; Temsah M.-H.; Tiyuri A.; Ullah I.; Ullah S.; Tahbaz S.V.; Valizadeh R.; Vo B.; Waheed Y.; Yahyazadeh Jabbari S.H.; Yazdanpanah F.; Yuce D.; Zaki N.; Zare I.; Zoladl M. Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2023 Frontiers in Oncology
116. Rezaei N.; Yazdanpanah N. Translational Neuroimmunology, Volume 8: Multiple Sclerosis 2023 Translational Neuroimmunology: Multiple Sclerosis: Volume 8
117. Moeinafshar A.; Rezaei N. Monoclonal antibodies in multiple sclerosis treatment 2023 Translational Neuroimmunology: Multiple Sclerosis: Volume 8
118. Shobeiri P.; Behnoush A.H.; Khalaji A.; Teixeira A.L.; Rezaei N. Peripheral Levels of the Brain-Derived Neurotrophic Factor in Coronary Artery Disease: A Systematic Review and Meta-Analysis 2023 Journal of Tehran University Heart Center
119. Uddin M.N.; Arifin M.S.; Rezaei N. A Novel Neuro-Fuzzy Based Direct Power Control of a DFIG Based Wind Farm Incorporated with Distance Protection Scheme and LVRT Capability 2023 IEEE Transactions on Industry Applications
120. Rasouli S.; Rezaei N.; Zendehboudi S.; Duan X.; Legge R.L.; Chatzis I. Selective and Continuous Oil Removal from Oil-Water Mixtures Using a Superhydrophobic and Superoleophilic Stainless Steel Mesh Tube 2023 Langmuir
121. Sanatkar S.A.; Heidari A.; Arya S.; Ghasemi M.; Rezaei N. The Potential Role of Immunotherapy in Wilms’ Tumor: Opportunities and Challenges 2023 Current Pharmaceutical Design
122. Pour-Rashidi A.; Turgut M.; Fallahpour M.; Mohammadi E.; Hanaei S.; Rezaei N. Central nervous system hydatidosis around the world: a systematic review 2023 Journal of Neurosurgical Sciences
123. Moosaie F.; Mohammadi S.; Saghazadeh A.; Firouzabadi F.D.; Rezaei N. Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis 2023 PLoS ONE
124. Hamedi H.; Zendehboudi S.; Rezaei N.; Azizi A.; Shahhoseini F. Application of Functionalized Fe3O4 Magnetic Nanoparticles Using CTAB and SDS for Oil Separation from Oil-in-Water Nanoemulsions 2023 Langmuir
125. Nooraei S.; Sarkar Lotfabadi A.; Akbarzadehmoallemkolaei M.; Rezaei N. Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review 2023 Vaccines
126. Saleki K.; Mohamadi M.; Alijanizadeh P.; Rezaei N. Inflammasome elements in epilepsy and seizures 2023 Translational Neuroimmunology: Neuroinflammation: Volume 7
127. Kolahchi Z.; Saien S.; Khaboushan A.S.; Naghavi E.; Perry G.; Rezaei N. Immune-mediated cognition impairment in multiple sclerosis 2023 Translational Neuroimmunology: Multiple Sclerosis: Volume 8
128. Rezaei N.; Yazdanpanah N. Translational Neuroimmunology, Volume 7: Neuroinflammation 2023 Translational Neuroimmunology: Neuroinflammation: Volume 7
129. Masrour M.; Khanmohammadi S.; Fallahtafti P.; Rezaei N. Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis 2023 PLoS ONE
130. Alimohammadi M.; Ghaffari-Nazari H.; Alimohammadi R.; Bakhshandeh M.; Jalali S.A.; Rezaei N. Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME) 2023 Avicenna Journal of Medical Biotechnology
131. Saleki K.; Mohamadi M.H.; Alijanizadeh P.; Rezaei N. Neurological adverse effects of chimeric antigen receptor T-cell therapy 2023 Expert Review of Clinical Immunology
132. Bagherzadeh-Fard M.; Amin Yazdanifar M.; Sadeghalvad M.; Rezaei N. Erenumab efficacy in migraine headache prophylaxis: A systematic review 2023 International Immunopharmacology
133. Amanollahi M.; Jameie M.; Heidari A.; Rezaei N. The Dialogue Between Neuroinflammation and Adult Neurogenesis: Mechanisms Involved and Alterations in Neurological Diseases 2023 Molecular Neurobiology
134. Moradian N.; Zoghi S.; Rayzan E.; Seyedpour S.; Jimenez Heredia R.; Boztug K.; Rezaei N. Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype of a patient 2023 Allergy, Asthma and Clinical Immunology
135. Aleebrahim-Dehkordi E.; Ghoshouni H.; Koochaki P.; Esmaili-Dehkordi M.; Aleebrahim E.; Chichagi F.; Jafari A.; Hanaei S.; Heidari-Soureshjani E.; Rezaei N. Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19 2023 Journal of Molecular Structure
136. Black R.J.; et al. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 2023 The Lancet Rheumatology
137. Azari M.; Bahreini F.; Uversky V.N.; Rezaei N. Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer 2023 Biochemical Pharmacology
138. Spoor J.; Farajifard H.; Keshavarz-Fathi M.; Rezaei N. Historical Cohort of Severe Congenital Neutropenia in Iran: Clinical Course, Laboratory Evaluation, Treatment, and Survival 2023 Journal of Pediatric Hematology/Oncology
139. Mahdiabadi S.; Momtazmanesh S.; Karimi A.; Rezaei N. Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics 2023 Expert Review of Anticancer Therapy
140. Zuo F.; Sun R.; Abolhassani H.; Du L.; Wang Y.; Vlachiotis S.; Bertoglio F.; Schubert M.; Rezaei N.; Chavoshzadeh Z.; Guerra C.; Cavalli A.; Andréll J.; Kumagai-Braesch M.; Xue Y.; Cao Y.; Hust M.; Robbiani D.F.; Xie X.S.; Hammarström L.; Marcotte H.; Pan-Hammarström Q. Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1 2023 The Lancet Regional Health - Western Pacific
141. Sharifinejad N.; Azizi G.; Rasouli S.E.; Chavoshzadeh Z.; Mahdaviani S.A.; Tavakol M.; Sadri H.; Nabavi M.; Ebrahimi S.S.; Shirkani A.; Vosughi Motlagh A.; Momen T.; Sharafian S.; Mesdaghi M.; Eslami N.; Delavari S.; Bahrami S.; Yazdani R.; Rezaei N.; Abolhassani H. Autoimmune versus Non-autoimmune Cutaneous Features in Monogenic Patients with Inborn Errors of Immunity 2023 Biology
142. Bayegi S.N.; Hamidieh A.A.; Behfar M.; Bozorgmehr M.; Saghazadeh A.; Tajik N.; Delbandi A.-A.; Zavareh F.T.; Delavari S.; Shekarabi M.; Rezaei N. Disturbance in the reconstitution of distinct T-cell subsets and the incidence of GvHD following allo-HSCT in pediatric patients with non-malignant hematological disorders 2023 Immunology Letters
143. Wu D.; et al. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 2023 eClinicalMedicine
144. Gardner W.M.; et al. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 2023 The Lancet Haematology
145. Sayyahfar S.; Esteghamati A.; Rezaei N. Is It Time to Change the BCG Vaccine Administration Time in Iran? 2023 Tanaffos
146. Saghazadeh A.; Rezaei N. Insights on Mpox virus infection immunopathogenesis 2023 Reviews in Medical Virology
147. Uddin M.N.; Rezaei N.; Arifin M.S. Hybrid Machine Learning-Based Intelligent Distance Protection and Control Schemes With Fault and Zonal Classification Capabilities for Grid- Connected Wind Farms 2023 IEEE Transactions on Industry Applications
148. Momtazmanesh S.; et al. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 2023 eClinicalMedicine
149. Yazdanpanah N.; Rezaei N. Introduction to the neuroimmunology of multiple sclerosis 2023 Translational Neuroimmunology: Multiple Sclerosis: Volume 8
150. Morrison F.M.M.; Rezaei N.; Arero A.G.; Graklanov V.; Iritsyan S.; Ivanovska M.; Makuku R.; Marquez L.P.; Minakova K.; Mmema L.P.; Rzymski P.; Zavolodko G. Maintaining scientific integrity and high research standards against the backdrop of rising artificial intelligence use across fields 2023 Journal of Medical Artificial Intelligence
151. Mohammadi F.; Yadegar A.; Mardani M.; Ayati A.; Abolhassani H.; Rezaei N. Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians 2023 Immunity, Inflammation and Disease
152. Amanollahi M.; Jameie M.; Rezaei N. Neuroinflammation as a potential therapeutic target in neuroimmunological diseases 2023 Translational Neuroimmunology: Neuroinflammation: Volume 7
153. Namazi Bayegi S.; Ali Hamidieh A.; Behfar M.; Saghazadeh A.; Bozorgmehr M.; Tajik N.; Delbandi A.-A.; Delavari S.; Shekarabi M.; Rezaei N. Unbalanced T-cell subsets in pediatric patients with beta-thalassemia 2023 Human Immunology
154. Mahdaviani S.A.; Ghadimi S.; Fallahi M.; Hashemi-Moghaddam S.A.; Chavoshzadeh Z.; Puel A.; Rezaei N.; Rekabi M.; Daneshmandi Z.; Sheikhy K.; Kakhki A.D.; Saghebi S.R.; Pejhan S.; Jamee M. Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome 2023 BMC Surgery
155. Lavafian A.; Pezeshki P.S.; Rezaei N. Investigation of the female infertility risk associated with anti-cancer therapy 2023 Clinical and Translational Oncology
156. Seyedmirzaei H.; Faramarzpour M.; Saghazadeh A.; Teixeira A.L.; Rezaei N. Post-COVID-19 depression and serum interleukin 6 levels: A systematic review and meta-analysis of COVID-19 convalescents with and without depression 2023 World Journal of Biological Psychiatry
157. Sadeghi P.; Pezeshki P.S.; Rezaei N. Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders 2023 European Journal of Pediatrics
158. Saleki K.; Banazadeh M.; Saghazadeh A.; Rezaei N. Aging, testosterone, and neuroplasticity: friend or foe? 2023 Reviews in the Neurosciences
159. Kazemzadeh K.; Behrouzieh S.; Rezaei N. Shedding light on the side effects of immunotherapies used for leukemia: an updated review of the literature 2023 Expert Review of Anticancer Therapy
160. Keshavarz-Fathi M.; Yazdanpanah N.; Kolahchi S.; Ziaei H.; Darmstadt G.L.; Dorigo T.; Dochy F.; Levin L.; Thongboonkerd V.; Ogino S.; Chen W.-H.; Perc M.; Tremblay M.S.; Olusanya B.O.; Rao I.M.; Hatziargyriou N.; Moradi-Lakeh M.; Bella F.; Rosivall L.; Gandomi A.H.; Sorooshian A.; Gupta M.; Gal C.; Lozano A.M.; Weaver C.; Tanzer M.; Poggi A.; Sepanlou S.G.; Weiskirchen R.; Jambrak A.R.; Torres P.J.; Capanoglu E.; Barba F.J.; Ernest C.K.J.; Sigman M.; Pluchino S.; Gharehpetian G.B.; Fereshtehnejad S.-M.; Yang M.-H.; Thomas S.; Cai W.; Comini E.; Scolding N.J.; Myles P.S.; Nieto J.J.; Perry G.; Sedikides C.; Rezaei N. Universal research index: An inclusive metric to quantify scientific research output 2023 Journal of Academic Librarianship
161. Ong K.L.; et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 2023 The Lancet
162. Huang P.; Sun L.; Li J.; Wu Q.; Rezaei N.; Jiang S.; Pan C. Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines 2023 Cell Discovery
163. Keshavarz F.; Rezaei N.; Barbiellini B. First-Principles Perspective on Gas Adsorption by [Fe4S4]-Based Metal-Organic Frameworks 2023 Langmuir
164. Jabbari P.; Taraghikhah N.; Jabbari F.; Ebrahimi S.; Rezaei N. Body Mass Index as a Predictor of Symptom Duration in COVID-19 Outpatients 2023 Disaster Medicine and Public Health Preparedness
165. Sabahi M.; Salehipour A.; Bazl M.S.Y.; Rezaei N.; Mansouri A.; Borghei-Razavi H. Local immunotherapy of glioblastoma: A comprehensive review of the concept 2023 Journal of Neuroimmunology
166. Sanati G.; Noruzinia M.; Jafari D.; Ahmadvand M.; Teimourian S.; Daryani N.E.; Rezaei N. Abnormal Promoter Methylation of Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Gene in the Pathogenesis of Crohn’s Disease 2023 Acta Medica Iranica
167. Ghaffari S.; Rezaei N. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy 2023 Journal of Translational Medicine
168. Rezghi Rami M.; Meskini M.; Rezaei Khozani N.; Forouzandehdel S.; Momtaz S.; Ghosh S.; Rezaei N.; Abdolghaffari A.H. Therapeutic Potentials and Candidates for COVID-19 2023 Iranian Journal of Science
169. Khademi R.; Mohammadi Z.; Khademi R.; Saghazadeh A.; Rezaei N. Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies 2023 Nanoscale Advances
170. Hantoushzadeh S.; Eshraghi N.; Younesi S.; Salehi M.; Rezaei N.; Hasheminejad M.M.; Rashidian P.; Shirdel S.; Asadi F.; Ghaemi M. Cord blood antibodies following BBIBP-CorV (Sinopharm) vaccination during pregnancy 2023 Immunity, Inflammation and Disease
171. Bagheri Y.; Moeini Shad T.; Namazi S.; Tofighi Zavareh F.; Azizi G.; Salami F.; Sadani S.; Hosseini A.; Saeidi M.; Pashangzadeh S.; Delavari S.; Mirminachi B.; Rezaei N.; Abolhassani H.; Aghamohammadi A.; Yazdani R. B cells and T cells abnormalities in patients with selective IgA deficiency 2023 Allergy, Asthma and Clinical Immunology
172. Meimand S.E.; Azizi G.; Yazdani R.; Sanadgol N.; Rezaei N. Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report 2023 Immunologic Research
173. Rezaei N.; Yazdanpanah N. Preface 2023 Translational Neuroimmunology: Neuroinflammation: Volume 7
174. Manzari Tavakoli G.; Mirzapour M.H.; Razi S.; Rezaei N. Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment 2023 International Immunopharmacology
175. Khakpoor-Koosheh M.; Rostamian H.; Masoumi E.; Jafarzadeh L.; Fallah-Mehrjardi K.; Tavassolifar M.J.; Noorbakhsh F.; Mirzaei H.R.; Hadjati J.; Rezaei N. MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells 2023 Iranian Journal of Allergy, Asthma and Immunology
176. Khalaji A.; Behnoush A.H.; Shobeiri P.; Saeedian B.; Teixeira A.L.; Rezaei N. Association between brain-derived neurotrophic factor levels and obstructive sleep apnea: a systematic review and meta-analysis 2023 Sleep and Breathing
177. Ghamartale A.; Rezaei N.; Zendehboudi S. Alternation of asphaltene binding arrangement in the presence of chemical inhibitors: Molecular dynamics simulation strategy 2023 Fuel
178. Mirnia K.; Saeedi M.; Sangsari R.; Mokhtarian Zavareh F.; Mirnia V.; Rezaei N. Immunoglobulin G Levels in Neonates After Receiving Phototherapy 2023 Iranian Journal of Pediatrics
179. Shobeiri P.; Maleki S.; Amanollahi M.; Habibzadeh A.; Teixeira A.L.; Rezaei N. Blood levels of brain-derived neurotrophic factor (BDNF) in systemic lupus erythematous (SLE): a systematic review and meta-analysis 2023 Advances in Rheumatology
180. Khanmohammadi S.; Noroozi A.; Yekaninejad M.S.; Rezaei N. Cryoablation for the Palliation of Painful Bone Metastasis: A Systematic Review 2023 CardioVascular and Interventional Radiology
181. Sadeghmousavi S.; Rezaei N. Activation of complement: A potent biomarker in multiple sclerosis 2023 Translational Neuroimmunology: Multiple Sclerosis: Volume 8
182. Vahabi Khah M.; Zahedi R.; Eskandarpanah R.; Mirzaei A.M.; Farahani O.N.; Malek I.; Rezaei N. Optimal sizing of residential photovoltaic and battery system connected to the power grid based on the cost of energy and peak load 2023 Heliyon
183. Moghimi M.; Roosta A.; Hekayati J.; Rezaei N. Estimating VLE behavior from SLE data in aqueous mixtures of choline chloride-sorbitol deep eutectic solvents: Experimental investigation and thermodynamic modeling using the e-NRTL model 2023 Journal of Molecular Liquids
184. Noori M.; Yazdanpanah N.; Rezaei N. Safety and efficacy of T-cell-redirecting bispecific antibodies for patients with multiple myeloma: a systematic review and meta-analysis 2023 Cancer Cell International
185. Malekan M.; Nezamabadi S.S.; Samami E.; Mohebalizadeh M.; Saghazadeh A.; Rezaei N. BDNF and its signaling in cancer 2023 Journal of Cancer Research and Clinical Oncology
186. Allami P.; Heidari A.; Rezaei N. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma 2023 Frontiers in Molecular Biosciences
187. Zinatizadeh M.R.; Zarandi P.K.; Ghiasi M.; Kooshki H.; Mohammadi M.; Amani J.; Rezaei N. Immunosenescence and inflamm-ageing in COVID-19 2023 Ageing Research Reviews
188. Tofighi Zavareh F.; Mirshafiey A.; Yazdani R.; Keshtkar A.A.; Abolhassani H.; Kiaee F.; Parvaneh N.; Shariat M.; Rezaei N.; Aghamohammadi A. Analysis of Lymphocyte and Clinical Profile in Nonmonogenic Common Variable Immunodeficiency Patients With and Without Class Switch Recombination Defect 2023 Journal of Investigational Allergology and Clinical Immunology
189. Rezaei N.; Yazdanpanah N. Preface 2023 Translational Neuroimmunology: Multiple Sclerosis: Volume 8
190. Alijanzadeh D.; Soltani A.; Afra F.; Salmanpour F.; Loghman A.H.; Samieefar N.; Rezaei N. Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies 2023 BMC Neurology
191. Karimi H.; Mansouri V.; Rezaei N. Vertical transmission and maternal passive immunity post-SARS-CoV-2 2023 Future Virology
192. Mirzapour M.H.; Heidari-Foroozan M.; Razi S.; Rezaei N. The pro-tumorigenic responses in metastatic niches: an immunological perspective 2023 Clinical and Translational Oncology
193. Azizi G.; Hesari M.F.; Sharifinejad N.; Fayyaz F.; Chavoshzadeh Z.; Mahdaviani S.A.; Alan M.S.; Jamee M.; Tavakol M.; Sadri H.; Shahrestanaki E.; Nabavi M.; Ebrahimi S.S.; Shirkani A.; Vosughi Motlagh A.; Delavari S.; Rasouli S.E.; Esmaeili M.; Salami F.; Yazdani R.; Rezaei N.; Abolhassani H. The Autoimmune Manifestations in Patients with Genetic Defects in the B Cell Development and Differentiation Stages 2023 Journal of Clinical Immunology
194. Bayegi S.N.; Hamidieh A.A.; Behfar M.; Saghazadeh A.; Bozorgmehr M.; Karamlou Y.; Shekarabi M.; Tajik N.; Delbandi A.-A.; Zavareh F.T.; Delavari S.; Rezaei N. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia 2023 Transplant Immunology
195. Fallahi M.; Mahdaviani S.A.; Shafiei M.; Ghadimi S.; Rezaei N.; Klein C.; Strobel S.; Jamee M. CARD9 deficiency with allergic bronchopulmonary aspergillosis (ABPA)-like presentation: a case report 2023 Oxford Medical Case Reports
196. Ghadimi S.; Jamee M.; Abolhassani H.; Parvaneh N.; Rezaei N.; Delavari S.; Sadeghi-Shabestari M.; Tabatabaei S.R.; Fahimzad A.; Armin S.; Chavoshzadeh Z.; Sharafian S. Demographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene 2023 Allergy, Asthma and Clinical Immunology
197. Khanmohammadi S.; et al. Burden of tracheal, bronchus, and lung cancer in North Africa and Middle East countries, 1990 to 2019: Results from the GBD study 2019 2023 Frontiers in Oncology
198. Nowroozi A.; Rezaei N. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant of concern breakthrough infections: Are vaccines failing us? 2022 Infection Control and Hospital Epidemiology
199. Haghpanah S.; Hosseini-Bensenjan M.; Sayadi M.; Nozari F.; Ramzi M.; Cohan N.; Rezaei N. Cytokine Levels in Patients with β-Thalassemia Major and Healthy Individuals: a Systematic Review and Meta-Analysis 2022 Clinical Laboratory
200. Aminorroaya A.; Rayzan E.; Shahkarami S.; Seyedpour S.; Zoghi S.; Aryan Z.; Somekh I.; Rohlfs M.; Klein C.; Esmaeilzadeh H.; Rezaei N. Novel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonary Collateral Artery 2023 Endocrine, Metabolic and Immune Disorders - Drug Targets
201. Mehrabi Nejad M.-M.; Moosaie F.; Dehghanbanadaki H.; Haji Ghadery A.; Shabani M.; Tabary M.; Aryannejad A.; SeyedAlinaghi S.A.; Rezaei N. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis 2022 European Journal of Medical Research
202. Tavakol M.; Delavari S.; Salami F.; Ansari S.; Rasouli S.E.; Chavoshzadeh Z.; Sherkat R.; Ahanchian H.; Aleyasin S.; Esmaeilzadeh H.; Moazzen N.; Shafiei A.; Abolnezhadian F.; Iranparast S.; Ebrahimi S.; Moeini Shad T.; Pashangzadeh S.; Nazari F.; Rezaei A.; Saeedi-Boroujeni A.; Nabavi M.; Arshi S.; Fallahpour M.; Bemanian M.; Sharafian S.; Shokri S.; Eshaghi S.; Nazari S.; Shamsian B.S.; Dargahi Mal-Amir M.; Khazaei R.; Ashkevari P.; Khavandegar A.; Haghi S.; Esmaeili M.; Abolhassani H.; Rezaei N. Diversity of malignancies in patients with different types of inborn errors of immunity 2022 Allergy, Asthma and Clinical Immunology
203. Shobeiri P.; Bagherieh S.; Mirzayi P.; Kalantari A.; Mirmosayyeb O.; Teixeira A.L.; Rezaei N. Serum and plasma levels of brain-derived neurotrophic factor in individuals with eating disorders (EDs): a systematic review and meta-analysis 2022 Journal of Eating Disorders
204. Sun M.; Rezaei N.; Firoozabadi A. Mitigating paraffin wax deposition by dispersants and crystal modifiers in flow testing 2022 Fuel
205. Kian N.; Behrouzieh S.; Razi S.; Rezaei N. Diet Influences Immunotherapy Outcomes in Cancer Patients: A Literature Review 2023 Nutrition and Cancer
206. Khanmohammadi S.; Zoghi S.; Rayzan E.; Shahkarami S.; Heredia R.J.; Frohne A.; Seyedpour S.; Boztug K.; Rezaei N. A Rare PTPN11 Mutation in a Patient with Juvenile Myelomonocytic Leukemia: A Case Report 2022 Current Pharmacogenomics and Personalized Medicine
207. Mirzayi P.; Shobeiri P.; Kalantari A.; Perry G.; Rezaei N. Optogenetics: implications for Alzheimer’s disease research and therapy 2022 Molecular Brain
208. Hanaei S.; Rezaei N. Preface to the Book 2023 Advances in Experimental Medicine and Biology
209. Javanmehr N.; Saleki K.; Alijanizadeh P.; Rezaei N. Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases 2022 Journal of Neuroinflammation
210. Fayyaz F.; Yazdanpanah N.; Rezaei N. Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer 2022 Cell Communication and Signaling
211. Zalpoor H.; Aziziyan F.; Liaghat M.; Bakhtiyari M.; Akbari A.; Nabi-Afjadi M.; Forghaniesfidvajani R.; Rezaei N. The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors 2022 Cell Communication and Signaling
212. Aliasin M.M.; Yazdanpanah N.; Rezaei N. Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines-where do we stand? 2022 Reviews in the Neurosciences
213. Mehrabi F.; Farshbafnadi M.; Rezaei N. Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis 2023 Clinical and Applied Thrombosis/Hemostasis
214. Mohammadi H.; Mohammadpour Ahranjani B.; Aghaei Moghadam E.; Kompani F.; Mirbeyk M.; Rezaei N. Hematological indices in pediatric patients with acyanotic congenital heart disease: a cross-sectional study of 248 patients 2022 Egyptian Journal of Medical Human Genetics
215. Rafiyan M.; Sadeghmousavi S.; Akbarzadeh M.; Rezaei N. Experimental animal models of chronic inflammation 2023 Current Research in Immunology
216. Tabari M.A.K.; Khandan M.; Mirjalili R.; Bhadra N.; Mathivathanan K.; Veeramani V.P.; Rezaei N. Corticosteroids Therapy for COVID-19-Induced Hyposmia and Anosmia 2022 B-ENT
217. Sanatkar S.A.; Heidari A.; Rezaei N. Cancer Immunotherapy: Diverse Approaches and Obstacles 2022 Current Pharmaceutical Design
218. Yazdanpanah N.; Rezaei N. Introduction on autoimmune rheumatic diseases 2023 Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases
219. Heidari A.; Rezaei N. The role of neurofilament light chain in COVID-19A potential prognostic biomarker 2023 Acta Neurobiologiae Experimentalis
220. Sadeghalvad M.; Mansourabadi A.H.; Noori M.; Nejadghaderi S.A.; Masoomikarimi M.; Alimohammadi M.; Rezaei N. Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies 2023 Reviews in Medical Virology
221. Shobeiri P.; Kalantari A.; Teixeira A.L.; Rezaei N. Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders 2022 Biology of Sex Differences
222. Haeuser E.; et al. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018 2022 BMC Medicine
223. Keshavarzi E.; Noveiry B.B.; Rezaei N. The relationship between GAD65 autoantibody and the risk of T1DM onset 2022 Journal of Diabetes and Metabolic Disorders
224. Noori M.; Nejadghaderi S.A.; Rezaei N. Original antigenic sin: A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants 2022 Infection Control and Hospital Epidemiology
225. Mahdiabadi S.; Rezaei N. Anaphylaxis and allergic reactions to COVID-19 vaccines: A narrative review of characteristics and potential obstacles on achieving herd immunity 2022 Health Science Reports
226. Makuku R.; Sinaei Far Z.; Khalili N.; Moyo A.; Razi S.; Keshavarz-Fathi M.; Mahmoudi M.; Rezaei N. The Role of Ketogenic Diet in the Treatment of Neuroblastoma 2023 Integrative Cancer Therapies
227. Afzali S.; Rezaei N.; Zendehboudi S.; Chatzis I. Computational fluid dynamic simulation of multi-phase flow in fractured porous media during water-alternating-gas injection process 2022 Journal of Hydrology
228. Rezaei N. Preface 2023 Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases
229. Zuo F.; Abolhassani H.; Du L.; Piralla A.; Bertoglio F.; de Campos-Mata L.; Wan H.; Schubert M.; Cassaniti I.; Wang Y.; Sammartino J.C.; Sun R.; Vlachiotis S.; Bergami F.; Kumagai-Braesch M.; Andréll J.; Zhang Z.; Xue Y.; Wenzel E.V.; Calzolai L.; Varani L.; Rezaei N.; Chavoshzadeh Z.; Baldanti F.; Hust M.; Hammarström L.; Marcotte H.; Pan-Hammarström Q. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant 2022 Nature Communications
230. Mehrabi Nejad M.-M.; Shobeiri P.; Dehghanbanadaki H.; Tabary M.; Aryannejad A.; Haji Ghadery A.; Shabani M.; Moosaie F.; SeyedAlinaghi S.A.; Rezaei N. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis 2022 Virology Journal
231. Sepanlou S.G.; et al. Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019 2022 Archives of Iranian Medicine
232. Mahdiabadi S.; Rajabi F.; Tavakolpour S.; Rezaei N. Immunological aspects of COVID-19-related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence 2022 Dermatologic Therapy
233. Abolhassani H.; Avcin T.; Bahceciler N.; Balashov D.; Bata Z.; Bataneant M.; Belevtsev M.; Bernatowska E.; Bidló J.; Blazsó P.; Boisson B.; Bolkov M.; Bondarenko A.; Boyarchuk O.; Bundschu A.; Casanova J.-L.; Chernishova L.; Ciznar P.; Csürke I.; Erdős M.; Farkas H.; Fomina D.S.; Galal N.; Goda V.; Guner S.N.; Hauser P.; Ilyina N.I.; Iremadze T.; Iritsyan S.; Ismaili-Jaha V.; Jesenak M.; Kelecic J.; Keles S.; Kindle G.; Kondratenko I.V.; Kostyuchenko L.; Kovzel E.; Kriván G.; Kuli-Lito G.; Kumánovics G.; Kurjane N.; Latysheva E.A.; Latysheva T.V.; Lázár I.; Markelj G.; Markovic M.; Maródi L.; Mammadova V.; Medvecz M.; Miltner N.; Mironska K.; Modell F.; Modell V.; Mosdósi B.; Mukhina A.A.; Murdjeva M.; Műzes G.; Nabieva U.; Nasrullayeva G.; Naumova E.; Nagy K.; Onozó B.; Orozbekova B.; Pac M.; Pagava K.; Pampura A.N.; Pasic S.; Petrosyan M.; Petrovic G.; Pocek L.; Prodeus A.P.; Reisli I.; Ress K.; Rezaei N.; Rodina Y.A.; Rumyantsev A.G.; Sciuca S.; Sediva A.; Serban M.; Sharapova S.; Shcherbina A.; Sitkauskiene B.; Snimshchikova I.; Spahiu-Konjusha S.; Szolnoky M.; Szűcs G.; Toplak N.; Tóth B.; Tsyvkina G.; Tuzankina I.; Vlasova E.; Volokha A. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021 2022 Frontiers in Immunology
234. Mojtabavi H.; Shaka Z.; Momtazmanesh S.; Ajdari A.; Rezaei N. Circulating brain-derived neurotrophic factor as a potential biomarker in stroke: a systematic review and meta-analysis 2022 Journal of Translational Medicine
235. Baris S.; Abolhassani H.; Massaad M.J.; Al-Nesf M.; Chavoshzadeh Z.; Keles S.; Reisli I.; Tahiat A.; Shendi H.M.; Elaziz D.A.; Belaid B.; Al Dhaheri F.; Haskologlu S.; Dogu F.; Ben-Mustapha I.; Sobh A.; Galal N.; Meshaal S.; Elhawary R.; El-marsafy A.; Alroqi F.J.; Al-Saud B.; Al-Ahmad M.; Al Farsi T.; AL Sukaiti N.; Al-Tamemi S.; Mehawej C.; Dbaibo G.; ElGhazali G.; Kilic S.S.; Genel F.; Kiykim A.; Musabak U.; Artac H.; Guner S.N.; Boukari R.; Djidjik R.; Kechout N.; Cagdas D.; El-Sayed Z.A.; Karakoc-Aydiner E.; Alzyoud R.; Barbouche M.R.; Adeli M.; Wakim R.H.; Reda S.M.; Ikinciogullari A.; Ozen A.; Bousfiha A.; Al-Mousa H.; Rezaei N.; Al-Herz W.; Geha R.S. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity 2023 Journal of Allergy and Clinical Immunology: In Practice
236. Saghazadeh A.; Rezaei N. Poxviruses and the immune system: Implications for monkeypox virus 2022 International Immunopharmacology
237. Abolhassani H.; Delavari S.; Landegren N.; Shokri S.; Bastard P.; Du L.; Zuo F.; Hajebi R.; Abolnezhadian F.; Iranparast S.; Modaresi M.; Vosughimotlagh A.; Salami F.; Aranda-Guillén M.; Cobat A.; Marcotte H.; Zhang S.-Y.; Zhang Q.; Rezaei N.; Casanova J.-L.; Kämpe O.; Hammarström L.; Pan-Hammarström Q. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19 2022 Journal of Allergy and Clinical Immunology
238. Samami E.; Aleebrahim-Dehkordi E.; Mohebalizadeh M.; Yaribash S.; Saghazadeh A.; Rezaei N. Inosine, gut microbiota, and cancer immunometabolism 2023 American journal of physiology. Endocrinology and metabolism
239. Khaboushan A.S.; Pahlevan-Fallahy M.-T.; Shobeiri P.; Teixeira A.L.; Rezaei N. Cytokines and chemokines profile in encephalitis patients: A meta-analysis 2022 PLoS ONE
240. Safaei R.; Mojtahedi H.; Hanaei S.; Razavi A.; Esmaeili M.; Sadr M.; Rezaei A.; Edalatfar M.; Kashani H.K.; Sadeghi-Naini M.; Darbeheshti F.; Gharehdaghi J.; Forouzesh M.; Ebrahimi A.; Rezaei N. MGMT Gene rs1625649 Polymorphism in Iranian Patients with Brain Glioblastoma: A Case Control Study 2023 Avicenna Journal of Medical Biotechnology
241. Nejadghaderi S.A.; Razi S.; Keshavarz-Fathi M.; Rezaei N. Immune checkpoint inhibition for pancreatic cancer 2023 Acta Medica Iranica
242. Shobeiri P.; Seyedmirzaei H.; Kalantari A.; Mohammadi E.; Rezaei N.; Hanaei S. The Epidemiology of Brain and Spinal Cord Tumors 2023 Advances in Experimental Medicine and Biology
243. Iranmehr A.; Namvar M.; Rezaei N.; Hanaei S. Brain and Spinal Cord Tumors Among the Life-Threatening Health Problems: An Introduction 2023 Advances in Experimental Medicine and Biology
244. Pour-Rashidi A.; Namvar M.; Iranmehr A.; Carpaneto A.; Hanaei S.; Rezaei N. Psychological and Psychiatric Aspects of Brain and Spinal Cord Tumors 2023 Advances in experimental medicine and biology
245. Asnaashari K.; Rezaei N. Rheumatologic manifestations of autoinflammatory diseases 2023 Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases
246. Yazdanpanah N.; Rezaei A.; Ziaee V.; Rezaei N. Study of NLRP3 Single Nucleotide Polymorphisms in Juvenile Systemic Lupus Erythematosus (JSLE) 2023 Immunological Investigations
247. Saghazadeh A.; Rezaei N. Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression 2022 International Immunopharmacology
248. Frostad J.J.; et al. Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study 2022 The Lancet Global Health
249. Farhangnia P.; Dehrouyeh S.; Safdarian A.R.; Farahani S.V.; Gorgani M.; Rezaei N.; Akbarpour M.; Delbandi A.-A. Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials 2022 International Immunopharmacology
250. Foroumadi R.; Rashedi S.; Asgarian S.; Mardani M.; Keykhaei M.; Farrokhpour H.; Javanshir S.; Sarallah R.; Rezaei N. Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta-analysis 2022 Cancer Reports
251. Sodeifian F.; Samieefar N.; Shahkarami S.; Rayzan E.; Seyedpour S.; Rohlfs M.; Klein C.; Babaie D.; Rezaei N. DNAH11 and a Novel Genetic Variant Associated with Situs Inversus: A Case Report and Review of the Literature 2023 Case Reports in Medicine
252. Jamee M.; Azizi G.; Baris S.; Karakoc-Aydiner E.; Ozen A.; Kiliç S.Ş.; Kose H.; Chavoshzadeh Z.; Mahdaviani S.A.; Momen T.; Shamsian B.S.; Fallahi M.; Sharafian S.; Gülez N.; Aygun A.; Karaca N.E.; Kutukculer N.; Al Sukait N.; Al Farsi T.; Al-Tamemi S.; Khalifa N.; Shereen R.; El-Ghoneimy D.; El-Owaidy R.; Radwan N.; Alzyoud R.; Barbouche M.-R.; Ben-Mustapha I.; Mekki N.; Rais A.; Boukari R.; Belbouab R.; Djenouhat K.; Tahiat A.; Touri S.; Elghazali G.; Al-Hammadi S.; Shendi H.M.; Alkuwaiti A.; Belaid B.; Djidjik R.; Artac H.; Adeli M.; Sobh A.; Elnagdy M.H.; Bahgat S.A.; Nasrullayeva G.; Chou J.; Rezaei N.; Al-Herz W.; Geha R.S.; Abolhassani H. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry 2022 Clinical Immunology
253. Shafeghat M.; Kazemian S.; Aminorroaya A.; Aryan Z.; Rezaei N. Toll-like receptor 7 regulates cardiovascular diseases 2022 International Immunopharmacology
254. Rahmah L.; Abarikwu S.O.; Arero A.G.; Essouma M.; Jibril A.T.; Fal A.; Flisiak R.; Makuku R.; Marquez L.; Mohamed K.; Ndow L.; Zarębska-Michaluk D.; Rezaei N.; Rzymski P. Oral antiviral treatments for COVID-19: opportunities and challenges 2022 Pharmacological Reports
255. Rahmah L.; Abarikwu S.O.; Arero A.G.; Essouma M.; Jibril A.T.; Fal A.; Flisiak R.; Makuku R.; Marquez L.; Mohamed K.; Ndow L.; Zarębska-Michaluk D.; Rezaei N.; Rzymski P. Correction: Oral antiviral treatments for COVID-19: opportunities and challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/s43440-022-00388-7) 2022 Pharmacological Reports
256. Nejadghaderi S.A.; Balibegloo M.; Noori M.; Fayyaz F.; Saghazadeh A.; Rezaei N. Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis 2023 Expert Review of Anticancer Therapy
257. Hosseini M.; Seyedpour S.; Khodaei B.; Loghman A.-H.; Seyedpour N.; Yazdi M.-H.; Rezaei N. Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review 2023 Vaccines
258. Zafari R.; Razi S.; Rezaei N. The role of dendritic cells in neuroblastoma: Implications for immunotherapy 2022 Immunobiology
259. Pour-Rashidi A.; Mohammadi E.; Rezaei N.; Hanaei S. Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors 2023 Advances in Experimental Medicine and Biology
260. Rashedi S.; Mardani M.; Rafati A.; Khavandi M.M.; Mohammadi F.; Javanshir S.; Sarallah R.; Dolatshahi M.; Sabahi M.; Azadnajafabad S.; Tavolinejad H.; Rezaei N. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma 2022 Journal of Clinical Laboratory Analysis
261. Fathi N.; Saadati A.; Alimohammadi M.; Abolhassani H.; Sharifi S.; Rezaei N.; Hasanzadeh M. Biosensors for the detection of protein kinases: Recent progress and challenges 2022 Microchemical Journal
262. Sepanlou S.G.; et al. Neonate, Infant, and Child Mortality by Cause in Provinces of Iran: An Analysis for the Global Burden of Disease Study 2019 2022 Archives of Iranian Medicine
263. Fathi N.; Mojtahedi H.; Nasiri M.; Abolhassani H.; Yousefpour Marzbali M.; Esmaeili M.; Salami F.; Biglari F.; Rezaei N. How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity? 2023 Expert Review of Clinical Immunology
264. Rezaei N. Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases 2023 Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases
265. Maródi L.; Abolhassani H.; Avcin T.; Bahceciler N.; Bataneant M.; Belevtsev M.; Bernatowska E.; Bolkov M.; Bondarenko A.; Boyarchuk O.; Erdős M.; Galal N.; Iritsyan S.; Ismaili-Jaha V.; Kelecic J.; Keles S.; Kostyuchenko L.; Kovzel E.; Kuli-Lito G.; Kurjane N.; Lázár I.; Litzman J.; Mammadova V.; Miltner N.; Mironska K.; Murdjeva M.; Nabieva U.; Nasrullayeva G.; Naumova E.; Orozbekova B.; Pac M.; Pagava K.; Petrosyan M.; Petrovic G.; Pocek L.; Reisli I.; Ress K.; Rezaei N.; Sciuca S.; Sediva A.; Serban M.; Sharapova S.; Snimshchikova I.; Spahiu-Konjusha S.; Toplak N.; Tuzankina I.; Volokha A. A Rose Amongst the Thorns: the Mission of the J Project in a Conflictual World 2022 Journal of Clinical Immunology
266. Lotfi M.E.; Pezeshki P.S.; Rezaei N. The role of interleukins in pathogenesis and prognosis of atrial fibrillation 2023 Expert Review of Clinical Immunology
267. Momtazmanesh S.; Nowroozi A.; Rezaei N. Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review 2022 Rheumatology and Therapy
268. Nejadghaderi S.A.; et al. Burden of thyroid cancer in North Africa and Middle East 1990–2019 2022 Frontiers in Oncology
269. Moslemizadeh A.; Nematollahi M.H.; Amiresmaili S.; Faramarz S.; Jafari E.; Khaksari M.; Rezaei N.; Bashiri H.; Kheirandish R. Combination therapy with interferon-gamma as a potential therapeutic medicine in rat's glioblastoma: A multi-mechanism evaluation 2022 Life Sciences
270. Hamedi H.; Rezaei N.; Zendehboudi S. A comprehensive review on demulsification using functionalized magnetic nanoparticles 2022 Journal of Cleaner Production
271. Karimi N.; Bayram Çatak F.; Arslan E.; Saghazadeh A.; Rezaei N. Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy 2022 International Immunopharmacology
272. Haghshomar M.; Shobeiri P.; Brand S.; Rossell S.L.; Akhavan Malayeri A.; Rezaei N. Changes of symptoms of eating disorders (ED) and their related psychological health issues during the COVID-19 pandemic: a systematic review and meta-analysis 2022 Journal of Eating Disorders
273. Rezaei N.; Saghazadeh A. Loneliness and health: An umbrella review 2022 Heart and Mind
274. Kacimi S.E.O.; Moeinafshar A.; Haghighi S.S.; Saghazadeh A.; Rezaei N. Venous thromboembolism in cancer and cancer immunotherapy 2022 Critical Reviews in Oncology/Hematology
275. Pourakbari B.; Mirbeyk M.; Mahmoudi S.; Hosseinpour Sadeghi R.H.; Rezaei N.; Ghasemi R.; Esfandiari F.; Mamishi S. Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran 2022 Journal of Medical Virology
276. Rahmani S.; Yazdanpanah N.; Rezaei N. Natural killer cells and acute myeloid leukemia: promises and challenges 2022 Cancer Immunology, Immunotherapy
277. Beheshtizadeh N.; Gharibshahian M.; Pazhouhnia Z.; Rostami M.; Zangi A.R.; Maleki R.; Azar H.K.; Zalouli V.; Rajavand H.; Farzin A.; Lotfibakhshaiesh N.; Sefat F.; Azami M.; Webster T.J.; Rezaei N. Commercialization and regulation of regenerative medicine products: Promises, advances and challenges 2022 Biomedicine and Pharmacotherapy
278. Yazdanpanah N.; Ziaei H.; Loghman A.; Lotfabadi A.S.; Akbarzadehmoallemkolaei M.; Zolfaghari K.; Bagheri A.; Nejad M.A.T.; Mohamed K.; Razi S.; Eslami A.; Mirbeyk M.; Naserpour M.; Jaberipour A.; Ashkevarian S.; Keshavarz-Fathi M.; Rezaei N. USERNversity: A New Educational Innovation to Improve Young Scholars’ Skills via Extracurricular Programs 2023 Acta Medica Iranica
279. Sadeghmousavi S.; Rezaei N.; Hanaei S. Nutrition and Diet: A Double-Edged Sword in Development and Treatment of Brain Tumors 2023 Advances in Experimental Medicine and Biology
280. Shobeiri P.; Seyedmirzaei H.; Karimi N.; Rashidi F.; Teixeira A.L.; Brand S.; Sadeghi-Bahmani D.; Rezaei N. IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis 2022 European Journal of Medical Research
281. Noori M.; Fayyaz F.; Rezaei N. Safety and efficacy of Elotuzumab combination therapy for patients with multiple myeloma: A systematic review and meta-analysis 2023 Expert Review of Anticancer Therapy
282. Khanmohammadi S.; Rezaei N. CAR-NK cells: a promising cellular immunotherapy in lymphoma 2023 Expert Opinion on Biological Therapy
283. Abhari A.P.; Etemadifar M.; Yazdanpanah N.; Rezaei N. N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective 2022 Mini-Reviews in Medicinal Chemistry
284. Saghazadeh A.; Rezaei N. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review 2022 International Immunopharmacology
285. Reiner R.C., Jr.; et al. The overlapping burden of the three leading causes of disability and death in sub-Saharan African children 2022 Nature Communications
286. Azarpour A.; Mohammadzadeh O.; Rezaei N.; Zendehboudi S. Current status and future prospects of renewable and sustainable energy in North America: Progress and challenges 2022 Energy Conversion and Management
287. Gharibpoor F.; Kamali Zonouzi S.; Razi S.; Rezaei N. AMPK’s double-faced role in advanced stages of prostate cancer 2022 Clinical and Translational Oncology
288. Tran K.B.; et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 2022 The Lancet
289. Sharifinejad N.; Azizi G.; Chavoshzadeh Z.; Mahdaviani S.A.; Alan M.S.; Tavakol M.; Sadri H.; Nabavi M.; Ebrahimi S.S.; Shirkani A.; Vosughi Motlagh A.; Safarirad M.; Aghamahdi F.; Nazari F.; Delavari S.; Jamee M.; Fayyaz F.; Samimisedeh P.; Matani R.; Esmaeili M.; Yazdani R.; Rezaei N.; Abolhassani H. Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features 2022 Frontiers in Immunology
290. Rasouli S.E.; Tavakol M.; Sadri H.; Chavoshzadeh Z.; Mahdaviani S.A.; Delavari S.; Jamee M.; Kalantari A.; Alan M.S.; Aghamahdi F.; Abolhassani H.; Yazdani R.; Rezaei N.; Azizi G. The spectrum of inborn errors of immunity: a single tertiary center retrospective study in Alborz, Iran 2023 European Annals of Allergy and Clinical Immunology
291. Razavi A.S.; Loskog A.; Razi S.; Rezaei N. The signaling and the metabolic differences of various CAR T cell designs 2023 International Immunopharmacology
292. Darbeheshti F.; Kadkhoda S.; Keshavarz-Fathi M.; Razi S.; Bahramy A.; Mansoori Y.; Rezaei N. Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness 2022 BMC Cancer
293. Danandeh K.; Jabbari P.; Rayzan E.; Zoghi S.; Shahkarami S.; Heredia R.J.; Krolo A.; Shamsian B.S.; Boztug K.; Rezaei N. Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient 2022 Endocrine, Metabolic and Immune Disorders - Drug Targets
294. Nowroozi A.; Momtazmanesh S.; Rezaei N. COVID-19 and MAFLD/NAFLD: An updated review 2023 Frontiers in Medicine
295. Heidari A.; Yazdanpanah N.; Rezaei N. The role of Toll-like receptors and neuroinflammation in Parkinson’s disease 2022 Journal of Neuroinflammation
296. Noori M.; Mahjoubfar A.; Azizi S.; Fayyaz F.; Rezaei N. Immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric and esophageal cancers: A systematic review and meta-analysis 2022 International Immunopharmacology
297. Azangou-Khyavy M.; et al. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019 2022 Scientific Reports
298. Shemirani F.; Djafarian K.; Fotouhi A.; Azadbakht L.; Rezaei N.; Chamari M.; Shabani S.; Mahmoudi M. Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial 2022 Clinical Nutrition ESPEN
299. Rezaei N. Preface 2022 Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5
300. Bahreini F.; Rayzan E.; Rezaei N. MicroRNAs and Diabetes Mellitus Type 1 2022 Current Diabetes Reviews
301. Razavi A.S.; Mohtashami M.; Razi S.; Rezaei N. TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: Foes or friends? 2022 Cytokine
302. Arab F.; Rezaei N.; Taheri F.; Kouhpeikar H.; Rayzan E.; Mirbeyk M.; Zare-Abdollahi D.; Ghadami M. Clinical and Molecular Assessment of Iranian Families with Severe Congenital Neutropenia, Identification of HYOU1 and SHOC2 as Potential Novel Gene Defects 2022 Iranian Journal of Allergy, Asthma and Immunology
303. Karimi A.; Ghafouri P.; Alilou S.; Rezaei N.; Talesh S.A.; Ashraf H. Echocardiographic Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review 2022 Iranian Journal of Pediatrics
304. Mahdavi Sharif P.; Pastaki Khoshbin A.; Nasrollahzadeh E.; Keshavarz-Fathi M.; Rezaei N. Tumor immunology 2022 Clinical Immunology
305. Yazdanpanah N.; Rezaei N. Autoimmune disorders associated with common variable immunodeficiency: prediction, diagnosis, and treatment 2022 Expert Review of Clinical Immunology
306. Yazdanpanah N.; Rezaei N. Introduction on challenges for autoimmune diseases 2022 Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5
307. Papari M.; Uddin M.N.; Rezaei N. An adaptive Neuro-Fuzzy Model-Based Algorithm for Fault Detection in PV Systems 2022 Conference Record - IAS Annual Meeting (IEEE Industry Applications Society)
308. Kian N.; Samieefar N.; Rezaei N. Prenatal risk factors and genetic causes of ADHD in children 2022 World Journal of Pediatrics
309. Demir D.D.; Asnaashari K.; Rezaei N.; Özen A. Management of Inborn Errors of Immunity in the Genomic Era 2022 Turkish Archives of Pediatrics
310. Rezaei N. Encyclopedia of Infection and Immunity, Four Volume Set 2022 Encyclopedia of Infection and Immunity
311. Rezaei N. Preface 2022 Encyclopedia of Infection and Immunity
312. Saghazadeh A.; Rezaei N. Evaluating COVID-19–Environment Fit 2022 Acta Biomedica
313. Rezaei N.; Yazdanpanah N. Autoimmune diseases in different organs 2022 Translational Autoimmunity: Autoimmune Diseases in Different Organs
314. Deravi N.; Poudineh M.; Pirzadeh M.; Yavarpour-Bali H.; Mehrabi H.; Erabi G.; Saghazadeh A.; Rezaei N. The Yin and Yang of toll-like receptors in endothelial dysfunction 2022 International Immunopharmacology
315. Farhangnia P.; Akbarpour M.; Yazdanifar M.; Aref A.R.; Delbandi A.-A.; Rezaei N. Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives 2022 Expert Review of Clinical Immunology
316. Salmanpour F.; Kian N.; Samieefar N.; Khazeei Tabari M.A.; Rezaei N. Asthma and Vitamin D Deficiency: Occurrence, Immune Mechanisms, and New Perspectives 2022 Journal of Immunology Research
317. Fan Y.; Murgia M.; Linder M.I.; Mizoguchi Y.; Wang C.; Łyszkiewicz M.; Ziȩtara N.; Liu Y.; Frenz S.; Sciuccati G.; Partida-Gaytan A.; Alizadeh Z.; Rezaei N.; Rehling P.; Dennerlein S.; Mann M.; Klein C. HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation 2022 Journal of Clinical Investigation
318. El-Sayed Z.A.; El-Ghoneimy D.H.; Ortega-Martell J.A.; Radwan N.; Aldave J.C.; Al-Herz W.; Al-Nesf M.A.; Condino-Neto A.; Cole T.; Eley B.; Erwa N.H.H.; Espinosa-Padilla S.; Faria E.; Rosario Filho N.A.; Fuleihan R.; Galal N.; Garabedian E.; Hintermeyer M.; Imai K.; Irani C.; Kamal E.; Kechout N.; Klocperk A.; Levin M.; Milota T.; Ouederni M.; Paganelli R.; Pignata C.; Qamar F.N.; Quinti I.; Qureshi S.; Radhakrishnan N.; Rezaei N.; Routes J.; Singh S.; Siniah S.; Abdel-Hakam Taha I.; Tanno L.K.; Van Dort B.; Volokha A.; Sullivan K. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study 2022 World Allergy Organization Journal
319. Yousefi H.; Gholami M.; Zoughi M.; Rezaei N.; Chuppani A.; Nikfar S.; Amoli M.M. Role of genetic polymorphisms in recurrent aphthous stomatitis: A systematic review and meta-analysis 2022 Cytokine
320. Saghazadeh A.; Rezaei N. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis 2022 Journal of Interferon and Cytokine Research
321. Farzadfar F.; et al. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 2022 The Lancet
322. Shahin T.; Mayr D.; Shoeb M.R.; Kuehn H.S.; Hoeger B.; Giuliani S.; Gawriyski L.M.; Petronczki Ö.Y.; Hadjadj J.; Bal S.K.; Zoghi S.; Haimel M.; Heredia R.J.; Boutboul D.; Triebwasser M.P.; Rialland-Battisti F.; Chalumeau N.C.; Quartier P.; Tangye S.G.; Fleisher T.A.; Rezaei N.; Romberg N.; Latour S.; Varjosalo M.; Halbritter F.; Rieux-Laucat F.; Castanon I.; Rosenzweig S.D.; Boztug K. Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation 2022 Blood Advances
323. Farmani A.R.; Mahdavinezhad F.; Scagnolari C.; Kouhestani M.; Mohammadi S.; Ai J.; Shoormeij M.H.; Rezaei N. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19 2022 Drug Delivery and Translational Research
324. Sadeghalvad M.; Rezaei N. Introduction on Laboratory Tests for Diagnosis of Infectious Diseases and Immunological Disorders 2022 Encyclopedia of Infection and Immunity
325. Saghazadeh A.; Rezaei N. COVID-19 Starts the War, but Neopterin Fights the Self: Anti-Neopterin Antibodies for COVID-19 Treatment in Severe Cases 2022 Acta Medica Iranica
326. Khanmohammadi S.; Shad T.M.; Delavari S.; Shirmast P.; Bagheri Y.; Azizi G.; Aghamohammadi A.; Abolhassani H.; Yazdani R.; Rezaei N. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia 2022 Endocrine, Metabolic and Immune Disorders - Drug Targets
327. Farshbafnadi M.; Razi S.; Rezaei N. Transplantation 2022 Clinical Immunology
328. Jamee M.; Rezaei N. Autoinflammatory disorders 2022 Translational Autoimmunity: Autoimmune Diseases in Different Organs
329. Rezaei N. Clinical Immunology 2022 Clinical Immunology
330. Samieefar N.; Rashedi R.; Akhlaghdoust M.; Mashhadi M.; Darzi P.; Rezaei N. Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics 2022 Acta bio-medica : Atenei Parmensis
331. Sharma R.; et al. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2022 The Lancet Gastroenterology and Hepatology
332. Tofighi Zavareh F.; Mirshafiey A.; Yazdani R.; Keshtkar A.A.; Abolhassani H.; Mahdaviani S.A.; Habibi S.; Sohani M.; Rezaei N.; Aghamohammadi A. Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects 2022 Scandinavian Journal of Immunology
333. Rezaei N.; Jabbari P. Immunoinformatics of Cancers 2022 Immunoinformatics of Cancers: Practical Machine Learning Approaches Using R
334. Soltani Khaboushan A.; Yazdanpanah N.; Rezaei N. Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis 2022 Molecular Neurobiology
335. Hanaei S.; Takian A.; Majdzadeh R.; Maboloc C.R.; Grossmann I.; Gomes O.; Milosevic M.; Gupta M.; Shamshirsaz A.A.; Harbi A.; Burhan A.M.; Uddin L.Q.; Kulasinghe A.; Lam C.-M.; Ramakrishna S.; Alavi A.; Nouwen J.L.; Dorigo T.; Schreiber M.; Abraham A.; Shelkovaya N.; Krysztofiak W.; Ebrahimi Warkiani M.; Sellke F.; Ogino S.; Barba F.J.; Brand S.; Vasconcelos C.; Salunke D.B.; Rezaei N. Emerging Standards and the Hybrid Model for Organizing Scientific Events during and after the COVID-19 Pandemic 2022 Disaster Medicine and Public Health Preparedness
336. Sadeghmousavi S.; Shahkarami S.; Rayzan E.; Ahmed S.; Gharalari F.H.; Rohlfs M.; Klein C.; Rezaei N. A 3-Year-Old Boy with an Xp21 Deletion Syndrome: A Case Report 2022 Endocrine, Metabolic and Immune Disorders - Drug Targets
337. Cousin E.; et al. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 2022 The Lancet Diabetes and Endocrinology
338. Rezaei N.; Sadeghalvad M.; Mohammadi-Motlagh H.-R. General Concepts of Immunity 2022 Encyclopedia of Infection and Immunity
339. Zoghi S.; Masoumi F.; Rezaei N. The immune system 2022 Clinical Immunology
340. Rezaei N.; Yazdanpanah N. Introduction on autoimmunity and associated conditions 2022 Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features
341. Haakenstad A.; et al. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 2022 The Lancet
342. Shobeiri P.; Karimi A.; Momtazmanesh S.; Teixeira A.L.; Teunissen C.E.; van Wegen E.E.H.; Hirsch M.A.; Yekaninejad M.S.; Rezaei N. Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials 2022 PLoS ONE
343. Khanmohammadi S.; Rezaei N. Influenza Viruses 2022 Encyclopedia of Infection and Immunity
344. Hassan S.S.; Choudhury P.P.; Dayhoff G.W., II; Aljabali A.A.A.; Uhal B.D.; Lundstrom K.; Rezaei N.; Pizzol D.; Adadi P.; Lal A.; Soares A.; Mohamed Abd El-Aziz T.; Brufsky A.M.; Azad G.K.; Sherchan S.P.; Baetas-da-Cruz W.; Takayama K.; Serrano-Aroca Ã.; Chauhan G.; Palu G.; Mishra Y.K.; Barh D.; Santana Silva R.J.; Andrade B.S.; Azevedo V.; Góes-Neto A.; Bazan N.G.; Redwan E.M.; Tambuwala M.; Uversky V.N. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2 2022 Archives of Biochemistry and Biophysics
345. Salami F.; Shariati S.; Rasouli S.E.; Delavari S.; Tavakol M.; Sadri H.; Asghari B.; Yazdani R.; Rezaei N.; Abolhassani H.; Azizi G. The Effects of Stimulation with PMA/Ionomycin on CD4+ T Cell Proliferation and Surface CD4 Molecule Modulation of Patients with LRBA Deficiency and CVID with the Unsolved Genetic Defect 2022 Endocrine, Metabolic and Immune Disorders - Drug Targets
346. Rezaei N. Preface 2022 Clinical Immunology
347. Saghazadeh A.; Rezaei N. Vascular endothelial growth factor levels in tuberculosis: A systematic review and metaanalysis 2022 PLoS ONE
348. Zahedi R.; Eskandarpanah R.; Akbari M.; Rezaei N.; Mazloumin P.; Farahani O.N. Development of a New Simulation Model for the Reservoir Hydropower Generation 2022 Water Resources Management
349. Ledesma J.R.; et al; Zumla A.; Mokdad A.H.; Salomon J.A.; Reiner R.C., Jr.; Lim S.S.; Naghavi M.; Vos T.; Hay S.I.; Murray C.J.L.; Kyu H.H. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 2022 The Lancet Infectious Diseases
350. Reza Khami M.; Asgari S.; Valizadeh S.; Karami J.; Rezaei A.; Rezaei N. AMELX and ENAM Polymorphisms and Dental Caries 2022 Genetics Research
351. Zamani R.; Pouremamali R.; Rezaei N. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies 2022 Reviews in the Neurosciences
352. Rezaei N. Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5 2022 Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5
353. Nichols E.; et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 2022 The Lancet Public Health
354. Mahdiabadi S.; Momtazmanesh S.; Perry G.; Rezaei N. Immune modulations and immunotherapies for Alzheimer's disease: A comprehensive review 2022 Reviews in the Neurosciences
355. Gharehzadehshirazi A.; Amini A.; Rezaei N. Hyper IgE syndromes: A clinical approach 2022 Clinical Immunology
356. Torabi S.; Bahreini F.; Rezaei N. Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19 2022 Infectious Disorders - Drug Targets
357. Pezeshki P.S.; Nowroozi A.; Razi S.; Rezaei N. Asthma and Allergy 2022 Clinical Immunology
358. Zinatizadeh M.R.; Zarandi P.K.; Zinatizadeh M.; Yousefi M.H.; Amani J.; Rezaei N. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines 2022 Biomedicine and Pharmacotherapy
359. Rezaei N. Preface 2022 Translational Autoimmunity: Autoimmune Diseases in Different Organs
360. Mahdiabadi S.; Rezaei N. Defects in Innate Immunity: Receptors and Signaling Components 2022 Encyclopedia of Infection and Immunity
361. Mohammadi-Motlagh H.-R.; Sadeghalvad M.; Rezaei N. Organs and Tissues of the Immune System 2022 Encyclopedia of Infection and Immunity
362. Moeinafshar A.; Razi S.; Rezaei N. Interleukin 17, the double-edged sword in atherosclerosis 2022 Immunobiology
363. Moeini Shad T.; Yazdani R.; Amirifar P.; Delavari S.; Heidarzadeh Arani M.; Mahdaviani S.A.; Sadeghi-Shabestari M.; Aghamohammadi A.; Rezaei N.; Abolhassani H. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature 2022 Frontiers in Immunology
364. Rahmani S.; Rezaei N. Omicron (B.1.1.529) variant: Development, dissemination, and dominance 2022 Journal of Medical Virology
365. Mohamed K.; Rzymski P.; Islam M.S.; Makuku R.; Mushtaq A.; Khan A.; Ivanovska M.; Makka S.A.; Hashem F.; Marquez L.; Cseprekal O.; Filgueiras I.S.; Fonseca D.L.M.; Mickael E.; Ling I.; Arero A.G.; Cuschieri S.; Minakova K.; Rodríguez-Román E.; Abarikwu S.O.; Faten A.-B.; Grancini G.; Cabral-Marques O.; Rezaei N. COVID-19 vaccinations: The unknowns, challenges, and hopes 2022 Journal of Medical Virology
366. Sadeghalvad M.; Mohammadi-Motlagh H.-R.; Rezaei N. Structure and Function of the Immune System 2022 Encyclopedia of Infection and Immunity
367. Hemmati S.; Sanati G.; Sadeghi M.A.; Daryani N.E.; Rezaei N. Association between Promotor hypomethylation of TFF1 and Crohn’s Disease 2022 Acta Biomedica
368. Khandan M.; Tabari M.A.K.; Samieefar N.; Rezaei N. COVID-19, from infection to cancer 2022 Acta Biomedica
369. Moeinafshar A.; Yazdanpanah N.; Rezaei N. Immune-based therapeutic approaches in COVID-19 2022 Biomedicine and Pharmacotherapy
370. Momtazmanesh S.; Rezaei N. Hypersensitivity 2022 Encyclopedia of Infection and Immunity
371. Sadeghalvad M.; Rezaei N. Introduction on Treatment for Infectious Diseases and Immunological Disorders 2022 Encyclopedia of Infection and Immunity
372. Hosseini Shabanan S.; Seyedmirzaei H.; Barnea A.; Hanaei S.; Rezaei N. Stem cell transplantation as a progressing treatment for retinitis pigmentosa 2022 Cell and Tissue Research
373. Rashedi R.; Samieefar N.; Masoumi N.; Mohseni S.; Rezaei N. COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts 2022 Journal of Medical Virology
374. Uddin M.N.; Arifin M.S.; Rezaei N. A Novel Neuro-Fuzzy Based Direct Power Control of a DFIG based Wind Farm Incorporated with Distance Protection Scheme and LVRT Capability 2022 Conference Record - IAS Annual Meeting (IEEE Industry Applications Society)
375. Rezaei N. Preface 2022 Translational Autoimmunity: Treatment of Autoimmune Diseases
376. Harsini S.; Rezaei N. Autoimmune diseases 2022 Clinical Immunology
377. Uddin M.N.; Rezaei N.; Arifin M.S. Hybrid Machine Learning-based Intelligent Distance Protection and Control Schemes with Fault and Zonal Classification Capabilities for Grid-connected Wind Farms 2022 Conference Record - IAS Annual Meeting (IEEE Industry Applications Society)
378. Jabbari P.; Taraghikhah N.; Jabbari F.; Ebrahimi S.; Rezaei N. Adherence of the General Public to Self-Protection Guidelines during the COVID-19 Pandemic 2022 Disaster Medicine and Public Health Preparedness
379. Rahmani S.; Rezaei N. SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait! 2022 Acta Biomedica
380. Sefer A.P.; Abolhassani H.; Ober F.; Kayaoglu B.; Bilgic Eltan S.; Kara A.; Erman B.; Surucu Yilmaz N.; Aydogmus C.; Aydemir S.; Charbonnier L.-M.; Kolukisa B.; Azizi G.; Delavari S.; Momen T.; Aliyeva S.; Kendir Demirkol Y.; Tekin S.; Kiykim A.; Baser O.F.; Cokugras H.; Gursel M.; Karakoc-Aydiner E.; Ozen A.; Krappmann D.; Chatila T.A.; Rezaei N.; Baris S. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency 2022 Journal of Clinical Immunology
381. Keshavarz-Fathi M.; Keshavarz-Fathi M.; Rezaei N. Cancer Immunology 2022 Encyclopedia of Infection and Immunity
382. Rahmani S.; Rezaei N. SARS-CoV-2 Omicron variant: Why global communities should take it seriously? 2022 Immunity, Inflammation and Disease
383. Kamali Zonouzi S.; Pezeshki P.S.; Razi S.; Rezaei N. Cancer-associated fibroblasts in colorectal cancer 2022 Clinical and Translational Oncology
384. Zokaei E.; Darbeheshti F.; Rezaei N. Prospect of exosomal circular RNAs in breast Cancer: presents and future 2022 Molecular Biology Reports
385. Matin S.; Safarzadeh E.; Rezaei N.; Negaresh M.; Salehzadeh H.; Matin S.; Sharifiazar A.H.; Abazari M.; Dadkhah M. Hematological Parameters as Diagnostic Factors: Correlation with Severity of COVID-19 2022 Acta Biomedica
386. Abadi B.; Shahsavani Y.; Faramarzpour M.; Rezaei N.; Rahimi H.-R. Antidepressants with anti-tumor potential in treating glioblastoma: A narrative review 2022 Fundamental and Clinical Pharmacology
387. Rezaei N. Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features 2022 Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features
388. Momtazmanesh S.; Rezaei N. Introduction on Viruses 2022 Encyclopedia of Infection and Immunity
389. Sodeifian F.; Mushtaq S.; Rezaei N. Cutaneous Manifestation of COVID-19: What Have we Learned an Year Into the Pandemic?; [[Artículo traducido] Manifestaciones cutáneas de la COVID-19: ¿Qué hemos aprendido tras un año de pandemia?] 2022 Actas Dermo-Sifiliograficas
390. Nejadghaderi S.A.; Balibegloo M.; Saghazadeh A.; Rezaei N. Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review 2022 PLoS ONE
391. Makuku R.; Seyedmirzaei H.; Tantuoyir M.M.; Rodríguez-Román E.; Albahash A.; Mohamed K.; Moyo E.; Ahmed A.O.; Razi S.; Rezaei N. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article 2022 International Immunopharmacology
392. Afkham S.A.; Hessami A.; Saghazadeh A.; Rezaei N. An overview of possible solutions putting an end to the COVID-19 pandemic 2022 Acta Biomedica
393. Saleki K.; Razi S.; Rezaei N. Infection and Immunity 2022 Clinical Immunology
394. Rezaei N. Translational Autoimmunity: Autoimmune Diseases in Different Organs 2022 Translational Autoimmunity: Autoimmune Diseases in Different Organs
395. Rezaei N. Preface 2022 Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features
396. Sadeghalvad M.; Rezaei N. Immunodeficiencies 2022 Clinical Immunology
397. Zarezadeh Mehrabadi A.; Aghamohamadi N.; Abolhassani H.; Aghamohammadi A.; Rezaei N.; Yazdani R. Comprehensive Assessment of Skin Disorders in Patients with Common Variable Immunodeficiency (CVID) 2022 Journal of Clinical Immunology
398. Rezaei N. Preface 2022 Translational Autoimmunity: Treatment of Autoimmune Diseases
399. Saghazadeh A.; Rezaei N. MicroRNA machinery in Parkinson’s disease: a platform for neurodegenerative diseases 2022 Expert Review of Neurotherapeutics
400. Esmaeilzadeh H.; Askarisarvestani A.; Hosseini N.; Samimi S.; Shafiei A.; Mahdaviani S.A.; Eslami N.; Chavoshzadeh Z.; Fallahi M.; Khakbazanfard N.; Shabestari M.S.; Aleyasin S.; Nabavizadeh S.H.; Cheraghi T.; Kalantari A.; Ahmadiafshar A.; Safari M.; Eslamian M.H.; Molatefi R.; Shirkani A.; Heidarzadeh Arani M.; Tavakol M.; Bemanian M.H.; Arshi S.; Nabavi M.; Shokri S.; Shahhosseini B.; Mortazavi N.; Nakhaei P.; Nazari F.; Fallahpour M.; Ahanchian H.; Moazzen N.; Khoshkhui M.; Motlagh A.V.; Aghamohammadi A.; Abolhassani H.; Yazdani R.; Rezaei N. Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin 2021 Clinical Immunology
401. Darbeheshti F.; Zokaei E.; Mansoori Y.; Emadi Allahyari S.; Kamaliyan Z.; Kadkhoda S.; Tavakkoly Bazzaz J.; Rezaei N.; Shakoori A. Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3 2021 Cancer Cell International
402. Shemirani F.; Fotouhi A.; Djafarian K.; Azadbakht L.; Rezaei N.; Mahmoudi M. Effects of modified-Paleo and moderate-carbohydrate diets on body composition, serum levels of hepatokines and adipocytokines, and flow cytometric analysis of endothelial microparticles in adults with metabolic syndrome: a study protocol for a randomized clinical trial 2021 Trials
403. Keshavarz P.; Yazdanpanah F.; Azhdari S.; Kavandi H.; Nikeghbal P.; Bazyar A.; Rafiee F.; Nejati S.F.; Sadabad F.E.; Rezaei N. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome 2021 Journal of Medical Virology
404. Afzali S.; Zendehboudi S.; Mohammadzadeh O.; Rezaei N. Hybrid mathematical modelling of three-phase flow in porous media: Application to water-alternating-gas injection 2021 Journal of Natural Gas Science and Engineering
405. Sadeghalvad M.; Mansouri K.; Mohammadi-Motlagh H.-R.; Noorbakhsh F.; Mostafaie A.; Alipour S.; Rezaei N. Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells 2022 Revista da Associacao Medica Brasileira
406. Tantuoyir M.M.; Rezaei N. Serological tests for COVID-19: Potential opportunities 2021 Cell Biology International
407. Jabalameli N.; Rajabi F.; Firooz A.; Rezaei N. The Overlap between Genetic Susceptibility to COVID-19 and Skin Diseases 2022 Immunological Investigations
408. Mojtahedi H.; Yazdanpanah N.; Rezaei N. Chronic myeloid leukemia stem cells: targeting therapeutic implications 2021 Stem Cell Research and Therapy
409. Jahromi A.M.; Khedri M.; Ghasemi M.; Omrani S.; Maleki R.; Rezaei N. Molecular insight into COF monolayers for urea sorption in artificial kidneys 2021 Scientific Reports
410. Rzymski P.; Camargo C.A., Jr.; Fal A.; Flisiak R.; Gwenzi W.; Kelishadi R.; Leemans A.; Nieto J.J.; Ozen A.; Perc M.; Poniedziałek B.; Sedikides C.; Sellke F.; Skirmuntt E.C.; Stashchak A.; Rezaei N. COVID-19 vaccine boosters: The good, the bad, and the ugly 2021 Vaccines
411. Yazdanpanah N.; Keshavarz-Fathi M.; Ziaei H.; Jaberipour A.; Mirbeyk M.; Hanaei S.; Seyedpour S.; Azami N.; Akbarzadehmoallemkolaei M.; Mohamed K.; Samieefar N.; Kolahchi Z.; Kolahchi S.; Pirkoohi Z.R.; Momtazmanesh S.; Sarzaeim M.; Moradian N.; Lotfabadi A.S.; Loghman A.H.; Ashkevarian S.; Rezaei N. Universal Accreditation System (UAS): An Innovative Education and Research Credit Appraisal by USERN 2022 Acta Medica Iranica
412. Tonkaboni A.; Ziaei H.; Rezaei N. Teledentistry during COVID-19 2021 International Journal of Clinical Practice
413. Kolahchi Z.; Sohrabi H.; Ekrami Nasab S.; Jelodari Mamaghani H.; Keyfari Alamdari M.; Rezaei N. Potential therapeutic approach of intravenous immunoglobulin against COVID-19 2021 Allergy, Asthma and Clinical Immunology
414. Ghaffari S.; Khalili N.; Rezaei N. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy 2021 Journal of Experimental and Clinical Cancer Research
415. Paulson K.R.; et al. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 2021 The Lancet
416. Amanat M.; Rezaei N.; Roozbeh M.; Shojaei M.; Tafakhori A.; Zoghi A.; Darazam I.A.; Salehi M.; Karimialavijeh E.; Lima B.S.; Garakani A.; Vaccaro A.; Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study 2021 BMC Neurology
417. Saleki K.; Yaribash S.; Banazadeh M.; Hajihosseinlou E.; Gouravani M.; Saghazadeh A.; Rezaei N. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies 2021 European Journal of Pharmacology
418. Uddin M.; Rezaei N.; Olufemi O.E. Adaptive and Optimal Overcurrent Protection of Wind Farms with Improved Reliability 2022 IEEE Transactions on Industry Applications
419. Kocarnik J.M.; et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019 2022 JAMA Oncology
420. Ghamartale A.; Zendehboudi S.; Rezaei N.; Chatzis I. Effects of inhibitor concentration and thermodynamic conditions on n-octylphenol-asphaltene molecular behaviours 2021 Journal of Molecular Liquids
421. Movahedi M.; Jamee M.; Ghaffaripour H.; Noori F.; Ghaini M.; Eskandarzadeh S.; Enayat J.; Eslamian G.; Pourdowlat G.; Sharifinejad N.; Poorabdollah M.; Nadji S.A.; Fallahi M.; Daneshmandi Z.; Heshmatnia J.; Eslaminejad A.; Fakharian A.; Vasheghani M.; Moniri A.; Mirenayat M.S.; Tabarsi P.; Marjani M.; Rezaei N.; Seppänen M.R.J.; Mansouri D.; Mahdaviani S.A.; Velayati A.A. Pulmonary manifestations in a cohort of patients with inborn errors of immunity: an 8-year follow-up study 2022 Allergologia et Immunopathologia
422. Sabourian R.; Mirjalili S.Z.; Rezaei N. Efficacy and safety of immune checkpoint inhibitors and cytokine therapy in autoimmune diseases 2022 Translational Autoimmunity: Treatment of Autoimmune Diseases
423. Sheida F.; Razi S.; Keshavarz-Fathi M.; Rezaei N. The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies 2022 Expert Review of Anticancer Therapy
424. Sadeghalvad M.; Mohammadi-Motlagh H.-R.; Rezaei N. Toll-Like Receptors 2022 Encyclopedia of Infection and Immunity
425. Ebrahimi M.; Balibegloo M.; Rezaei N. Monoclonal antibodies in diabetic retinopathy 2022 Expert Review of Clinical Immunology
426. Dadkhah M.; Talei S.; Doostkamel D.; Molaei S.; Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: A review 2022 Reviews in the Neurosciences
427. Sanati G.; Jafari D.; Noruzinia M.; Daryani N.E.; Ahmadvand M.; Teimourian S.; Rezaei N. Association of Aberrant Promoter Methylation Changes in the Suppressor of Cytokine Signaling 3 (SOCS3) Gene with Susceptibility to Crohn's Disease 2022 Avicenna Journal of Medical Biotechnology
428. Nowroozi A.; Khalili N.; Razi S.; Keshavarz-Fathi M.; Rezaei N. Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigms 2022 Expert Opinion on Biological Therapy
429. Ahanchian H.; Moazzen N.; Saeidinia A.; Joghatayi S.H.; Khoshkhui M.; Aelami M.H.; Haghi N.S.M.; Rezaei N. Death due to covid-19 in an infant with combined immunodeficiencies 2021 Endocrine, Metabolic and Immune Disorders - Drug Targets
430. Madani S.; Sayarifard F.; Tajdini P.; Mohsenipour R.; Khorshid H.R.K.; Rezaei N. Novel Treatment for Congenital Disorder of Glycosylation in a Patient with Novel Homozygote Mutation of PMM2: A Case Report and Review Literature 2021 Endocrine, Metabolic and Immune Disorders - Drug Targets
431. Bayan N.; Yazdanpanah N.; Rezaei N. Role of toll-like receptor 4 in diabetic retinopathy 2022 Pharmacological Research
432. Cork M.A.; et al. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems 2021 BMC Medicine
433. Hassan S.S.; Lundstrom K.; Barh D.; Silva R.J.S.; Andrade B.S.; Azevedo V.; Choudhury P.P.; Palu G.; Uhal B.D.; Kandimalla R.; Seyran M.; Lal A.; Sherchan S.P.; Azad G.K.; Aljabali A.A.A.; Brufsky A.M.; Serrano-Aroca Á.; Adadi P.; Abd El-Aziz T.M.; Redwan E.M.; Takayama K.; Rezaei N.; Tambuwala M.; Uversky V.N. Implications derived from S-protein variants of SARS-CoV-2 from six continents 2021 International Journal of Biological Macromolecules
434. Pourriyahi H.; Yazdanpanah N.; Saghazadeh A.; Rezaei N. Loneliness: An immunometabolic syndrome 2021 International Journal of Environmental Research and Public Health
435. Aghamohammadi A.; Rezaei N.; Yazdani R.; Delavari S.; Kutukculer N.; Topyildiz E.; Ozen A.; Baris S.; Karakoc-Aydiner E.; Kilic S.S.; Kose H.; Gulez N.; Genel F.; Reisli I.; Djenouhat K.; Tahiat A.; Boukari R.; Ladj S.; Belbouab R.; Ferhani Y.; Belaid B.; Djidjik R.; Kechout N.; Attal N.; Saidani K.; Barbouche R.; Bousfiha A.; Sobh A.; Rizk R.; Elnagdy M.H.; Al-Ahmed M.; Al-Tamemi S.; Nasrullayeva G.; Adeli M.; Al-Nesf M.; Hassen A.; Mehawej C.; Irani C.; Megarbane A.; Quinn J.; Chavoshzadeh Z.; Mahdaviani S.A.; Nabavi M.; Tavakol M.; Behniafard N.; Momen T.; Azizi G.; Bemanian M.H.; Arshi S.; Molatefi R.; Sherkat R.; Shirkani A.; Amin R.; Aleyasin S.; Faridhosseini R.; Jabbari-Azad F.; Ahanchian H.; Khoshkhui M.; Shafiei A.; Kalantari A.; Mohammadzadeh I.; Ghaffari J.; Cheraghi T.; Mansouri M.; Mesdaghi M.; Babaie D.; Eslamian M.H.; Dabbaghzadeh A.; Tavassoli M.; Ghasemi R.; Kalmarzi R.N.; Mortazavi S.H.; Kashef S.; Tafaroji J.; Khalili A.; Zandieh F.; Sadeghi-Shabestari M.; Darougar S.; Behmanesh F.; Akbari H.; Zandkarimi M.; Abolnezhadian F.; Fayezi A.; Torabizadeh M.; Moghtaderi M.; Soheili H.; Ahmadiafshar A.; Shakerian B.; Sajedi V.; Taghvaei B.; Safari M.; Heidarzadeh M.; Ghalebaghi B.; Fathi S.M.; Darabi B.; Darabi K.; Bazregari S.; Bazargan N.; Fallahpour M.; Khayatzadeh A.; Bashardoust B.; Sadri H.; Zamani M.; Mohsenzadeh A.; Ebrahimi S.; Ghaemi R.; Mehrjerdi F.Z.; Sharafian S.; Nabavizadeh S.H.; Baniadam L.; Salari F.; Rekabi M.; Vosughimotlagh A.; Tafakoridelbari M.; Pourvali A.; Rezaei A.; Hamidieh A.A.; Shariat M.; Gharagozlou M.; Movahedi M.; Parvaneh N.; Karaca N.E.; Aksu G.; Bilgiç Eltan S.; Kasap N.; Kolukisa B.; Sefer A.P.; Yalcin E.; babayeva R.; Mahammed L.L.; Al-Khabaz A.; Maródi L.; Modell V.; Modell F.; Abolhassani H. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity 2021 Journal of Clinical Immunology
436. Sharif P.M.; Nematizadeh M.; Saghazadeh M.; Saghazadeh A.; Rezaei N. Computed tomography scan in COVID-19: a systematic review and meta-analysis 2022 Polish Journal of Radiology
437. Mardani M.; Rashedi S.; Keykhaei M.; Farrokhpour H.; Azadnajafabad S.; Tavolinejad H.; Rezaei N. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis 2022 Pathology Research and Practice
438. Roudsari N.M.; Lashgari N.-A.; Momtaz S.; Abaft S.; Jamali F.; Safaiepour P.; Narimisa K.; Jackson G.; Bishayee A.; Rezaei N.; Abdolghaffari A.H.; Bishayee A. Inhibitors of the PI3K/Akt/mTOR pathway in prostate cancer chemoprevention and intervention 2021 Pharmaceutics
439. Amirifar P.; Mehrmohamadi M.; Ranjouri M.R.; Akrami S.M.; Rezaei N.; Saberi A.; Yazdani R.; Abolhassani H.; Aghamohammadi A. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients 2022 Journal of Clinical Immunology
440. Moeinafshar A.; Yazdanpanah N.; Rezaei N. Diagnostic biomarkers of dilated cardiomyopathy 2021 Immunobiology
441. Thalhammer J.; et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 2021 Journal of Allergy and Clinical Immunology
442. Bahreini F.; Jabbari P.; Gossing W.; Aziziyan F.; Frohme M.; Rezaei N. The role of noncoding RNAs in pituitary adenoma 2021 Epigenomics
443. Khedri M.; Rezvantalab S.; Maleki R.; Rezaei N. Effect of ligand conjugation site on the micellization of Bio-Targeted PLGA-Based nanohybrids: A computational biology approach 2022 Journal of Biomolecular Structure and Dynamics
444. Farshbafnadi M.; Pastaki Khoshbin A.; Rezaei N. Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence 2021 International Immunopharmacology
445. Khanmohammadi S.; Rezaei N.; Khazaei M.; Shirkani A. A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19 2022 Journal of Clinical Immunology
446. Redwan E.M.; Alghamdi M.F.; El-Aziz T.M.A.; Adadi P.; Aljabali A.A.A.; Attrish D.; Azad G.K.; Baetas-da-Cruz W.; Barh D.; Bazan N.G.; Brufsky A.M.; Chauhan G.; Hassan S.K.S.; Kandimalla R.; Lal A.; Lundstrom K.; Mishra Y.K.; Choudhury P.P.; Palù G.; Panda P.K.; Pizzol D.; Rezaei N.; Serrano-Aroca Á.; Sherchan S.P.; Seyran M.; Takayama K.; Tambuwala M.M.; Uhal B.D.; Uversky V.N. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19 2021 Autoimmunity Reviews
447. Alimohammadi E.; Nikzad A.; Khedri M.; Shafiee S.; Miri Jahromi A.; Maleki R.; Rezaei N. Molecular Tuning of the Nano-Bio Interface: Alpha-Synuclein's Surface Targeting with Doped Carbon Nanostructures 2021 ACS Applied Bio Materials
448. Mansouri V.; Beheshtizadeh N.; Gharibshahian M.; Sabouri L.; Varzandeh M.; Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment 2021 Biomedicine and Pharmacotherapy
449. Nejadghaderi S.A.; Saghazadeh A.; Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? 2022 International Journal of Health Services
450. Sazgarnejad S.; Yazdanpanah N.; Rezaei N. Anti-inflammatory effects of GLP-1 in patients with COVID-19 2022 Expert Review of Anti-Infective Therapy
451. Baharlooi H.; Salehi Z.; Moeini M.M.; Rezaei N.; Azimi M. Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis 2022 Advanced Pharmaceutical Bulletin
452. Yazdanpanah N.; Rezaei N. Autoimmune complications of COVID-19 2022 Journal of Medical Virology
453. Alvarez E.M.; et al. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 2022 The Lancet Oncology
454. Sadeghi P.; Salari K.; Ziaee V.; Rezaei N.; Eftekhari K. Serological screening of celiac disease in patients with juvenile idiopathic arthritis 2021 Archives of Iranian Medicine
455. Kouhi A.; Shakeri S.; Yazdani N.; Shababi N.; Mohseni A.; Mohseni A.; Sadr M.; Amoli M.M.; Rezaei A.; Rezaei N. Association of Pro-inflammatory Cytokine Gene Polymorphism with Meniere’s Disease in an Iranian Sample 2021 Iranian Journal of Allergy, Asthma and Immunology
456. Keshavarz-Fathi M.; Rezaei N. Cancer Immunoprevention: Current Status and Future Directions 2021 Archivum Immunologiae et Therapiae Experimentalis
457. Seyran M.; Takayama K.; Uversky V.N.; Lundstrom K.; Palù G.; Sherchan S.P.; Attrish D.; Rezaei N.; Aljabali A.A.A.; Ghosh S.; Pizzol D.; Chauhan G.; Adadi P.; Mohamed Abd El-Aziz T.; Soares A.G.; Kandimalla R.; Tambuwala M.; Hassan S.S.; Azad G.K.; Pal Choudhury P.; Baetas-da-Cruz W.; Serrano-Aroca Á.; Brufsky A.M.; Uhal B.D. The structural basis of accelerated host cell entry by SARS-CoV-2† 2021 FEBS Journal
458. Darbeheshti F.; Mahdiannasser M.; Uhal B.D.; Ogino S.; Gupta S.; Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus 2021 Reviews in Medical Virology
459. Samieefar N.; Yari Boroujeni R.; Jamee M.; Lotfi M.; Golabchi M.R.; Afshar A.; Miri H.; Khazeei Tabari M.A.; Darzi P.; Abdullatif Khafaie M.; Amirheidari B.; Tamadon A.; Rambod Rad N.; Samimi N.; Farjam M.; Shiravi F.; Farshidi N.; Hedayati Ch M.; Doostkamel D.; Alikhani R.; Razmkhah M.; Abdollahifard S.; Nasiri Kalmarzi R.; Kelishadi R.; Khazaei H.; Aghamohammadi A.; Jafari Mousavi F.S.; Shamsizadeh M.; Khojasteh A.; Rezaei N. Country quarantine during COVID-19: Critical or not? 2021 Disaster Medicine and Public Health Preparedness
460. Meimand S.E.; Pour-Rashidi A.; Shahrbabak M.M.; Mohammadi E.; Meimand F.E.; Rezaei N. The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study 2022 World Neurosurgery
461. Moeinafshar A.; Hemmati S.; Rezaei N. Immunotherapy in AML: a brief review on emerging strategies 2021 Clinical and Translational Oncology
462. Sodeifian F.; Nikfarjam M.; Kian N.; Mohamed K.; Rezaei N. The role of type I interferon in the treatment of COVID-19 2022 Journal of Medical Virology
463. Kinyoki D.; et al. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 2021 Nature Medicine
464. Zibadi S.; Samieefar N.; Sodeifian F.; Mosavari N.; Rezaei N. Covid-19 vaccination: What challenges are we going to face 2021 Acta Biomedica
465. Elrashdy F.; Tambuwala M.M.; Hassan S.S.; Adadi P.; Seyran M.; Abd El-Aziz T.M.; Rezaei N.; Lal A.; Aljabali A.A.A.; Kandimalla R.; Bazan N.G.; Azad G.K.; Sherchan S.P.; Choudhury P.P.; Serrano-Aroca Á.; Takayama K.; Chauhan G.; Pizzol D.; Barh D.; Panda P.K.; Mishra Y.K.; Palù G.; Lundstrom K.; Redwan E.M.; Uversky V.N. Autoimmunity roots of the thrombotic events after COVID-19 vaccination 2021 Autoimmunity Reviews
466. Abadi B.; Yazdanpanah N.; Nokhodchi A.; Rezaei N. Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives 2021 Advanced Drug Delivery Reviews
467. Ziaei H.; Tonkaboni A.; Shamshiri A.; Rezaei N. “Oral Manifestations of Patients with Inherited Defect in Phagocyte Number or Function” a systematic review 2021 Clinical Immunology
468. Mojtabavi H.; Fatehi F.; Shahkarami S.; Rezaei N.; Nafissi S. Novel Mutations of the TYMP Gene in Mitochondrial Neurogastrointestinal Encephalomyopathy: Case Series and Literature Review 2021 Journal of Molecular Neuroscience
469. Karimi A.; Shobeiri P.; Kulasinghe A.; Rezaei N. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis 2021 Frontiers in Immunology
470. Safiri S.; et al. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease study 2019 2021 BMJ Global Health
471. Heidari A.; Sharif P.M.; Rezaei N. The association between tumor-associated macrophages and glioblastoma: A potential target for therapy 2021 Current Pharmaceutical Design
472. Rajabi F.; Jabalameli N.; Rezaei N. The Concept of Immunogenetics 2022 Advances in Experimental Medicine and Biology
473. Rezaei N.; Rajabi F. Preface 2022 Advances in Experimental Medicine and Biology
474. Kumar A.; Ladha A.; Choudhury A.; Ikbal A.M.A.; Bhattacharjee B.; Das T.; Gupta G.; Sharma C.; Sarbajna A.; Mandal S.C.; Choudhury M.D.; Ali N.; Slama P.; Rezaei N.; Palit P.; Tiwari O.N. The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19? 2022 Expert Review of Vaccines
475. Razavi A.; Hamblin M.R.; Rezaei N. COVID-19 in patients with cancer: Risks and precautions 2021 American Journal of Emergency Medicine
476. Rezaei N. Translational Autoimmunity: Treatment of Autoimmune Diseases 2022 Translational Autoimmunity: Treatment of Autoimmune Diseases
477. Khanmohammadi S.; Malekpour M.; Jabbari P.; Rezaei N. Genetic basis of Guillain-Barre syndrome 2021 Journal of Neuroimmunology
478. Jahagirdar D.; et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 2021 The Lancet HIV
479. Ward J.L.; et al. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 2021 The Lancet
480. Farhat S.A.; Jabbari F.; Jabbari P.; Rezaei N. Targeting signaling pathways involved in primordial follicle growth or dormancy: potential application in prevention of follicular loss and infertility 2022 Expert Opinion on Biological Therapy
481. Mansouri V.; Yazdanpanah N.; Rezaei N. The immunologic aspects of cytokine release syndrome and graft versus host disease following CAR T cell therapy 2022 International Reviews of Immunology
482. Mirjalili S.Z.; Sabourian R.; Sadeghalvad M.; Rezaei N. Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disorders 2021 International Immunopharmacology
483. Nichols E.; et al. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study 2021 BMC Medical Informatics and Decision Making
484. Pirzadeh M.; Khalili N.; Rezaei N. The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer 2022 International Reviews of Immunology
485. Maroufi S.F.; Shaka Z.; Mojtabavi H.; Sadeghalvad M.; Rayzan E.; Sedighi I.; Shahkarami S.; Najafi M.; Rohlfs M.; Klein C.; Rezaei N. Novel g6pc3 mutations in patients with congenital neutropenia: Case reports and review of the literature 2021 Endocrine, Metabolic and Immune Disorders - Drug Targets
486. Keshavarz-Fathi M.; Sanati G.; Sadr M.; Mohebbi B.; Ziaee V.; Rezaei N. DNA Methylation of CD70 Promoter in Juvenile Systemic Lupus Erythematosus 2022 Fetal and Pediatric Pathology
487. Shahin T.; Kuehn H.S.; Shoeb M.R.; Gawriyski L.; Giuliani S.; Repiscak P.; Hoeger B.; Petronczki Ö.Y.; Bal S.K.; Zoghi S.; Dmytrus J.; Seruggia D.; Castanon I.; Rezaei N.; Varjosalo M.; Halbritter F.; Rosenzweig S.D.; Boztug K. Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity 2021 Science Immunology
488. Momtazmanesh S.; Rayzan E.; Zoghi S.; Shahkarami S.; Mo-Latefi R.; Mohammadzadeh I.; Ghaffari J.; Mahmoudi H.; Dmytrus J.; Segarra-Roca A.; Somekh I.; Witzel M.; Hauck F.; Boztug K.; Klein C.; Rezaei N. Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients 2022 Endocrine, Metabolic and Immune Disorders - Drug Targets
489. Shafeghat M.; Aminorroaya A.; Rezaei N. How stable ischemic heart disease leads to acute coronary syndrome in COVID-19? 2021 Acta Biomedica
490. Abolhassani H.; Vosughimotlagh A.; Asano T.; Landegren N.; Boisson B.; Delavari S.; Bastard P.; Aranda-Guillén M.; Wang Y.; Zuo F.; Sardh F.; Marcotte H.; Du L.; Zhang S.-Y.; Zhang Q.; Rezaei N.; Kämpe O.; Casanova J.-L.; Hammarström L.; Pan-Hammarström Q. X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia 2022 Journal of Clinical Immunology
491. Farshbafnadi M.; Agah E.; Rezaei N. The second brain: The connection between gut microbiota composition and multiple sclerosis 2021 Journal of Neuroimmunology
492. Hessami A.; Rezaei N. Cardiovascular diseases burden in COVID-19 2021 American Journal of Emergency Medicine
493. Keshavarz-Fathi M.; Sanati G.; Sadr M.; Mohebbi B.; Ziaee V.; Rezaei N. Aberrant DNA methylation of the promoters of JAK2 and SOCS3 in juvenile systemic lupus erythematosus 2021 European Cytokine Network
494. Hosseini M.; Habibi Z.; Hosseini N.; Abdoli S.; Rezaei N. Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review 2022 Expert Opinion on Biological Therapy
495. Rezaei N.; Yazdanpanah N. Introduction on therapeutic opportunities for autoimmunity 2022 Translational Autoimmunity: Treatment of Autoimmune Diseases
496. Azarpour A.; Rezaei N.; Zendehboudi S. Performance analysis and modeling of catalytic trickle-bed reactors: a comprehensive review 2021 Journal of Industrial and Engineering Chemistry
497. Asna Ashari K.; Rezaei N. PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome: an overview of genetic background 2021 Clinical Rheumatology
498. Ahanchian H.; Moazzen N.; Sezavar M.; Khalighi N.; Khoshkhui M.; Aelami M.H.; Motevalli Haghi N.S.; Rezaei N. COVID-19 in a child with primary antibody deficiency 2021 Clinical Case Reports
499. Mobasheri T.; Rayzan E.; Shabani M.; Hosseini M.; Mahmoodi Chalbatani G.; Rezaei N. Neuroblastoma-targeted nanoparticles and novel nanotechnology-based treatment methods 2021 Journal of Cellular Physiology
500. Ebrahimi H.; et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 2021 The Lancet Respiratory Medicine
501. Mohamed K.; Rezaei N. COVID-19 pandemic is not the time of trial and error 2021 American Journal of Emergency Medicine
502. Shafeghat M.; Esmaeilzadeh H.; Sadeghalvad M.; Rayzan E.; Zoghi S.; Shahkarami S.; Heredia R.J.; Krolo A.; Boztug K.; Rezaei N. A novel homozygous RAG1 mutation is associated with severe combined immunodeficiency and neurological presentations 2021 Allergologia et Immunopathologia
503. Pezeshki P.S.; Mahdavi Sharif P.; Rezaei N. Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors 2021 Expert Opinion on Biological Therapy
504. Nowroozi M.; Ghaedi E.; Behnamfar A.; Amini E.; Momeni S.; Mahmoudi M.; Rezaei N.; Bokaie S.; Sharifi L. The role of nutritional interventions in prostate cancer: A review 2021 Journal of Research in Medical Sciences
505. Sarvizadeh M.; Hasanpour O.; Naderi Ghale-Noie Z.; Mollazadeh S.; Rezaei M.; Pourghadamyari H.; Masoud Khooy M.; Aschner M.; Khan H.; Rezaei N.; Shojaie L.; Mirzaei H. Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities 2021 Frontiers in Oncology
506. Rezaei N. Translational Autoimmunity: Etiology of Autoimmune Diseases 2021 Translational Autoimmunity: Etiology of Autoimmune Diseases
507. Sbarra A.N.; et al. Mapping routine measles vaccination in low- and middle-income countries 2021 Nature
508. Sobouti B.; Bahrami A.; Rahmani F.; Talebi S.; Sherafati V.; Vafapour M.; Rezaei N. Wiskott-Aldrich syndrome with possible congenital Cytomegalovirus infection: A diagnostic dilemma 2021 National Medical Journal of India
509. Momtazmanesh S.; Shobeiri P.; Saghazadeh A.; Teunissen C.E.; Burman J.; Szalardy L.; Klivenyi P.; Bartos A.; Fernandes A.; Rezaei N. Neuronal and glial CSF biomarkers in multiple sclerosis: A systematic review and meta-analysis 2021 Reviews in the Neurosciences
510. Agah E.; Nafissi S.; Saleh F.; Sarraf P.; Tafakhori A.; Mousavi S.V.; Saghazadeh A.; Sadr M.; Sinaei F.; Mohebbi B.; Mahmoudi M.; Shadi H.; Rezaei N. Investigating the possible association between NLRP3 gene polymorphisms and myasthenia gravis 2021 Muscle and Nerve
511. Mirbeyk M.; Saghazadeh A.; Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates 2021 Archives of Gynecology and Obstetrics
512. Rezaei N. TRANSLATIONAL AUTOIMMUNITY, VOL. 1: Etiology of Autoimmune Diseases 2021 Translational Autoimmunity: Etiology of Autoimmune Diseases
513. Samimi N.; Farjam M.; Klionsky D.J.; Rezaei N. The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types 2021 Autophagy
514. Fotouhi M.; Samami E.; Mohseni S.; Nasrollahizadeh A.; Haddadi M.; Mirbeyk M.; Saghazadeh A.; Rezaei N. How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes? 2021 Advances in Experimental Medicine and Biology
515. Balibegloo M.; Nejadghaderi S.A.; Sadeghalvad M.; Soleymanitabar A.; Salehi Nezamabadi S.; Saghazadeh A.; Rezaei N. Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis 2021 International Immunopharmacology
516. Eskian M.; Rezaei N. Clinical Manifestations of COVID-19 2021 Advances in Experimental Medicine and Biology
517. Rezalotfi A.; Vrynas A.V.; Dehghanian M.; Rezaei N. Lessons from the Embryo: an Unrejected Transplant and a Benign Tumor 2021 Stem Cell Reviews and Reports
518. Harsini S.; Alavi A.; Rezaei N. Introduction on Nuclear Medicine and Immunology 2021 Nuclear Medicine and Immunology
519. Palit P.; Chattopadhyay D.; Thomas S.; Kundu A.; Kim H.S.; Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? 2021 Phytomedicine
520. Tantuoyir M.M.; Rezaei N. Serological tests for COVID-19: Potential opportunities 2021 Cell Biology International
521. Hassan S.S.; Aljabali A.A.A.; Panda P.K.; Ghosh S.; Attrish D.; Choudhury P.P.; Seyran M.; Pizzol D.; Adadi P.; Abd El-Aziz T.M.; Soares A.; Kandimalla R.; Lundstrom K.; Lal A.; Azad G.K.; Uversky V.N.; Sherchan S.P.; Baetas-da-Cruz W.; Uhal B.D.; Rezaei N.; Chauhan G.; Barh D.; Redwan E.M.; Dayhoff G.W., II; Bazan N.G.; Serrano-Aroca Á.; El-Demerdash A.; Mishra Y.K.; Palu G.; Takayama K.; Brufsky A.M.; Tambuwala M.M. A unique view of SARS-COV-2 through the lens of ORF8 protein 2021 Computers in Biology and Medicine
522. Mousavi M.J.; Shayesteh M.R.H.; Jamalzehi S.; Alimohammadi R.; Rahimi A.; Aslani S.; Rezaei N. Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis 2021 Journal of Research in Medical Sciences
523. Harsini S.; Alavi A.; Rezaei N. Nuclear Medicine and Immunology 2021 Nuclear Medicine and Immunology
524. Mojtabavi H.; Javidi N.; Naviaux A.-F.; Janne P.; Gourdin M.; Mohammadpour M.; Saghazadeh A.; Rezaei N. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the COVID-19 Pandemic 2021 Advances in Experimental Medicine and Biology
525. Shakerian N.; Mofateh R.; Rezaei N.; Saghazadeh A.; Rezaei N. Potential prophylactic and therapeutic effects of respiratory physiotherapy for covid-19 2021 Acta Biomedica
526. Mousavi M.J.; Farhadi E.; Vodjgani M.; Karami J.; Tahmasebi M.N.; Vaziri A.S.; Asgari M.; Rezaei N.; Mostafaei S.; Jamshidi A.; Mahmoudi M. Role of fibroblast activation protein alpha in fibroblast-like synoviocytes of rheumatoid arthritis 2021 Iranian Journal of Allergy, Asthma and Immunology
527. Rezaei N.; Uddin M.N. An Analytical Review on State-of-the-Art Microgrid Protective Relaying and Coordination Techniques 2021 IEEE Transactions on Industry Applications
528. Farmani A.R.; Mahdavinezhad F.; Moslemi R.; Mehrabi Z.; Noori A.; Kouhestani M.; Noroozi Z.; Ai J.; Rezaei N. Anti-IgE monoclonal antibodies as potential treatment in COVID-19 2021 Immunopharmacology and Immunotoxicology
529. Seitmaganbetov N.; Rezaei N.; Shafiei A. Characterization of crude oils and asphaltenes using the PC-SAFT EoS: A systematic review 2021 Fuel
530. Rezaei N.; Ghaffari J.; Khalili A.; Dabbaghzadeh A.; Ghaffari N.; Abolhassani H.; Seppänen M.; Ehlayel M. Congenital defects of phagocytes 2021 Inborn Errors of Immunity: A Practical Guide
531. Seyedmirzaei H.; Shobeiri P.; Turgut M.; Hanaei S.; Rezaei N. VEGF levels in patients with glioma: A systematic review and meta-analysis 2021 Reviews in the Neurosciences
532. Pourriyahi H.; Saghazadeh A.; Rezaei N. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities 2021 Journal of Neuroimmunology
533. Rasouli S.; Rezaei N.; Hamedi H.; Zendehboudi S.; Duan X. Design, fabrication, and characterization of a facile superhydrophobic and superoleophilic mesh-based membrane for selective oil-water separation 2021 Chemical Engineering Science
534. Seyedmirzaei H.; Keshavarz-Fathi M.; Razi S.; Gity M.; Rezaei N. Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2) 2021 Journal of Oncology Pharmacy Practice
535. Alimohammadi E.; Nikzad A.; Khedri M.; Rezaian M.; Jahromi A.M.; Rezaei N.; Maleki R. Potential treatment of Parkinson's disease using new-generation carbon nanotubes: A biomolecular in silico study 2021 Nanomedicine
536. Bahrami A.; Vafapour M.; Moazzami B.; Rezaei N. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran 2021 Journal of Paediatrics and Child Health
537. Mohamed Khosroshahi L.; Rezaei N. Dysregulation of the immune response in coronavirus disease 2019 2021 Cell Biology International
538. Aghamohammadi A.; Abolhassani H.; Rezaei N.; Yazdani R. Inborn Errors of Immunity: A Practical Guide 2021 Inborn Errors of Immunity: A Practical Guide
539. Delavari S.; Abolhassani H.; Abolnezhadian F.; Babaha F.; Iranparast S.; Ahanchian H.; Moazzen N.; Nabavi M.; Arshi S.; Fallahpour M.; Bemanian M.H.; Shokri S.; Momen T.; Sadeghi-Shabestari M.; Molatefi R.; Shirkani A.; Vosughimotlagh A.; Safarirad M.; Sharifzadeh M.; Pashangzadeh S.; Salami F.; Shirmast P.; Rezaei A.; Moeini Shad T.; Mohraz M.; Rezaei N.; Hammarström L.; Yazdani R.; Aghamohamamdi A. Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency 2021 Journal of Clinical Immunology
540. Barzegar A.; Ghadipasha M.; Rezaei N.; Forouzesh M.; Valizadeh R. New hope for treatment of respiratory involvement following covid-19 by bromhexine 2021 Journal of Nephropharmacology
541. Mohamed K.; Makuku R.; Rodríguez-Román E.; Hejleh A.P.A.; Joya M.; Ivanovska M.; Makka S.A.; Islam M.S.; Radwan N.; Faten A.-B.; Xiao C.; Marquez L.; Rezaei N. A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, the Universal Invader 2021 Advances in Experimental Medicine and Biology
542. Mohammadi S.; Moosaie F.; Saghazadeh A.; Mahmoudi M.; Rezaei N. Metabolic profile in patients with narcolepsy: a systematic review and meta-analysis 2021 Sleep Medicine
543. Kadkhoda S.; Darbeheshti F.; Rezaei N.; Azizi-Tabesh G.; Zolfaghari F.; Tavakolibazaz S.; Taslimi R.; Tavakkoly-Bazzaz J. Investigation of circRNA-miRNA-mRNA network in colorectal cancer using an integrative bioinformatics approach 2021 Gastroenterology and Hepatology from Bed to Bench
544. Rasouli S.; Rezaei N.; Hamedi H.; Zendehboudi S.; Duan X. Superhydrophobic and superoleophilic membranes for oil-water separation application: A comprehensive review 2021 Materials and Design
545. Basiri A.; Pazhouhnia Z.; Beheshtizadeh N.; Hoseinpour M.; Saghazadeh A.; Rezaei N. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises 2021 Stem Cell Reviews and Reports
546. Seyran M.; Pizzol D.; Adadi P.; El-Aziz T.M.A.; Hassan S.S.; Soares A.; Kandimalla R.; Lundstrom K.; Tambuwala M.; Aljabali A.A.A.; Lal A.; Azad G.K.; Choudhury P.P.; Uversky V.N.; Sherchan S.P.; Uhal B.D.; Rezaei N.; Brufsky A.M. Questions concerning the proximal origin of SARS-CoV-2 2021 Journal of Medical Virology
547. Ahmadi M.; Pashangzadeh S.; Mousavi P.; Saffarzadeh N.; Amin Habibi M.; Hajiesmaeili F.; Rezaei N. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19 2021 International Immunopharmacology
548. Sodeifian F.; Mushtaq S.; Rezaei N. Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic?; [Manifestaciones cutáneas de la COVID-19: ¿Qué hemos aprendido tras un año de pandemia?] 2021 Actas Dermo-Sifiliograficas
549. Jalalvand M.; Darbeheshti F.; Rezaei N. Immune checkpoint inhibitors: Review of the existing evidence and challenges in breast cancer 2021 Immunotherapy
550. Zeynali Bujani M.; Behnampour M.; Rahimi N.; Safari T.; Khazaei Feizabad A.; Hossein Sarbazi A.; Baniasadi M.; Rezaei N.; Ansari Moghaddam A. The effect of influenza vaccination on covid-19 morbidity, severity and mortality: Systematic review and meta-analysis 2021 Malaysian Journal of Medical Sciences
551. Rezaei N.; Yazdanpanah N. Introduction on translational autoimmunity: From bench to bedside 2021 Translational Autoimmunity: Etiology of Autoimmune Diseases
552. Moossavi S.; Fehr K.; Maleki H.; Seyedpour S.; Keshavarz-Fathi M.; Tabasi F.; Heravi M.; Sharifian R.; Shafiei G.; Badihian N.; Kelishadi R.; Nematollahi S.; Almasi M.; Popescu S.; Keshavarz-Fathi M.; Rezaei N. Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions 2021 Advances in Experimental Medicine and Biology
553. Hassan S.S.; Attrish D.; Ghosh S.; Choudhury P.P.; Uversky V.N.; Aljabali A.A.A.; Lundstrom K.; Uhal B.D.; Rezaei N.; Seyran M.; Pizzol D.; Adadi P.; Soares A.; Abd El-Aziz T.M.; Kandimalla R.; Tambuwala M.M.; Azad G.K.; Sherchan S.P.; Baetas-da-Cruz W.; Lal A.; Palù G.; Takayama K.; Serrano-Aroca Á.; Barh D.; Brufsky A.M. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 2021 International Journal of Biological Macromolecules
554. Mahdaviani S.A.; Eskian M.; Khorasanizadeh M.; Bashardoost B.; Nejad S.T.; Jamaati H.; Rezaei A.; Sadr M.; Aryan Z.; Rezaei N. Interleukin 9 serum level and single nucleotide polymorphism in patients with asthma 2021 Acta Biomedica
555. Aghamohammadi A.; Abolhassani H.; Rezaei N.; Yazdani R. Preface 2021 Inborn Errors of Immunity: A Practical Guide
556. Jaseb K.; Nameh Goshay Fard N.; Rezaei N.; Sadeghian S.; Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease 2021 Clinical Case Reports
557. Aghamohammadi A.; Abolhassani H.; Rezaei N. Primary immunodeficiency diseases in Iran: Past, present and future 2021 Archives of Iranian Medicine
558. Khanmohammadi S.; Rezaei N. Role of Toll-like receptors in the pathogenesis of COVID-19 2021 Journal of Medical Virology
559. Nichols E.; et al. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019 2021 Alzheimer's and Dementia: Translational Research and Clinical Interventions
560. Azizi G.; Tavakol M.; Yazdani R.; Delavari S.; Moeini Shad T.; Rasouli S.E.; Jamee M.; Pashangzadeh S.; Kalantari A.; Shariat M.; Shafiei A.; Mohammadi J.; Hassanpour G.; Chavoshzadeh Z.; Mahdaviani S.A.; Momen T.; Behniafard N.; Nabavi M.; Bemanian M.H.; Arshi S.; Molatefi R.; Sherkat R.; Shirkani A.; Alyasin S.; Jabbari-Azad F.; Ghaffari J.; Mesdaghi M.; Ahanchian H.; Khoshkhui M.; Eslamian M.H.; Cheraghi T.; Dabbaghzadeh A.; Nasiri Kalmarzi R.; Esmaeilzadeh H.; Tafaroji J.; Khalili A.; Sadeghi-Shabestari M.; Darougar S.; Moghtaderi M.; Ahmadiafshar A.; Shakerian B.; Heidarzadeh M.; Ghalebaghi B.; Fathi S.M.; Darabi B.; Fallahpour M.; Mohsenzadeh A.; Ebrahimi S.; Sharafian S.; Vosughimotlagh A.; Tafakoridelbari M.; Rahimi Haji-Abadi M.; Ashournia P.; Razaghian A.; Rezaei A.; Salami F.; Shirmast P.; Bazargan N.; Mamishi S.; Khazaei H.A.; Negahdari B.; Shokri S.; Nabavizadeh S.H.; Bazregari S.; Ghasemi R.; Bayat S.; Eshaghi H.; Rezaei N.; Abolhassani H.; Aghamohammadi A. Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity 2021 Pediatric Allergy and Immunology
561. Kolahchi Z.; De Domenico M.; Uddin L.Q.; Cauda V.; Grossmann I.; Lacasa L.; Grancini G.; Mahmoudi M.; Rezaei N. Erratum: Correction to: COVID-19 and Its Global Economic Impact (Advances in experimental medicine and biology (2021) 1318 (825-837)) 2021 Advances in experimental medicine and biology
562. Sargazi S.; Sheervalilou R.; Rokni M.; Shirvaliloo M.; Shahraki O.; Rezaei N. The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets 2021 Cell Biology International
563. Zarandi P.K.; Zinatizadeh M.R.; Zinatizadeh M.; Yousefi M.H.; Rezaei N. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments 2021 Biomedicine and Pharmacotherapy
564. Rezaei N. Preface 2021 Translational Autoimmunity: Etiology of Autoimmune Diseases
565. Uddin M.N.; Rezaei N.; Emmanuel O. Adaptive and Optimal Overcurrent Protection of Wind Farms with Improved Reliability 2021 Conference Record - IAS Annual Meeting (IEEE Industry Applications Society)
566. Seyran M.; Hassan S.S.; Uversky V.N.; Choudhury P.P.; Uhal B.D.; Lundstrom K.; Attrish D.; Rezaei N.; Aljabali A.A.A.; Ghosh S.; Pizzol D.; Adadi P.; El-Aziz T.M.A.; Kandimalla R.; Tambuwala M.M.; Lal A.; Azad G.K.; Sherchan S.P.; Baetas-Da-cruz W.; Palù G.; Brufsky A.M. Urgent need for field surveys of coronaviruses in southeast asia to understand the sars-cov-2 phylogeny and risk assessment for future outbreaks 2021 Biomolecules
567. Seyedmirzaei H.; Rezaei N. Cytokine alterations in psoriasis: an updated review 2021 Expert Review of Clinical Immunology
568. Harsini S.; Alavi A.; Rezaei N. Preface 2021 Nuclear Medicine and Immunology
569. Sabahi M.; Joshaghanian A.; Dolatshahi M.; Jabbari P.; Rahmani F.; Rezaei N. Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases 2021 Journal of Molecular Neuroscience
570. Sadeghmousavi S.; Rezaei N. COVID-19 infection and stroke risk 2021 Reviews in the Neurosciences
571. Wong H.H.; Seet S.H.; Maier M.; Gurel A.; Traspas R.M.; Lee C.; Zhang S.; Talim B.; Loh A.Y.T.; Chia C.Y.; Teoh T.S.; Sng D.; Rensvold J.; Unal S.; Shishkova E.; Cepni E.; Nathan F.M.; Sirota F.L.; Liang C.; Yarali N.; Simsek-Kiper P.O.; Mitani T.; Ceylaner S.; Arman-Bilir O.; Mbarek H.; Gumruk F.; Efthymiou S.; Uğurlu Çi̇men D.; Georgiadou D.; Sotiropoulou K.; Houlden H.; Paul F.; Pehlivan D.; Lainé C.; Chai G.; Ali N.A.; Choo S.C.; Keng S.S.; Boisson B.; Yılmaz E.; Xue S.; Coon J.J.; Ly T.T.N.; Gilani N.; Hasbini D.; Kayserili H.; Zaki M.S.; Isfort R.J.; Ordonez N.; Tripolszki K.; Bauer P.; Rezaei N.; Seyedpour S.; Khotaei G.T.; Bascom C.C.; Maroofian R.; Chaabouni M.; Alsubhi A.; Eyaid W.; Işıkay S.; Gleeson J.G.; Lupski J.R.; Casanova J.-L.; Pagliarini D.J.; Akarsu N.A.; Maurer-Stroh S.; Cetinkaya A.; Bertoli-Avella A.; Mathuru A.S.; Ho L.; Bard F.A.; Reversade B. Loss of C2orf69 defines a fatal autoinflammatory syndrome in humans and zebrafish that evokes a glycogen-storage-associated mitochondriopathy 2021 American Journal of Human Genetics
572. Bahreini F.; Rayzan E.; Rezaei N. microRNA-related single-nucleotide polymorphisms and breast cancer 2021 Journal of Cellular Physiology
573. Yazdanpanah F.; Yazdanpanah S.; Rezaei N. COVID-19 Delta variation; more contagious or more pernicious? 2021 Acta Biomedica
574. Mohamed K.; Yazdanpanah N.; Saghazadeh A.; Rezaei N. Cognitive biases affecting the maintenance of covid-19 pandemic 2021 Acta Biomedica
575. Pezeshki P.S.; Moeinafshar A.; Ghaemdoust F.; Razi S.; Keshavarz-Fathi M.; Rezaei N. Advances in pharmacotherapy for neuroblastoma 2021 Expert Opinion on Pharmacotherapy
576. Hessami A.; Shamshirian A.; Heydari K.; Pourali F.; Alizadeh-Navaei R.; Moosazadeh M.; Abrotan S.; Shojaie L.; Sedighi S.; Shamshirian D.; Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis 2021 American Journal of Emergency Medicine
577. Sartorius B.; et al. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study 2021 The Lancet HIV
578. Lundstrom K.; Barh D.; Uhal B.D.; Takayama K.; Aljabali A.A.A.; Abd El-Aziz T.M.; Lal A.; Redwan E.M.; Adadi P.; Chauhan G.; Sherchan S.P.; Azad G.K.; Rezaei N.; Serrano-Aroca Á.; Bazan N.G.; Hassan S.S.; Panda P.K.; Choudhury P.P.; Pizzol D.; Kandimalla R.; Baetas-Da-cruz W.; Mishra Y.K.; Palu G.; Brufsky A.M.; Tambuwala M.M.; Uversky V.N. Covid-19 vaccines and thrombosis—roadblock or dead-end street? 2021 Biomolecules
579. Arabpour M.; Saghazadeh A.; Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes 2021 International Immunopharmacology
580. Salehi M.; Amanat M.; Mohammadi M.; Salmanian M.; Rezaei N.; Saghazadeh A.; Garakani A. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis 2021 Journal of Affective Disorders
581. Heidari A.; Rostam-Abadi Y.; Rezaei N. The immune system and autism spectrum disorder: Association and therapeutic challenges 2021 Acta Neurobiologiae Experimentalis
582. Eftekhar S.P.; Yazdanpanah N.; Rezaei N. Immune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management 2021 Expert Review of Anticancer Therapy
583. Momtazmanesh S.; Samieefar N.; Uddin L.Q.; Ulrichs T.; Kelishadi R.; Roudenok V.; Karakoc-Aydiner E.; Salunke D.B.; Nouwen J.L.; Becerra J.C.A.; Vieira D.N.; Goudouris E.; Jamee M.; Khafaie M.A.; Shamsizadeh M.; Golabchi M.R.; Samimiat A.; Doostkamel D.; Afshar A.; Tabari M.A.K.; Lotfi M.; Boroujeni R.Y.; Rambod N.; Stashchak A.; Volokha A.; Pavalkis D.; Pereira A.; Latiff A.H.A.; Baylarov R.; Amirheidari B.; Ch M.H.; Condino-Neto A.; Rezaei N. Socialization During the COVID-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing 2021 Advances in Experimental Medicine and Biology
584. Sadri Nahand J.; Shojaie L.; Akhlagh S.A.; Ebrahimi M.S.; Mirzaei H.R.; Bannazadeh Baghi H.; Mahjoubin-Tehran M.; Rezaei N.; Hamblin M.R.; Tajiknia V.; Rahimian N.; Mirzaei H. Cell death pathways and viruses: Role of microRNAs 2021 Molecular Therapy Nucleic Acids
585. Sadeghi Rad H.; Monkman J.; Warkiani M.E.; Ladwa R.; O'Byrne K.; Rezaei N.; Kulasinghe A. Understanding the tumor microenvironment for effective immunotherapy 2021 Medicinal Research Reviews
586. Saghazadeh A.; Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19 2021 Emergent Materials
587. Akbarpour M.; Sharifi L.; Safdarian A.R.; Farhangnia P.; Borjkhani M.; Rezaei N. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV 2021 Advances in Experimental Medicine and Biology
588. Rezaei N. Preface 2021 Translational Autoimmunity: Etiology of Autoimmune Diseases
589. Madani S.; Zandieh F.; Ahmadi M.; Parvizi M.; Rezaei N. Does the reaction size of skin prick test associated with the allergic rhinitis symptom severity? 2021 Allergologia et Immunopathologia
590. Ghamartale A.; Afzali S.; Rezaei N.; Zendehboudi S. Asphaltene Deposition Control by Chemical Inhibitors: Theoretical and Practical Prospects 2021 Asphaltene Deposition Control by Chemical Inhibitors: Theoretical and Practical Prospects
591. Sedighzadeh S.S.; Khoshbin A.P.; Razi S.; Keshavarz-Fathi M.; Rezaei N. A narrative review of tumor-associated macrophages in lung cancer: Regulation of macrophage polarization and therapeutic implications 2021 Translational Lung Cancer Research
592. Behrouzieh S.; Sheida F.; Rezaei N. Review of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy 2021 Expert Review of Anticancer Therapy
593. Seyedpour S.; Khodaei B.; Loghman A.H.; Seyedpour N.; Kisomi M.F.; Balibegloo M.; Nezamabadi S.S.; Gholami B.; Saghazadeh A.; Rezaei N. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies 2021 Journal of Cellular Physiology
594. Tofighi Zavareh F.; Mirshafiey A.; Yazdani R.; Keshtkar A.A.; Abolhassani H.; Bagheri Y.; Rezaei A.; Delavari S.; Rezaei N.; Aghamohammadi A. Lymphocytes subsets in correlation with clinical profile in CVID patients without monogenic defects 2021 Expert Review of Clinical Immunology
595. Momtazmanesh S.; Rezaei N. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review 2021 Frontiers in Oncology
596. Khedri M.; Zandi P.; Ghasemy E.; Nikzad A.; Maleki R.; Rezaei N. In-silico study on perovskites application in capturing and distorting coronavirus 2021 Informatics in Medicine Unlocked
597. Lotfi M.; Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences 2020 Journal of Medical Virology
598. Farmani A.R.; Nekoofar M.H.; Ebrahimi Barough S.; Azami M.; Rezaei N.; Najafipour S.; Ai J. Application of Platelet Rich Fibrin in Tissue Engineering: Focus on Bone Regeneration 2021 Platelets
599. Sadeghalvad M.; Mohammadi-Motlagh H.-R.; Rezaei N. Immune microenvironment in different molecular subtypes of ductal breast carcinoma 2021 Breast Cancer Research and Treatment
600. Hanaei S.; Abdollahzade S.; Sadr M.; Fattahi E.; Mirbolouk M.H.; Khoshnevisan A.; Rezaei N. Lack of association between COL1A1 and COL9A2 single nucleotide polymorphisms and intervertebral disc degeneration 2021 British Journal of Neurosurgery
601. Pashaei M.; Rezaei N. Immunotherapy for SARS-CoV-2: potential opportunities 2020 Expert Opinion on Biological Therapy
602. Mansourabadi A.H.; Sadeghalvad M.; Mohammadi-Motlagh H.-R.; Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19 2020 Life Sciences
603. Aghaie M.; Rezaei N.; Zendehboudi S. New insights into bulk and interface properties of [Bmim][Ac]/[Bmim][BF4] ionic liquid/CO2 systems — Molecular dynamics simulation approach 2020 Journal of Molecular Liquids
604. Najdaghi S.; Razi S.; Rezaei N. An overview of the role of interleukin-8 in colorectal cancer 2020 Cytokine
605. Zamani R.; Shahkarami S.; Rezaei N. Primary immunodeficiency associated with hypopigmentation: A differential diagnosis approach 2021 Allergologia et Immunopathologia
606. Asgardoon M.H.; Azizi G.; Yazdani R.; Sohani M.; Pashangzadeh S.; Kalantari A.; Shariat M.; Shafiei A.; Salami F.; Jamee M.; Rasouli S.E.; Mohammadi J.; Hassanpour G.; Tavakol M.; Chavoshzadeh Z.; Mahdaviani S.A.; Momen T.; Behniafard N.; Nabavi M.; Bemanian M.H.; Arshi S.; Molatefi R.; Sherkat R.; Shirkani A.; Alyasin S.; Jabbari-Azad F.; Ghaffari J.; Mesdaghi M.; Ahanchian H.; Khoshkhui M.; Eslamian M.H.; Cheraghi T.; Dabbaghzadeh A.; Nasiri Kalmarzi R.; Esmaeilzadeh H.; Tafaroji J.; Khalili A.; Sadeghi-Shabestari M.; Darougar S.; Moghtaderi M.; Ahmadiafshar A.; Shakerian B.; Heidarzadeh M.; Ghalebaghi B.; Fathi S.M.; Darabi B.; Fallahpour M.; Mohsenzadeh A.; Ebrahimi S.; Sharafian S.; Vosughimotlagh A.; Tafakoridelbari M.; Rahimi Haji-Abadi M.; Ashournia P.; Razaghian A.; Rezaei A.; Delavari S.; Shirmast P.; Babaha F.; Samavat A.; Mamishi S.; Khazaei H.A.; Negahdari B.; Rezaei N.; Abolhassani H.; Aghamohammadi A. Monogenic Primary Immunodeficiency Disorder Associated with Common Variable Immunodeficiency and Autoimmunity 2020 International Archives of Allergy and Immunology
607. Shaka Z.; Mojtabavi H.; Rayzan E.; Zoghi S.; Shahkarami S.; Raul J.H.; Sedighi I.; Boztug K.; Rezaei N. Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male 2021 Allergologia et Immunopathologia
608. Hanaei S.; Mohebi F.; Moradi-Lakeh M.; Jabbari P.; Mehta S.K.; Kryvenko L.S.; Luongo L.; Dupré L.; Rezaei N. The Epidemiologic Aspects of COVID-19 Outbreak: Spreading Beyond Expectations 2021 Advances in Experimental Medicine and Biology
609. Taghavi-Farahabadi M.; Mahmoudi M.; Mahdaviani S.A.; Baghaei K.; Rayzan E.; Hashemi S.M.; Rezaei N. Improving the function of neutrophils from chronic granulomatous disease patients using mesenchymal stem cells’ exosomes 2020 Human Immunology
610. Uddin M.N.; Rezaei N. An FPGA-based Cost-effective Digital Differential Relay for Wind Farm Protection 2020 2020 IEEE Industry Applications Society Annual Meeting, IAS 2020
611. Khalili N.; Khalili N.; Rezaei N. Immunotherapy in bladder and renal cancers 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
612. Moradian N.; Gouravani M.; Salehi M.A.; Heidari A.; Shafeghat M.; Hamblin M.R.; Rezaei N. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality 2020 European Cytokine Network
613. Ghaffari N.; Razi S.; Keshavarz-Fathi M.; Rezaei N. Immunopathology and immunotherapy for breast cancer 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
614. Yazdanpanah N.; Saghazadeh A.; Rezaei N. Anosmia: A missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19) 2020 Reviews in the Neurosciences
615. Ebadi M.; Keshavarz-Fathi M.; Zeng Y.; Gkotzamanidou M.; Rezaei N. Immunopathology and immunotherapy of hodgkin lymphoma 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
616. Aalaei-Andabili S.H.; Amini N.; Delavari F.; Keshavarz-Fathi M.; Basith S.; Choi S.; Rezaei N. Toll-like receptor pathway and its targeting in treatment of cancers 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
617. Chamkalani A.; Zendehboudi S.; Rezaei N.; Hawboldt K. A critical review on life cycle analysis of algae biodiesel: current challenges and future prospects 2020 Renewable and Sustainable Energy Reviews
618. Vakhshoori M.; Heidarpour M.; Shafie D.; Taheri M.; Rezaei N.; Sarrafzadegan N. Acute cardiac injury in COVID-19: A systematic review and meta-analysis 2020 Archives of Iranian Medicine
619. Mohamed K.; Rodríguez-Román E.; Rahmani F.; Zhang H.; Ivanovska M.; Makka S.A.; Joya M.; Makuku R.; Islam M.S.; Radwan N.; Rahmah L.; Goda R.; Abarikwu S.O.; Shaw M.; Zoghi S.; Irtsyan S.; Ling I.; Cseprekal O.; Faten A.-B.; Sayar E.H.; Soloukey C.; Grancini G.; Rezaei N. International efforts to save healthcare personnel during COVID-19 2020 Acta Biomedica
620. Hassan S.S.; Ghosh S.; Attrish D.; Choudhury P.P.; Aljabali A.A.A.; Uhal B.D.; Lundstrom K.; Rezaei N.; Uversky V.N.; Seyran M.; Pizzol D.; Adadi P.; Soares A.; Abd El-Aziz T.M.; Kandimalla R.; Tambuwala M.M.; Azad G.K.; Sherchan S.P.; Baetas-Da-cruz W.; Takayama K.; Serrano-Aroca Á.; Chauhan G.; Palu G.; Brufsky A.M. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features 2020 Molecules
621. Nejadghaderi S.A.; Heidari A.; Shakerian N.; Saghazadeh A.; Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19 2020 Acta Biomedica
622. Jabbari P.; Sadeghalvad M.; Rezaei N. An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammation 2021 Expert Opinion on Biological Therapy
623. Babaha F.; Rezaei N. Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? 2020 American Journal of the Medical Sciences
624. Maleki A.; Khanmiri J.M.; Eshrat Abadi M.K.; Soveyzi F.; Moazzami B.; Hamblin M.R.; Rezaei N. Innate lymphoid cell subsets and their cytokines in autoimmune diseases 2020 European Cytokine Network
625. Mohamed K.; Rodríguez-Román E.; Rahmani F.; Zhang H.; Ivanovska M.; Makka S.A.; Joya M.; Makuku R.; Islam M.S.; Radwan N.; Rahmah L.; Goda R.; Abarikwu S.O.; Shaw M.; Zoghi S.; Irtsyan S.; Ling I.; Cseprekal O.; Faten A.-B.; Hazar Sayar E.; Soloukey C.; Grancini G.; Rezaei N. Borderless collaboration is needed for COVID-19 - A disease that knows no borders 2020 Infection Control and Hospital Epidemiology
626. Rezaei N.; Uddin M.N. Fuzzy Logic Based Adaptive Overcurrent Protection for Wind Farms 2021 International Conference on Robotics, Electrical and Signal Processing Techniques
627. Ghamartale A.; Zendehboudi S.; Rezaei N. New Molecular Insights into Aggregation of Pure and Mixed Asphaltenes in the Presence of n-Octylphenol Inhibitor 2020 Energy and Fuels
628. Atabati H.; Esmaeili S.-A.; Saburi E.; Akhlaghi M.; Raoofi A.; Rezaei N.; Momtazi-Borojeni A.A. Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies 2020 Journal of Cellular Physiology
629. Lotfi M.; Rezaei N. CRISPR/Cas13: A potential therapeutic option of COVID-19 2020 Biomedicine and Pharmacotherapy
630. Rezaei N. Preface 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
631. Balibegloo M.; Keshavarz-Fathi M.; Rezaei N. Tumor antigen identification for cancer immunotherapy 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
632. Rezaei N. Preface 2021 Advances in Experimental Medicine and Biology
633. Mohammadi T.; Nasab M.G.; Mohebalizadeh M.; Kheirandish A.; Saghazadeh A.; Rezaei N. Dynamic antibody response: A biomarker for covid-19 2021 Clinical Laboratory
634. Kolahchi Z.; De Domenico M.; Uddin L.Q.; Cauda V.; Grossmann I.; Lacasa L.; Grancini G.; Mahmoudi M.; Rezaei N. COVID-19 and Its Global Economic Impact 2021 Advances in Experimental Medicine and Biology
635. Rokni M.; Hamblin M.R.; Rezaei N. Cytokines and COVID-19: friends or foes? 2020 Human Vaccines and Immunotherapeutics
636. Pezeshki P.S.; Rezaei N. Immune checkpoint inhibition in COVID-19: risks and benefits 2021 Expert Opinion on Biological Therapy
637. Gholami B.; Gholami S.; Loghman A.H.; Khodaei B.; Seyedpour S.; Seyedpour N.; Saghazadeh A.; Rezaei N. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease 2021 Advances in Experimental Medicine and Biology
638. Makuku R.; Khalili N.; Razi S.; Keshavarz-Fathi M.; Rezaei N. Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy 2021 Journal of Immunology Research
639. Azarpour A.; Rezaei N.; Zendehboudi S. Product quality control in hydropurification process by monitoring reactor feed impurities: Dynamic mathematical modeling 2020 Journal of Industrial and Engineering Chemistry
640. Moallemian Isfahani M.; Emam-Djomeh Z.; Rao I.M.; Rezaei N. Nutrition and Immunity in COVID-19 2021 Advances in Experimental Medicine and Biology
641. Khalili N.; Mohammadzadeh I.; Khalili N.; Heredia R.J.; Zoghi S.; Boztug K.; Rezaei N. BCGitis as the primary manifestation of chronic granulomatous disease 2021 IDCases
642. Sadr M.; Khalili N.; Mohebbi B.; Mosharmovahed B.; Afradi P.; Rezaei N. Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticaria 2021 Allergologia et Immunopathologia
643. Kafieh R.; Arian R.; Saeedizadeh N.; Amini Z.; Serej N.D.; Minaee S.; Yadav S.K.; Vaezi A.; Rezaei N.; Haghjooy Javanmard S. COVID-19 in Iran: Forecasting Pandemic Using Deep Learning 2021 Computational and Mathematical Methods in Medicine
644. Pezeshki P.S.; Eskian M.; Hamblin M.R.; Rezaei N. Immune checkpoint inhibition in classical hodgkin lymphoma 2021 Expert Review of Anticancer Therapy
645. Rezaei N.; Vahed A.; Ziaei H.; Bashari N.; Afkham S.A.; Bahrami F.; Bakhshi S.; Ghanadan A.; Ghanadan A.; Hosseini N.; Kafi P.; Khalilianfard R.; Mohammed K.; Sargoli S.; Tavasoli K.; Zare M.; Saghazadeh A. Health and Art (HEART): Integrating Science and Art to Fight COVID-19 2021 Advances in Experimental Medicine and Biology
646. Rzymski P.; Nowicki M.; Mullin G.E.; Abraham A.; Rodríguez-Román E.; Petzold M.B.; Bendau A.; Sahu K.K.; Ather A.; Naviaux A.-F.; Janne P.; Gourdin M.; Delanghe J.R.; Ochs H.D.; Talmadge J.E.; Garg M.; Hamblin M.R.; Rezaei N. Quantity does not equal quality: Scientific principles cannot be sacrificed 2020 International Immunopharmacology
647. Abbafati C.; et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2020 The Lancet
648. Jahanshahlu L.; Rezaei N. Central Nervous System Involvement in COVID-19 2020 Archives of Medical Research
649. Ebrahimi Meimand S.; Rostam-Abadi Y.; Rezaei N. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment 2021 Expert Review of Clinical Immunology
650. Darbeheshti F.; Abolhassani H.; Bashashati M.; Ghavami S.; Shahkarami S.; Zoghi S.; Gupta S.; Orange J.S.; Ochs H.D.; Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition 2021 Advances in Experimental Medicine and Biology
651. Basiri A.; Heidari A.; Nadi M.F.; Fallahy M.T.P.; Nezamabadi S.S.; Sedighi M.; Saghazadeh A.; Rezaei N. Microfluidic devices for detection of RNA viruses 2021 Reviews in Medical Virology
652. Moradian N.; Moallemian M.; Delavari F.; Sedikides C.; Camargo C.A., Jr; Torres P.J.; Sorooshian A.; Mehdiabadi S.P.; Nieto J.J.; Bordas S.; Ahmadieh H.; Abdollahi M.; Hamblin M.R.; Sellke F.W.; Cuzick J.; Biykem B.; Schreiber M.; Eshrati B.; Perry G.; Montazeri A.; Saboury A.A.; Kelishadi R.; Sahebkar A.; Moosavi-Movahed A.A.; Vatandoost H.; Gorji-Bandpy M.; Mobasher B.; Rezaei N. Interdisciplinary Approaches to COVID-19 2021 Advances in Experimental Medicine and Biology
653. Nowroozi A.; Razi S.; Sahu K.K.; Grizzi F.; Arends J.; Keshavarz-Fathi M.; Rezaei N. COVID-19 in Patients with Cancer 2021 Advances in Experimental Medicine and Biology
654. Quinaglia T.; Shabani M.; Rezaei N. COVID-19 in Patients with Hypertension 2021 Advances in Experimental Medicine and Biology
655. Ghosh S.; Bal S.K.; Edwards E.S.J.; Pillay B.; Heredia R.J.; Cipe F.E.; Rao G.; Salzer E.; Zoghi S.; Abolhassani H.; Momen T.; Gostick E.; Price D.A.; Zhang Y.; Oler A.J.; Gonzaga-Jauregui C.; Erman B.; Metin A.; Ilhan I.; Haskologlu S.; Islamoglu C.; Baskin K.; Ceylaner S.; Yilmaz E.; Unal E.; Karakukcu M.; Berghuis D.; Cole T.; Gupta A.K.; Hauck F.; Kogler H.; Hoepelman A.I.M.; Baris S.; Karakoc-Aydiner E.; Ozen A.; Kager L.; Holzinger D.; Paulussen M.; Krüger R.; Meisel R.; Oommen P.T.; Morris E.; Neven B.; Worth A.; van Montfrans J.; Fraaij P.L.A.; Choo S.; Dogu F.; Graham Davies E.; Burns S.; Dückers G.; Becker R.P.; von Bernuth H.; Latour S.; Faraci M.; Gattorno M.; Su H.C.; Pan-Hammarström Q.; Hammarström L.; Lenardo M.J.; Ma C.S.; Niehues T.; Aghamohammadi A.; Rezaei N.; Ikinciogullari A.; Tangye S.G.; Lankester A.C.; Boztug K. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency 2020 Blood
656. Bahrami A.; Sayyahfar S.; Soltani Z.; Khodadost M.; Moazzami B.; Rezaei N. Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: A cross-sectional study in Iran 2020 Allergologia et Immunopathologia
657. Hanaei S.; Sarzaeim M.; Yazdanpanah N.; Pirkoohi Z.R.; Ziaei H.; Mohamed K.; Samieefar N.; Keshavarz-Fathi M.; Kolahchi Z.; Moradian N.; Momtazmanesh S.; Seyedpour S.; Jaberipour A.; Ashkevarian S.; Rezaei N. The hybrid usern 2020 congress: New standards for events in practice 2021 Acta Medica Iranica
658. Khazaei H.A.; Naderi M.; Aliabad G.M.; Tabatabaei S.M.N.; Alidadi A.; Moulaei N.A.; Safdari M.; Nahvi H.; Cohan N.; Dehghan J.; Mehraban A.; Jalili A.; Khazaei A.; Khazaei E.; Khazaei B.; Khazaei B.; Rezaei N.; Salarzaie M.; Soleimani G. The effect of T helper (Th)/T cytotoxic (Tc) ratio on disease severity in type A hemophilia patients 2021 Human Antibodies
659. Yazdanpanah F.; Hamblin M.R.; Rezaei N. The immune system and COVID-19: Friend or foe? 2020 Life Sciences
660. Sharifkashani S.; Bafrani M.A.; Khaboushan A.S.; Pirzadeh M.; Kheirandish A.; Yavarpour_Bali H.; Hessami A.; Saghazadeh A.; Rezaei N. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting 2020 European Journal of Pharmacology
661. Aryan Z.; Keshavarz-Fathi M.; Mellstedt H.; Rezaei N. Cancer immunotherapy confers a global benefit 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
662. Mojtabavi H.; Saghazadeh A.; van den Heuvel L.; Bucker J.; Rezaei N. Peripheral blood levels of brain-derived neurotrophic factor in patients with posttraumatic stress disorder (PTSD): A systematic review and meta-analysis 2020 PLoS ONE
663. Delavari F.; Varzaneh F.N.; Rezaei N. Neurologic Manifestations of COVID-19 2021 Advances in Experimental Medicine and Biology
664. Ebadi M.; Sadeghi M.A.; Reddy N.M.; Rezaei N. Immunopathology and immunotherapy of non-hodgkin lymphoma 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
665. Goudarzi S.; Dehghani Firouzabadi F.; Dehghani Firouzabadi M.; Rezaei N. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2 2020 Dermatologic Therapy
666. Razavi A.; Keshavarz-Fathi M.; Pawelek J.; Rezaei N. Chimeric antigen receptor T-cell therapy for melanoma 2021 Expert Review of Clinical Immunology
667. Rezaei N.; Uddin M.N. Fuzzy Logic Based Adaptive Overcurrent Protection for Wind Farms 2021 International Conference on Robotics, Electrical and Signal Processing Techniques
668. Hemmati S.; Keshavarz-Fathi M.; Razi S.; Rezaei N. Gene therapy and genetic vaccines 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
669. Nasrollahzadeh E.; Razi S.; Keshavarz-Fathi M.; Mazzone M.; Rezaei N. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site 2020 Cancer Immunology, Immunotherapy
670. Rezaei N. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
671. Sedaghat A.; Oloomi S.A.A.; Malayer M.A.; Band S.; Rezaei N.; Mosavi A.; Nadai L. Coronavirus (COVID-19) Outbreak Prediction Using Epidemiological Models of Richards Gompertz Logistic Ratkowsky and SIRD 2020 CANDO-EPE 2020 - Proceedings, IEEE 3rd International Conference and Workshop in Obuda on Electrical and Power Engineering
672. Rezaei N. Cancer immunology: Cancer immunotherapy for organ-specific tumors 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
673. Lozano R.; et al. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2020 The Lancet
674. Abbafati C.; et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2020 The Lancet
675. Shojaeefar E.; Malih N.; Rezaei N. The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis 2021 Cell Biology International
676. Sharif P.M.; Keshavarz-Fathi M.; Rezaei N. Biomarkers for immune checkpoint inhibitors 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
677. Jahanshahlu L.; Rezaei N. Monoclonal antibody as a potential anti-COVID-19 2020 Biomedicine and Pharmacotherapy
678. Mirbeyk M.; Saghazadeh A.; Rezaei N. Geriatrics and COVID-19 2021 Advances in Experimental Medicine and Biology
679. Torabi-Rahvar M.; Rezaei N. Storm at the time of corona: A glimpse at the current understanding and therapeutic opportunities of the sars-cov-2 cytokine storm 2021 Current Pharmaceutical Design
680. Rabiee N.; Rabiee M.; Bagherzadeh M.; Rezaei N. COVID-19 and picotechnology: Potential opportunities 2020 Medical Hypotheses
681. Yazdani R.; Aghamohammadi A.; Rezaei N. Application of flow cytometry in predominantly antibody deficiencies 2021 Endocrine, Metabolic and Immune Disorders - Drug Targets
682. Saghazadeh A.; Rezaei N. How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment 2021 Advances in Experimental Medicine and Biology
683. Sadeghmousavi S.; Eskian M.; Rahmani F.; Rezaei N. The effect of insomnia on development of Alzheimer's disease 2020 Journal of Neuroinflammation
684. Mohamed K.; Yazdanpanah N.; Saghazadeh A.; Rezaei N. Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review 2021 Bioorganic Chemistry
685. Rezaei N. Preface 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
686. Sahu K.K.; Siddiqui A.D.; Rezaei N.; Cerny J. Challenges for management of immune thrombocytopenia during COVID-19 pandemic 2020 Journal of Medical Virology
687. Taghavi-Farahabadi M.; Mahmoudi M.; Rezaei N.; Hashemi S.M. Wharton’s Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity 2021 Immunological Investigations
688. Saghazadeh A.; Keshavarz-Fathi M.; Delavari F.; Rezaei N. Radiation and immunity: Hand in hand from tumorigenesis to therapeutic targets 2020 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition
689. Saghazadeh A.; Rezaei N. Immunopathology and immunotherapy of melanoma 2020 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
690. Lundstrom K.; Seyran M.; Pizzol D.; Adadi P.; El-Aziz T.M.A.; Hassan S.S.; Soares A.; Kandimalla R.; Tambuwala M.M.; Aljabali A.A.A.; Azad G.K.; Choudhury P.P.; Uversky V.N.; Sherchan S.P.; Uhal B.D.; Rezaei N.; Brufsky A.M. Viewpoint: Origin of SARS-CoV-2 2020 Viruses
691. Rezaei N.; Ashkevarian S.; Fathi M.K.; Hanaei S.; Kolahchi Z.; Ladi Seyedian S.-S.; Rayzan E.; Sarzaeim M.; Vahed A.; Mohamed K.; Momtazmanesh S.; Moradian N.; Pirkoohi Z.R.; Sameeifar N.; Yousefpour M.; Sargoli S.; Adiban S.; Yazdanpanah N.; Ziaei H.; Saghazadeh A. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge 2021 Advances in Experimental Medicine and Biology
692. Jenab Y.; Rezaei N.; Hedayat B.; Naderian M.; Shirani S.; Hosseini K. Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID-19 2020 Clinical Case Reports
693. Shahrezaee M.; Keshtkari S.; Moradi-Lakeh M.; Abbasifard M.; Alipour V.; Amini S.; Arabloo J.; Arzani A.; Bakhshaei M.; Barzegar A.; Bijani A.; Dianatinasab M.; Eskandarieh S.; Gheshlagh R.G.; Ghashghaee A.; Heidari-Soureshjani R.; Irvani S.S.N.; Lahimchi A.; Maleki S.; Manafi N.; Manafi A.; Mansournia M.A.; Mohammadian-Hafshejani A.; Bandpei M.A.M.; Moradzadeh R.; Naderi M.; Pakshir K.; Rafiei A.; Rashedi V.; Rezaei N.; Rezapour A.; Sahraian M.A.; Shahabi S.; Shamsi M.; Soheili A.; Soroush A.; Zamani M.; Mohajer B.; Farzadfar F. Burden of musculoskeletal disorders in Iran during 1990–2017: estimates from the Global Burden of Disease Study 2017 2020 Archives of Osteoporosis
694. Aleebrahim-Dehkordi E.; Soveyzi F.; Deravi N.; Rabbani Z.; Saghazadeh A.; Rezaei N. Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children 2021 Journal of Pediatric Nursing
695. Momtazmanesh S.; Perry G.; Rezaei N. Toll-like receptors in Alzheimer's disease 2020 Journal of Neuroimmunology
696. Abbafati C.; et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 2020 The Lancet
697. Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients 2020 Infection Control and Hospital Epidemiology
698. Aghamohammadi A.; Shaghaghi M.; Abolhassani H.; Yazdani R.; Zahraie S.M.; Goya M.M.; Mahmoudi S.; Rezaei N.; Shahmahmoodi S. Establishment of national primary immunodeficiency network, requisite of health organization and final stage of polio eradication: Review article 2020 Tehran University Medical Journal
699. Momtazmanesh S.; Zare-Shahabadi A.; Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review 2019 Frontiers in Psychiatry
700. Rahmani F.; Eghbali A.; Rezaei N. Skin abscess and blonde hair 2019 Pediatric Immunology: A Case-Based Collection with MCQs
701. Mohammadzadeh O.; Rezaei N.; Chatzis I. Mechanistic study and performance evaluation of steam assisted gravity drainage using direct visualisation of pore-level experiments 2020 International Journal of Oil, Gas and Coal Technology
702. Sharifi L.; Aghamohammadi A.; Rezaei N.; Yazdani R.; Rezaei F.; Bokaie S.; Zavareh F.T.; Kiaee F.; Kamali A.N.; Azizi G.; Mirshafiey A. Interleukin-1β and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine 2019 European Cytokine Network
703. Momtazmanesh S.; Rayzan E.; Shahkarami S.; Rohlfs M.; Klein C.; Rezaei N. A novel VPS13B mutation in Cohen syndrome: A case report and review of literature 2020 BMC Medical Genetics
704. Afzali S.; Ghamartale A.; Rezaei N.; Zendehboudi S. Mathematical modeling and simulation of water-alternating-gas (WAG) process by incorporating capillary pressure and hysteresis effects 2020 Fuel
705. Hanaei S.; Abdollahzade S.; Sadr M.; Mirbolouk M.H.; Fattahi E.; Khoshnevisan A.; Rezaei N. The role of interleukin 4 and IL-4RA in intervertebral disc degeneration: investigation of single nucleotide polymorphisms in genes and a systematic review & meta-analysis of IL-4 expression level 2020 British Journal of Neurosurgery
706. Sanaei R.; Rezaei N.; Aghamohammadi A.; Delbandi A.-A.; Tavasolian P.; Tajik N. Disturbed Transcription of TLRs’ Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients 2019 Immunological Investigations
707. Saghazadeh A.; Mahmoudi M.; Shahrokhi S.; Mojarrad M.; Dastmardi M.; Mirbeyk M.; Rezaei N. Trace elements in schizophrenia: A systematic review and meta-analysis of 39 studies (N=5151 participants) 2020 Nutrition Reviews
708. Moradian N.; Ochs H.D.; Sedikies C.; Hamblin M.R.; Camargo C.A., Jr.; Martinez J.A.; Biamonte J.D.; Abdollahi M.; Torres P.J.; Nieto J.J.; Ogino S.; Seymour J.F.; Abraham A.; Cauda V.; Gupta S.; Ramakrishna S.; Sellke F.W.; Sorooshian A.; Wallace Hayes A.; Martinez-Urbistondo M.; Gupta M.; Azadbakht L.; Esmaillzadeh A.; Kelishadi R.; Esteghamati A.; Emam-Djomeh Z.; Majdzadeh R.; Palit P.; Badali H.; Rao I.; Saboury A.A.; Jagan Mohan Rao L.; Ahmadieh H.; Montazeri A.; Fadini G.P.; Pauly D.; Thomas S.; Moosavi-Movahed A.A.; Aghamohammadi A.; Behmanesh M.; Rahimi-Movaghar V.; Ghavami S.; Mehran R.; Uddin L.Q.; Von Herrath M.; Mobasher B.; Rezaei N. The urgent need for integrated science to fight COVID-19 pandemic and beyond 2020 Journal of Translational Medicine
709. Aryan Z.; Nabavi M.; Shabani M.; Keles S.; Zoghi S.; Chatila T.; Rezaei N. Hypomorphic DOCK8 deletion causes hypereosinophilic syndrome 2020 Pediatric Blood and Cancer
710. Seyedizade S.S.; Afshari K.; Bayat S.; Rahmani F.; Momtaz S.; Rezaei N.; Abdolghaffari A.H. Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease 2020 Archivum Immunologiae et Therapiae Experimentalis
711. Sabahi M.; Jabbari P.; Alizadeh Haghighi M.; Soltani S.; Soudi S.; Rahmani F.; Rezaei N. Proposing a tandem AND-gate CAR T cell targeting glioblastoma multiforme 2020 Medical Hypotheses
712. Saleki K.; Banazadeh M.; Saghazadeh A.; Rezaei N. The involvement of the central nervous system in patients with COVID-19 2020 Reviews in the Neurosciences
713. Rezaei N.; Uddin M.N.; Amin I.K.; Othman M.L.; Marsadek M. Genetic Algorithm-Based Optimization of Overcurrent Relay Coordination for Improved Protection of DFIG Operated Wind Farms 2019 IEEE Transactions on Industry Applications
714. Saghazadeh A.; Rezaei N. Immune-epidemiological parameters of the novel coronavirus–a perspective 2020 Expert Review of Clinical Immunology
715. Shahbazi Z.; Yazdani R.; Shahkarami S.; Shahbazi S.; Hamid M.; Sadeghi-Shabestari M.; Momen T.; Aleyasin S.; Esmaeilzadeh H.; Darougar S.; Delavari S.; Mahdaviani S.A.; Ahanchian H.; Behmanesh F.; Kiaee F.; Chavoshzade Z.; Shariat M.; Keramatipour M.; Rezaei N.; Abolhassani H.; Parvaneh N.; Mahdian R.; Aghamohammadi A. Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran 2019 Immunology Letters
716. Heidarpour M.; Vakhshoori M.; Abbasi S.; Shafie D.; Rezaei N. Adrenal insufficiency in coronavirus disease 2019: A case report 2020 Journal of Medical Case Reports
717. Torabi S.; Bahreini F.; Rezaei N. The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury 2020 Acta Biomedica
718. Rezaei N. Preface 2019 Pediatric Immunology: A Case-Based Collection with MCQs
719. Gorji Z.; Modaresi M.; Yekanni-Nejad S.; Rezaei N.; Mahmoudi M. Comparing effects of low glycemic index/high-fat, high-calorie diet and high-fat, high-calorie diet on cytokine levels of patients with cystic fibrosis: A randomized controlled clinical trial 2020 European Cytokine Network
720. Rezaei N. Pediatric Immunology: A Case-Based Collection with MCQs 2019 Pediatric Immunology: A Case-Based Collection with MCQs
721. Fekrvand S.; Yazdani R.; Olbrich P.; Azizi G.; Shirzadi R.; Modaresi M.; Sohani M.; Delavari S.; Kalantari A.; Shariat M.; Shafiei A.; Lu N.; Hassanpour G.; Rahimi Hajiabadi M.; Ashournia P.; Razaghian A.; Asgharyan M.; Shahraki-Ghadimi Z.; Rouhani R.; Hoda Fallah F.; Rezaei N.; Abolhassani H.; Aghamohammadi A. Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia 2020 Pediatric Allergy and Immunology
722. Rahmani F.; Rezaei N. Lethargy in a toddler 2019 Pediatric Immunology: A Case-Based Collection with MCQs
723. Rezaei N. Cancer immunology: A translational medicine context, second edition 2020 Cancer Immunology: A Translational Medicine Context, Second Edition
724. Mojtabavi H.; Saghazadeh A.; Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis 2020 European Cytokine Network
725. Rezaei N.; de Vries E.; Gambineri E.; Meyts I.; Haddad E. Common presentations and diagnostic approaches 2020 Stiehm's Immune Deficiencies: Inborn Errors of Immunity
726. Agha-Hosseini F.; Rezaei N.; Moosavi M.-S. Interleukin-10 in oral lichen planus – review and meta-analysis 2020 Current Immunology Reviews
727. Darbeheshti F.; Rezaei N. Genetic predisposition models to COVID-19 infection 2020 Medical Hypotheses
728. Jabbari P.; Jabbari F.; Ebrahimi S.; Rezaei N. COVID-19: A Chimera of Two Pandemics 2020 Disaster Medicine and Public Health Preparedness
729. Khanmohammadi S.; Shabani M.; Tabary M.; Rayzan E.; Rezaei N. Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms 2020 Critical Reviews in Oncology/Hematology
730. Ebrahimi M.; Khalili N.; Razi S.; Keshavarz-Fathi M.; Khalili N.; Rezaei N. Effects of lead and cadmium on the immune system and cancer progression 2020 Journal of Environmental Health Science and Engineering
731. Pourshams A.; et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 2019 The Lancet Gastroenterology and Hepatology
732. Dezfouli M.; Bergström S.; Skattum L.; Abolhassani H.; Neiman M.; Torabi-Rahvar M.; Franco Jarava C.; Martin-Nalda A.; Ferrer Balaguer J.M.; Slade C.A.; Roos A.; Fernandez Pereira L.M.; López-Trascasa M.; Gonzalez-Granado L.I.; Allende-Martinez L.M.; Mizuno Y.; Yoshida Y.; Friman V.; Lundgren Å.; Aghamohammadi A.; Rezaei N.; Hernández-Gonzalez M.; von Döbeln U.; Truedsson L.; Hara T.; Nonoyama S.; Schwenk J.M.; Nilsson P.; Hammarström L. Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies 2020 Frontiers in Immunology
733. Rezaei H.; Mosavi A.; Yousefi A.; Larijani B.; Rezaei N.; Dehnavieh R.; Adibi P. Strengths of Iran for internationalization of medical sciences education 2020 Journal of Education and Health Promotion
734. Lotfi M.; Hamblin M.R.; Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities 2020 Clinica Chimica Acta
735. Bahrami T.; Valilou S.F.; Sadr M.; Soltani S.; Salmaninejad A.; Soltaninejad E.; Yekaninejad M.S.; Ziaee V.; Rezaei N. PTPN22 Gene Polymorphisms in Pediatric Systemic Lupus Erythematosus 2020 Fetal and Pediatric Pathology
736. Gouravani M.; Khalili N.; Razi S.; Keshavarz-Fathi M.; Khalili N.; Rezaei N. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers 2020 Expert Review of Clinical Immunology
737. Valizadeh A.; Sanaei R.; Rezaei N.; Azizi G.; Fekrvand S.; Aghamohammadi A.; Yazdani R. Potential role of regulatory B cells in immunological diseases 2019 Immunology Letters
738. Mojtabavi H.; Saghazadeh A.; Valenti V.E.; Rezaei N. Can music influence cardiac autonomic system? A systematic review and narrative synthesis to evaluate its impact on heart rate variability 2020 Complementary Therapies in Clinical Practice
739. Rayzan E.; Pouladfar G.; Parvaneh N.; Shahrooei M.; Aryan Z.; Rezaei N. Novel CYBA mutation in a family with BCGitis 2020 Acta Microbiologica et Immunologica Hungarica
740. Shahkarami S.; Zoghi S.; Rezaei N. The role of DNA methylation in cancer 2020 Cancer Immunology: A Translational Medicine Context, Second Edition
741. Jabbari P.; Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? 2020 Disaster Medicine and Public Health Preparedness
742. Rahmani F.; Rayzan E.; Rahmani M.R.; Shahkarami S.; Zoghi S.; Rezaei A.; Aryan Z.; Najafi M.; Rohlfs M.; Jeske T.; Aflatoonian M.; Chavoshzadeh Z.; Farahmand F.; Motamed F.; Rohani P.; Alimadadi H.; Mahdaviani A.; Mansouri M.; Tavakol M.; Vanderberg M.; Kotlarz D.; Klein C.; Rezaei N. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR) 2020 Immunological Investigations
743. Mahmoodi M.; Rezaei N.; Zendehboudi S.; Heagle D. Fluid dynamic modeling of multiphase flow in heterogeneous porous media with matrix, fracture, and skin 2020 Journal of Hydrology
744. Fitzmaurice C.; et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study 2019 JAMA Oncology
745. Amirsardari Z.; Rahmani F.; Rezaei N. Cognitive impairments in HCV infection: From pathogenesis to neuroimaging 2019 Journal of Clinical and Experimental Neuropsychology
746. Bahrami A.; Nateghian A.; Salehi S.; Bahoush G.; Talebi S.; Ghasemi S.; Razi S.; Rezaei N. Griscelli syndrome type 2: A rare case with apparently normal skin and hair pigmentation 2020 Acta Medica Iranica
747. Saghazadeh A.; Rezaei N. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids 2020 International Immunopharmacology
748. Saghazadeh A.; Ataeinia B.; Keynejad K.; Abdolalizadeh A.; Hirbod-Mobarakeh A.; Rezaei N. Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis 2019 Cytokine
749. Harsini S.; Rezaei N. Cancer imaging with radiolabeled monoclonal antibodies 2020 Cancer Immunology: A Translational Medicine Context, Second Edition
750. Hanaei S.; Abdollahzade S.; Sadr M.; Mirbolouk M.H.; Fattahi E.; Khoshnevisan A.; Rezaei N. Association of interleukin 2, interleukin 12, and interferon-γwith intervertebral disc degeneration in Iranian population 2020 BMC Medical Genetics
751. Rezaei N. Preface 2020 Cancer Immunology: A Translational Medicine Context, Second Edition
752. Rezaei N.; Pandey S.; Harville T.; Bondarenko A.; Rahmani F.; Sharapova S.O.; Wekell P.; Cossou-Gbeto C.; Bal S.K. Introduction to primary immunodeficiencies 2019 Pediatric Immunology: A Case-Based Collection with MCQs
753. Sadeghi Rad H.; Bazaz S.R.; Monkman J.; Ebrahimi Warkiani M.; Rezaei N.; O'Byrne K.; Kulasinghe A. The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies 2020 Clinical and Translational Immunology
754. Kianiamin M.; Rezaei N. Neonatal jaundice and leukopenia 2019 Pediatric Immunology: A Case-Based Collection with MCQs
755. Fathi N.; Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities 2020 Cell Biology International
756. Momtazmanesh S.; Ochs H.D.; Uddin L.Q.; Perc M.; Routes J.M.; Vieira D.N.; Al-Herz W.; Baris S.; Prando C.; Rosivall L.; Abdul Latiff A.H.; Ulrichs T.; Roudenok V.; Aldave Becerra J.C.; Salunke D.B.; Goudouris E.; Condino-Neto A.; Stashchak A.; Kryvenko O.; Stashchak M.; Bondarenko A.; Rezaei N. All together to fight COVID-19 2020 American Journal of Tropical Medicine and Hygiene
757. Kinyoki D.K.; et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 2019 The Lancet Gastroenterology and Hepatology
758. Taghavi-Farahabadi M.; Mahmoudi M.; Hashemi S.M.; Rezaei N. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients 2020 International Immunopharmacology
759. Rezaei A.; Harsini S.; Sadr M.; Ziaee V.; Rezaei N. Interleukin-23 receptor gene polymorphisms in Iranian patients with juvenile systemic lupus erythematosus 2020 Allergologia et Immunopathologia
760. Mahdaviani S.A.; Mansouri D.; Jamee M.; Zaki-Dizaji M.; Aghdam K.R.; Mortaz E.; Khorasanizadeh M.H.; Eskian M.; Movahedi M.; Ghaffaripour H.; Baghaie N.; Hassanzad M.; Chavoshzadeh Z.; Mansouri M.; Mesdaghi M.; Ghaini M.; Noori F.; Eskandarzadeh S.; Kahkooi S.; Poorabdolah M.; Tabarsi P.; Moniri A.; Farnia P.; Karimi A.; Boisson-Dupuis S.; Rezaei N.; Marjani M.; Casanova J.-L.; Bustamante J.; Velayati A.A. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients 2020 Journal of Clinical Immunology
761. Sinehbaghizadeh S.; Roosta A.; Rezaei N.; Ghiasi M.M.; Javanmardi J.; Zendehboudi S. Evaluation of phase equilibrium conditions of clathrate hydrates using connectionist modeling strategies 2019 Fuel
762. Alatab S.; et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 2020 The Lancet Gastroenterology and Hepatology
763. Aghaie M.; Rezaei N.; Zendehboudi S. Effect of Water on Molecular and Transport Phenomena Behaviors of [Bmim][Ac]/Water/CO2, Using Molecular Dynamics Strategy 2020 Journal of Physical Chemistry B
764. Jafari D.; Noorbakhsh F.; Delavari A.; Tavakkoli-Bazzaz J.; Farashi-Bonab S.; Abdollahzadeh R.; Rezaei N. Expression level of long noncoding RNA NKILA-miR103-miR107 inflammatory axis and its clinical significance as potential biomarker in patients with colorectal cancer 2020 Journal of Research in Medical Sciences
765. Salzer E.; Zoghi S.; Kiss M.G.; Kage F.; Rashkova C.; Stahnke S.; Haimel M.; Platzer R.; Caldera M.; Ardy R.C.; Hoeger B.; Block J.; Medgyesi D.; Sin C.; Shahkarami S.; Kain R.; Ziaee V.; Hammerl P.; Bock C.; Menche J.; Dupré L.; Huppa J.B.; Sixt M.; Lomakin A.; Rottner K.; Binder C.J.; Stradal T.E.B.; Rezaei N.; Boztug K. The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity 2020 Science Immunology
766. Maródi L.; Abolhassani H.; Aghamohamaddi A.; Avcin T.; Bataneant M.; Belevtsev M.; Bernatowska E.; Bolkov M.; Bondarenko A.; Boyarchuk O.; Caliskaner Z.; Chernyshova L.; Ciznar P.; El-Marsafy A.; Erdős M.; Galal N.; Gherghina I.; Guseva M.; Iritsyan S.; Ismaili-Jaha V.; Ispaeva Z.; Kelecic J.; Keles S.; Kondratenko I.; Kostyuchenko L.; Kovzel E.; Kuli-Lito G.; Kurjane N.; Lázár I.; Litzman J.; Lutovac B.; Mammadova V.; Markelj G.; Mijanovic R.; Miltner N.; Mironska K.; Mulaosmanovich V.; Murdjeva M.; Nabieva U.; Naumova E.; Nashrullayeva G.; Pac M.; Pagava K.; Pasic S.; Pischalnikov A.; Prokofjeva T.; Reisli I.; Rezaei N.; Ress K.; Sakovich I.; Savchak I.; Sciuca S.; Sediva A.; Serban M.; Sharapova S.; Sitkauskiene B.; Skomska M.; Snimschchikova I.; Spahiu-Konjusha S.; Szolnoky M.; Tóth B.; Totolian A.; Tsyvkina G.; Tuzankina I.; Volokha A. The Konya Declaration for Patients with Primary Immunodeficiencies 2020 Journal of Clinical Immunology
767. Fekrvand S.; Yazdani R.; Olbrich P.; Gennery A.; Rosenzweig S.D.; Condino-Neto A.; Azizi G.; Rafiemanesh H.; Hassanpour G.; Rezaei N.; Abolhassani H.; Aghamohammadi A. Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine–Derived Complications: A Systematic Review 2020 Journal of Allergy and Clinical Immunology: In Practice
768. Rezaei N.; Aalaei-Andabili S.H.; Amini N.; Delavari F.; Keshavarz-Fathi M.; Kaufman H.L. Introduction on cancer immunology and immunotherapy 2020 Cancer Immunology: A Translational Medicine Context, Second Edition
769. Yousefzadegan S.; Rezaei N. Case report: Death due to COVID-19 in three brothers 2020 American Journal of Tropical Medicine and Hygiene
770. Mahdavi Sharif P.; Jabbari P.; Razi S.; Keshavarz-Fathi M.; Rezaei N. Importance of TNF-alpha and its alterations in the development of cancers 2020 Cytokine
771. Pezeshki S.; Hemmati S.; Rezaei N. Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma 2020 Expert Review of Anticancer Therapy
772. Beigmohammadi F.; Mahmoudi M.; Karami J.; Ahmadzadeh N.; Ebrahimi-Daryani N.; Rezaei N. Analysis of killer cell immunoglobulin-like receptor genes and their HLA ligands in inflammatory bowel diseases 2020 Journal of Immunology Research
773. Hirbod-Mobarakeh A.; Shabani M.; Keshavarz-Fathi M.; Delavari F.; Amirzargar A.A.; Nikbin B.; Kutikhin A.; Rezaei N. Immunogenetics of cancer 2020 Cancer Immunology: A Translational Medicine Context, Second Edition
774. Safdarian A.R.; Momenzadeh K.; Kahe F.; Farhangnia P.; Rezaei N. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities 2020 Clinical Case Reports
775. Hemmati S.; Sadeghi M.A.; Yousefi-Manesh H.; Eslamiyeh M.; Vafaei A.; Foroutani L.; Donyadideh G.; Dehpour A.; Rezaei N. Protective effects of leukadherin1 in a rat model of targeted experimental autoimmune encephalomyelitis (EAE): Possible role of p47phox and MDA downregulation 2020 Journal of Inflammation Research
776. Mahmoudi M.; Taghavi-Farahabadi M.; Namaki S.; Baghaei K.; Rayzan E.; Rezaei N.; Hashemi S.M. Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro 2019 Human Immunology
777. Hanaei S.; Rezaei N. COVID-19: Developing from an Outbreak to A Pandemic 2020 Archives of Medical Research
778. Etemadi A.; et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 2020 The Lancet Gastroenterology and Hepatology
779. Rahmani M.; Rahmani F.; Rezaei N. The Brain-Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression 2020 Neurochemical Research
780. Hanaei S.; Sanati G.; Zoghi S.; Gharibzadeh S.; Ziaee V.; Rezaei N. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus 2020 Allergologia et Immunopathologia
781. Nasab M.G.; Saghazadeh A.; Rezaei N. SARS-CoV-2–A Tough Opponent for the Immune System 2020 Archives of Medical Research
782. Darbeheshti F.; Rezaei N.; Amoli M.M.; Mansoori Y.; Tavakkoly Bazzaz J. Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactions 2019 Journal of Cellular Physiology
783. Dehdari B.; Parsaei R.; Riazi M.; Rezaei N.; Zendehboudi S. New insight into foam stability enhancement mechanism, using polyvinyl alcohol (PVA) and nanoparticles 2020 Journal of Molecular Liquids
784. Mohammadi S.; Mayeli M.; Saghazadeh A.; Rezaei N. Cytokines in narcolepsy: A systematic review and meta-analysis 2020 Cytokine
785. Rezaei N. COVID-19 and medical biotechnology 2020 Avicenna Journal of Medical Biotechnology
786. Balibegloo M.; Rezaei N. Development and clinical application of bispecific antibody in the treatment of colorectal cancer 2020 Expert Review of Clinical Immunology
787. Goodarzi F.; Kondori J.; Rezaei N.; Zendehboudi S. Meso- and molecular-scale modeling to provide new insights into interfacial and structural properties of hydrocarbon/water/surfactant systems 2019 Journal of Molecular Liquids
788. Moazzami B.; Razavi-Khorasani N.; Dooghaie Moghadam A.; Farokhi E.; Rezaei N. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being 2020 Journal of Clinical Virology
789. Saadati S.; Eskandari V.; Rahmani F.; Mahmoudi M.J.; Rahnemoon Z.; Rahmati Z.; Gorzin F.; Hedayat M.; Amirzargar A.A.; Rezaei N. Gene expression and levels of tgf-Β in pbmc is associated with severity of symptoms in chronic heart failure 2020 Avicenna Journal of Medical Biotechnology
790. Momtazmanesh S.; Rahmani F.; Delavari F.; Vahedi Z.; Ebadirad S.; Keshavarz-Fathi M.; Moallemian M.; Ashkevarian S.; Kolahi M.R.; Samimiat A.; Raei N.; Rouzrokh P.; Alesaeidi S.; Jaberipour A.; Bakhshi S.; Paryad-Zanjani S.; Perc M.; Uddin L.Q.; Allali A.; Sullivan K.; Taher A.; Baris S.; Ozen A.; Karakoc-Aydiner E.; Aldave J.C.; Latiff A.H.A.; Al-Herz W.; Phantumvanit P.; Stashchak A.; Kryvenko O.; Stashchak M.; Utomo D.; Salunke D.; Kelishadi R.; Hedayati M.; Mirzahosseini S.; Bondarenko A.; Goudouris E.; Condino-Neto A.; Vieira D.N.; Ulrichs T.; Pavalkis D.; Rosivall L.; Ochs H.; Rezaei N. U100: An innovative usern platform for education and research without borders 2020 Acta Medica Iranica
791. Kamangar F., et al. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 2020 The Lancet Gastroenterology and Hepatology
792. Rezaei N.; Uddin M.N.; Amin I.K.; Othman M.L.; Marsadek M.B.; Hasan M.M. A Novel Hybrid Machine Learning Classifier-Based Digital Differential Protection Scheme for Intertie Zone of Large-Scale Centralized DFIG-Based Wind Farms 2020 IEEE Transactions on Industry Applications
793. Hanaei S.; Sanati G.; Sadr M.; Salmanroghani R.; Rezaei N. DNA methylation of SOCS3 in intestinal biopsy and peripheral blood samples of Iranian patients with ulcerative colitis 2020 European Journal of Gastroenterology and Hepatology
794. Rezaei N.; Keshavarz-Fathi M. Preface 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
795. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Mahmoudi M.; Rezaei N. The sixth sense organs: The gut 2019 Biophysics and Neurophysiology of the Sixth Sense
796. Moazzami B.; Moazzami K.; Rezaei N. Early onset inflammatory bowel disease: Manifestations, genetics and diagnosis 2019 Turkish Journal of Pediatrics
797. Rezaei N.; Saghazadeh A. Preface 2019 Biophysics and Neurophysiology of the Sixth Sense
798. Pourvali A.; Arshi S.; Nabavi M.; Bemanian M.H.; Shokri S.; Shahrooei M.; Rezaei N.; Fallahpour M. Atypical omenn syndrome due to rag2 gene mutation, a case report 2019 Iranian Journal of Immunology
799. Jalilian M.; Tabzar A.; Ghasemi V.; Mohammadzadeh O.; Pourafshary P.; Rezaei N.; Zendehboudi S. An experimental investigation of nanoemulsion enhanced oil recovery: Use of unconsolidated porous systems 2019 Fuel
800. Mahmoudi M.; Taghavi-Farahabadi M.; Rezaei N.; Hashemi S.M. Comparison of the effects of adipose tissue mesenchymal stromal cell-derived exosomes with conditioned media on neutrophil function and apoptosis 2019 International Immunopharmacology
801. Spoor J.; Farajifard H.; Rezaei N. Congenital neutropenia and primary immunodeficiency diseases 2019 Critical Reviews in Oncology/Hematology
802. Razi S.; Rezaei N. Immune Cell Vaccine for Cancer 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
803. Aghamiri S.; Mehrjardi K.F.; Shabani S.; Keshavarz-Fathi M.; Kargar S.; Rezaei N. Nanoparticle-siRNA: A potential strategy for ovarian cancer therapy? 2019 Nanomedicine
804. Yousefi A.; Zare Bidoki A.; Shafioyoun A.; Sadr M.; Varzaneh F.N.; Shabani M.; Motamed F.; Farahmand F.; Khodadad A.; Fallahi G.; Najafi M.; Rezaei N. Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis 2019 Clinics and Research in Hepatology and Gastroenterology
805. Valilou S.F.; Rezaei N. Tumor Antigens 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
806. Saghazadeh A.; Khaksar R.; Rezaei N. Learning the sixth sense 2019 Biophysics and Neurophysiology of the Sixth Sense
807. Force L.M.; et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017 2019 The Lancet Oncology
808. Rezaei N. Oral ulcers and candidiasis 2019 Pediatric Immunology: A Case-Based Collection with MCQs
809. Yazdani R.; Amirifar P.; Abolhassani H.; Azizi G.; Parvaneh N.; Rezaei N.; Aghamohammadi A. UNC13D deficiency associated with epileptic seizures and antibody deficiency: The first case from the Iranian National Registry 2019 Journal of Investigational Allergology and Clinical Immunology
810. Rezaei N.; Keshavarz-Fathi M. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
811. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Rezaei N. The sixth sense organs: The hands 2019 Biophysics and Neurophysiology of the Sixth Sense
812. Rezaei N.; Saghazadeh A. What would happen if humans live beyond time? 2019 Biophysics and Neurophysiology of the Sixth Sense
813. Rezaei N. Extensive Rash and Swollen Eyelids Following Eating Peanut Cookie 2019 Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1
814. Pastaki Khoshbin A.; Eskian M.; Keshavarz-Fathi M.; Rezaei N. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond 2019 Archivum Immunologiae et Therapiae Experimentalis
815. Sanaei R.; Rezaei N.; Aghamohammadi A.; Delbandi A.-A.; Teimourian S.; Yazdani R.; Tavasolian P.; Kiaee F.; Tajik N. Evaluation of the TLR negative regulatory network in CVID patients 2019 Genes and Immunity
816. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Rezaei N. Dreams tell the brain true stories 2019 Biophysics and Neurophysiology of the Sixth Sense
817. Keshavarz-Fathi M.; Rezaei N. Peptide and Protein Vaccines for Cancer 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
818. Moradi L.; Cheraghi T.; Yazdani R.; Azizi G.; Rasouli S.; Zavareh F.T.; Parvaneh L.; Parvaneh N.; Sohani M.; Delavari S.; Abolhassani H.; Rezaei N.; Aghamohammadi A. Mendelian susceptibility to mycobacterial disease: Clinical and immunological findings of patients suspected for IL12Rβ1 deficiency 2019 Allergologia et Immunopathologia
819. Eskian M.; Alavi A.; Khorasanizadeh M.H.; Viglianti B.L.; Jacobsson H.; Barwick T.D.; Meysamie A.; Yi S.K.; Iwano S.; Bybel B.; Caobelli F.; Lococo F.; Gea J.; Sancho-Muñoz A.; Schildt J.; Tatcı E.; Lapa C.; Keramida G.; Peters M.; Boktor R.R.; John J.; Pitman A.G.; Mazurek T.; Rezaei N. Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements 2019 European Journal of Nuclear Medicine and Molecular Imaging
820. Rahmani F.; Rezaei N. Concerning Weight Loss Over Three Weeks 2019 Pediatric Autoimmunity and Transplantation: A Case-Based Collection with MCQs, Volume 3
821. Rahmani F.; Saghazadeh A.; Rahmani M.; Teixeira A.L.; Rezaei N.; Aghamollaei V.; Ardebili H.E. Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis 2019 Brain Research
822. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Rezaei N. The sixth sense organs: The ears 2019 Biophysics and Neurophysiology of the Sixth Sense
823. Saghazadeh A.; Khaksar R.; Rezaei N. Stem cells have more than five senses 2019 Biophysics and Neurophysiology of the Sixth Sense
824. Aghaie M.; Rezaei N.; Zendehboudi S. Assessment of carbon dioxide solubility in ionic liquid/toluene/water systems by extended PR and PC-SAFT EOSs: Carbon capture implication 2019 Journal of Molecular Liquids
825. Rahmani F.; Ziaee V.; Assari R.; Sadr M.; Rezaei A.; Sadr Z.; Reza Raeeskarami S.; Hassan Moradinejad M.; Aghighi Y.; Rezaei N. Interleukin 10 and transforming growth factor beta polymorphisms as risk factors for kawasaki disease: A case-control study and meta-analysis 2019 Avicenna Journal of Medical Biotechnology
826. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Rezaei N. The sixth sense organs: The eyes 2019 Biophysics and Neurophysiology of the Sixth Sense
827. Rezaei H.; Yousefi A.; Larijani B.; Dehnavieh R.; Rezaei N.; Kazemi M.; Adibi P. Iran's international collaborative articles in medical sciences 2019 Medical Journal of the Islamic Republic of Iran
828. Jabbari P.; Hanaei S.; Rezaei N. State of the art in immunotherapy of neuroblastoma 2019 Immunotherapy
829. Harville T.; Pandey S.; Kumar P.; Yamazaki-Nakashimada M.A.; Tangie L.N.; Rahmani F.; Rezaei N. Introduction to Autoimmunity, Secondary Immunodeficiency, and Transplantation 2019 Pediatric Autoimmunity and Transplantation: A Case-Based Collection with MCQs, Volume 3
830. Saghazadeh A.; Rezaei N. The physical burden of immunoperception 2019 Biophysics and Neurophysiology of the Sixth Sense
831. Keshavarz-Fathi M.; Rezaei N. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
832. Rahmani F.; Rezaei N. Refractory oral thrush 2019 Pediatric Immunology: A Case-Based Collection with MCQs
833. Tafakori Delbari M.; Cheraghi T.; Yazdani R.; Fekrvand S.; Delavari S.; Azizi G.; Chavoshzadeh Z.; Mahdaviani S.A.; Ahanchian H.; Khoshkhui M.; Behmanesh F.; Aleyasin S.; Esmaeilzadeh H.; Jabbari-Azad F.; Fallahpour M.; Zamani M.; Madani S.P.; Moazzami B.; Habibi S.; Rezaei A.; Lotfalikhani A.; Movahed M.; Shariat M.; Kalantari A.; Aghamohammadi A.; Darabi M.; Parvaneh N.; Rezaei N.; Abolhassani H. Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran 2019 International Archives of Allergy and Immunology
834. Saghazadeh A.; Rezaei N. The sixth sense: Symphony of spooky actions 2019 Biophysics and Neurophysiology of the Sixth Sense
835. Saghazadeh A.; Rahmani F.; Rezaei N. Neurocircuitry of intuition 2019 Biophysics and Neurophysiology of the Sixth Sense
836. Rezaei L.A. Preface 2019 Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1
837. Rezaei N.; Saghazadeh A. Gut feelings in practice 2019 Biophysics and Neurophysiology of the Sixth Sense
838. Saghazadeh A.; Khaksar R.; Rezaei N. The manager's sixth sense: An art in organizational, educational, moral, and expert thinking 2019 Biophysics and Neurophysiology of the Sixth Sense
839. Soltani Z.E.; Rahmani F.; Rezaei N. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options 2019 European Cytokine Network
840. Yazdani R.; Shapoori S.; Rezaeepoor M.; Sanaei R.; Ganjalikhani-Hakemi M.; Azizi G.; Rae W.; Aghamohammadi A.; Rezaei N. Features and roles of T helper 9 cells and interleukin 9 in immunological diseases 2019 Allergologia et Immunopathologia
841. Farahmand F.; Ahmadi M.; Khodadad A.; Najafi M.; Fallahi G.; Motamed F.; Movahedi M.; Aghamohammadi A.; Rezaei N.; Javaherizadeh H. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis 2019 Clinical and Experimental Hepatology
842. Rezaei N.; Uddin M.N.; Amin I.K.; Othman M.L.; Marsadek M. A Novel Differential-based Protection Scheme for Intertie Zone of Large-Scale Centralized DFIG Wind Farms 2019 2019 IEEE Industry Applications Society Annual Meeting, IAS 2019
843. Eskian M.; Khorasanizadeh M.; Zinzani P.L.; Illidge T.M.; Rezaei N. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma 2019 International Reviews of Immunology
844. Tavassoli M.; Abolhassani H.; Yazdani R.; Ghadami M.; Azizi G.; Abdolrahim Poor Heravi S.; Moeini Shad T.; Kokabee M.; Movahedi M.; Abdshahzadeh H.; Gharagozlou M.; Rezaei N.; Esmaeilzadeh H.; Aleyasin S.; Aghamohammadi A. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis 2019 Pediatric Allergy and Immunology
845. Rezaei N.; Saghazadeh A. Biophysics and Neurophysiology of the Sixth Sense 2019 Biophysics and Neurophysiology of the Sixth Sense
846. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Rezaei N. The sixth sense organs: The heart 2019 Biophysics and Neurophysiology of the Sixth Sense
847. Keshavarz-Fathi M.; Rezaei N. Candidate Cancers for Vaccination 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
848. Saghazadeh A.; Rezaei N. Fuzzy sets: Application to the sixth sense 2019 Biophysics and Neurophysiology of the Sixth Sense
849. Keshavarz-Fathi M.; Rezaei N. Immunotherapeutic Approaches in Cancer 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
850. Saghazadeh A.; Ataeinia B.; Keynejad K.; Abdolalizadeh A.; Hirbod-Mobarakeh A.; Rezaei N. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude 2019 Journal of Psychiatric Research
851. Sadr M.; Moazzami B.; Soleimanifar N.; Elhamian N.; Rezaei A.; Ebrahimi Daryani N.; Rezaei N. Single Nucleotide Polymorphisms of PTPN22 Gene in Iranian Patients with Ulcerative Colitis 2019 Fetal and Pediatric Pathology
852. Valilou S.F.; Rezaei N. Strategy of Allogeneic and Autologous Cancer Vaccines 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
853. Rahmani F.; Rezaei N. Pediatric Autoimmunity and Transplantation: A Case-Based Collection with MCQs, Volume 3 2019 Pediatric Autoimmunity and Transplantation: A Case-Based Collection with MCQs, Volume 3
854. Dashti A.; Raji M.; Razmi A.; Rezaei N.; Zendehboudi S.; Asghari M. Efficient hybrid modeling of CO2 absorption in aqueous solution of piperazine: Applications to energy and environment 2019 Chemical Engineering Research and Design
855. Keshavarz-Fathi M.; Rezaei N. Combination Therapy 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
856. Yazdani R.; Abolhassani H.; Kiaee F.; Habibi S.; Azizi G.; Tavakol M.; Chavoshzadeh Z.; Mahdaviani S.A.; Momen T.; Gharagozlou M.; Movahedi M.; Hamidieh A.A.; Behniafard N.; Nabavi M.; Bemanian M.H.; Arshi S.; Molatefi R.; Sherkat R.; Shirkani A.; Amin R.; Aleyasin S.; Faridhosseini R.; Jabbari-Azad F.; Mohammadzadeh I.; Ghaffari J.; Shafiei A.; Kalantari A.; Mansouri M.; Mesdaghi M.; Babaie D.; Ahanchian H.; Khoshkhui M.; Soheili H.; Eslamian M.H.; Cheraghi T.; Dabbaghzadeh A.; Tavassoli M.; Kalmarzi R.N.; Mortazavi S.H.; Kashef S.; Esmaeilzadeh H.; Tafaroji J.; Khalili A.; Zandieh F.; Sadeghi-Shabestari M.; Darougar S.; Behmanesh F.; Akbari H.; Zandkarimi M.; Abolnezhadian F.; Fayezi A.; Moghtaderi M.; Ahmadiafshar A.; Shakerian B.; Sajedi V.; Taghvaei B.; Safari M.; Heidarzadeh M.; Ghalebaghi B.; Fathi S.M.; Darabi B.; Bazregari S.; Bazargan N.; Fallahpour M.; Khayatzadeh A.; Javahertrash N.; Bashardoust B.; Zamani M.; Mohsenzadeh A.; Ebrahimi S.; Sharafian S.; Vosughimotlagh A.; Tafakoridelbari M.; Rahim M.; Ashournia P.; Razaghian A.; Rezaei A.; Samavat A.; Mamishi S.; Khazaei H.A.; Mohammadi J.; Negahdari B.; Parvaneh N.; Rezaei N.; Lougaris V.; Giliani S.; Plebani A.; Ochs H.D.; Hammarström L.; Aghamohammadi A. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort 2019 Journal of Allergy and Clinical Immunology: In Practice
857. Saghazadeh A.; Khaksar R.; Mahmoudi M.; Rezaei N. Intuition and food preferences 2019 Biophysics and Neurophysiology of the Sixth Sense
858. Rahmani F.; Rezaei N. Toddler with Bruising on Knees 2019 Pediatric Autoimmunity and Transplantation: A Case-Based Collection with MCQs, Volume 3
859. Keshavarz-Fathi M.; Rezaei N. Cancer Immunology 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
860. Ebrahimiyan H.; Rezaei N.; Vojdanian M.; Aslani S.; Jamshidi A.; Mahmoudi M. microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients 2019 International Journal of Rheumatic Diseases
861. Saghazadeh A.; Hafizi S.; Rezaei N. The mental burden of immunoperception 2019 Biophysics and Neurophysiology of the Sixth Sense
862. Saghazadeh A.; Rezaei N. Follow aura and find the sixth sense 2019 Biophysics and Neurophysiology of the Sixth Sense
863. Keshavarz-Fathi M.; Rezaei N. Personalized Cancer Vaccine 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
864. Rezaei L.A. Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1 2019 Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1
865. Jabbari P.; Rezaei N. Artificial intelligence and immunotherapy 2019 Expert Review of Clinical Immunology
866. Keshavarz-Fathi M.; Rezaei N. Obstacles in the Development of Therapeutic Cancer Vaccines 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
867. Saghazadeh A.; Rezaei N. The immunoemotional regulatory system 2019 Biophysics and Neurophysiology of the Sixth Sense
868. Armin S.; Ramezani K.; Shamsian B.S.; Chavoshzadeh Z.; Eghbali M.; Bidoki A.Z.; Sadr M.; Mesdaghi M.; Gorjipour H.; Razi S.; Rezaei N. Novel CD40LG mutation in two cousins with immunoglobulin class switch recombinant deficiency 2019 Acta Medica Iranica
869. Amanat M.; Salehi M.; Rezaei N. Autoimmune encephalitis in brief 2019 Acta Medica Iranica
870. Kheiri G.; Dolatshahi M.; Rahmani F.; Rezaei N. Role of p38/MAPKs in Alzheimer's disease: Implications for amyloid beta toxicity targeted therapy 2019 Reviews in the Neurosciences
871. Mohammadzadeh I.; Rahmani F.; Rezaei N. Allergy to Bus 2019 Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1
872. Afshari F.; Soleyman-Jahi S.; Keshavarz-Fathi M.; Roviello G.; Rezaei N. The promising role of monoclonal antibodies for gastric cancer treatment 2019 Immunotherapy
873. Mahalleh M.; Shabani M.; Rayzan E.; Rezaei N. Reinforcing the primary immunotherapy modulators against acute leukemia; Monoclonal antibodies in AML 2019 Immunotherapy
874. Saghazadeh A.; Rezaei N. More than a chance 2019 Biophysics and Neurophysiology of the Sixth Sense
875. Razi B.; Reykandeh S.E.; Alizadeh S.; Amirzargar A.; Saghazadeh A.; Rezaei N. TIM family gene polymorphism and susceptibility to rheumatoid arthritis: Systematic review and meta-analysis 2019 PLoS ONE
876. Ghaemi M.R.; Hemmati S.; Rezaei A.; Sadr M.; Mohebbi B.; Ghaffaripour H.; Rezaei N.; Mahdaviani S.A. Association of ADAM33 T1 polymorphism with subgroups of pediatric asthma patients in Iran 2019 Acta Medica Iranica
877. Saghazadeh A.; Mojtabavi H.; Khaksar R.; Rezaei N. The sixth sense: Let your mind go to sleep 2019 Biophysics and Neurophysiology of the Sixth Sense
878. Khalili N.; Keshavarz-Fathi M.; Shahkarami S.; Hirbod-Mobarakeh A.; Rezaei N. Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review 2019 Journal of Oncology Pharmacy Practice
879. Saghazadeh A.; Rezaei N. An evolutionary perspective of the sixth sense 2019 Biophysics and Neurophysiology of the Sixth Sense
880. Shabani M.; Aleyasin S.; Kashef S.; Zoghi S.; Deswarte C.; Casanova J.-L.; Bustamante J.; Rezaei N. A Novel Recessive Mutation of Interferon-γ Receptor 1 in a Patient with Mycobacterium tuberculosis in Bone Marrow Aspirate 2019 Journal of Clinical Immunology
881. Rahmani F.; Keshavarz-Fathi M.; Hanaei S.; Aminorroaya A.; Delavari F.; Paryad-Zanjani S.; Ahmadi N.S.; Akbari P.; Ashkevarian S.; Barghi F.; Ebadirad S.; Jaberipour A.; Kolahi M.R.; Moallemian M.; Pourebrahimi A.; Samimiat A.; Vahedi Z.; Seyedian S.-S.L.; Rezaei N. Universal scientific education and research network (USERN): Step strong in scientific networking 2019 Acta Medica Iranica
882. Rahmani F.; Rezaei N. Preface 2019 Pediatric Autoimmunity and Transplantation: A Case-Based Collection with MCQs, Volume 3
883. Kianiamin M.; Rahmani F.; Rezaei N. Yellow-Colored Facial Skin Rash 2019 Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1
884. Mahmoudi M.J.; Hedayat M.; Taghvaei M.; Harsini S.; Nematipour E.; Farhadi E.; Mahmoudi M.; Sadr M.; Esfahanian N.; Nourijelyani K.; Amirzargar A.A.; Rezaei N. Interleukin-10 and transforming growth factor beta1 gene polymorphisms in chronic heart failure 2019 Acta Biomedica
885. Saghazadeh A.; Rezaei N. The sixth sense organs: The immune system 2019 Biophysics and Neurophysiology of the Sixth Sense
886. Saghazadeh A.; Rezaei N. Asymmetry: Extra sparkle to the sixth sense? 2019 Biophysics and Neurophysiology of the Sixth Sense
887. Esene C.; Rezaei N.; Aborig A.; Zendehboudi S. Comprehensive review of carbonated water injection for enhanced oil recovery 2019 Fuel
888. Keshavarz-Fathi M.; Rezaei N. Vaccines, Adjuvants, and Delivery Systems 2019 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
889. Ghaemdoust F.; Keshavarz-Fathi M.; Rezaei N. Natural killer cells and cancer therapy, what we know and where we are going 2019 Immunotherapy
890. Abolhassani H.; Aghamohammadi A.; Fang M.; Rezaei N.; Jiang C.; Liu X.; Pan-Hammarström Q.; Hammarström L. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency 2019 Genetics in Medicine
891. Wall L.A.; Rahmani M.; Rahmani F.; Topalusic I.; Esmaeilzadeh H.; Manti S.; Sharafian S.; Salpietro C.D.; Cuppari C.; Gipson K.S.; Rezaei N. Introduction to Allergy 2019 Pediatric Allergy: A Case-Based Collection with MCQs,: Volume 1
892. Razi S.; Baradaran Noveiry B.; Keshavarz-Fathi M.; Rezaei N. IL-17 and colorectal cancer: From carcinogenesis to treatment 2019 Cytokine
893. El-Sayed Z.A.; Abramova I.; Aldave J.C.; Al-Herz W.; Bezrodnik L.; Boukari R.; Bousfiha A.A.; Cancrini C.; Condino-Neto A.; Dbaibo G.; Derfalvi B.; Dogu F.; Edgar J.D.M.; Eley B.; El-Owaidy R.H.; Espinosa-Padilla S.E.; Galal N.; Haerynck F.; Hanna-Wakim R.; Hossny E.; Ikinciogullari A.; Kamal E.; Kanegane H.; Kechout N.; Lau Y.L.; Morio T.; Moschese V.; Neves J.F.; Ouederni M.; Paganelli R.; Paris K.; Pignata C.; Plebani A.; Qamar F.N.; Qureshi S.; Radhakrishnan N.; Rezaei N.; Rosario N.; Routes J.; Sanchez B.; Sediva A.; Seppanen M.R.; Serrano E.G.; Shcherbina A.; Singh S.; Siniah S.; Spadaro G.; Tang M.; Vinet A.M.; Volokha A.; Sullivan K.E. X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world 2019 World Allergy Organization Journal
894. Shaghaghi M.; Soleyman-jahi S.; Abolhassani H.; Yazdani R.; Azizi G.; Rezaei N.; Barbouche M.-R.; McKinlay M.A.; Aghamohammadi A. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data 2018 Vaccine
895. Mahdaviani S.A.; Rezaei N. Pulmonary manifestations of primary immunodeficiency diseases 2018 Pulmonary Manifestations of Primary Immunodeficiency Diseases
896. Saghazadeh A.; Rezaei N. Pulmonary manifestations of predominantly antibody deficiencies 2018 Pulmonary Manifestations of Primary Immunodeficiency Diseases
897. Farajzadeh Valilou S.; Keshavarz-Fathi M.; Silvestris N.; Argentiero A.; Rezaei N. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer 2018 Cytokine and Growth Factor Reviews
898. Keshavarz-Fathi M.; Rezaei N. Cancer Immunology 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
899. Hedayat M.; Mahmoudi M.J.; Taghvaei M.; Nematipour E.; Farhadi E.; Esfahanian N.; Mahmoudi M.; Sadr M.; Nourijelyani K.; Amirzargar A.A.; Rezaei N. Tumor necrosis factor-alpha and interleukin-6 gene polymorphisms in iranian patients with ischemic heart failure 2018 Avicenna Journal of Medical Biotechnology
900. Keshavarz-Fathi M.; Rezaei N. Personalized Cancer Vaccine 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
901. Mahdaviani S.A.; Rezaei N. Preface 2018 Pulmonary Manifestations of Primary Immunodeficiency Diseases
902. Mahmoudi M.; Hamzeh E.; Aslani S.; Ziaee V.; Poursani S.; Rezaei N. Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis 2018 Clinical Rheumatology
903. Sadeghi-Shabestari M.; Dousti S.; Rezamand A.; Harsini S.; Rezaei N. A single center survey of patients with congenital neutropenia: Report from northwestern Iran 2018 Acta Medica Iranica
904. Esmaeili Reykande S.; Rezaei A.; Sadr M.; Shabani M.; Najmi Varzaneh F.; Ziaee V.; Rezaei N. Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis 2018 Clinical Rheumatology
905. Khajeh Alizadeh Attar M.; Anwar M.A.; Eskian M.; Keshavarz-Fathi M.; Choi S.; Rezaei N. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis 2018 Medicinal Research Reviews
906. Zoghi S.; Ziaee V.; Hirschmugl T.; Jimenez-Heredia R.; Krolo A.; Boztug K.; Rezaei N. Exome sequencing revealed C1Q homozygous mutation in Pediatric Systemic Lupus Erythematosus 2018 Allergologia et Immunopathologia
907. Rezahosseini O.; Hanaei S.; Hamadani M.; Keshavarz-Fathi M.; Rezaei N. The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma 2018 International Reviews of Immunology
908. Keshavarz-Fathi M.; Rezaei N. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
909. Azizi G.; Mirshafiey A.; Abolhassani H.; Yazdani R.; Ghanavatinejad A.; Noorbakhsh F.; Rezaei N.; Aghamohammadi A. The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: Correlation with disease severity 2018 Journal of Cellular Physiology
910. Hanaei S.; Abdollahzade S.; Sadr M.; Mirbolouk M.H.; Khoshnevisan A.; Rezaei N. Association of IL10 and TGFB single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population: A case control study 2018 BMC Medical Genetics
911. Bashiri K.; Rezaei N.; Nasi M.; Cossarizza A. The role of latency reversal agents in the cure of HIV: A review of current data 2018 Immunology Letters
912. Valilou S.F.; Rezaei N. Tumor Antigens 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
913. Yousefzadegan S.; Tavakol M.; Abolhassani H.; Nadjafi A.; Mansouri S.; Yazdani R.; Azizi G.; Negahdari B.; Rezaei N.; Aghamohammadi A. Systematic investigation for underlying causes of recurrent infections in children: Surveillance of primary immunodeficiency 2018 European Annals of Allergy and Clinical Immunology
914. Nasir Uddin M.; Khairul Amin I.; Rezaei N.; Marsadek M. Grey Wolf optimization based power management strategy for battery storage of dfig-wecs in standalone operating mode 2018 2018 IEEE Industry Applications Society Annual Meeting, IAS 2018
915. Agah E.; Zardoui A.; Saghazadeh A.; Ahmadi M.; Tafakhori A.; Rezaei N. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis 2018 PLoS ONE
916. Ebrahimi Daryani N.; Sadr M.; Soltani S.; Saghazadeh A.; Moossavi S.; Shahkarami S.; Farhadi E.; Rezaei N. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease 2018 Digestive Diseases
917. Keshavarz-Fathi M.; Rezaei N. Preface 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
918. Sodagari H.R.; Aryan Z.; Abdolghaffari A.H.; Rezaei N.; Sahebkar A. Immunomodulatory and anti-inflammatory phytochemicals for the treatment of inflammatory bowel disease (IBD) 2018 Journal of Pharmacopuncture
919. Keshavarz-Fathi M.; Rezaei N. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
920. Keshavarz-Fathi M.; Rezaei N. Combination Therapy: Cancer Vaccines and Other Therapeutics 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
921. Keshavarz-Fathi M.; Rezaei N. Candidate Cancers for Vaccination 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
922. Farrokhi S.; Shabani M.; Aryan Z.; Zoghi S.; Krolo A.; Boztug K.; Rezaei N. MHC class II deficiency: Report of a novel mutation and special review 2018 Allergologia et Immunopathologia
923. Farajifard H.; Zavvar M.; Rajaei T.; Noorbakhsh F.; Nikougoftar-zarif M.; Azadmanesh K.; Kompani F.; Rezaei N. In vitro study of HAX1 gene therapy by retro viral transduction as a therapeutic target in severe congenital neutropenia 2018 European Cytokine Network
924. Assari R.; Aghighi Y.; Ziaee V.; Sadr M.; Rahmani F.; Rezaei A.; Sadr Z.; Moradinejad M.H.; Raeeskarami S.R.; Rezaei N. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease 2018 International Journal of Rheumatic Diseases
925. Zoghi S.; Rezaei N. Whole exome sequencing could help to distinguish between pediatric systemic lupus erythematosus and primary immunodeficiency disease 2018 Acta Medica Iranica
926. Yousefi A.; Mahmoudi E.; Baradaran Noveiry B.; Zare Bidoki A.; Sadr M.; Motamed F.; Najafi M.; Farahmand F.; Khodadad A.; Fallahi G.H.; Rezaei N. Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma 2018 Clinics and Research in Hepatology and Gastroenterology
927. Razi S.; Rezaei N. Immune Cell Vaccine for Cancer 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
928. Amanat M.; Salehi M.; Rezaei N. A guideline for early diagnosis of autoimmune epilepsy based on clinical manifestations and common para-clinical tests 2018 Acta Medica Iranica
929. Aghamohammadi A.; Akrami S.M.; Yaghmaie M.; Rezaei N.; Azizi G.; Yaseri M.; Nosrati H.; Dizaji M.Z. Individual radiosensitivity assessment of the families of ataxia-Telangiectasia patients by g2-checkpoint abrogation 2018 Sultan Qaboos University Medical Journal
930. Kordjazy N.; Haj-Mirzaian A.; Haj-Mirzaian A.; Rohani M.M.; Gelfand E.W.; Rezaei N.; Abdolghaffari A.H. Role of toll-like receptors in inflammatory bowel disease 2018 Pharmacological Research
931. Azizi G.; Mirshafiey A.; Abolhassani H.; Yazdani R.; Jafarnezhad-Ansariha F.; Shaghaghi M.; Mortazavi-Jahromi S.S.; Noorbakhsh F.; Rezaei N.; Aghamohammadi A. Circulating helper T-cell subsets and regulatory T cells in patients with common variable immunodeficiency without known monogenic disease 2018 Journal of Investigational Allergology and Clinical Immunology
932. Fathollahi A.; Aslani S.; Mostafaei S.; Rezaei N.; Mahmoudi M. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis 2018 Inflammation Research
933. Amanat M.; Salehi M.; Rezaei N. The role of immune system dysfunction in co-existence of neurological disorders in Psoriasis 2018 Acta Medica Iranica
934. Amanat M.; Salehi M.; Rezaei N. Pulmonary manifestations of other well-defined immunodeficiencies 2018 Pulmonary Manifestations of Primary Immunodeficiency Diseases
935. Abdollahzade S.; Hanaei S.; Sadr M.; Mirbolouk M.H.; Fattahi E.; Rezaei N.; Khoshnevisan A. Significant association of TNF-α, but not other pro-inflammatory cytokines, single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population 2018 Clinical Neurology and Neurosurgery
936. Bahrami A.; Soltani Z.; Fazlollahi M.R.; Rahmani F.; Houshmand M.; Mazinani M.; Rezaei N. Adenoid hyperplasia in a patient with a rare type of hyper immunoglobulin M syndrome due to CD40 deficiency 2018 Acta Medica Iranica
937. Hanaei S.; Afshari K.; Hirbod-Mobarakeh A.; Mohajer B.; Amir Dastmalchi D.; Rezaei N. Therapeutic efficacy of specific immunotherapy for glioma: A systematic review and meta-analysis 2018 Reviews in the Neurosciences
938. Ghanei N.; Rezaei N.; Amiri G.A.; Zayeri F.; Makki G.; Nasseri E. The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial 2018 Journal of Functional Foods
939. Béziat V.; Li J.; Lin J.-X.; Ma C.S.; Li P.; Bousfiha A.; Pellier I.; Zoghi S.; Baris S.; Keles S.; Gray P.; Du N.; Wang Y.; Zerbib Y.; Lévy R.; Leclercq T.; About F.; Lim A.I.; Rao G.; Payne K.; Pelham S.J.; Avery D.T.; Deenick E.K.; Pillay B.; Chou J.; Guery R.; Belkadi A.; Guérin A.; Migaud M.; Rattina V.; Ailal F.; Benhsaien I.; Bouaziz M.; Habib T.; Chaussabel D.; Marr N.; El-Benna J.; Grimbacher B.; Wargon O.; Bustamante J.; Boisson B.; Müller-Fleckenstein I.; Fleckenstein B.; Chandesris M.-O.; Titeux M.; Fraitag S.; Alyanakian M.-A.; Leruez-Ville M.; Picard C.; Meyts I.; Di Santo J.P.; Hovnanian A.; Somer A.; Ozen A.; Rezaei N.; Chatila T.A.; Abel L.; Leonard W.J.; Tangye S.G.; Puel A.; Casanova J.-L. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 2018 Science Immunology
940. Rezaei N. Universal scientific education and research network (USERN): Twinkling stars unite to make the world glow 2018 Acta Medica Iranica
941. Rashid Chehreh Bargh S.; Tafakhori A.; Masoumi F.; Rahmani F.; Ahmadi M.; Namdar A.; Azimi M.; Tavasolian P.; Habibi S.; Zamani B.; Maserrat M.; Sadr M.; Noorbakhsh F.; Rezaei N. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis 2018 Irish Journal of Medical Science
942. Rayzan E.; Rezaei N. Cancer immunotherapy: The way to nobel prize in medicine 2018 Acta Medica Iranica
943. Azarpour A.; Rezaei N.; Zendehboudi S. Dynamic Modeling Strategy to Assess Impacts of Hydrodynamic Parameters on Industrial Hydropurification Process by Considering Catalyst Deactivation 2018 Industrial and Engineering Chemistry Research
944. Bahrami A.; Sadeghian M.; Sheikhvatan M.; Foroudi A.; Harsini S.; Rezaei N. Cytomegalovirus infection in a patient with leukocyte adhesion deficiency type 1 2018 Acta Medica Iranica
945. Fallahi G.-H.; Khatami G.-R.; Esmailzadehha N.; Najafi M.; Farahmand F.; Motamed F.; Khodadad A.; Rezaei N.; Modarresi M.-R.; Qorbani M.; Bagherian R. Association of food allergies, cow’s milk allergy, and asthma with pediatric inflammatory bowel disease 2018 Acta Medica Iranica
946. Bragh S.R.C.; Rahmani F.; Rezaei N. Regulatory T lymphocytes in amyotrophic lateral sclerosis: Emerging evidence to support adaptive immunotherapy? 2018 Acta Medica Iranica
947. Hanaei S.; Sadr M.; Rezaei A.; Shahkarami S.; Ebrahimi Daryani N.; Bidoki A.Z.; Rezaei N. Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study 2018 Clinics and Research in Hepatology and Gastroenterology
948. Behniafard N.; Amirzargar A.A.; Gharagozlou M.; Delavari F.; Hosseinverdi S.; Sotoudeh S.; Farhadi E.; Mahmoudi M.; Khaledi M.; Moghaddam Z.G.; Aghamohammadi A.; Rezaei N. Single nucleotide polymorphisms of the genes encoding IL-10 and TGF-β1 in Iranian children with atopic dermatitis 2018 Allergologia et Immunopathologia
949. Keshavarz-Fathi M.; Rezaei N. Vaccines, Adjuvants, and Delivery Systems 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
950. Tavasolian P.; Sharifi L.; Aghamohammadi A.; Noorbakhsh F.; Sanaei R.; Shabani M.; Rezaei N. Toll-like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA) 2018 European Cytokine Network
951. Eskian M.; Khorasanizadeh M.; Zinzani P.L.; Rezaei N. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma 2018 Immunotherapy
952. Azizi G.; Abolhassani H.; Zaki-Dizaji M.; Habibi S.; Mohammadi H.; Shaghaghi M.; Yazdani R.; Anaya J.-M.; Rezaei N.; Hammarström L.; Aghamohammadi A. Polyautoimmunity in Patients with LPS-Responsive Beige-Like Anchor (LRBA) Deficiency 2018 Immunological Investigations
953. Saghazadeh A.; Tonekaboni S.H.; Najmabadi H.; Rezaei N. A novel homozygous ATP8A2 variant in a patient with phenotypic features of dysequilibrium syndrome 2018 Acta Medica Iranica
954. Aghaie M.; Rezaei N.; Zendehboudi S. A systematic review on CO2 capture with ionic liquids: Current status and future prospects 2018 Renewable and Sustainable Energy Reviews
955. Agah E.; Saleh F.; Sanjari Moghaddam H.; Saghazadeh A.; Tafakhori A.; Rezaei N. CSF and blood biomarkers in amyotrophic lateral sclerosis: Protocol for a systematic review and meta-analysis 2018 Systematic Reviews
956. Zare Bidoki A.; Massoud A.; Najafi S.; Mohammadzadeh M.; Rezaei N. Autosomal dominant deficiency of the interleukin-17F in recurrent aphthous stomatitis: Possible novel mutation in a new entity 2018 Gene
957. Eskandari V.; Amirzargar A.A.; Mahmoudi M.J.; Rahnemoon Z.; Rahmani F.; Sadati S.; Rahmati Z.; Gorzin F.; Hedayat M.; Rezaei N. Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure 2018 Irish Journal of Medical Science
958. Rajabi F.; Drake L.A.; Senna M.M.; Rezaei N. Alopecia areata: a review of disease pathogenesis 2018 British Journal of Dermatology
959. Seppänen M.; Rezaei N. General considerations 2018 Pulmonary Manifestations of Primary Immunodeficiency Diseases
960. Eghbali A.; Rahmani F.; Aryan Z.; Borkhardt A.; Tanzifi P.; Zoghi S.; Rezaei N. Non-pathogenic heterozygous polymorphism in RAB27A gene in a case suspicious to griscelli syndrome, type II 2018 Acta Medica Iranica
961. Rezaei N.; Nasir Uddin M.; Khairul Amin I.; Lutfi Othman M.; Marsadek M. Genetic algorithm based optimization of overcurrent relay coordination for improved protection of DFIG operated wind farms 2018 2018 IEEE Industry Applications Society Annual Meeting, IAS 2018
962. Fathollahi A.; Massoud A.; Amirzargar A.A.; Aghili B.; Nasli Esfahani E.; Rezaei N. sICAM-1, sVCAM-1 and sE-Selectin Levels in Type 1 Diabetes 2018 Fetal and Pediatric Pathology
963. Najafi S.; Mohammadzadeh M.; Rajabi F.; Zare Bidoki A.; Yousefi H.; Farhadi E.; Rezaei N. Interleukin-4 and Interleukin-4 Receptor Alpha Gene Polymorphisms in Recurrent Aphthous Stomatitis 2018 Immunological Investigations
964. Zaridoust A.; Rabbani A.; Hosseinverdi S.; Hilbert P.; Rezaei N. Novel homozygous mutation in the agpat2 gene in a child with berardinelli-seip congenital lipodystrophy syndrome 2018 Acta Medica Iranica
965. Rezaei N.; Nasir Uddin M.; Khairul Amin I.; Lutfi Othman M.; Abidin I.Z. Grey Wolf optimization based improved protection of wind power generation systems 2018 2018 IEEE Industry Applications Society Annual Meeting, IAS 2018
966. Fallah S.; Mesdaghi M.; Mansouri M.; Babaei D.; Karimi A.; Fahimzad S.A.; Armin S.; Tabatabaei S.R.; Azma R.; Khanbabaee G.; Bashardoost B.; Amirmoeini M.; Sadr S.; Jalilianhasanpour R.; Ghanaei R.; Rezaei N.; Chavoshzadeh Z. Severe Combined Immunodeficiency: A Case Series and Review from a Tertiary Pediatric Hospital 2018 Iranian Journal of Allergy, Asthma and Immunology
967. Eskian M.; Khorasanizadeh M.H.; Assa’ad A.H.; Rezaei N. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis 2018 Clinical Reviews in Allergy and Immunology
968. Eskandari V.; Amirzargar A.A.; Moazzami B.; Mahmoudi M.J.; Rahnemoon Z.; Sadati S.; Rahmati Z.; Gorzin F.; Hedayat M.; Rezaei N. Increased levels of IL-23 in peripheral blood mononuclear cells of patients with chronic heart failure 2018 Acta Medica Iranica
969. Harsini S.; Saghazadeh A.; Nedjat S.; Rezaei N. Associations between interleukin-10 polymorphisms and susceptibility to juvenile idiopathic arthritis: a systematic review and meta-analysis 2018 European Cytokine Network
970. Yousefi A.; Najafi M.; Motamed F.; Mahmoudi E.; Bidoki A.Z.; Sadr M.; Rahmani F.; Farhmand F.; Khodadad A.; Fallahi G.; Rezaei N. Association of interleukin-6 and interleukin-1 family gene polymorphisms in autoimmune hepatitis 2018 Annals of Hepatology
971. Farzaei M.H.; El-Senduny F.F.; Momtaz S.; Parvizi F.; Iranpanah A.; Tewari D.; Naseri R.; Abdolghaffari A.H.; Rezaei N. An update on dietary consideration in inflammatory bowel disease: anthocyanins and more 2018 Expert Review of Gastroenterology and Hepatology
972. Amanat M.; Salehi M.; Rezaei N. Neurological and psychiatric disorders in psoriasis 2018 Reviews in the Neurosciences
973. Mahmoodi M.; Abolhassani H.; Mozdarani H.; Rezaei N.; Azizi G.; Yazdani R.; Farzanfar F.; Rafiemanesh H.; Mohagheghi M.-A.; Divsalar K.; Kalmarzi R.N.; Ramyar A.; Aghamohammadi A. In vitro chromosomal radiosensitivity in patients with common variable immunodeficiency 2018 Central European Journal of Immunology
974. Dehghani R.; Rahmani F.; Rezaei N. MicroRNA in Alzheimer's disease revisited: Implications for major neuropathological mechanisms 2018 Reviews in the Neurosciences
975. Afzali S.; Rezaei N.; Zendehboudi S. A comprehensive review on Enhanced Oil Recovery by Water Alternating Gas (WAG) injection 2018 Fuel
976. Keshavarz-Fathi M.; Rezaei N. Immunotherapeutic Approaches in Cancer 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
977. Fallahi G.; Rashtian P.; Aflatoonian M.; Babaei N.; Gaisari M.; Rezaei N. Gastrointestinal manifestations in a child with mastocytosis 2018 Acta Medica Iranica
978. Zendehboudi S.; Rezaei N.; Lohi A. Applications of hybrid models in chemical, petroleum, and energy systems: A systematic review 2018 Applied Energy
979. Keshavarz-Fathi M.; Rezaei N. Obstacles in the Development of Therapeutic Cancer Vaccines 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
980. Valilou S.F.; Rezaei N. Strategy of Allogeneic and Autologous Cancer Vaccines 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
981. Abolhassani H.; Chou J.; Bainter W.; Platt C.D.; Tavassoli M.; Momen T.; Tavakol M.; Eslamian M.H.; Gharagozlou M.; Movahedi M.; Ghadami M.; Hamidieh A.A.; Azizi G.; Yazdani R.; Afarideh M.; Ghajar A.; Havaei A.; Chavoshzadeh Z.; Mahdaviani S.A.; Cheraghi T.; Behniafard N.; Amin R.; Aleyasin S.; Faridhosseini R.; Jabbari-Azad F.; Nabavi M.; Bemanian M.H.; Arshi S.; Molatefi R.; Sherkat R.; Mansouri M.; Mesdaghi M.; Babaie D.; Mohammadzadeh I.; Ghaffari J.; Shafiei A.; Kalantari N.; Ahanchian H.; Khoshkhui M.; Soheili H.; Dabbaghzadeh A.; Shirkani A.; Nasiri Kalmarzi R.; Mortazavi S.H.; Tafaroji J.; Khalili A.; Mohammadi J.; Negahdari B.; Joghataei M.-T.; al-Ramadi B.K.; Picard C.; Parvaneh N.; Rezaei N.; Chatila T.A.; Massaad M.J.; Keles S.; Hammarström L.; Geha R.S.; Aghamohammadi A. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency 2018 Journal of Allergy and Clinical Immunology
982. Imani D.; Rezaei R.; Jafari D.; Razi B.; Alizadeh S.; Bashashati M.; Rezaei N. Il-6 174 g/c polymorphism in inflammatory bowel disease: A systematic review and meta-analysis 2018 Acta Medica Iranica
983. Shahkarami S.; Mehrasa R.; Younesian S.; Yaghmaie M.; Chahardouli B.; Vaezi M.; Rezaei N.; Nikbakht M.; Alimoghaddam K.; Ghavamzadeh A.; Tavakkoly-Bazzaz J.; Ghaffari S.H. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL) 2018 Annals of Hematology
984. Imani D.; Azimi A.; Salehi Z.; Rezaei N.; Emamnejad R.; Sadr M.; Izad M. Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing–remitting multiple sclerosis 2018 International Journal of Immunogenetics
985. Sharifi L.; Aghamohammadi A.; Rezaei N.; Yazdani R.; Mahmoudi M.; Amiri M.M.; Masoumi F.; Bokaie S.; Tavasolian P.; Sanaei R.; Moshiri M.; Tavakolinia N.; Alinia T.; Azizi G.; Mirshafiey A. The Profile of Toll-like Receptor 2 (TLR2), TLR4 and Their Cytosolic Downstream Signaling Pathway in Common Variable Immunodeficiency (CVID) Patients 2018 Iranian Journal of Allergy, Asthma and Immunology
986. Rahmati Z.; Amirzargar A.A.; Saadati S.; Rahmani F.; Mahmoudi M.J.; Rahnemoon Z.; Eskandari V.; Gorzin F.; Hedayat M.; Rezaei N. Association of levels of interleukin 17 and T-helper 17 count with symptom severity and etiology of chronic heart failure: A case-control study 2018 Croatian Medical Journal
987. Mahmoudi M.J.; Harsini S.; Farhadi E.; Hedayat M.; Taghvaei M.; Mahmoudi M.; Sadr M.; Esfahanian N.; Nematipour E.; Nourijelyani K.; Amirzargar A.A.; Rezaei N. Interleukin-2 and Interferon-Gamma single nucleotide polymorphisms in Iranian patients with chronic heart failure 2018 Avicenna Journal of Medical Biotechnology
988. Daryabor G.; Harsini S.; Rezaei N. Immunopathogenesis of ankylosing spondylitis: An updated review 2018 Acta Medica Iranica
989. Sharifi L.; Mohsenzadegan M.; Aghamohammadi A.; Rezaei N.; Zavareh F.T.; Bokaie S.; Moshiri M.; Aghazadeh Z.; Norouzbabaie Z.; Azizi G.; Mirshafiey A. Immunomodulatory effect of G2013 (α-L-guluronic acid) on the TLR2 and TLR4 in human mononuclear cells 2018 Current Drug Discovery Technologies
990. Baharlooi H.; Rezaei N.; Sharif-Paghaleh E. CXCR4 is important for lymphopoiesis not only in mice, but also in man 2018 Acta Medica Iranica
991. Abolhassani H.; Kiaee F.; Tavakol M.; Chavoshzadeh Z.; Mahdaviani S.A.; Momen T.; Yazdani R.; Azizi G.; Habibi S.; Gharagozlou M.; Movahedi M.; Hamidieh A.A.; Behniafard N.; Nabavi M.; Bemanian M.H.; Arshi S.; Molatefi R.; Sherkat R.; Shirkani A.; Amin R.; Aleyasin S.; Faridhosseini R.; Jabbari-Azad F.; Mohammadzadeh I.; Ghaffari J.; Shafiei A.; Kalantari A.; Mansouri M.; Mesdaghi M.; Babaie D.; Ahanchian H.; Khoshkhui M.; Soheili H.; Eslamian M.H.; Cheraghi T.; Dabbaghzadeh A.; Tavassoli M.; Kalmarzi R.N.; Mortazavi S.H.; Kashef S.; Esmaeilzadeh H.; Tafaroji J.; Khalili A.; Zandieh F.; Sadeghi-Shabestari M.; Darougar S.; Behmanesh F.; Akbari H.; Zandkarimi M.; Abolnezhadian F.; Fayezi A.; Moghtaderi M.; Ahmadiafshar A.; Shakerian B.; Sajedi V.; Taghvaei B.; Safari M.; Heidarzadeh M.; Ghalebaghi B.; Fathi S.M.; Darabi B.; Bazregari S.; Bazargan N.; Fallahpour M.; Khayatzadeh A.; Javahertrash N.; Bashardoust B.; Zamani M.; Mohsenzadeh A.; Ebrahimi S.; Sharafian S.; Vosughimotlagh A.; Tafakoridelbari M.; Rahimi M.; Ashournia P.; Razaghian A.; Rezaei A.; Mamishi S.; Parvaneh N.; Rezaei N.; Hammarström L.; Aghamohammadi A. Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis 2018 Journal of Clinical Immunology
992. Keshavarz-Fathi M.; Rezaei N. Peptide and Protein Vaccines for Cancer 2018 Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
993. Sadeghi M.; Keshavarz-Fathi M.; Baracos V.; Arends J.; Mahmoudi M.; Rezaei N. Cancer cachexia: Diagnosis, assessment, and treatment 2018 Critical Reviews in Oncology/Hematology
994. Saghazadeh A.; Hafizi S.; Hosseini F.; Ashrafi M.R.; Rezaei N. Early-onset friedreich’s ataxia with oculomotor apraxia 2017 Acta Medica Iranica
995. Reisi M.; Jalilian R.; Azizi G.; Rashti A.; Faghihi Nia J.; Akbari M.; Babaei N.; Sayedi S.J.; Rezaei N.; Modarresi M.R. Academic performance, sleep disorders and their association in middle school students in Iran 2017 International Journal of Pediatrics
996. Zaki-Dizaji M.; Akrami S.M.; Abolhassani H.; Rezaei N.; Aghamohammadi A. Ataxia telangiectasia syndrome: moonlighting ATM 2017 Expert Review of Clinical Immunology
997. Taher M.; Ebrahimi Daryani N.; Hedayat M.; Eslamian M.; Farhadi E.; Mahmoudi M.; Shirzad S.; Nouri Taromlou M.K.; Chaharmahali M.; Nicknam M.H.; Bashashati M.; Rezaei N. Association analysis of RAC1 single nucleotide polymorphisms with ulcerative colitis 2017 Clinics and Research in Hepatology and Gastroenterology
998. Salmaninejad A.; Mahmoudi M.; Aslani S.; Poursani S.; Ziaee V.; Rezaei N. Association of STAT4 gene single nucleotide polymorphisms with iranian juvenile-onset systemic lupus erythematosus patients 2017 Turkish Journal of Pediatrics
999. Sotoudeh A.; Rostami P.; Nakhaeimoghadam M.; Mohsenipour R.; Rezaei N. Pericentric inversion of chromosome 9 in an infant with ambiguous genitalia 2017 Acta Medica Iranica
1000. Ziaee V.; Maddah M.; Moradinejad M.-H.; Rezaei A.; Zoghi S.; Sadr M.; Harsini S.; Rezaei N. Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis 2017 Clinical Rheumatology
1001. Salmaninejad A.; Zamani M.R.; Pourvahedi M.; Golchehre Z.; Hosseini Bereshneh A.; Rezaei N. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers 2016 Immunological Investigations
1002. Gholami K.; Laali E.; Abolhassani H.; Ahmadvand A.; Mohebbi N.; Javadi M.R.; Aghamohammadi A.; Rezaei N. Costs of hospital admission on primary immunodeficiency diseases 2017 Iranian Journal of Public Health
1003. Baradaran Noveiry B.; Hirbod-Mobarakeh A.; Khalili N.; Hourshad N.; Greten T.F.; Abou-Alfa G.K.; Rezaei N. Specific immunotherapy in hepatocellular cancer: A systematic review 2017 Journal of Gastroenterology and Hepatology (Australia)
1004. Mohammadi Ayenehdeh J.; Niknam B.; Rasouli S.; Hashemi S.M.; Rahavi H.; Rezaei N.; Soleimani M.; Liaeiha A.; Niknam M.H.; Tajik N. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes 2017 Immunology Letters
1005. Azizi G.; Abolhassani H.; Asgardoon M.H.; Alinia T.; Yazdani R.; Mohammadi J.; Rezaei N.; Ochs H.D.; Aghamohammadi A. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management 2017 Expert Review of Clinical Immunology
1006. Saghazadeh A.; Ferrari C.C.; Rezaei N. Deciphering variability in the role of interleukin-1β in Parkinson's disease 2016 Reviews in the Neurosciences
1007. Farrokhi S.; Abbasirad N.; Movahed A.; Khazaei H.A.; Pishjoo M.; Rezaei N. TLR9-based immunotherapy for the treatment of allergic diseases 2017 Immunotherapy
1008. Yousefi H.; Najafi S.; Mohammadzadeh M.; Bidoki A.Z.; Farhadi E.; Rezaei N. Association of transforming growth factor-beta gene polymorphisms in recurrent aphthous stomatitis 2017 Acta Medica Iranica
1009. Rezaei N.; Zendehboudi S.; Chatzis I.; Lohi A. Combined benefits of capillary barrier and injection pressure control to improve fluid recovery at breakthrough upon gas injection: An experimental study 2018 Fuel
1010. Abbasi F.; Soltani S.; Saghazadeh A.; Soltaninejad E.; Rezaei A.; Zare Bidoki A.; Bahrami T.; Amirzargar A.A.; Rezaei N. PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus 2017 Immunological Investigations
1011. Fathi S.M.; Tavakol M.; Rezaei N.; Movahedi M.; Aghamohammadi A.; Shariat M.; Sadeghi B.; Behniafard N.; Darabi B.; Hajikhani A.; Abdollapour I.; Gharagozlou M. Impact of IgE-mediated food allergy on parental quality of life in Iranian patients 2016 Iranian Journal of Allergy, Asthma and Immunology
1012. Assari R.; Aghighi Y.; Ziaee V.; Sadr M.; Rezaei A.; Rahmani F.; Sadr Z.; Raeeskarami S.R.; Moradinejad M.H.; Rezaei N. Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: a case-control study and a review of knowledge 2018 International Journal of Rheumatic Diseases
1013. Scott E.M.; Halees A.; Itan Y.; Spencer E.G.; He Y.; Azab M.A.; Gabriel S.B.; Belkadi A.; Boisson B.; Abel L.; Clark A.G.; Rahim S.A.; Alkuraya F.S.; Casanova J.-L.; Gleeson J.G.; Abdou M.; Abhytankar A.; Adimi P.; Ahmad J.; Akcakus M.; Aksu G.; Al Hajjar S.; Al Juamaah S.; Al Muhsen S.; Al Sannaa N.; Al Tameni S.; Al-Aama J.; Al-Allawi N.; Al-Baradie R.; Al-Gazali L.; Al-Hashem A.; Al-Herz W.; Al-Jeaid D.; Al-Tawari A.; Alangari A.; Alcais A.; AlFawaz T.S.; Alsum Z.; Ammar-Khodja A.; Amouian S.; Arikan C.; Aryani O.; Aslanger A.; Aydogmus C.; Aytekin C.; Azam M.; Bansagi B.; Barbouche M.-R.; Bastaki L.; Ben-Omran T.; Bindu P.S.; Blancas L.; Boisson-Dupuis S.; Bonnet D.; Stambouli O.B.; Bousfiha A.; Boussafara L.; Boutros J.; Bustamante J.; Caksen H.; Camcioglu Y.; Catherinot E.; Celik F.C.; Ciancanelli M.; Cipe F.E.; Clark G.; Cobat A.; Comu S.; Condie A.; Condino-Neto A.; Desai M.; Dobyns W.; Dogu F.; Domaia M.; Dorum M.; Egritas O.; El Azbaoui S.; El Baghdadi J.; El Ruby M.; El-Harouni A.; Elfeky R.A.; Elghazali G.; Faqeih E.; Fenerci E.; Fieschi C.; Funda C.; Gamal I.; Gelik U.; Genel F.; Gezdirici A.; Girisha K.M.; Goldstein A.; Grattan-Smith P.; Gupta N.; Hahn J.; Hatipoglu N.; Hennekam R.; Houshmand M.; Ichai P.; Ikinciogullari A.; Ismail S.; Jalas C.; Jouanguy E.; Kabra M.; Kalkan G.; Kara M.; Karaca N.; Karaer K.; Kariminejad A.; Kayserili H.; Keser-Emiroglu M.; Kilic S.S.; Kissani N.; Kokron C.; Koul R.; Kutukculer N.; Lanternier F.; Mahdaviani A.; Mahlaoui N.; Mansour L.; Mansouri D.; Margari L.; Valente E.M.; Marzouki N.; Masri A.; Megahed A.; Megahed H.; Mekki N.; Mesdaghi M.; Mikati M.; Mojahedi F.; Mulley J.; Nampoothiri S.; Navarrete C.; Omar T.; Oraby A.; Pandaluz A.; Parvaneh N.; Patiroglu T.; Koc Z.P.; Pellier I.; Picard C.; Puel A.; Raas-Rothschild A.; Rajab A.; Raoult D.; Reisli I.; Rezaei N.; Sabri A.; Sahin Y.; Saleem L.; Salem F.; AlSediq N.S.; Sanal O.; Sanger T.; Shakankiry H.; Shang L.; Shehata N.; Shembesh N.; Shkalim V.; Softah A.; Sogaty S.; Soliman N.; Sonmez-Aunaci F.; Sztriha L.; Taibi-Berrah L.; Temtamy S.; Tonekaboni H.; Trauner D.; Tuysuz B.; Varan A.; Vogt G.; Walsh C.; Woods G.; Yesil G.; Yildiran A.; Yildiz B.; Yuksel A.; Zaki M.; Zhang S.Y. Characterization of greater middle eastern genetic variation for enhanced disease gene discovery 2016 Nature Genetics
1014. Rezaei S.; Rezaei N.; Mahmoudi M.; Aryan Z. Is there sufficient evidence to support the use of vitamin supplements in the asthmatic patient? 2017 Expert Review of Respiratory Medicine
1015. Maddah M.; Harsini S.; Ziaee V.; Moradinejad M.H.; Rezaei A.; Zoghi S.; Sadr M.; Aghighi Y.; Rezaei N. Association of tumour necrosis factor-alpha G/A -238 and G/A -308 single nucleotide polymorphisms with juvenile idiopathic arthritis 2016 International Journal of Immunogenetics
1016. Najafi S.; Mohammadzadeh M.; Bidoki A.Z.; Meighani G.; Aslani S.; Mahmoudi M.; Rezaei N. HLA-DRB and HLA-DQB Allele and haplotype frequencies in Iranian patients with recurrent aphthous stomatitis 2016 Iranian Journal of Allergy, Asthma and Immunology
1017. Shaghaghi M.; Shahmahmoodi S.; Abolhassani H.; Soleyman-Jahi S.; Parvaneh L.; Mahmoudi S.; Chavoshzadeh Z.; Yazdani R.; Zahraei S.M.; Ebrahimi M.; Eslamian M.H.; Tabatabaie H.; Yousefi M.; Kandelousi Y.M.; Oujaghlou A.; Rezaei N.; Aghamohammadi A. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995–2014 2016 Emerging Infectious Diseases
1018. Ziaee V.; Rezaei A.; Harsini S.; Maddah M.; Zoghi S.; Sadr M.; Moradinejad M.H.; Rezaei N. Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis 2016 Clinical Rheumatology
1019. Yousefi H.; Rezaei N. A theory towards a measurable definition for health: Introducing two variables 2017 Acta Medica Iranica
1020. Mohammadzadeh I.; Moazzami B.; Ghaffari J.; Aghamohammadi A.; Rezaei N. Primary immunodeficiency diseases in Northern Iran 2017 Allergologia et Immunopathologia
1021. Saghazadeh A.; Rezaei N. The role of timing in the treatment of spinal cord injury 2017 Biomedicine and Pharmacotherapy
1022. Motamed F.; Bagherian R.; Adalat G.; Moradinejad M.H.; Hajizadeh N.; Vasei M.; Mehdizadeh M.; Rezaei N. Systemic amyloidosis in a teenage boy with inflammatory bowel disease 2017 Acta Medica Iranica
1023. Kasraianfard A.; Watt K.D.; Lindberg L.; Alexopoulos S.; Rezaei N. HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation 2016 International Reviews of Immunology
1024. Alipour S.; Zoghi S.; Khalili N.; Hirbod-Mobarakeh A.; Emens L.A.; Rezaei N. Specific immunotherapy in ovarian cancer: A systematic review 2016 Immunotherapy
1025. Aghamohammadi A.; Abolhassani H.; Puchalka J.; Greif-Kohistani N.; Zoghi S.; Klein C.; Rezaei N. Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome 2017 Journal of Clinical Immunology
1026. Aflatounian M.; Rezaei A.; Sadr M.; Saghazadeh A.; Elhamian N.; Sadeghi H.; Motevasselian F.; Farahmand F.; Fallahi G.; Motamed F.; Najafi M.; Rezaei N. Association of PTPN22 Single Nucleotide Polymorphisms with Celiac Disease 2017 Fetal and Pediatric Pathology
1027. Azizi G.; Ghanavatinejad A.; Abolhassani H.; Yazdani R.; Rezaei N.; Mirshafiey A.; Aghamohammadi A. Autoimmunity in primary T-cell immunodeficiencies 2016 Expert Review of Clinical Immunology
1028. Hadizadeh H.; Salehi M.; Khoramnejad S.; Vosoughi K.; Rezaei N. The association between parental consanguinity and primary immunodeficiency diseases: A systematic review and meta-analysis 2017 Pediatric Allergy and Immunology
1029. Harsini S.; Ziaee V.; Tahghighi F.; Mahmoudi M.; Rezaei A.; Soltani S.; Sadr M.; Moradinejad M.H.; Aghighi Y.; Rezaei N. Association of interleukin-2 and interferon-γ single nucleotide polymorphisms with Juvenile systemic lupus erythematosus 2016 Allergologia et Immunopathologia
1030. Sharifi L.; Tavakolinia N.; Kiaee F.; Rezaei N.; Mohsenzadegan M.; Azizi G.; Yazdani R.; Shariat M.; Mirshafiey A.; Aghamohammadi A. A review on defects of dendritic cells in common variable immunodeficiency 2017 Endocrine, Metabolic and Immune Disorders - Drug Targets
1031. Aryan Z.; Rezaei N.; Camargo C.A., Jr. Vitamin D status, aeroallergen sensitization, and allergic rhinitis: A systematic review and meta-analysis 2017 International Reviews of Immunology
1032. Mahmoudi M.; Aslani S.; Hamzeh E.; Ziaee V.; Poursani S.; Nicknam M.H.; Rezaei N. Association Study of MECP2 Gene Single Nucleotide Polymorphisms in Juvenile-Onset Systemic Lupus Erythematosus Patients from Iran 2017 Fetal and Pediatric Pathology
1033. Zamani M.R.; Salmaninejad A.; Akbari Asbagh F.; Masoud A.; Rezaei N. STAT4 single nucleotide gene polymorphisms and susceptibility to endometriosis-related infertility 2016 European Journal of Obstetrics and Gynecology and Reproductive Biology
1034. Sharifi L.; Aghamohammadi A.; Mohsenzadegan M.; Rezaei N.; Zavareh F.T.; Moshiri M.; Bokaie S.; Barati A.; Sayedi S.J.; Azizi G.; Mirshafiey A. Immunomodulation of TLR2 and TLR4 by G2013 (α-L-Guluronic acid) in CVID patients 2017 International Journal of Pediatrics
1035. Khorasanizadeh M.; Eskian M.; Rezaei N. Reductions in eosinophil biomarkers by benralizumab in patients with Asthma 2017 Acta Medica Iranica
1036. Yazdani R.; Ganjalikhani-Hakemi M.; Esmaeili M.; Abolhassani H.; Vaeli S.; Rezaei A.; Sharifi Z.; Azizi G.; Rezaei N.; Aghamohammadi A. Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency 2017 Clinical Immunology
1037. Sukalo M.; Schäflein E.; Schanze I.; Everman D.B.; Rezaei N.; Argente J.; Lorda-Sanchez I.; Deshpande C.; Takahashi T.; Kleger A.; Zenker M. Expanding the mutational spectrum in Johanson-Blizzard syndrome: identification of whole exon deletions and duplications in the UBR1 gene by multiplex ligation-dependent probe amplification analysis 2017 Molecular Genetics and Genomic Medicine
1038. Moqadam I.F.; Najafi S.; Mohammadzadeh M.; Bidoki A.Z.; Yousefi H.; Farhadi E.; Tonekaboni A.; Meighani G.; Mohammadzadeh M.; Amirzargar A.A.; Rezaei N. Lack of association between interleukin-12 gene polymorphisms and recurrent aphthous stomatitis 2016 Avicenna Journal of Medical Biotechnology
1039. Hirbod-Mobarakeh A.; Gordan H.A.; Zahiri Z.; Mirshahvalad M.; Hosseinverdi S.; Rini B.I.; Rezaei N. Specific immunotherapy in renal cancer: A systematic review 2017 Therapeutic Advances in Urology
1040. Najafi S.; Mohammadzadeh M.; Zahedi A.; Heidari M.; Rezaei N. Association of serotonin transporter gene polymorphism with recurrent aphthous stomatitis 2018 Avicenna Journal of Medical Biotechnology
1041. Rezaei N.; Saghazadeh A. The role of PIEZO2 in human mechanosensation 2017 Acta Medica Iranica
1042. Shabani M.; Nichols K.E.; Rezaei N. Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders 2016 Critical Reviews in Oncology/Hematology
1043. Movahedi M.; Tavakol M.; Rahmani F.; Amirzargar A.A.; Bidoki A.Z.; Heidari K.; Gharagozlou M.; Aghamohammadi A.; Nabavi M.; Soltani S.; Rezaei N. Single nucleotide polymorphisms of IL-2, but not IL-12 and IFN-γ, are associated with increased susceptibility to chronic spontaneous urticaria 2017 Allergologia et Immunopathologia
1044. Saghazadeh A.; Rezaei N. Implications of Toll-like receptors in Ebola infection 2017 Expert Opinion on Therapeutic Targets
1045. Emami S.; Ziaee V.; Rezaei A.; Sadr M.; Maddah M.; Amirzargar A.A.; Rezaei N. IL23R gene polymorphism with juvenile idiopathic arthritis and its association with serum IL-17A 2016 International Journal of Rheumatic Diseases
1046. Azizi G.; Abolhassani H.; Mahdaviani S.A.; Chavoshzadeh Z.; Eshghi P.; Yazdani R.; Kiaee F.; Shaghaghi M.; Mohammadi J.; Rezaei N.; Hammarström L.; Aghamohammadi A. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study 2017 Pediatric Allergy and Immunology
1047. Ataeinia B.; Montazeri A.; Tavakol M.; Azizi G.; Kiaee F.; Tavakolinia N.; Negahdari B.; Mohammadi J.; Abolhassani H.; Rezaei N.; Aghamohammadi A. Measurement of Health-Related Quality of Life in Primary Antibody-Deficient Patients 2017 Immunological Investigations
1048. Shariat M.; Abedinia N.; Rezaei N.; Farrokhzad N. Increase concentration of transforming growth factor beta (TGF-β) in breast milk of mothers with psychological disorders 2017 Acta Medica Iranica
1049. Saghazadeh A.; Esfahani S.A.; Rezaei N. Genetic polymorphisms and the adequacy of brain stimulation: state of the art 2016 Expert Review of Neurotherapeutics
1050. Saghazadeh A.; Rezaei N. Immuno-epileptology 2017 Expert Review of Clinical Immunology
1051. Najafi S.; Yousefi H.; Mohammadzadeh M.; Bidoki A.Z.; Farhadi E.; Rezaei N. Interleukin-2, Interferon-gamma Gene Polymorphisms in Recurrent Aphthous Stomatitis 2017 Prague medical report
1052. Azizi G.; Ahmadi M.; Abolhassani H.; Yazdani R.; Mohammadi H.; Mirshafiey A.; Rezaei N.; Aghamohammadi A. Autoimmunity in Primary Antibody Deficiencies 2017 International Archives of Allergy and Immunology
1053. Bahrami T.; Soltani S.; Moazzami K.; Yekaninejad M.S.; Salmaninejad A.; Soltaninejad E.; Ziaee V.; Rezaei N. Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population 2017 Fetal and Pediatric Pathology
1054. Aghamohammadi A.; Abolhassani H.; Kutukculer N.; Wassilak S.G.; Pallansch M.A.; Kluglein S.; Quinn J.; Sutter R.W.; Wang X.; Sanal O.; Latysheva T.; Ikinciogullari A.; Bernatowska E.; Tuzankina I.A.; Costa-Carvalho B.T.; Franco J.L.; Somech R.; Karakoc-Aydiner E.; Singh S.; Bezrodnik L.; Espinosa-Rosales F.J.; Shcherbina A.; Lau Y.-L.; Nonoyama S.; Modell F.; Modell V.; Ozen A.; Berlin A.; Chouikha A.; Partida-Gaytán A.; Kiykim A.; Prakash C.; Suri D.; Ayvaz D.C.; Peláez D.; da Silva E.E.; Deordieva E.; Pérez-Sánchez E.E.; Ulusoy E.; Dogu F.; Seminario G.; Cuzcanci H.; Triki H.; Shimizu H.; Tezcan I.; Ben-Mustapha I.; Sun J.; Mazzucchelli J.T.L.; Orrego J.C.; Pac M.; Bolkov M.; Giraldo M.; Belhaj-Hmida N.; Mekki N.; Kuzmenko N.; Karaca N.E.; Rezaei N.; Diop O.M.; Baris S.; Chan S.M.; Shahmahmoodi S.; Haskologlu S.; Ying W.; Wang Y.; Barbouche M.-R.; McKinlay M.A. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication 2017 Frontiers in Immunology
1055. Rahmani F.; Rezaei N. Brain-derived neurotrophic factor role in autism remains elusive: A flashback on the route that has brought us here 2017 Acta Medica Iranica
1056. Bashashati M.; Moossavi S.; Cremon C.; Barbaro M.R.; Moraveji S.; Talmon G.; Rezaei N.; Hughes P.A.; Bian Z.X.; Choi C.H.; Lee O.Y.; Coëffier M.; Chang L.; Ohman L.; Schmulson M.J.; McCallum R.W.; Simren M.; Sharkey K.A.; Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 2018 Neurogastroenterology and Motility
1057. Zamani M.R.; Aslani S.; Salmaninejad A.; Javan M.R.; Rezaei N. PD-1/PD-L and autoimmunity: A growing relationship 2016 Cellular Immunology
1058. Rahmani F.; Rezaei N. Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis 2016 Expert Review of Clinical Immunology
1059. Roozbehkia M.; Mahmoudi M.; Aletaha S.; Rezaei N.; Fattahi M.J.; Jafarnezhad-Ansariha F.; Barati A.; Mirshafiey A. The potent suppressive effect of β-D-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients 2017 International Immunopharmacology
1060. Khorasanizadeh M.; Eskian M.; Assa’ad A.H.; Camargo C.A., Jr.; Rezaei N. Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma 2016 International Reviews of Immunology
1061. Moghaddam H.S.; Zare-Shahabadi A.; Rahmani F.; Rezaei N. Neurotransmission systems in Parkinson's disease 2017 Reviews in the Neurosciences
1062. Khorasanizadeh M.; Eskian M.; Gelfand E.W.; Rezaei N. Mitogen-activated protein kinases as therapeutic targets for asthma 2017 Pharmacology and Therapeutics
1063. Saghazadeh A.; Rezaei N. Cancer immunotherapy: Friend or foe of mental health? 2017 Cancer Genetics and Psychotherapy
1064. Eskian M.; Khorasanizadeh M.; Kraeber-Bodere F.; Rezaei N. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response 2016 Critical Reviews in Oncology/Hematology
1065. Namazi S.; Tajik N.; Ziaee V.; Sadr M.; Soltani S.; Rezaei A.; Zoghi S.; Rezaei N. APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus 2017 Clinical Rheumatology
1066. Aryan Z.; Aghamohammadi A.; Rezaei N. Toward the stratification and personalization of common variable immunodeficiency treatment 2016 Expert Opinion on Orphan Drugs
1067. Ziaee V.; Maddah M.; Harsini S.; Rezaei A.; Sadr M.; Zoghi S.; Moradinejad M.H.; Rezaei N. Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population 2016 Allergologia et Immunopathologia
1068. Ayenehdeh J.M.; Niknam B.; Hashemi S.M.; Rahavi H.; Rezaei N.; Soleimani M.; Tajik N. Introducing a new experimental islet transplantation model using biomimetic hydrogel and a simple high yield islet isolation technique 2017 Iranian Biomedical Journal
1069. Saghazadeh A.; Mahmoudi M.; Ashkezari A.D.; Rezaie N.O.; Rezaei N. Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: Lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium 2017 PLoS ONE
1070. Gorzin F.; Amirzargar A.A.; Mahmoudi M.J.; Rahnemoon Z.; Najmi Varzaneh F.; Hedayat M.; Sadati S.; Eskandari V.; Rahmati Z.; Rezaei N. FOXP3, RORγt and IL-10 cytokine profile in chronic heart failure 2017 Bratislava Medical Journal
1071. Maaref S.; Ayatollahi S.; Rezaei N.; Masihi M. The Effect of Dispersed Phase Salinity on Water-in-Oil Emulsion Flow Performance: A Micromodel Study 2017 Industrial and Engineering Chemistry Research
1072. Fazel A.; Kashef S.; Aleyasin S.; Harsini S.; Karamizadeh Z.; Zoghi S.; Flores S.K.; Boztug K.; Rezaei N. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity 2017 Allergologia et Immunopathologia
1073. Eslami N.; Tavakol M.; Mesdaghi M.; Gharegozlou M.; Casanova J.-L.; Puel A.; Okada S.; Arshi S.; Bemanian M.H.; Fallahpour M.; Molatefi R.; Seif F.; Zoghi S.; Rezaei N.; Nabavi M. A Gain-of-function mutation of stat1: A novel genetic factor contributing to chronic mucocutaneous candidiasis 2017 Acta Microbiologica et Immunologica Hungarica
1074. Zare-Shahabadi A.; Ataei A.; Rezaei N. Proteins brighten the brain 2016 Life Sciences
1075. Masoud S.; Rajabi G.; Delavari F.; Rezaei N. Evaluating awareness of pediatricians and general practitioners on transformation of the health system in iran 2017 Acta Medica Iranica
1076. Rezaei N. Universal scientific education and research network (USERN): To make the knowledge without borders 2017 Acta Medica Iranica
1077. Ganjalikhani-Hakemi M.; Yazdani R.; Esmaeili M.; Abolhassani H.; Rae W.; Azizi G.; Dizaji M.Z.; Shaghaghi M.; Rezaei A.; Abbasi-Rad F.; Afshar-Qasemloo S.; Mohammadi S.; Rezaei N.; Aghamohammadi A. Role of apoptosis in the pathogenesis of common variable immunodeficiency (CVID) 2017 Endocrine, Metabolic and Immune Disorders - Drug Targets
1078. Abolhassani H.; Edwards E.S.J.; Ikinciogullari A.; Jing H.; Borte S.; Buggert M.; Du L.; Matsuda-Lennikov M.; Romano R.; Caridha R.; Bade S.; Zhang Y.; Frederiksen J.; Fang M.; Bal S.K.; Haskologlu S.; Dogu F.; Tacyildiz N.; Matthews H.F.; McElwee J.J.; Gostick E.; Price D.A.; Palendira U.; Aghamohammadi A.; Boisson B.; Rezaei N.; Karlsson A.C.; Lenardo M.J.; Casanova J.-L.; Hammarström L.; Tangye S.G.; Su H.C.; Pan-Hammarström Q. Combined immunodeficiency and Epstein-Barr virus- induced B cell malignancy in humans with inherited CD70 deficiency 2017 Journal of Experimental Medicine
1079. Yousefi H.; Yuan J.; Keshavarz-Fathi M.; Murphy J.F.; Rezaei N. Immunotherapy of cancers comes of age 2017 Expert Review of Clinical Immunology
1080. Mahmoudi M.; Rezaiemanesh A.; Harsini S.; Salmaninejad A.; Poursani S.; Bahrami T.; Ziaee V.; Rezaei N. PDCD1 single nucleotide polymorphisms in Iranian patients with juvenile idiopathic arthritis 2017 Acta Medica Iranica
1081. Rahmani F.; Aghamohammadi A.; Ochs H.D.; Rezaei N. Agammaglobulinemia: comorbidities and long-term therapeutic risks 2017 Expert Opinion on Orphan Drugs
1082. Ebrahimi Daryani N.; Saghazadeh A.; Moossavi S.; Sadr M.; Shahkarami S.; Soltani S.; Farhadi E.; Rezaei N. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease 2017 Immunological Investigations
1083. Saghazadeh A.; Ahangari N.; Hendi K.; Saleh F.; Rezaei N. Status of essential elements in autism spectrum disorder: Systematic review and meta-analysis 2017 Reviews in the Neurosciences
1084. Shahrokhi A.; Zare-Shahabadi A.; Poor M.N.; Sajedi F.; Soltani S.; Zoghi S.; Badv R.S.; Ashrafi M.R.; Rezaei N. Association of the single nucleotide polymorphisms of the genes encoding IL-2 and IFN-γ with febrile seizure 2017 Acta Medica Iranica
1085. Yazdani R.; Seify R.; Ganjalikhani-Hakemi M.; Abolhassani H.; Eskandari N.; Golsaz-Shirazi F.; Ansaripour B.; Salehi E.; Azizi G.; Rezaei N.; Aghamohammadi A. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets 2017 Allergologia et Immunopathologia
1086. Shabaninejad H.; Asgharzadeh A.; Rezaei N.; Rezapour A. Estimating the cost of immunoglobulin replacement therapy in primary immunodeficiency patients 2017 Iranian Journal of Pediatrics
1087. Mahmoodi M.; Soleyman-Jahi S.; Zendehdel K.; Mozdarani H.; Azimi C.; Farzanfar F.; Safari Z.; Mohagheghi M.-A.; Khaleghian M.; Divsalar K.; Asgari E.; Rezaei N. Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs 2017 Drug and Chemical Toxicology
1088. Aslani S.; Mahmoudi M.; Salmaninejad A.; Poursani S.; Ziaee V.; Rezaei N. Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients 2017 Fetal and Pediatric Pathology
1089. Shabaninejad H.; Asgharzadeh A.; Rezapour A.; Rezaei N. Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies 2017 Medical Journal of the Islamic Republic of Iran
1090. Ebrahimiyan H.; Aslani S.; Rezaei N.; Jamshidi A.; Mahmoudi M. Survivin and autoimmunity; the ins and outs 2018 Immunology Letters
1091. Saghazadeh A.; Rezaei N. Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis 2017 Journal of Autism and Developmental Disorders
1092. Eghbali M.; Sadeghi-Shabestari M.; Najmi Varzaneh F.; Zare Bidoki A.; Rezaei N. Novel WASP mutation in a patient with Wiskott–Aldrich syndrome: Case report and review of the literature 2016 Allergologia et Immunopathologia
1093. Saghazadeh A.; Rezaei N. Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: Higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury 2017 Progress in Neuro-Psychopharmacology and Biological Psychiatry
1094. Yazdani R.; Abolhassani H.; Rezaei N.; Azizi G.; Hammarström L.; Aghamohammadi A. Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency 2016 International Reviews of Immunology
1095. Mahmoudi M.; Rezaiemanesh A.; Salmaninejad A.; Harsini S.; Poursani S.; Bahrami T.; Tahghighi F.; Ziaee V.; Rezaei N. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus 2015 Autoimmunity
1096. Sodagari H.R.; Farzaei M.H.; Bahramsoltani R.; Abdolghaffari A.H.; Mahmoudi M.; Rezaei N. Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease 2015 Expert Review of Gastroenterology and Hepatology
1097. Belkadi A.; Pedergnana V.; Cobat A.; Itan Y.; Vincent Q.B.; Abhyankar A.; Shang L.; El Baghdadi J.; Bousfiha A.; Al-Herz W.; Arikan C.; Arkwright P.; Aydogmus C.; Bernard O.; Blancas-Galicia L.; Boisson-Dupuis S.; Bonnet D.; Stambouli O.B.; Boussafara L.; Boutros J.; Bustamante J.; Ciancanelli M.; Cole T.; Condino-Neto A.; Desai M.; Fieschi C.; Luis Franco J.; Ichai P.; Jouanguy E.; Keser-Emiroglu M.; Kilic S.S.; Alireza Mahdaviani S.; Malhaoui N.; Mansouri D.; Parvaneh N.; Picard C.; Puel A.; Raoult D.; Rezaei N.; Sanal O.; Ramon S.S.; Vandenesch F.; Vogt G.; Zhang S.-Y.; Alcais A.; Boisson B.; Casanova J.-L.; Abel L. Whole-exome sequencing to analyze population structure, parental inbreeding, and familial linkage 2016 Proceedings of the National Academy of Sciences of the United States of America
1098. Soltani S.; Zare-Shahabadi A.; Shahrokhi A.; Rezaei A.; Zoghi S.; Zamani G.R.; Mohammadi M.; Ashrafi M.R.; Rezaei N. Association of interleukin-1 gene cluster and interleukin-1 receptor polymorphisms with febrile seizures 2016 Journal of Child Neurology
1099. Nasiri R.; Hirbod-Mobarakeh A.; Movahedi M.; Farhadi E.; Ansaripour B.; Amirzargar A.A.; Rezaei N. Gene polymorphisms of interleukin-10 and transforming growth factor beta in allergic rhinitis 2016 Allergologia et Immunopathologia
1100. Abolhassani H.; Vitali M.; Lougaris V.; Giliani S.; Parvaneh N.; Parvaneh L.; Mirminachi B.; Cheraghi T.; Khazaei H.; Mahdaviani S.A.; Kiaei F.; Tavakolinia N.; Mohammadi J.; Negahdari B.; Rezaei N.; Hammarstrom L.; Plebani A.; Aghamohammadi A. Cohort of Iranian Patients with Congenital Agammaglobulinemia: Mutation Analysis and Novel Gene Defects 2016 Expert Review of Clinical Immunology
1101. Esmaeilzadeh H.; Nabavi M.; Amirzargar A.A.; Aryan Z.; Arshi S.; Bemanian M.H.; Fallahpour M.; Mortazavi N.; Rezaei N. HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease 2015 American Journal of Rhinology and Allergy
1102. Majdzadeh R.; Rezaei N. The knowledge without border 2016 Archives of Iranian Medicine
1103. Yousefi A.; Mahmoudi E.; Zare Bidoki A.; Najmi Varzaneh F.; Baradaran Noveiry B.; Sadr M.; Motamed F.; Najafi M.; Farahmand F.; Rezaei N. IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis 2016 Expert Review of Gastroenterology and Hepatology
1104. Shahrokhi A.; Zare-Shahabadi A.; Soltani S.; Soleimani F.; Vameghi R.; Konjkav A.R.; Karimi P.; Katibeh P.; Vafaei M.; Zoghi S.; Ashrafi M.R.; Rezaei N. Association of TGFB, but not IL10, single nucleotide polymorphisms with febrile seizures 2015 Seizure
1105. Matin N.; Tabatabaie O.; Mohammadinejad P.; Rezaei N. Therapeutic targeting of Toll-like receptors in cutaneous disorders 2015 Expert Opinion on Therapeutic Targets
1106. Rezaei A.; Ziaee V.; Sharabian F.T.; Harsini S.; Mahmoudi M.; Soltani S.; Sadr M.; Moradinejad M.H.; Aghighi Y.; Rezaei N. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus 2015 Clinical Rheumatology
1107. Mohammadzadeh M.; Rezaei N.; Kamran E.; Abdolhoseinpour F.; Mohammadzadeh M.; Moqadam I.F.; Najafi S.; Ahmadabadi M.H. Evaluation of antioxidant efficacy of Purslane extract in Patients with Recurrent Aphthous Stomatitis: A randomized, placebo-controlled, triple-blinded, clinical trial 2016 Brazilian Journal of Oral Sciences
1108. Bidoki A.Z.; Harsini S.; Sadr M.; Soltani S.; Mohammadzadeh M.; Najafi S.; Rezaei N. NLRP3 gene polymorphisms in Iranian patients with recurrent aphthous stomatitis 2016 Journal of Oral Pathology and Medicine
1109. Mohammadzadeh O.; Rezaei N.; Chatzis I. Pore-Scale Performance Evaluation and Mechanistic Studies of the Solvent-Aided SAGD (SA-SAGD) Process Using Visualization Experiments 2015 Transport in Porous Media
1110. Zamani M.M.; Keshavarz-Fathi M.; Fakhri-Bafghi M.S.; Hirbod-Mobarakeh A.; Rezaei N.; Bahrami A.; Nader N.D. Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: A systematic review 2016 Journal of Critical Care
1111. Azimi M.; Aghamohammadi A.; Ochs H.D.; Rezaei N. Soluble molecules in intravenous immunoglobulin: Benefits and limitations 2016 Expert Review of Clinical Immunology
1112. Daryani N.E.; Sadr M.; Moossavi S.; Shahkarami S.; Soltani S.; Farhadi E.; Rezaei N. Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease 2015 Digestive Diseases and Sciences
1113. Khodadad A.; Aflatoonian M.; Jalilian R.; Babaei N.; Motamed F.; Soltani A.E.; Rasoolzadeh B.; Motavasselian F.; Rezaei N. Comparison of oral midazolam with intravenous midazolam for sedation of children during upper gastrointestinal endoscopy 2016 Acta Medica Iranica
1114. Tahghighi F.; Ziaee V.; Moradinejad M.H.; Rezaei A.; Harsini S.; Soltani S.; Sadr M.; Mahmoudi M.; Aghighi Y.; Rezaei N. Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus 2015 Human Immunology
1115. Aryan Z.; Rezaei N. Toll-like receptors as targets for allergen immunotherapy 2015 Current Opinion in Allergy and Clinical Immunology
1116. Alkhairy O.K.; Rezaei N.; Graham R.R.; Abolhassani H.; Borte S.; Hultenby K.; Wu C.; Aghamohammadi A.; Williams D.A.; Behrens T.W.; Hammarström L.; Pan-Hammarström Q. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency 2015 Journal of Allergy and Clinical Immunology
1117. Aflatounian M.; Smith H.; Farahani F.; Tofighi Naeem A.; Straatman-Iwanowska A.; Zoghi S.; Khatri U.; Tajdini P.; Fallahi G.H.; Gissen P.; Rezaei N. Novel VIPAS39 mutation in a syndromic patient with arthrogryposis, renal tubular dysfunction and intrahepatic cholestasis 2016 European Journal of Medical Genetics
1118. Aydin S.E.; Kilic S.S.; Aytekin C.; Kumar A.; Porras O.; Kainulainen L.; Kostyuchenko L.; Genel F.; Kütükcüler N.; Karaca N.; Gonzalez-Granado L.; Abbott J.; Al-Zahrani D.; Rezaei N.; Baz Z.; Thiel J.; Ehl S.; Marodi L.; Orange J.S.; Sawalle-Belohradsky J.; Keles S.; Holland S.M.; Sanal Ö.; Ayvaz D.C.; Tezcan I.; Al-Mousa H.; Alsum Z.; Hawwari A.; Metin A.; Matthes-Martin S.; Hönig M.; Schulz A.; Picard C.; Barlogis V.; Gennery A.; Ifversen M.; van Montfrans J.; Kuijpers T.; Bredius R.; Dückers G.; Al-Herz W.; Pai S.-Y.; Geha R.; Notheis G.; Schwarze C.-P.; Tavil B.; Azik F.; Bienemann K.; Grimbacher B.; Heinz V.; Gaspar H.B.; Aydin R.; Hagl B.; Gathmann B.; Belohradsky B.H.; Ochs H.D.; Chatila T.; Renner E.D.; Su H.; Freeman A.F.; Engelhardt K.; Albert M.H. DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients 2015 Journal of Clinical Immunology
1119. Najafi M.; Fallahi G.H.; Motamed F.; Farahmand F.; Khodadad A.; Ghajarzadeh M.; Rezaei N.; Mehrabani S. Comparison of one and two-day bowel preparation with polyethylene glycol in pediatric colonoscopy 2015 Turkish Journal of Gastroenterology
1120. Esmaeilzadeh H.; Bemanian M.H.; Nabavi M.; Arshi S.; Fallahpour M.; Fuchs I.; zur Stadt U.; Warnatz K.; Ammann S.; Ehl S.; Lehmberg K.; Rezaei N. Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia 2015 Journal of Clinical Immunology
1121. Maghami M.; Hizam H.; Gomes C.; Hajighorbani S.; Rezaei N. Evaluation of the 2013 southeast Asian haze on solar generation performance 2015 PLoS ONE
1122. Yaghmaei B.; Rostami P.; Varzaneh F.N.; Gharib B.; Bazargani B.; Rezaei N. Methylmalonic acidemia with emergency hypertension; [Acidemia metilmalónica con hipertensión de emergencia] 2016 Nefrologia
1123. Hirbod-Mobarakeh A.; Mirghorbani M.; Hajiju F.; Marvi M.; Bashiri K.; Rezaei N. Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review 2016 Journal of Gastroenterology and Hepatology (Australia)
1124. Gharagozlou M.; Behniafard N.; Amirzargar A.A.; Hosseinverdi S.; Sotoudeh S.; Farhadi E.; Khaledi M.; Aryan Z.; Moghaddam Z.G.; Mahmoudi M.; Aghamohammadi A.; Rezaei N. Association between single nucleotide polymorphisms of the interleukin-4 gene and atopic dermatitis 2015 Acta Dermatovenerologica Croatica
1125. Zare-Shahabadi A.; Rashidian A.; Sahraian M.A.; Rezaei N. Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: A systematic review 2015 Expert Review of Clinical Immunology
1126. Parvaneh N.; Pourakbari B.; Rezaei N.; Omidvar A.; Sabouni F.; Mahmoudi S.; Khotaei G.; Mamishi S. Impaired in-vitro responses to IL-12 and IFN-γ in Iranian patients with Mendelian susceptibility to mycobacterial disease 2015 Allergologia et immunopathologia
1127. Farzaei M.H.; Farzaei F.; Gooshe M.; Abbasabadi Z.; Rezaei N.; Abdolghaffari A.H. Potentially effective natural drugs in treatment for the most common rheumatic disorder: osteoarthritis 2015 Rheumatology International
1128. Sadeghi B.; Abolhassani H.; Naseri A.; Rezaei N.; Aghamohammadi A. Economic burden of common variable immunodeficiency: Annual cost of disease 2015 Expert Review of Clinical Immunology
1129. Movahedi M.; Tavakol M.; Hirbod-Mobarakeh A.; Gharagozlou M.; Aghamohammadi A.; Tavakol Z.; Momenzadeh K.; Nabavi M.; Dabbaghzade A.; Mosallanejad A.; Rezaei N. Vitamin D deficiency in chronic idiopathic urticaria 2015 Iranian Journal of Allergy, Asthma and Immunology
1130. Maddah M.; Harsini S.; Rezaei A.; Sadr M.; Zoghi S.; Moradinejad M.H.; Ziaee V.; Rezaei N. Association of Interleukin-2, but not Interferon-Gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis 2016 Allergologia et Immunopathologia
1131. Nabavi M.; Arshi S.; Bemanian M.H.; Aghamohammadi A.; Mansouri D.; Hedayat M.; Nateghian A.; Noorbakhsh S.; Ehsanipour F.; Faranoush M.; Shakeri R.; Mesdaghi M.; Taghvaei B.; Ghalebaghi B.; Babaie D.; Bahrami A.; Fallahpour M.; Esmaeilzadeh H.; Ali Hamidieh A.; Rekabi M.; Ahmadian J.; Eslami N.; Shokri S.; Afshar M.; Jalali F.; Akbarpour N.; Molatefi R.; Rezaei N. Long-term follow-up of ninety eight Iranian patients with primary immune deficiency in a single tertiary centre 2016 Allergologia et Immunopathologia
1132. Zabetian-Targhi F.; Mahmoudi M.J.; Rezaei N.; Mahmoudi M. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases 2015 Advances in Nutrition
1133. Bahrami Mahneh S.; Movahedi M.; Ali Bahar M.; Rezaei A.; Sadr M.; Hirbod-Mobarakeh A.; Rezaei N. IL9 Single Nucleotide Polymorphism and Serum Levels of Interleukin 9 in Children with Asthma 2016 Pediatric, Allergy, Immunology, and Pulmonology
1134. Sanati G.; Aryan Z.; Barbadi M.; Rezaei N. Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases 2015 Expert Review of Clinical Immunology
1135. Arshi S.; Nabavi M.; Bemanian M.H.; Shakeri R.; Taghvaei B.; Ghalebaghi B.; Babaie D.; Bahrami A.; Fallahpour M.; Esmaeilzadeh H.; Rekabi M.; Amadian J.; Eslami N.; Shokri S.; Jalali F.; Akbarpour N.; Molatefi R.; Rezaei N. Phenotyping and follow up of forty-seven Iranian patients with common variable immunodeficiency 2016 Allergologia et Immunopathologia
1136. Azizi G.; Rezaei N.; Kiaee F.; Tavakolinia N.; Yazdani R.; Mirshafiey A.; Aghamohammadi A. T-cell abnormalities in common variable immunodeficiency 2016 Journal of Investigational Allergology and Clinical Immunology
1137. Alahgholi-Hajibehzad M.; Kasapoglu P.; Jafari R.; Rezaei N. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: Implications for therapeutics 2015 Expert Review of Clinical Immunology
1138. Abolhassani H.; Gharib B.; Shahinpour S.; Masoom S.N.; Havaei A.; Mirminachi B.; Arandi N.; Torabi-Sagvand B.; Khazaei H.A.; Mohammadi J.; Rezaei N.; Aghamohammadi A. Autoimmunity in patients with selective IgA deficiency 2015 Journal of Investigational Allergology and Clinical Immunology
1139. Alkhairy O.K.; Abolhassani H.; Rezaei N.; Fang M.; Andersen K.K.; Chavoshzadeh Z.; Mohammadzadeh I.; El-Rajab M.A.; Massaad M.; Chou J.; Aghamohammadi A.; Geha R.S.; Hammarström L. Spectrum of Phenotypes Associated with Mutations in LRBA 2016 Journal of Clinical Immunology
1140. Koochakzadeh L.; Hosseinverdi S.; Hedayat M.; Farahani F.; Tofighi A.; Eghbali M.; Bidoki A.Z.; Izadyar M.; Rahiminejad M.S.; Ramyar A.; Aghamohammadi A.; Rezaei N. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma 2015 Allergologia et Immunopathologia
1141. Abolhassani H.; Rezaei N.; Mohammadinejad P.; Mirminachi B.; Hammarstrom L.; Aghamohammadi A. Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children 2015 Expert Review of Clinical Immunology
1142. Zare-Shahabadi A.; Ashrafi M.R.; Shahrokhi A.; Soltani S.; Zoghi S.; Soleimani F.; Vameghi R.; Badv R.S.; Rezaei N. Single nucleotide polymorphisms of TNF-A gene in febrile seizures 2015 Journal of the Neurological Sciences
1143. Ghanadan A.; Saghazadeh A.; Jahanzad I.; Rezaei N. Clinical aspects of indirect immunofluorescence for autoimmune diseases 2015 Expert Review of Clinical Immunology
1144. Rezaei N. Universal scientific education and research network: A new horizon for science 2016 Acta Medica Iranica
1145. Mahmoudi M.J.; Saboor-Yaraghi A.-A.; Zabetian-Targhi F.; Siassi F.; Zarnani A.H.; Eshraghian M.R.; Shokri F.; Rezaei N.; Kalikias Y.; Mahmoudi M. Vitamin A decreases cytotoxicity of oxidized low-density lipoprotein in patients with atherosclerosis 2016 Immunological Investigations
1146. Zare-Shahabadi A.; Masliah E.; Johnson G.V.W.; Rezaei N. Autophagy in Alzheimer's disease 2015 Reviews in the Neurosciences
1147. Abolhassani H.; Asgardoon M.H.; Rezaei N.; Hammarstrom L.; Aghamohammadi A. Different brands of intravenous immunoglobulin for primary immunodeficiencies: How to choose the best option for the patient? 2015 Expert Review of Clinical Immunology
1148. Najmi Varzandeh F.; Farhadi E.; Ebrahimi Daryani N.; Taher M.; Mahmoudi M.; Bashashati M.; Hedayat M.; Rezaei N. Interleukin-23 receptor single nucleotide polymorphisms in Crohn's disease 2015 Clinics and Research in Hepatology and Gastroenterology
1149. Najafi M.; Alimadadi H.; Rouhani P.; Kiani M.A.; Khodadad A.; Motamed F.; Moraveji A.; Hooshmand M.; Ashtiani M.T.H.; Rezaei N. Genotype-phenotype relationship in Iranian patients with cystic fibrosis 2015 Turkish Journal of Gastroenterology
1150. Shafieyoun A.; Moraveji S.; Bashashati M.; Rezaei N. Discs large homolog 5 (DLG5) gene polymorphism and crohn’s disease: A meta-analysis of the published studies 2016 Acta Medica Iranica
1151. Alizadeh M.; Hashtroodi L.G.; Chavoshzadeh Z.; Rezaei N. Effect of air pollution in frequency of hospitalizations in asthmatic children 2016 Acta Medica Iranica
1152. Andalib M.M.; Malekzadeh M.M.; Agharahimi Z.; Daryabeigi M.; Yaghmaei B.; Ashrafi M.-R.; Rabbani A.; Rezaei N. Evaluation of educational environment for medical students of a tertiary pediatric hospital in Tehran, using DREEM questionnaire 2015 Iranian Journal of Pediatrics
1153. Sharifi L.; Mirshafiey A.; Rezaei N.; Azizi G.; Magaji Hamid K.; Amirzargar A.A.; Asgardoon M.H.; Aghamohammadi A. The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency 2016 Expert Review of Clinical Immunology
1154. Zare-Shahabadi A.; Soltani S.; Ashrafi M.R.; Shahrokhi A.; Zoghi S.; Pourakbari B.; Zamani G.R.; Mohammadi M.; Rezaei N. Association of IL4 single-nucleotide polymorphisms with febrile seizures 2015 Journal of Child Neurology
1155. Namazi S.; Ziaee V.; Rezaei N. The role of cytokines in systemic lupus erythematosis: Review article 2015 Tehran University Medical Journal
1156. Saghazadeh A.; Rezaei N. Inflammation as a cause of venous thromboembolism 2016 Critical Reviews in Oncology/Hematology
1157. Aalaei-Andabili S.H.; Rezaei N. MicroRNAs (MiRs) Precisely Regulate Immune System Development and Function in Immunosenescence Process 2016 International Reviews of Immunology
1158. Zaki dizaji M.; Rezaei N.; Yaghmaie M.; Yaseri M.; Sayedi S.J.; Azizi G.; Aghamohammadi A.; Akrami S.M. Phospho-SMC1 in-cell ELISA based detection of ataxia telangiectasia 2016 International Journal of Pediatrics
1159. Farzaei M.H.; Bahramsoltani R.; Abdolghaffari A.H.; Sodagari H.R.; Esfahani S.A.; Rezaei N. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease 2016 Expert Review of Gastroenterology and Hepatology
1160. Emmanuel O.; Othman M.L.; Hizam H.; Rezaei N.; Othman M.M. Time-current characteristic curve prediction for directional overcurrent relays in interconnected network using artificial neural network 2015 ARPN Journal of Engineering and Applied Sciences
1161. Yazdani R.; Fatholahi M.; Ganjalikhani-Hakemi M.; Abolhassani H.; Azizi G.; Hamid K.M.; Rezaei N.; Aghamohammadi A. Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency 2016 Molecular Immunology
1162. Harsini S.; Ziaee V.; Maddah M.; Rezaei A.; Sadr M.; Zoghi S.; Moradinejad M.H.; Tahghighi F.; Aghighi Y.; Rezaei N. Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis 2016 Bratislava Medical Journal
1163. Alkhairy O.K.; Perez-Becker R.; Driessen G.J.; Abolhassani H.; Van Montfrans J.; Borte S.; Choo S.; Wang N.; Tesselaar K.; Fang M.; Bienemann K.; Boztug K.; Daneva A.; Mechinaud F.; Wiesel T.; Becker C.; Dückers G.; Siepermann K.; Van Zelm M.C.; Rezaei N.; Van Der Burg M.; Aghamohammadi A.; Seidel M.G.; Niehues T.; Hammarström L. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency 2015 Journal of Allergy and Clinical Immunology
1164. Najafi S.; Yousefi H.; Mohammadzadeh M.; Bidoki A.Z.; Firouze Moqadam I.; Farhadi E.; Amirzargar A.A.; Rezaei N. Association study of interleukin-1 family and interleukin-6 gene single nucleotide polymorphisms in recurrent aphthous stomatitis 2015 International Journal of Immunogenetics
1165. Yousefi H.; Rezaei N. "Post Modern Medicine" would be "calculable and energy-based medicine": A hypothesis paper 2015 Journal of Medical Hypotheses and Ideas
1166. Shabaninejad H.; Asgharzadeh A.; Rezaei N.; Rezapoor A. A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis 2016 Expert Review of Clinical Immunology
1167. Azizi G.; Abolhassani H.; Asgardoon M.H.; Shaghaghi S.; Negahdari B.; Mohammadi J.; Rezaei N.; Aghamohammadi A. Managing patients with side effects and adverse events to immunoglobulin therapy 2016 Expert Review of Clinical Pharmacology
1168. Nemati S.; Amirzargar A.A.; Farhadi E.; Hirbod-Mobarakeh A.; Nabavi M.; Soltani S.; Mahdaviani S.A.; Shahinpour S.; Arshi S.; Mirahmadian M.; Nicknam M.H.; Aghamohammadi A.; Rezaei N. RAD50 single-nucleotide polymorphism in predominantly antibody deficiency 2015 Journal of Investigational Allergology and Clinical Immunology
1169. Mahmoudi M.J.; Taghvaei M.; Harsini S.; Amirzargar A.A.; Hedayat M.; Mahmoudi M.; Nematipour E.; Farhadi E.; Esfahanian N.; Sadr M.; Nourijelyani K.; Rezaei N. Association of interleukin 1 gene cluster and interleukin 1 receptor gene polymorphisms with ischemic heart failure 2016 Bratislava Medical Journal
1170. Motamed F.; Mehrabani S.; Monajemzadeh M.; Ashtiani M.T.H.; Hosseinverdi S.; Houshmand M.; Aryani O.; Najafi M.; Farahmand F.; Kiani M.A.; Khodadad A.; Fallahi G.H.; Khatami G.; Rezaei N. Low incidence of alpha 1 antitrypsin deficiency in Iranian patients with neonatal cholestasis 2015 Turkish Journal of Gastroenterology
1171. Mohammadinejad P.; Pourhamdi S.; Abolhassani H.; Mirminachi B.; Havaei A.; Masoom S.N.; Sadeghi B.; Ghajar A.; Afarideh M.; Parvaneh N.; Mirsaeed-Ghazi B.; Movahedi M.; Gharagozlou M.; Chavoushzadeh Z.; Mahdaviani A.; Zandieh F.; Sherkat R.; Sadeghi-Shabestari M.; Faridhosseini R.; Jabbari-Azad F.; Ahanchian H.; Zandkarimi M.; Cherghi T.; Fayezi A.; Mohammadzadeh I.; Amin R.; Aleyasin S.; Moghtaderi M.; Ghaffari J.; Bemanian M.; Shafiei A.; Kalantari N.; Ahmadiafshar A.; Khazaei H.A.; Mohammadi J.; Nabavi M.; Rezaei N.; Aghamohammadi A. Primary antibody deficiency in a tertiary referral hospital: A 30-year experiment 2015 Journal of Investigational Allergology and Clinical Immunology
1172. Motamed F.; Fallahi G.; Ahmadi F.; Bazvand F.; Ahmadi M.; Eftekhari K.; Rezaei N. Gastroesophageal variceal bleeding as a complication of cystic fibrosis in a 3-month old patient 2016 Acta Medica Iranica
1173. Fallahi G.H.; Latifi S.; Mahmoudi M.; Kushki D.; Ashtiani M.T.H.; Morteza A.; Rezaei N. Growth status and its relationship with serum lipids and albumin in children with cystic fibrosis 2016 Acta Medica Iranica
1174. Soltani S.; Saghazadeh A.; Movahedi M.; Tavakol M.; Sadr M.; Farhadi E.; Rezaei N. FLG single nucleotide polymorphisms in chronic idiopathic urticaria 2016 Allergologia et Immunopathologia
1175. Mosallanejad A.; Sayarifard F.; Hosseinverdi S.; Abbasi F.; Mirzaee H.S.; Rezaei N. Proptosis, micrognathia, low set ear and chest deformity in a patient with extra marker chromosome 22 2015 Acta Medica Iranica
1176. Rezaei N. Preface 2015 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
1177. Borbas P.; Leithner A.; Sadoghi P.; Berndt A.; Liegl B.; Haas O.A.; Rezaei N. Clonality assessment in a case ofmultifocal adamantinoma and a review of the literature 2015 Case Reports in Medicine
1178. Hanaei S.; Abdollahzade S.; Khoshnevisan A.; Kepler C.K.; Rezaei N. Genetic aspects of intervertebral disc degeneration 2015 Reviews in the Neurosciences
1179. Yousefi H.; Aghamohammadi A.; Rezaei N. Clinical recommendations for oral management of patients with primary antibody deficiencies 2016 Expert Review of Clinical Immunology
1180. Ashrafi M.R.; Amirkashani D.; Hirbod-Mobarakeh A.; Yaghmaei B.; Tavassoli A.; Manafi F.; Rezaei N. Acute disseminated encephalomyelitis mimicking acute meningoencephalitis; [Akutni diseminirani encefalomijelitis koji izgleda kao akutni meningoencefalitis] 2015 Acta Clinica Croatica
1181. Saghazadeh A.; Mahmoudi M.; Meysamie A.; Gharedaghi M.; Zamponi G.W.; Rezaei N. Possible role of trace elements in epilepsy and febrile seizures: A meta-analysis 2015 Nutrition Reviews
1182. Sodagari H.R.; Bahramsoltani R.; Farzaei M.H.; Abdolghaffari A.H.; Rezaei N.; Taylor-Robinson A.W. Tea polyphenols as natural products for potential future management of HIV infection - an overview 2016 Journal of Natural Remedies
1183. Bahrami Mahneh S.; Movahedi M.; Aryan Z.; Bahar M.A.; Rezaei A.; Sadr M.; Rezaei N. Serum IL-33 Is Elevated in Children with Asthma and Is Associated with Disease Severity 2016 International Archives of Allergy and Immunology
1184. Shokri S.; Nabavi M.; Hirschmugl T.; Aghamohammadi A.; Arshi S.; Bemanian M.H.; Fallahpour M.; Molatefi R.; Rekabi M.; Eslami N.; Ahmadian J.; Darabi K.; Sedighi G.R.; Monajemzadeh M.; Modaresi M.; Parvaneh N.; Boztug K.; Rezaei N. LPS-responsive beige-like anchor gene mutation associated with possible bronchiolitis obliterans organizing pneumonia associated with hypogammaglobulinemia and normal IgM phenotype and low number of B 2016 Acta Medica Iranica
1185. Gámez-Díaz L.; August D.; Stepensky P.; Revel-Vilk S.; Seidel M.G.; Noriko M.; Morio T.; Worth A.J.J.; Blessing J.; Van De Veerdonk F.; Feuchtinger T.; Kanariou M.; Schmitt-Graeff A.; Jung S.; Seneviratne S.; Burns S.; Belohradsky B.H.; Rezaei N.; Bakhtiar S.; Speckmann C.; Jordan M.; Grimbacher B. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency 2016 Journal of Allergy and Clinical Immunology
1186. Yazdani R.; Latif A.; Tabassomi F.; Abolhassani H.; Azizi G.; Rezaei N.; Aghamohammadi A. Clinical phenotype classification for selective immunoglobulin A deficiency 2015 Expert Review of Clinical Immunology
1187. Ghanadan A.; Saghazadeh A.; Daneshpazhooh M.; Rezaei N. Direct immunofluorescence for immunobullous and other skin diseases 2015 Expert Review of Clinical Immunology
1188. Tonekaboni S.H.; Jafari N.; Chavoshzadeh Z.; Shamsian B.S.; Rezaei N. DRESS syndrome presents as leukoencephalopathy 2015 Turkish Journal of Pediatrics
1189. Saghazadeh A.; Hafizi S.; Rezaei N. Inflammation in venous thromboembolism: Cause or consequence? 2015 International Immunopharmacology
1190. Mohammadinejad P.; Ataeinia B.; Kaynejad K.; Zeinoddini A.; Sadeghi B.; Hosseini M.; Rezaei N.; Aghamohammadi A. Antibiotic resistance in patients with primary immunodeficiency disorders versus immunocompetent patients 2015 Expert Review of Clinical Immunology
1191. Khodadad A.; Elahi E.; Hassani S.B.; Rouhani P.; Sadeghi B.; Rezaei N. Frequency of genotype with Δf508 mutation in CFTR gene among Iranian cystic fibrosis patients with pancreatic insufficiency 2015 Iranian Journal of Pediatrics
1192. Abolhassani H.; Cheraghi T.; Rezaei N.; Aghamohammadi A.; Hammarström L. Common variable immunodeficiency or late-onset combined immunodeficiency: A new hypomorphic JAK3 patient and review of the literature 2015 Journal of Investigational Allergology and Clinical Immunology
1193. Bahramsoltani R.; Sodagari H.R.; Farzaei M.H.; Abdolghaffari A.H.; Gooshe M.; Rezaei N. The preventive and therapeutic potential of natural polyphenols on influenza 2016 Expert Review of Anti-Infective Therapy
1194. Taher M.; Daryani N.E.; Hedayat M.; Eslamian M.; Farhadi E.; Mahmoudi M.; Shirzad S.; Taromlou M.K.N.; Chaharmahali M.; Nicknam M.H.; Bashashati M.; Rezaei N. Erratum to "RAC1 single nucleotide polymorphisms in Crohn's disease" [Clin. Res. Hepatol. Gastroenterol. doi: 10.1016/j.clinre.2014.01.013; pii: S2210-7401(14)00043-6] 2014 Clinics and Research in Hepatology and Gastroenterology
1195. Massoud A.; Rezaei N. Preface 2014 Immunology of Aging
1196. Rezaei N.; de Vries E.; Gambineri E.; Haddad E. Common Presentations and Diagnostic Approaches 2014 Stiehm's Immune Deficiencies
1197. Seppänen M.; Aghamohammadi A.; Rezaei N. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? 2014 Expert Review of Clinical Immunology
1198. Hirbod-Mobarakeh A.; Mahmoudi M.; Rezaei N. Nutrition, immunity, and aging 2014 Immunology of Aging
1199. Khazaei H.A.; Teymuri B.; Nakhaei A.; Mohammadi M.; Noura M.; Khazaei A.; Tofigh N.; Rezaei N. Evaluation of haptoglobin phenotypes in association with clinical features of patients suffered from preterm labor disease 2014 Acta Medica Iranica
1200. Taher M.; Ebrahimi Daryani N.; Hedayat M.; Eslamian M.; Farhadi E.; Mahmoudi M.; Shirzad S.; Nouri Taromlou M.K.; Chaharmahali M.; Nicknam M.H.; Bashashati M.; Rezaei N. RAC1 single nucleotide polymorphisms in Crohn's disease 2014 Clinics and Research in Hepatology and Gastroenterology
1201. Mortazavi H.; Esmaili N.; Khezri S.; Khamesipour A.; Farahani I.V.; Daneshpazhooh M.; Rezaei N. The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients 2014 Iranian Journal of Allergy, Asthma and Immunology
1202. Tavakol M.; Movahedi M.; Amirzargar A.A.; Aryan Z.; Bidoki A.Z.; Heidari K.; Soltani S.; Gharagozlou M.; Aghamohammadi A.; Nabavi M.; Nasiri R.; Ahmadvand A.; Rezaei N. Association of interleukin 10 and transforming growth factor β gene polymorphisms with chronic idiopathic urticaria 2014 Acta Dermatovenerologica Croatica
1203. Abolhassani H.; Mirminachi B.; Daryabeigi M.; Agharahimi Z.; Aghamohammadi A.; Rabbani A.; Rezaei N. Evaluation of physicians' awareness of pediatric diseases in Iran 2014 Iranian Journal of Pediatrics
1204. Fadakar K.; Dadkhahfar S.; Esmaeili A.; Rezaei N. The role of toll-like receptors (TLRs) in stroke 2014 Reviews in the Neurosciences
1205. Rezaei N.; Aalaei-Andabili S.H.; Kaufman H.L. Introduction on cancer immunology and immunotherapy 2015 Cancer Immunology: A Translational Medicine Context
1206. Parsapoor A.; Parsapoor M.-B.; Rezaei N.; Asghari F. Autonomy of children and adolescents in consent to treatment: Ethical, jurisprudential and legal considerations 2014 Iranian Journal of Pediatrics
1207. Marciano B.E.; Huang C.-Y.; Joshi G.; Rezaei N.; Carvalho B.C.; Allwood Z.; Ikinciogullari A.; Reda S.M.; Gennery A.; Thon V.; Espinosa-Rosales F.; Al-Herz W.; Porras O.; Shcherbina A.; Szaflarska A.; Kiliç Ş.; Franco J.L.; Gómez Raccio A.C.; Roxo Jr. P.; Esteves I.; Galal N.; Grumach A.S.; Al-Tamemi S.; Yildiran A.; Orellana J.C.; Yamada M.; Morio T.; Liberatore D.; Ohtsuka Y.; Lau Y.-L.; Nishikomori R.; Torres-Lozano C.; Mazzucchelli J.T.L.; Vilela M.M.S.; Tavares F.S.; Cunha L.; Pinto J.A.; Espinosa-Padilla S.E.; Hernandez-Nieto L.; Elfeky R.A.; Ariga T.; Toshio H.; Dogu F.; Cipe F.; Formankova R.; Nuñez-Nuñez M.E.; Bezrodnik L.; Marques J.G.; Pereira M.I.; Listello V.; Slatter M.A.; Nademi Z.; Kowalczyk D.; Fleisher T.A.; Davies G.; Neven B.; Rosenzweig S.D. BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies 2014 Journal of Allergy and Clinical Immunology
1208. Zamani M.R.; Asbagh F.A.; Massoud A.H.; Salmaninejad A.; Massoud A.; Rezaei N. Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men 2015 Journal of Assisted Reproduction and Genetics
1209. Ebadi M.; Zeng Y.; Gkotzamanidou M.; Rezaei N. Immunopathology and immunotherapy of hodgkin lymphoma 2015 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
1210. Nabavi M.; Esmaeilzadeh H.; Arshi S.; Fallahpour M.; Mortazavi N.; Rezaei N. Could oral administration of immunoglobulin reduce diarrheal severity in common variable immunodeficiency? 2014 Allergologia et Immunopathologia
1211. Khaledi M.; Fotouhi A.; Farhadi E.; Mahdaviani B.; Sotoudeh S.; Tavakoli M.; Behniafard N.; Gharagozlou M.; Rezaei N. Filaggrin single nucleotide polymorphisms in atopic dermatitis 2014 Acta Dermatovenerologica Croatica
1212. Behniafard N.; Gharagozlou M.; Sotoudeh S.; Farhadi E.; Khaledi M.; Moghaddam Z.G.; Mahmoudi M.; Fathi S.M.; Darabi B.; Aghamohammadi A.; Amirzargar A.A.; Rezaei N. Association of single nucleotide polymorphisms of interleukin-1 family with atopic dermatitis 2014 Allergologia et Immunopathologia
1213. Tavakol M.; Amirzargar A.A.; Movahedi M.; Aryan Z.; Bidoki A.Z.; Gharagozlou M.; Aghamohammadi A.; Nabavi M.; Ahmadvand A.; Behniafard N.; Heidari K.; Soltani S.; Rezaei N. Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria 2014 Allergologia et Immunopathologia
1214. Rostami P.; Setoodeh A.; Rabbani A.; Nakhaei-Moghadam M.; Najmi-Varzaneh F.; Rezaei N. A randomized clinical trial of insulin Glargine and Aspart, compared to NPH and regular insulin in children with type 1 diabetes mellitus 2014 Iranian Journal of Pediatrics
1215. Nabavi M.; Arshi S.; Bahrami A.; Aryan Z.; Bemanian M.H.; Esmaeilzadeh H.; Jalali F.; Pousti S.B.; Rezaei N. Increased level of interleukin-13, but not interleukin-4 and interferon-γ in chronic rhinosinusitis with nasal polyps 2014 Allergologia et Immunopathologia
1216. Zamani G.; Shiva S.; Mohammadi M.; Mahmoudi Gharaie J.; Rezaei N. A survey of quality of life in adolescents with epilepsy in Iran 2014 Epilepsy and Behavior
1217. Massoud A.; Rezaei N. Immunology of aging 2014 Immunology of Aging
1218. Najafi S.; Moqadam I.F.; Mohammadzadeh M.; Bidoki A.Z.; Yousefi H.; Farhadi E.; Tonekaboni A.; Meighani G.; Amirzargar A.A.; Rezaei N. Interleukin-10 gene polymorphisms in recurrent aphthous stomatitis 2014 Immunological Investigations
1219. Aryan Z.; Mellstedt H.; Rezaei N. Cancer immunotherapy confers a global benefit 2015 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
1220. Nasiri R.; Akbar Amirzargar A.; Movahedi M.; Hirbod-Mobarakeh A.; Farhadi E.; Behniafard N.; Tavakkol M.; Ansaripour B.; Moradi B.; Zare A.; Rezaei N. Single-nucleotide polymorphisms of TNFA and IL1 in allergic rhinitis 2013 Journal of Investigational Allergology and Clinical Immunology
1221. Gooshe M.; Aleyasin A.R.; Abdolghaffari A.H.; Rezaei N. Toll like receptors: A new hope on the horizon to treat multiple sclerosis 2014 Expert Review of Clinical Immunology
1222. Hirbod-Mobarakeh A.; Amirzargar A.A.; Nikbin B.; Nicknam M.H.; Kutikhin A.; Rezaei N. Simmunogenetics of cancer 2015 Cancer Immunology: A Translational Medicine Context
1223. Hosseinverdi S.; Hashemi H.; Aghamohammadi A.; Ochs H.D.; Rezaei N. Ocular involvement in primary immunodeficiency diseases 2014 Journal of Clinical Immunology
1224. Zamani G.; Tavasoli A.; Zare-Shahabadi A.; Rezaei N.; Ahmadvand A. Efficacy of pregabalin in childhood refractory partial seizure 2014 Iranian Journal of Pediatrics
1225. Moazzami K.; McElhaney J.E.; Rezaei N. Influenza infection in the elderly 2014 Immunology of Aging
1226. Sukalo M.; Fiedler A.; Guzmán C.; Spranger S.; Addor M.-C.; Mcheik J.N.; Oltra Benavent M.; Cobben J.M.; Gillis L.A.; Shealy A.G.; Deshpande C.; Bozorgmehr B.; Everman D.B.; Stattin E.-L.; Liebelt J.; Keller K.-M.; Bertola D.R.; van Karnebeek C.D.M.; Bergmann C.; Liu Z.; Düker G.; Rezaei N.; Alkuraya F.S.; Oǧur G.; Alrajoudi A.; Venegas-Vega C.A.; Verbeek N.E.; Richmond E.J.; Kirbiyik O.; Ranganath P.; Singh A.; Godbole K.; Ali F.A.M.; Alves C.; Mayerle J.; Lerch M.M.; Witt H.; Zenker M. Mutations in the Human UBR1 Gene and the Associated Phenotypic Spectrum 2014 Human Mutation
1227. Rezaei N. Cancer immunology: A translational medicine context 2015 Cancer Immunology: A Translational Medicine Context
1228. Aalaei-Andabili S.H.; Zare-Bidoki A.; Rezaei N. The Role of MicroRNAs in immunosenescence process 2014 Immunology of Aging
1229. Najmi Varzaneh F.; Najmi Varzaneh F.; Azimi A.R.; Rezaei N.; Sahraian M.A. Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis 2014 Acta Neurologica Belgica
1230. Boztug K.; Järvinen P.M.; Salzer E.; Racek T.; Mönch S.; Garncarz W.; Gertz E.M.; Schäffer A.A.; Antonopoulos A.; Haslam S.M.; Schieck L.; Puchałka J.; Diestelhorst J.; Appaswamy G.; Lescoeur B.; Giambruno R.; Bigenzahn J.W.; Elling U.; Pfeifer D.; Conde C.D.; Albert M.H.; Welte K.; Brandes G.; Sherkat R.; Van Der Werff Ten Bosch J.; Rezaei N.; Etzioni A.; Bellanné-Chantelot C.; Superti-Furga G.; Penninger J.M.; Bennett K.L.; Von Blume J.; Dell A.; Donadieu J.; Klein C. JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia 2014 Nature Genetics
1231. Sani M.N.; Ahmadi M.; Roohani P.; Rezaei N. Early onset hepatocellular disease in an infant with Zellweger syndrome 2015 Acta Medica Iranica
1232. Majnoon M.T.; Mamishi S.; Moazzami K.; Shahbaznejad L.; Izadyar M.; Sabouni F.; Koochakzadeh L.; Ramyar A.; Aghamohammadi A.; Rezaei N. Spectrum of bone marrow failures of myeloid series: New report of neutropenic patients from a referral pediatric center in Iran 2014 Pediatric Hematology and Oncology
1233. Nabavi M.; Esmaeilzadeh H.; Arshi S.; Fallahpour M.; Rezaei N. Multiple cancers in a patient with common variable immunodeficiency 2014 Allergologia et Immunopathologia
1234. Ataee P.; Najafi M.; Gharagozlou M.; Aflatounian M.; Mahmoudi M.; Khodadad A.; Farahmand F.; Motamed F.; Fallahi G.H.; Kalantari N.; Soheili H.; Modarresi V.; Sabbaghian M.; Rezaei N. Effect of supplementary zinc on body mass index, pulmonary function and hospitalization in children with cystic fibrosis 2014 Turkish Journal of Pediatrics
1235. Rezaei N.; Othman M.L.; Wahab N.I.A.; Hizam H. Coordination of overcurrent relays protection systems for wind power plants 2014 Conference Proceeding - 2014 IEEE International Conference on Power and Energy, PECon 2014
1236. Hirbod-Mobarakeh A.; Aghamohammadi A.; Rezaei N. Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: From bedside to bench and back again 2014 Expert Review of Clinical Immunology
1237. Rezaei N.; Mohammadzadeh O.; James L.A.; Chatzis I. Experimental investigation of the VAPEX process in vuggy porous media 2014 SPE Journal
1238. Shahrokhi A.; Zare-Shahabadi A.; Soltani S.; Ashrafi M.R.; Zoghi S.; Hosseini S.A.; Heidari M.; Yaghmaei B.; Pourakbari B.; Rezaei N. Association of IL6 single nucleotide polymorphisms with febrile seizures 2014 Journal of the Neurological Sciences
1239. Harsini S.; Beigy M.; Akhavan-Sabbagh M.; Rezaei N. Toll-like receptors in lymphoid malignancies: Double-edged sword 2014 Critical Reviews in Oncology/Hematology
1240. Ziaee V.; Tahghighi F.; Moradinejad M.H.; Harsini S.; Mahmoudi M.; Rezaei A.; Soltani S.; Sadr M.; Aghighi Y.; Rezaei N. Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in iranian patients with juvenile systemic lupus erythematosus 2014 European Cytokine Network
1241. Saghazadeh A.; Gharedaghi M.; Meysamie A.; Bauer S.; Rezaei N. Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: Systematic review and meta-analysis1 2014 Reviews in the Neurosciences
1242. Koochakzadeh L.; Khosravi M.H.; Pourakbari B.; Hosseinverdi S.; Aghamohammadi A.; Rezaei N. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia 2014 Pediatric Hematology and Oncology
1243. Aghamohammadi A.; Moghaddam Z.; Abolhassani H.; Hallaji Z.; Mortazavi H.; Pourhamdi S.; Mohammadinejad P.; Rezaei N. Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis 2014 Allergologia et Immunopathologia
1244. Mousavi S.M.H.; Agharahimi Z.; Daryabeigi M.; Rezaei N. Implementation of clinical governance in hospitals: Challenges and the keys for success 2014 Acta Medica Iranica
1245. Cheraghi T.; Aghamohammadi A.; Mirminachi B.; Keihanian T.; Hedayat E.; Abolhassani H.; Torabi Sagvand B.; Rezaei N. Prediction of the evolution of common variable immunodeficiency: HLA typing for patients with selective IgA deficiency 2014 Journal of Investigational Allergology and Clinical Immunology
1246. Aghamohammadi A.; Abolhassani H.; Latif A.; Tabassomi F.; Shokuhfar T.; Torabi Sagvand B.; Shahinpour S.; Mirminachi B.; Parvaneh N.; Movahedi M.; Gharagozlou M.; Sherkat R.; Amin R.; Aleyasin S.; Faridhosseini R.; Jabbari-Azad F.; Cheraghi T.; Eslamian M.H.; Khalili A.; Kalantari N.; Shafiei A.; Dabbaghzade A.; Khayatzadeh A.; Ebrahimi M.; Razavinejad D.; Bazregari S.; Ebrahimi M.; Ghaffari J.; Bemanian M.H.; Behniafard N.; Kashef S.; Mohammadzadeh I.; Hammarström L.; Rezaei N. Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients 2014 Expert Review of Clinical Immunology
1247. Arshi S.; Bahrami A.; Faranoush M.; Mehrvar A.; Rezaei N. Non-Hodgkin's lymphoma in a patient with leucocyte adhesion deficiency 2014 Allergologia et Immunopathologia
1248. Rezaei N.; Firoozabadi A. Macro- and microscale waterflooding performances of crudes which form w/o emulsions upon mixing with brines 2014 Energy and Fuels
1249. Abolhassani H.; Akbari F.; Mirminachi B.; Bazregari S.; Hedayat E.; Rezaei N.; Aghamohammadi A. Morbidity and mortality of Iranian patients with hyper IgM syndrome: A clinical analysis 2014 Iranian Journal of Immunology
1250. Saghazadeh A.; Rezaei N. Why has the use of antiepileptic drugs increased and may be increasing yet? 2014 Epilepsia
1251. Mohammadinejad P.; Mirminachi B.; Sadeghi B.; Movahedi M.; Gharagozlou M.; Mohammadi J.; Abolhassani H.; Rezaei N.; Aghamohammadi A. Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center, Tehran, Iran (2006-2013) 2014 Iranian Journal of Immunology
1252. Abolhassani H.; Parvaneh N.; Rezaei N.; Hammarström L.; Aghamohammadi A. Genetic defects in B-cell development and their clinical consequences 2014 Journal of Investigational Allergology and Clinical Immunology
1253. Mahmoudi M.; Tahghighi F.; Ziaee V.; Harsini S.; Rezaei A.; Soltani S.; Sadr M.; Moradinejad M.H.; Aghighi Y.; Rezaei N. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus 2014 International Journal of Immunogenetics
1254. Rezaei N. Ahmad Massoud (1943-2014) 2014 Acta medica Iranica
1255. Saghazadeh A.; Saghazadeh M.; Rezaei N. Immunology of cutaneous tumors and immunotherapy for melanoma 2015 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
1256. Fallahi G.; Aghamohammadi A.; Khodadad A.; Hashemi M.; Mohammadinejad P.; Asgarian-Omran H.; Najafi M.; Farhmand F.; Motamed F.; Soleimani K.; Soheili H.; Parvaneh N.; Darabi B.; Kalmarzi R.N.; Pourhamdi S.; Abolhassani H.; Mirminachi B.; Rezaei N. Evaluation of antibody response to polysaccharide vaccine and switched memory B Cells in pediatric patients with inflammatory bowel disease 2014 Gut and Liver
1257. Mahdaviani S.A.; Mehrian P.; Najafi A.; Khalilzadeh S.; Eslampanah S.; Nasri A.; Karam M.B.; Rezaei N.; Velayati A.A. Pulmonary computed tomography scan findings in chronic granulomatous disease 2014 Allergologia et Immunopathologia
1258. Avitzur Y.; Guo C.; Mastropaolo L.A.; Bahrami E.; Chen H.; Zhao Z.; Elkadri A.; Dhillon S.; Murchie R.; Fattouh R.; Huynh H.; Walker J.L.; Wales P.W.; Cutz E.; Kakuta Y.; Dudley J.; Kammermeier J.; Powrie F.; Shah N.; Walz C.; Nathrath M.; Kotlarz D.; Puchaka J.; Krieger J.R.; Racek T.; Kirchner T.; Walters T.D.; Brumell J.H.; Griffiths A.M.; Rezaei N.; Rashtian P.; Najafi M.; Monajemzadeh M.; Pelsue S.; McGovern D.P.B.; Uhlig H.H.; Schadt E.; Klein C.; Snapper S.B.; Muise A.M. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease 2014 Gastroenterology
1259. Shayanfar N.; Bahari L.; Safaie-Naraghi Z.; Kamyab K.; Gheytanchi E.; Rezaei N. Negative HER2/neu amplification using immunohistochemistry and chromogenic in situ hybridization techniques in skin melanoma cases 2015 Asian Pacific Journal of Cancer Prevention
1260. Nabavi M.; Esmaeilzadeh H.; Arshi S.; Bemanian M.H.; Fallahpour M.; Bahrami A.; Mortazavi N.; Kamrava K.; Farhadi M.; Taghipour R.; Rezaei N. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: Frequency and contributing factors 2014 American Journal of Rhinology and Allergy
1261. Saghazadeh A.; Mastrangelo M.; Rezaei N. Genetic background of febrile seizures 2014 Reviews in the Neurosciences
1262. Routes J.; Abinun M.; Al-Herz W.; Bustamante J.; Condino-Neto A.; De La Morena M.T.; Etzioni A.; Gambineri E.; Haddad E.; Kobrynski L.; Le Deist F.; Nonoyama S.; Oliveira J.B.; Perez E.; Picard C.; Rezaei N.; Sleasman J.; Sullivan K.E.; Torgerson T. ICON: The early diagnosis of congenital immunodeficiencies 2014 Journal of Clinical Immunology
1263. Larki P.; Khoshbakht S.; Rezaei N. Genetics of Neoplasia: Inherited monogenic defects associated with cancers 2014 Acta Medica Iranica
1264. Al-Herz W.; Aldhekri H.; Barbouche M.-R.; Rezaei N. Consanguinity and primary immunodeficiencies 2014 Human Heredity
1265. Farahmand F.; Khalili M.; Shahbaznejad L.; Hirbod-Mobarakeh A.; Najafi Sani M.; Khodadad A.; Motamed F.; Rezaei N. Clinical presentation of cystic fibrosis at the time of diagnosis: A multicenter study in a region without newborn screening 2013 Turkish Journal of Gastroenterology
1266. Nasiri R.; Movahedi M.; Amirzargar A.A.; Hirbod-Mobarakeh A.; Farhadi E.; Ansaripour B.; Moradi B.; Rezaei N. Association of interleukin 6 single nucleotide polymorphisms with allergic rhinitis 2014 International Journal of Pediatric Otorhinolaryngology
1267. Ebrahimi Daryani N.; Najmi Varzaneh F.; Hedayat M.; Taher M.; Farhadi E.; Mahmoudi M.; Nicknam M.H.; Bashashati M.; Rezaei N. Interleukin-23 receptor single nucleotide polymorphisms in ulcerative colitis. A study in Iranian populations 2014 Clinics and Research in Hepatology and Gastroenterology
1268. Sabouni F.; Movahedi Z.; Mehdizadeh M.; Rahimi A.; Rezaei N. Posterior mediastinal mass: An unusual presentation of pediatric tuberculosis 2014 Turkish Journal of Pediatrics
1269. Rezaei N. Preface 2015 Cancer Immunology: A Translational Medicine Context
1270. Rostami P.; Mahmoudi E.; Sotoudeh A.; Nakhaeimoghadam M.; Lurkin I.; Zwarthoff E.C.; Rezaei N. Epidermal nevus in association with some uncommon manifestations 2013 Acta Dermatovenerologica Croatica
1271. Hedayat M.; Al-Herz W.; Aghamohammadi A.; Nichols K.E.; Rezaei N. Primary immunodeficiencies and cancers 2015 Cancer Immunology: A Translational Medicine Context
1272. Rezaei N.; Firoozabadi A. Pressure evolution and production performance of waterflooding in n-Heptane-saturated fired Berea cores 2014 SPE Journal
1273. Khalili A.; Plebani A.; Vitali M.; Abolhassani H.; Lougaris V.; Mirminachi B.; Rezaei N.; Aghamohammadi A. Autosomal recessive agammaglobulinemia: A novel non-sense mutation in CD79a 2014 Journal of Clinical Immunology
1274. Farhadi E.; Nemati S.; Amirzargar A.A.; Hirbod-Mobarakeh A.; Nabavi M.; Soltani S.; Mahdaviani S.A.; Shahinpour S.; Arshi S.; Nikbin B.; Aghamohammadi A.; Rezaei N. AICDA single nucleotide polymorphism in common variable immunodeficiency and selective IgA deficiency 2014 Allergologia et Immunopathologia
1275. Rezaei N. Cancer immunology: Cancer immunotherapy for organ-specific tumors 2015 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
1276. Bahrami Mahne S.; Mahdaviani S.A.; Rezaei N. Role of the immune cells, mediators and cytokines in pathogenesis of asthma: A review article 2014 Tehran University Medical Journal
1277. Bashashati M.; Rezaei N.; Shafieyoun A.; Mckernan D.P.; Chang L.; Öhman L.; Quigley E.M.; Schmulson M.; Sharkey K.A.; Simrén M. Cytokine imbalance in irritable bowel syndrome: A systematic review and meta-analysis 2014 Neurogastroenterology and Motility
1278. Gooshe M.; Abdolghaffari A.H.; Gambuzza M.E.; Rezaei N. The role of toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes 2014 Reviews in the Neurosciences
1279. Ebadi M.; Reddy N.M.; Rezaei N. Immunopathology and immunotherapy of non-hodgkin lymphoma 2015 Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
1280. Varzaneh F.N.; Keller B.; Unger S.; Aghamohammadi A.; Warnatz K.; Rezaei N. Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - A review of the current knowledge 2014 Journal of Clinical Immunology
1281. Khanbabaee G.; Omidian A.; Imanzadeh F.; Adibeshgh F.; Ashayeripanah M.; Rezaei N. Serum level of zinc in asthmatic patients: A case-control study 2014 Allergologia et Immunopathologia
1282. Rezaei N. Preface 2015 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
1283. Aalaei-Andabili S.H.; Basith S.; Choi S.; Rezaei N. Toll-Like receptor pathway and its targeting in treatment of cancers 2015 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
1284. Abolhassani H.; Wang N.; Aghamohammadi A.; Rezaei N.; Lee Y.N.; Frugoni F.; Notarangelo L.D.; Pan-Hammarström Q.; Hammarström L. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency 2014 Journal of Allergy and Clinical Immunology
1285. Aghamohammadi A.; Mohammadinejad P.; Abolhassani H.; Mirminachi B.; Movahedi M.; Gharagozlou M.; Parvaneh N.; Zeiaee V.; Mirsaeed-Ghazi B.; Chavoushzadeh Z.; Mahdaviani A.; Mansouri M.; Yousefzadegan S.; Sharifi B.; Zandieh F.; Hedayat E.; Nadjafi A.; Sherkat R.; Shakerian B.; Sadeghi-Shabestari M.; Farid Hosseini R.; Jabbari-Azad F.; Ahanchian H.; Behmanesh F.; Zandkarimi M.; Shirkani A.; Cheraghi T.; Fayezi A.; Mohammadzadeh I.; Amin R.; Aleyasin S.; Moghtaderi M.; Ghaffari J.; Arshi S.; Javahertrash N.; Nabavi M.; Bemanian M.H.; Shafiei A.; Kalantari N.; Ahmadiafshar A.; Khazaei H.A.; Atarod L.; Rezaei N. Primary immunodeficiency disorders in Iran: Update and new insights from the third report of the national registry 2014 Journal of Clinical Immunology
1286. Movahedi M.; Tavakol M.; Mohammadinejad P.; Baiardini I.; Braido F.; Gharagozlou M.; Aghamohammadi A.; Nabavi M.; Dabbaghzade A.; Tavakol Z.; Afarideh M.; Rezaei N. The persian version of the chronic urticaria quality of life questionnaire: Factor analysis, validation, and initial clinical findings 2014 Iranian Journal of Allergy, Asthma and Immunology
1287. Rezaei N. Cancer immunology: Bench to bedside immunotherapy of cancers 2015 Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
1288. Fallahi G.; Motamed F.; Yousefi A.; Shafieyoun A.; Najafi M.; Khodadad A.; Farhmand F.; Ahmadvand A.; Rezaei N. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis 2013 Turkish Journal of Pediatrics
1289. Ebadi M.; Aghamohammadi A.; Rezaei N. Primary immunodeficiencies: A decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics 2014 Expert Review of Clinical Immunology
1290. Yousefi A.; Shafieyoun A.; Fallahi G.; Rezaei N. Probiotics on fecal calprotectin of cystic fibrosis. Reply 2014 The Turkish journal of pediatrics
1291. Aryan Z.; Holgate S.T.; Radzioch D.; Rezaei N. A new era of targeting the ancient gatekeepers of the immune system: Toll-like agonists in the treatment of allergic rhinitis and asthma 2014 International Archives of Allergy and Immunology
1292. Mahmoudi M.J.; Hedayat M.; Taghvaei M.; Nematipour E.; Farhadi E.; Esfahanian N.; Sadr M.; Mahmoudi M.; Nourijelyani K.; Amirzargar A.A.; Rezaei N. Association of IL-4 gene polymorphisms with ischemic heart failure 2014 Cardiology Journal
1293. Daryani N.E.; Varzaneh F.N.; Hedayat M.; Taher M.; Farhadi E.; Mahmoudi M.; Nicknam M.H.; Bashashati M.; Rezaei N. Erratum to "Interleukin-23 receptor single nucleotide polymorphisms with ulcerative colitis. A studying Iranian population" [Clin. Res. Hepatol. Gastroenterol. 38 (2014) 360-5] 2014 Clinics and Research in Hepatology and Gastroenterology
1294. Rostami P.; Sotoudeh A.; Nakhaeimoghadam M.; Rabbani A.; Rezaei N. Insulin edema in a child with diabetes mellitus type 1 2012 Turkish Journal of Pediatrics
1295. Farahmand F.; Soleimani K.; Hashemi M.; Shafieyoun A.; Rezaei N.; Yousefi A. Familial congenital hepatic fibrosis: Report of a family with three affected children 2013 Acta Medica Iranica
1296. Khotaei G.; Hirbod-Mobarakeh A.; Amirkashani D.; Manafi F.; Rezaei N. Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease 2012 Brazilian Journal of Infectious Diseases
1297. Moossavi S.; Rezaei N. Toll-like receptor signalling and their therapeutic targeting in colorectal cancer 2013 International Immunopharmacology
1298. Oraei M.; Aghamohammadi A.; Rezaei N.; Bidad K.; Gheflati Z.; Amirkhani A.; Abolhassani H.; Massoud A. Naïve CD4 + T cells and recent thymic emigrants in common variable immunodeficiency 2012 Journal of Investigational Allergology and Clinical Immunology
1299. Bashashati M.; Rezaei N.; Bashashati H.; Shafieyoun A.; Daryani N.E.; Sharkey K.A.; Storr M. Cytokine gene polymorphisms are associated with irritable bowel syndrome: A systematic review and meta-analysis 2012 Neurogastroenterology and Motility
1300. Esmaeili A.; Dadkhahfar S.; Fadakar K.; Rezaei N. Post-Stroke immunodeficiency: Effects of sensitization and tolerization to brain antigens 2012 International Reviews of Immunology
1301. Najafi M.; Zamani M.M.; Rezaei N.; Sabbaghian M. Autoimmunity in inflammatory bowel disease: A case of ulcerative colitis with diabetes mellitus, autoimmune hepatitis and autoimmune hypothyroidism 2012 Turkish Journal of Pediatrics
1302. Monajemzadeh M.; Sarmadi S.; Moeini M.; Vasei M.; Rezaei N.; Abbasi A.; Shahsiah R.; Tanzifi P.; Eghbali M. Contributory role of viral infection in congenital tumour development 2013 ecancermedicalscience
1303. Babaei Jandaghi A.; Daliri S.; Kikkawa M.; Khaledi M.; Soleimanifar N.; Alizadeh A.; Habibzadeh M.; Haghi-Ashtiani M.T.; Seyama K.; Rezaei N. The discovery of a Persian family with a form of Birt-Hogg-Dubé syndrome lacking the typical cutaneous stigmata of the syndrome 2013 Clinical Imaging
1304. Nourijelyani K.; Aghamohammadi A.; Sadaghiani M.S.; Behniafard N.; Abolhassani H.; Pourjabar S.; Rezvanizadeh A.; Khadamy J.; Imanzaeh A.; Sedaghat M.; Rezaei N. Physicians awareness on primary immunodeficiency disorders in Iran 2012 Iranian Journal of Allergy, Asthma and Immunology
1305. Mottaghi A.; Salehi E.; Sezavar H.; Keshavarz S.A.; Eshraghian M.R.; Rezaei N.; Rejali L.; Saboor-Yaraghi A.-A. The in vitro effect of oxidized LDL and PHA on proliferation and gene expression of regulatory T cells in patients with atherosclerosis 2012 Iranian Journal of Allergy, Asthma and Immunology
1306. Moghimpour Bijani F.; Vallejo J.G.; Rezaei N. Toll-like receptor signaling pathways in cardiovascular diseases: Challenges and opportunities 2012 International Reviews of Immunology
1307. Haghi Ashtiani M.T.; Mamishi S.; Masoomi A.; Nasiri N.; Hosseini M.; Nikmanesh B.; Pourakbari B.; Rezaei N. Antimicrobial susceptibility associated with bloodstream infections in children: A referral hospital-based study 2013 Brazilian Journal of Infectious Diseases
1308. Moossavi S.; Zhang H.; Sun J.; Rezaei N. Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer 2013 Expert Review of Clinical Immunology
1309. Khanbabaee G.; Akbarizadeh M.; Sayyari A.; Ashayeri-Panah M.; Abdollahgorji F.; Sheibani K.; Rezaei N. A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients 2012 Brazilian Journal of Infectious Diseases
1310. Mortazavi H.; Babaeijandaghi F.; Akbarzadeh M.; Rezaei N.; Amirzargar A.A.; Daneshpazhooh M.; Jalali A.; Hallaji Z. The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris 2013 Journal of the European Academy of Dermatology and Venereology
1311. Monajemzadeh M.; Shahsiah R.; Vasei M.; Tanzifi P.; Rezaei N.; Najafi M.; Soleimanifar N.; Eghbali M. Alpha 1 antitrypsin deficiency in infants with neonatal cholestasis 2013 Iranian Journal of Pediatrics
1312. Shoar S.; Shoar N.; Rezaei N.; Talebian A.; Lahgani M.J.; Naderan M.; Hoseini S.S. Cerebral sinovenous thrombosis (CSVT) in a neonate with different manifestations 2012 Acta Medica Iranica
1313. Mortazavi H.; Amirzargar A.A.; Esmaili N.; Toofan H.; Ehsani A.H.; Hosseini S.H.; Rezaei N. Association of human leukocyte antigen class i antigens in Iranian patients with pemphigus vulgaris 2013 Journal of Dermatology
1314. Mahmoodi M.; Alizadeh A.M.; Sohanaki H.; Rezaei N.; Amini-Najafi F.; Khosravi A.R.; Hosseini S.-K.; Safari Z.; Hydarnasab D.; Khori V. Impact of fumonisin B1 on the production of inflammatory cytokines by gastric and colon cell lines 2012 Iranian Journal of Allergy, Asthma and Immunology
1315. Nakhaeimoghadam M.; Rostami P.; Zare-Shahabadi A.; Mehdizadeh M.; Rabbani A.; Rezaei N. Hypothalamic hamartoma in an unusual case with delayed puberty 2013 Acta Medica Iranica
1316. Mahmoudi M.J.; Rezaei N.; Mahmoudi M. Serum ox-LDL level and severity of stenosis in coronary arteries 2013 Acta Medica Iranica
1317. Aghamohammadi A.; Abolhassani H.; Mohammadinejad P.; Rezaei N. The approach to children with recurrent infections 2012 Iranian Journal of Allergy, Asthma and Immunology
1318. Zare-Shahabadi A.; Renaudineau Y.; Rezaei N. MicroRNAs and multiple sclerosis: from physiopathology toward therapy 2013 Expert Opinion on Therapeutic Targets
1319. Moossavi S.; Rezaei N. Host-microbiota interaction is MyD88-independent in the intestinal tract under physiologic condition 2012 Avicenna Journal of Medical Biotechnology
1320. Rahiminejad M.S.; Sadeghi M.M.; Mohammadinejad P.; Sadeghi B.; Abolhassani H.; Firoozabadi M.M.D.; Fathi S.M.; Rezvani H.; Bahoush G.; Ehsani M.A.; Faranoush M.; Mehrvar A.; Sagvand B.T.; Ghadiani M.; Rezaei N.; Aghamohammadi A. Evaluation of Humoral immune function in patients with chronic idiopathic thrombocytopenic Purpura 2013 Iranian Journal of Allergy, Asthma and Immunology
1321. Mohammadzadeh I.; Khaledi M.; Rezaei N. Stevens-johnson syndrome: Report on a case with a strange complaint of allergy to bus 2013 Acta Clinica Croatica
1322. Lopez-Herrera G.; Tampella G.; Pan-Hammarström Q.; Herholz P.; Trujillo-Vargas C.M.; Phadwal K.; Simon A.K.; Moutschen M.; Etzioni A.; Mory A.; Srugo I.; Melamed D.; Hultenby K.; Liu C.; Baronio M.; Vitali M.; Philippet P.; Dideberg V.; Aghamohammadi A.; Rezaei N.; Enright V.; Du L.; Salzer U.; Eibel H.; Pfeifer D.; Veelken H.; Stauss H.; Lougaris V.; Plebani A.; Gertz E.M.; Schäffer A.A.; Hammarström L.; Grimbacher B. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity 2012 American Journal of Human Genetics
1323. Varzaneh F.N.; Rezaei N. Cranial nerve palsy in tuberculous meningitis versus acute bacterial meningitis 2013 Acta Medica Iranica
1324. Shahkarami S.; Rezaei N. Genetic predisposition to cutaneous sarcoidosis 2012 Acta Medica Iranica
1325. Shahkarami S.; Rezaei N. Genetics of neonatal diabetes mellitus 2013 Acta Medica Iranica
1326. Aghamohammadi A.; Rezaei N. Clinical cases in primary immunodeficiency diseases: A problem-solving approach 2012 Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach
1327. Horváth Z.; Rezaei N.; Reisli I.; Tuzankina I.; Otarbayev N.; Popandopulo P.; Maródi L. The spread of the J project 2013 Journal of Clinical Immunology
1328. Rezaei N.; Abolhassani H.; Kasraian A.; Mohammadinejad P.; Sadeghi B.; Aghamohammadi A. Family study of pediatric patients with primary antibody deficiencies 2013 Iranian Journal of Allergy, Asthma and Immunology
1329. Sadaghiani M.S.; Aghamohammadi A.; Ashrafi M.-R.; Hosseini F.; Abolhassani H.; Rezaei N. Autism in a child with common variable immunodeficiency 2013 Iranian Journal of Allergy, Asthma and Immunology
1330. Mohammadzadeh I.; Shahbaznejad L.; Wang N.; Farhadi E.; Aghamohammadi A.; Hammarström L.; Rezaei N. A novel CD40 Ligand mutation in a patient with pneumonia, neutropenia, and hyperimmunoglobulin M phenotype 2013 Journal of Investigational Allergology and Clinical Immunology
1331. Mahdaviani S.A.; Hirbod-Mobarakeh A.; Wang N.; Aghamohammadi A.; Hammarström L.; Masjedi M.R.; Pan-Hammarström Q.; Rezaei N. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: Special review on hyper-immunoglobulin M syndrome 2012 Expert Review of Clinical Immunology
1332. Khanbabaee G.; Tabatabaei S.A.; Rahimpoor F.; Khatami A.; Jadali F.; Ghoroobi J.; Sheibani K.; Rezaei N. Congenital pulmonary airway malformation 2013 Bratislava Medical Journal
1333. Rezaei N.; Hedayat M. Allele Frequency 2013 Brenner's Encyclopedia of Genetics: Second Edition
1334. Khazaei H.A.; Teymuri B.; Nakhaei A.; Mohammadi M.; Noura M.; Khazaei A.; Tofiqh N.; Rezaei N. Association of haptoglobin phenotypes with clinical features of preterm labor disease 2013 Acta Medica Iranica
1335. Behniafard N.; Gharagozlou M.; Farhadi E.; Khaledi M.; Sotoudeh S.; Darabi B.; Fathi S.M.; Moghaddam Z.G.; Mahmoudi M.; Aghamohammadi A.; Amirzargar A.A.; Rezaei N. TNF-alpha single nucleotide polymorphisms in atopic dermatitis 2012 European Cytokine Network
1336. Fallahi G.H.; Rezaei N.; Sadjadei N. Bloody diarrhea as a presentation manifestation of familial mediterranean fever in a patient with compound heterozygote mutations of the MEFV Gene 2013 Gut and Liver
1337. Erdős M.; Maródi L.; Mahdaviani S.A.; Rosenzweig S.D.; Roesler J.; Rezaei N. Defects in innate immunity: Receptors and signaling components 2012 Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach
1338. Mirghorbani M.; Van Gool S.; Rezaei N. Myeloid-derived suppressor cells in glioma 2013 Expert Review of Neurotherapeutics
1339. Aalaei-Andabili S.H.; Fabbri M.; Rezaei N. Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: A systematic review 2013 Immunotherapy
1340. Zendehboudi S.; Rezaei N.; Chatzis I. Effects of fracture properties on the behavior of free-fall and controlled gravity drainage processes 2012 Journal of Porous Media
1341. Abdollahpour H.; Appaswamy G.; Kotlarz D.; Diestelhorst J.; Beier R.; Schäffer A.A.; Gertz E.M.; Schambach A.; Kreipe H.H.; Pfeifer D.; Engelhardt K.R.; Rezaei N.; Grimbacher B.; Lohrmann S.; Sherkat R.; Klein C. The phenotype of human STK4 deficiency 2012 Blood
1342. Khanbabaee G.; Enayat J.; Chavoshzadeh Z.; Tabatabaei S.; Gorji F.; Rezaei N. Serum level of specific IgG antibody for Aspergillus and its association with severity of asthma in asthmatic children 2012 Acta Microbiologica et Immunologica Hungarica
1343. Mohammadinejad P.; Aghamohammadi A.; Abolhassani H.; Sadaghiani M.S.; Abdollahzade S.; Sadeghi B.; Soheili H.; Tavassoli M.; Fathi S.M.; Tavakol M.; Behniafard N.; Darabi B.; Pourhamdi S.; Rezaei N. Pediatric patients with common variable immunodeficiency: Long-term follow-up 2012 Journal of Investigational Allergology and Clinical Immunology
1344. Mansouri D.; Mahdaviani S.A.; Khalilzadeh S.; Mohajerani S.A.; Hasanzad M.; Sadr S.; Nadji S.A.; Karimi S.; Droodinia A.; Rezaei N.; Linka R.M.; Bienemann K.; Borkhardt A.; Masjedi M.R.; Velayati A.A. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated epstein-barr virus infection 2012 International Archives of Allergy and Immunology
1345. Rostami P.; Nakhaeimoghadam M.; Bijani F.-M.; Sotoudeh A.; Rabbani A.; Hilbert P.; Rezaei N. AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome 2013 Annales d'Endocrinologie
1346. Mahdaviani S.A.; Hirbod-Mobarakeh A.; Wang N.; Aghamohammadi A.; Hammarström L.; Masjedi M.R.; Pan-Hammarström Q.; Rezaei N. Erratum: Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: Special review on hyper-immunoglobulin M syndrome (Expert Review of Clinical Immunology (2012) 8:6 (539-546)) 2013 Expert Review of Clinical Immunology
1347. Abolhassani H.; Sagvand B.T.; Shokuhfar T.; Mirminachi B.; Rezaei N.; Aghamohammadi A. A review on guidelines for management and treatment of common variable immunodeficiency 2013 Expert Review of Clinical Immunology
1348. Abolhassani H.; Sadaghiani M.S.; Aghamohammadi A.; Ochs H.D.; Rezaei N. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: Systematic review and meta analysis 2012 Journal of Clinical Immunology
1349. Hedayat M.; Takeda K.; Rezaei N. Prophylactic and therapeutic implications of toll-like receptor ligands 2012 Medicinal Research Reviews
1350. Dehkordy S.F.; Aghamohammadi A.; Ochs H.D.; Rezaei N. Primary immunodeficiency diseases associated with neurologic manifestations 2012 Journal of Clinical Immunology
1351. Sullivan K.; Eibl M.M.; Erdős M.; Maródi L.; Wolf H.M.; Mahmoudi M.; Rezaei N. Complement deficiencies 2012 Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach
1352. Shoaran M.; Khodadad A.; Mahjoub F.; Kiani M.-A.; Rezaei N. Immunoprolifera tive small intestinal disease presented with ascites and edema 2013 Acta Clinica Croatica
1353. Aghamohammadi A.; Abolhassani H.; Hirbod-Mobarakeh A.; Ghassemi F.; Shahinpour S.; Behniafard N.; Naghibzadeh G.; Imanzadeh A.; Rezaei N. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis 2012 Viral Immunology
1354. Aryan Z.; Comapalati E.; Canonica G.W.; Rezaei N. Allergen-specific immunotherapy in asthmatic children: From the basis to clinical applications 2013 Expert Review of Vaccines
1355. Shamsian B.S.; Rezaei N.; Alavi S.; Hedayat M.; Amin Asnafi A.; Pourpak Z.; Gharib A.; Jadali F.; Arzanian M.T. Primary hemophagocytic lymphohistiocytosis in Iran: Report from a single referral center 2012 Pediatric Hematology and Oncology
1356. Sayyahfar S.; Chavoshzadeh Z.; Khaledi M.; Madadi F.; Yeganeh M.H.; Sawamura D.; Nakano H.; Rezaei N. Congenital insensitivity to pain with anhidrosis presenting with palmoplantar keratoderma 2013 Pediatric Dermatology
1357. Aryan Z.; Comapalati E.; Canonica G.W.; Rezaei N. Erratum: Allergenspecific immunotherapy in asthmatic children: From the basis to clinical applications (Expert Review of Vaccines (2013) 12:6 (639-659)) 2013 Expert Review of Vaccines
1358. Mahdaviani S.A.; Mohajerani S.A.; Rezaei N.; Casanova J.-L.; Mansouri S.D.; Velayati A.A. Pulmonary manifestations of chronic granulomatous disease 2013 Expert Review of Clinical Immunology
1359. Mahmoudi M.J.; Mahmoudi M.; Siassi F.; Hedayat M.; Pasalar P.; Chamari M.; Abolhassani H.; Rezaei N.; Saboor-Yaraghi A.-A. Circulating retinol-binding protein 4 concentrations in patients with coronary artery disease and patients with type 2 diabetes mellitus 2012 International Journal of Diabetes in Developing Countries
1360. Aryan Z.; Rezaei N. Comment on 'Allergy and acute leukaemia in children with Down syndrome: A population study. Report from the Mexican Inter Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)' - Is increased surveillance by hypersensitive immune system a reality or myth? 2013 British Journal of Cancer
1361. Motamed F.; Benabbas R.; Ashrafi M.R.; Aghamohammadi A.; Rezaei N. Ataxia-telangiectasia or neurologic Wilson's disease: When strong family history becomes a diagnostic bias 2013 Acta Neurologica Belgica
1362. Shayanfar N.; Mohammadpour M.; Hashemi-Moghadam S.A.; Ashtiani M.T.H.; Mirzaie A.Z.; Rezaei N. Group b streptococci urine isolates and their antimicrobial susceptibility profiles in a group of iranian females: Prevalence and seasonal variations 2012 Acta Clinica Croatica
1363. Noorian S.; Sayarifard F.; Farhadi E.; Barbetti F.; Rezaei N. GCK mutation in a child with maturity onset diabetes of the young, type 2 2013 Iranian Journal of Pediatrics
1364. Jessen B.; Bode S.F.N.; Ammann S.; Chakravorty S.; Davies G.; Diestelhorst J.; Frei-Jones M.; Gahl W.A.; Gochuico B.R.; Griese M.; Griffiths G.; Janka G.; Klein C.; Kögl T.; Kurnik K.; Lehmberg K.; Maul-Pavicic A.; Mumford A.D.; Pace D.; Parvaneh N.; Rezaei N.; De Saint Basile G.; Schmitt-Graeff A.; Schwarz K.; Karasu G.T.; Zieger B.; Zur Stadt U.; Aichele P.; Ehl S. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2 2013 Blood
1365. Espanol T.; Fillat C.; Barlan I.B.; Aydiner E.; Caracseghi F.; Niehues T.; Soler-Palacín P.; Rezaei N. Other well-defined immunodeficiency syndromes 2012 Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach
1366. Abolhassani H.; Amirkashani D.; Parvaneh N.; Mohammadinejad P.; Gharib B.; Shahinpour S.; Hirbod-Mobarakeh A.; Mirghorbani M.; Movahedi M.; Gharagozlou M.; Rezaei N.; Aghamohammadi A. Autoimmune phenotype in patients with common variable immunodeficiency 2013 Journal of Investigational Allergology and Clinical Immunology
1367. Norouzi S.; Aghamohammadi A.; Mamishi S.; Rosenzweig S.D.; Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases 2012 Journal of Infection
1368. Movahedi M.; Amirzargar A.A.; Nasiri R.; Hirbod-Mobarakeh A.; Farhadi E.; Tavakol M.; Behniafard N.; Ansaripour B.; Moradi B.; Zare A.; Rezaei N. Gene polymorphisms of Interleukin-4 in allergic rhinitis and its association with clinical phenotypes 2013 American Journal of Otolaryngology - Head and Neck Medicine and Surgery
1369. Rezaei N.; Aghamohammadi A.; Albert M.H.; Belohradsky B.H.; Espanol T.; Erdős M.; Klein C.; Maródi L.; Mohammadinejad P.; Nicolai T.; Notheis G.; Hedayat M.; Pourhamdi S.; Roesler J.; Rosenzweig S.D.; Wintergerst U. Disorders of phagocytic cells 2012 Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach
1370. Abolhassani H.; Aghamohammadi A.; Pourjabbar S.; Sadaghiani M.S.; Nikayin S.; Rabiee A.; Imanzadeh A.; Gharaei J.M.; Arbabi M.; Rezaei N. Psychiatric aspects of primary immunodeficiency diseases: The parental study 2013 Iranian Journal of Allergy, Asthma and Immunology
1371. Zaridoust A.; Rabbani A.; Sayarifard F.; Thiel C.T.; Rezaei N. Acanthosis nigricans, abnormal facial appearance and dentition in an insulin resistance syndrome 2013 Iranian Journal of Pediatrics
1372. Abolhassani H.; Aghamohammadi A.; Imanzadeh A.; Mohammadinejad P.; Sadeghi B.; Rezaei N. Malignancy phenotype in common variable immunodeficiency 2012 Journal of Investigational Allergology and Clinical Immunology
1373. Najafi S.; Mohammadzadeh M.; Monsef Esfahani H.R.; Meighani G.; Rezaei N. The effect of purslane in the treatment of recurrent aphthous stomatitis 2013 Tehran University Medical Journal
1374. Shoaran M.; Najafi M.; Jalilian R.; Rezaei N. Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guérin vaccination 2013 Annals of Saudi Medicine
1375. Mohammadzadeh I.; Yeganeh M.; Khaledi M.; Salehiomran M.; Aghamohammadi A.; Rezaei N. Debilitating progressive encephalitis in a patient with BTK deficiency 2012 Acta Microbiologica et Immunologica Hungarica
1376. Bashashati M.; Rezaei N.; Andrews C.N.; Chen C.-Q.; Daryani N.E.; Sharkey K.A.; Storr M.A. Cytokines and irritable bowel syndrome: Where do we stand? 2012 Cytokine
1377. Mohammadzadeh O.; Rezaei N.; Chatzis I. Production characteristics of the steam-assisted gravity drainage (SAGD) and solvent-aided SAGD (SA-SAGD) processes using a 2-D macroscale physical model 2012 Energy and Fuels
1378. Canessa C.; Romano F.; Lippi F.; Bianchi L.; Kashef S.; Rezaei N.; Moriondo M.; Nieddu F.; Martini M.; Azzari C. BCGitis and vaccine-derived poliovirus infection in a patient with a novel deletion in RAG1 binding site 2013 International Journal of Immunopathology and Pharmacology
1379. Shamsian B.S.; Abdar Esfahani S.; Milani H.; Akhlaghpoor S.; Mojtahedzadeh S.; Karimi A.; Shamshiri A.R.; Alavi S.; Safari A.; Rezaei N.; Arzanian M.T. Magnetic resonance imaging in the evaluation of iron overload: A comparison of MRI, echocardiography and serum ferritin level in patients with β-thalassemia major 2012 Clinical Imaging
1380. Sayarifard F.; Aghamohammadi A.; Haghi-Ashtiani M.T.; Rajab A.; Irani H.; Ahmadian J.H.; Zaridoost A.; Parvaneh N.; Rezaei N.; Rabbani A. Evaluation of serum IgA levels in Iranian patients with type 1 diabetes mellitus 2012 Acta Diabetologica
1381. Ameli S.; Zenker M.; Zare-Shahabadi A.; Esfahani S.T.; Madani A.; Monajemzadeh M.; Bazargani B.; Ataei N.; Hajezadeh N.; Rezaei N. Novel NPHS1 gene mutation in an Iranian patient with congenital nephrotic syndrome of the Finnish type 2013 Nefrologia
1382. Rezaei N.; Notarangelo L.D. Hematopoietic stem cell transplantation for hyper-IgM syndromes 2013 Pediatric Transplantation
1383. Aalaei-andabili S.H.; Rezaei N. Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) promotes proper immune response against infections: A systematic review 2013 Journal of Infection
1384. Khalili M.; Farahmand F.; Hirbod-Mobarakeh A.; Yousefi A.; Sotoudeh S.; Monajemzadeh M.; Razaghian A.; Rezaei N. Erythropoietic protoporphyria and early onset of cholestasis 2012 Turkish Journal of Pediatrics
1385. Mahmoudi M.; Hedayat M.; Aghamohammadi A.; Rezaei N. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency 2013 Journal of Investigational Allergology and Clinical Immunology
1386. Behniafard N.; Aghamohammadi A.; Abolhassani H.; Pourjabbar S.; Sabouni F.; Rezaei N. Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature 2012 Expert Review of Clinical Immunology
1387. Mohammadzadeh I.; Yeganeh M.; Aghamohammadi A.; Parvaneh N.; Behniafard N.; Abolhassani H.; Tabassomi F.; Hemmat M.; Kanegane H.; Miyawaki T.; Ohara O.; Rezaei N. Severe primary antibody deficiency due to a novel mutation of μ heavy chain 2012 Journal of Investigational Allergology and Clinical Immunology
1388. Rabbani A.; Abbasi F.; Taghvaei M.; Rabbani B.; Moradi B.; Shakiba Y.; Rezaei N.; Amirzargar A. HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I 2013 Pediatric Diabetes
1389. Soheili H.; Abolhassani H.; Arandi N.; Khazaei H.A.; Shahinpour S.; Hirbod-Mobarakeh A.; Rezaei N.; Aghamohammadi A. Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: From senior idea to novel opportunities 2013 International Archives of Allergy and Immunology
1390. Moossavi S.; Rezaei N. Toll-like receptor expression pattern: Clinical application 2012 Journal of Clinical Immunology
1391. Gharagozlou M.; Farhadi E.; Khaledi M.; Behniafard N.; Sotoudeh S.; Salari R.; Darabi B.; Fathi S.M.; Mahmoudi M.; Aghamohammadi A.; Amirzargar A.A.; Rezaei N. Association between the interleukin 6 genotype at position -174 and atopic dermatitis 2013 Journal of Investigational Allergology and Clinical Immunology
1392. Ameli S.; Mazaheri M.; Zare-Shahabadi A.; Ozaltin F.; Asgarian F.; Monajemzadeh M.; Bazargani B.; Ataei N.; Hajezadeh N.; Madani A.; Esfahani T.; Isaian A.; Zenker M.; Rezaei N. NPHS2 gene mutation in an Iranian family with familial steroid-resistant nephrotic syndrome 2012 Nefrologia
1393. Jalilian R.; Rezaei N. Genetics of Mondini malformation 2013 Acta Medica Iranica
1394. Motamed F.; Famouri F.; Najafi M.; Moazzami K.; Farahmand F.; Khodadad A.; Fallahi G.-H.; Khatami G.-R.; Rezaei N. Response to induction therapy in a pediatric population of inflammatory bowel disease 2010 Zeitschrift fur Gastroenterologie
1395. Fallahi G.H.; Sabbaghian M.; Khalili M.; Parvaneh N.; Zenker M.; Rezaei N. Novel UBR1 gene mutation in a patient with typical phenotype of Johanson-Blizzard syndrome 2011 European Journal of Pediatrics
1396. Shamsian B.S.; Gharib A.; Rezaei N.; Esfahani S.A.; Alavi S.; Goudarzipour K.; Arzanian M.T. Development of secondary T-cell acute lymphoblastic leukemia in a child with hemophagocytic lymphohistiocytosis 2010 Pediatric Blood and Cancer
1397. Rezaei N.; Siadat S.D.; Aghamohammadi A.; Moin M.; Pourpak Z.; Norouzian D.; Mobarakeh J.I.; Aghasadeghi M.R.; Nejati M.; Read R.C. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency 2010 Clinical and Vaccine Immunology
1398. Kashef S.; Moghtaderi M.; Borzouee M.; Rezaei N. Giant aneurysm of thoracic and proximal abdominal aorta in a patient with common variable immunodeficiency 2011 Iranian Journal of Allergy, Asthma and Immunology
1399. Eghbali A.; Eshghi P.; Malek F.; Rezaei N. Cardiac and renal malformations in a patient with sepsis and severe congenital neutropenia 2010 Iranian Journal of Pediatrics
1400. Taghi Haghi-Ashtiani M.; Mamishi S.; Shayanfar N.; Mohammadpour M.; Yaghmaei B.; Abedini M.; Farahani N.; Rezaei N. Antimicrobial susceptibility profiles associated with bacterial meningitis among children: A referral hospital-based study in Iran 2011 Acta Microbiologica et Immunologica Hungarica
1401. Rezaei N.; Aghamohammadi A.; Nourizadeh M.; Kardar G.A.; Pourpak Z.; Zare A.; Read R.C. Cytokine production by activated T cells in common variable immunodeficiency 2010 Journal of Investigational Allergology and Clinical Immunology
1402. Rezaei N.; Mohammadzadeh O.; Chatzis I. Experimental investigation of vapor extraction process for the recovery of bitumen from vuggy porous media 2010 Society of Petroleum Engineers - Canadian Unconventional Resources and International Petroleum Conference 2010
1403. Shahram F.; Nikoopour E.; Rezaei N.; Saeedfar K.; Ziaei N.; Davatchi F.; Amirzargar A. Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behçet's disease 2011 Clinical and Experimental Rheumatology
1404. Rezaei N.; Mohammadzadeh O.; Chatzis I. Warm VAPEX: A thermally improved vapor extraction process for recovery of heavy oil and bitumen 2010 Energy and Fuels
1405. Hadi N.; Kashef S.; Moazzen M.; Pour M.S.; Rezaei N. Survey of Mycoplasma pneumoniae in Iranian children with acute lower respiratory tract infections 2011 Brazilian Journal of Infectious Diseases
1406. Shamsian B.S.; Nikoufar M.; Esfahani S.A.; Shamshiri A.R.; Arzanian M.T.; Alavi S.; Jadali F.; Gharib A.; Rezaei N. A 10-year single center survey of pediatric patients with histiocytic disorders in Iran 2011 Turkish Journal of Pediatrics
1407. Rezaei N.; Chatzis I. Characterization of heterogeneities in porous media using constant rate air injection porosimetry 2011 Journal of Petroleum Science and Engineering
1408. Aghamohammadi A.; Moin M.; Rezaei N. History of primary immunodeficiency diseases in Iran 2010 Iranian Journal of Pediatrics
1409. Barkhordari E.; Amirzargar A.A.; Ebrahimi-Daryani N.; Mahmoudi M.; Ansaripour B.; Alighardashi M.; Ahmadi-Ashtiani H.R.; Bashashati M.; Rezaei N. Lack of association between interleukin 12 C(-1188)A polymorphism and irritable bowel syndrome 2011 Avicenna Journal of Medical Biotechnology
1410. Fallahi G.; Najafi M.; Farhmand F.; Bazvand F.; Ahmadi M.; Ahmadi F.; Eftekhari K.; Khodad A.; Motamed F.; Khatami G.; Aghamohammadi A.; Rezaei N. The clinical and laboratory manifestations of Iranian patients with cystic fibrosis 2010 Turkish Journal of Pediatrics
1411. Modarres Mosalla S.M.; Rezaei N.; Tavakoli H.; Gholamrezanezhad A. Prediction of future cardiac events using myocardial perfusion SPECT: A middle-term follow-up study 2011 Revista Espanola de Medicina Nuclear
1412. Sancho-Shimizu V.; Pérez De Diego R.; Lorenzo L.; Halwani R.; Alangari A.; Israelsson E.; Fabrega S.; Cardon A.; Maluenda J.; Tatematsu M.; Mahvelati F.; Herman M.; Ciancanelli M.; Guo Y.; AlSum Z.; Alkhamis N.; Al-Makadma A.S.; Ghadiri A.; Boucherit S.; Plancoulaine S.; Picard C.; Rozenberg F.; Tardieu M.; Lebon P.; Jouanguy E.; Rezaei N.; Seya T.; Matsumoto M.; Chaussabel D.; Puel A.; Zhang S.-Y.; Abel L.; Al-Muhsen S.; Casanova J.-L. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency 2011 Journal of Clinical Investigation
1413. Farrokhi S.; Mousavi T.; Arshi S.; Varasteh A.; Rezaei N.; Salekmoghadam A. Co-administration of chenopodium album allergens and CpG oligodeoxy-nucleotides effects on peripheral blood mononuclear cells of patients with allergic rhinitis treated with intranasal corticosteroids and antihistamines 2011 Iranian Journal of Allergy, Asthma and Immunology
1414. Moghtaderi M.; Kashef S.; Rezaei N. Interstitial lung disease in a patient with chronic granulomatous disease 2012 Iranian Journal of Pediatrics
1415. Farahmand F.; Sadjadei N.; Haghi-Ashtiani M.-T.; Modaresi V.; Rezaei N.; Pakseresht B. Comparison of classic sweat test and crystallization test in diagnosis of cystic fibrosis 2012 Iranian Journal of Pediatrics
1416. Rezaei N.; Mahmoudi E.; Aghamohammadi A.; Das R.; Nichols K.E. X-linked lymphoproliferative syndrome: A genetic condition typified by the triad of infection, immunodeficiency and lymphoma 2011 British Journal of Haematology
1417. Rezaei N.; Mohammadzadeh O.; Parsaei R.; Chatzis I. The Effect of Reservoir Wettability on the Production Characteristics of the VAPEX Process: An Experimental Study 2011 Transport in Porous Media
1418. Aghamohammadi A.; Abolhassani H.; Rezaei N.; Kalantari N.; Tamizifar B.; Cheraghi T.; Parvaneh N.; Yeganeh M.; Moazzami K.; Ebrahimi-Daryani N.; Anaraki M.R. Cutaneous granulomas in common variable immunodeficiency: Case report and review of literature 2010 Acta Dermatovenerologica Croatica
1419. Nasseri S.; Sorouri R.; Pourpak Z.; Yeganeh M.; Aghamohammadi A.; Fiorini M.; Shahkarami S.; Mosallaei M.; Rezaei N.; Parvaneh N. Molecular characterization of Bruton's tyrosine kinase defi ciency in 12 Iranian patients with presumed X-linked agammaglobulinemia 2011 Journal of Investigational Allergology and Clinical Immunology
1420. Arzanian M.T.; Eghbali A.; Karimzade P.; Ahmadi M.; Houshmand M.; Rezaei N. mtDNA deletion in an Iranian infant with pearson marrow syndrome 2010 Iranian Journal of Pediatrics
1421. Eghbali A.; Eshghi P.; Malek F.; Abdollahpour H.; Rezaei N. HAX1 mutation in an infant with severe congenital neutropenia 2010 Turkish Journal of Pediatrics
1422. Movahedi Z.; Norouzi S.; Mamishi S.; Rezaei N. BCGiosis as a presenting feature of a child with chronic granulomatous disease 2011 Brazilian Journal of Infectious Diseases
1423. Ramyar A.; Shafiei M.; Moazzami K.; Rezaei N. Severe valvular toxicity and pericarditis early after radiation therapy in a patient treated for Hodgkin's lymphoma 2010 Turkish Journal of Pediatrics
1424. Bakhtiyari S.; Haghani K.; Farhadi E.; Soukhtanloo M.; Rezaei N.; Taghikhani M. A novel monoclonal antibody against A60 antigen of mycobacterium bovis bacillus calmette-guerin 2010 Hybridoma
1425. de Vries E.; Alvarez Cardona A.; Abdul Latiff A.H.; Badolato R.; Brodszki N.; Cant A.J.; Carbone J.; Casper J.T.; Čižnár P.; Cochino A.V.; Derfalvi B.; Driessen G.J.; Elfeky R.; El-Ghoneimy D.; Espanol T.; Etzioni A.; Gambineri E.; Gilmour K.; Gonzalez-Granado L.I.; Guseva M.N.; Haverkamp M.H.; Helminen M.; Hönig M.; Kanariou M.G.; Kirschfink M.; Klein C.; Kuijpers T.W.; Kutukculer N.; Martire B.; Meyts I.; Niehues T.; Pignata C.; Reda S.M.; Renner E.D.; Rezaei N.; Rizzi M.; Sampalo Lainz M.A.; Sargur R.B.; Sediva A.; Seidel M.G.; Seneviratne S.L.; Soler-Palacín P.; Tommasini A.; Warnatz K. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update 2012 Clinical and Experimental Immunology
1426. Inanlou H.; Shourmasti K.S.; Marjani H.; Rezaei N.A. FFDA: A tree based energy aware data aggregation protocol in wireless sensor networks 2010 WINSYS 2010 - Proceedings of the International Conference on Wireless Information Networks and Systems
1427. Zeinaloo A.A.; Aghamohammadi A.; Shabanian R.; Salavati A.; Abdollahzade S.; Rezaei N.; Alizadeh H.; Zanjani K.S.; Kiani A. Echocardiographic abnormalities and their correlation with bronchiectasis score in primary antibody deficiencies 2010 Journal of Cardiovascular Medicine
1428. Rezaei N.; Hedayat M.; Aghamohammadi A.; Nichols K.E. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies 2011 Journal of Allergy and Clinical Immunology
1429. Mohammadzadeh O.; Rezaei N.; Chatzis I. Pore-level investigation of heavy oil and bitumen recovery using solvent -Aided steam assisted gravity drainage (SA-SAGD) process 2010 Energy and Fuels
1430. Abolhassani H.; Aghamohammadi A.; Abolhassani F.; Eftekhar H.; Heidarnia M.; Rezaei N. Health policy for common variable immunodeficiency: Burden of the disease 2011 Journal of Investigational Allergology and Clinical Immunology
1431. Sabouni F.; Ferdosian F.; Mamishi S.; Nejat F.; Monnajemzadeh M.; Rezaei N. Multiple Organ Involvement with Hydatid Cysts 2010 Iranian Journal of Parasitology
1432. Ahmadiafshar A.; Mogimi Hadji M.; Rezaei N. Comparison of effectiveness between beclomethasone dipropionate and fluticasone propionate in treatment of children with moderate asthma 2010 World Allergy Organization Journal
1433. Rezaei N.; Mohammadinejad P.; Aghamohammadi A. The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment 2011 Annals of the New York Academy of Sciences
1434. Rezaei N.; Abolhassani H.; Aghamohammadi A.; Ochs H.D. Indications and safety of intravenous and subcutaneous immunoglobulin therapy 2011 Expert Review of Clinical Immunology
1435. Motamed F.; Najafi M.; Taghvaei M.; Moazzami K.; Farahmand F.; Khodadad A.; Fallahi G.-H.; Parvaneh N.; Khatami G.-R.; Rezaei N. NOD2 sequencing in Iranian children with crohns disease 2011 Zeitschrift fur Gastroenterologie
1436. Shamsian B.S.; Norbakhsh K.; Rezaei N.; Safari A.; Gharib A.; Pourpak Z.; Alavi S.; Parvaneh N.; Arzanian M.T. A novel RAB27A mutation in a patient with griscelli syndrome type 2 2010 Journal of Investigational Allergology and Clinical Immunology
1437. Aghamohammadi A.; Shafiei A.; Abolhassani H.; Sherkat R.; Mahjoub F.; Rezaei N. Renal amyloidosis in common variable immunodeficiency 2010 Nefrologia
1438. Fallahi G.-H.; Ahmadian J.H.; Rabbani A.; Yousefnezhad A.; Rezaei N. Screening for celiac disease in diabetic children from Iran 2010 Indian Pediatrics
1439. Barkhordari E.; Rezaei N.; Mahmoudi M.; Larki P.; Ahmadi-Ashtiani H.R.; Ansaripour B.; Alighardashi M.; Bashashati M.; Amirzargar A.A.; Ebrahimi-Daryani N. T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome 2010 Inflammation
1440. Ashrafi M.-R.; Hosseini S.-A.; Biglari M.; Abolmaali S.; Malamiri R.A.; Mombeini H.; Pourpak Z.; Saladjegheh N.; Rezaei N.; Saghafi S.; Aghamohammadi A. Effect of anti-epileptic drugs on serum level of igG subclasses 2010 Iranian Journal of Pediatrics
1441. Fallah S.; Tabatabaei A.; Pournasir Z.; Chavoshzadeh Z.; Rezaei N. Cutaneous cytomegalovirus infection in a child with hyper IgE and specific defects in antibody response to protein vaccines 2011 Brazilian Journal of Infectious Diseases
1442. Aghamohammadi A.; Abolhassani H.; Moazzami K.; Parvaneh N.; Rezaei N. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults 2010 Journal of Investigational Allergology and Clinical Immunology
1443. Aghamohammadi A.; Mahmoodi M.; Rezaei N.; Safari Z.; Heidarnasab D.; Divsalar K.; Mohagheghi M.-A. The assessment of antibody response following immunization with polysaccharide vaccine in patients with chronic kidney disease 2011 Tehran University Medical Journal
1444. Abdollahzade S.; Aghamohammadi A.; Soheili H.; Sadaghiani M.S.; Abolhassani H.; Rezaei N. The clinical immunological and long-term follow-up of pediatric patients with common variable immunodeficiency 2011 Tehran University Medical Journal
1445. Saroukhani S.; Aghamohammadi A.; Mahmoudi-Gharaei J.; Abolhassani H.; Cheraghi T.; Imanzadeh A.; Moazzami K.; Parvaneh N.; Rezaei N. Behavior abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies 2010 Human Psychopharmacology
1446. Mahmoudi M.J.; Hedayat M.; Rezaei N.; Saboor-Yaraghi A.-A.; Mahmoudi M. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease 2011 Iranian Journal of Allergy, Asthma and Immunology
1447. Rezaei N.; Sabbaghian M.; Liu Z.; Zenker M. Eponym: Johanson-Blizzard syndrome 2011 European Journal of Pediatrics
1448. Rezaei N.; Aghamohammadi A.; Mansouri D.; Parvaneh N.; Casanova J.-L. Tuberculosis: A new look at an old disease 2011 Expert Review of Clinical Immunology
1449. Shamsian B.S.; Arzanian M.T.; Kaviani R.; Alavi S.; Hedayat M.; Rezaei N. Splenectomy for hematological disorders in Iranian pediatric patients: A single center study 2012 Iranian Journal of Pediatrics
1450. Shayanfar N.; Mohammadpour M.; Haghi-Ashtiani M.T.; Nejat F.; Farahani N.N.; Abedini M.; Rezaei N. Invasive bacteria isolates from children with cerebral shunt and pattern of antimicrobial drug susceptibility in an Iranian referral pediatrics center 2011 Brazilian Journal of Infectious Diseases
1451. Farahmand F.; Najafi M.; Ataee P.; Modarresi V.; Shahraki T.; Rezaei N. Cow's milk allergy among children with gastroesophageal reflux disease 2011 Gut and Liver
1452. Kiani-Amin M.; Daneshi M.; Ayazi P.; Mohammadian S.; Rezaei N. Serum immunoglobulin levels in splenectomized and non-splenectomized patients with major beta-thalassemia 2011 Iranian Journal of Pediatrics
1453. Bastanfard A.; Rezaei N.A.; Mottaghizadeh M.; Fazel M. A novel multimedia educational speech therapy system for hearing impaired children 2010 Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)
1454. Farrokhi S.; Mousavi T.; Arshi S.; Javahertarash N.; Varasteh A.; Falak R.; Rezaei N.; Salekmoghadam A. Effect of treatment with intranasal corticosteroid and oral antihistamine on cytokine profiles of peripheral blood mononuclear cells of patients with allergic rhinitis sensitive to Chenopodium album 2010 Iranian Journal of Allergy, Asthma and Immunology
1455. Bazvand F.; Shams S.; Esfahani M.B.; Koochakzadeh L.; Monajemzadeh M.; Ashtiani M.-T.H.; Rezaei N. Total antioxidant status in patients with major β-thalassemia 2011 Iranian Journal of Pediatrics
1456. Meighani G.; Aghamohammadi A.; Javanbakht H.; Abolhassani H.; Nikayin S.; Jafari S.M.; Motlagh M.G.; Shamshiri A.R.; Rezaei N. Oral and dental health status in patients with primary antibody deficiencies 2011 Iranian Journal of Allergy, Asthma and Immunology
1457. Mamishi S.; Eghbali A.N.; Rezaei N.; Abolhassani H.; Parvaneh N.; Aghamohammadi A. A single center 14 years study of infectious complications leading to hospitalization of patients with primary antibody deficiencies 2010 Brazilian Journal of Infectious Diseases
1458. Zendehboudi S.; Rezaei N.; Chatzis I. Effect of wettability in free-fall and controlled gravity drainage in fractionally wet porous media with fractures 2011 Energy and Fuels
1459. Sani M.N.; Sabbaghian M.; Mahjoob F.; Cefalù A.B.; Averna M.R.; Rezaei N. Identification of a novel mutation of MTP gene in a patient with abetalipoproteinemia 2011 Annals of Hepatology
1460. Mamishi S.; Ahmadi F.; Ahmadi M.; Rezaei N. Liver abscess as the presenting manifestation of chronic granulomatous disease 2011 Acta Microbiologica et Immunologica Hungarica
1461. Parvaneh N.; Mamishi S.; Rezaei A.; Rezaei N.; Tamizifar B.; Parvaneh L.; Sherkat R.; Ghalehbaghi B.; Kashef S.; Chavoshzadeh Z.; Isaeian A.; Ashrafi F.; Aghamohammadi A. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene 2010 Journal of Clinical Immunology
1462. Chavoshzadeh Z.; Golnabi A.; Rezaei N.; Mehdizadeh M. Laryngeal foreign body aspiration misdiagnosed as asthma: Two case reports and a review of the literature 2011 B-ENT
1463. Mohammadzadeh O.; Rezaei N.; Chatzis I. Pore-level investigation of heavy oil and bitumen recovery using hybrid SAGD process 2010 Proceedings - SPE Symposium on Improved Oil Recovery
1464. Rezaei N.; Wing J.B.; Aghamohammadi A.; Carlring J.; Lees A.; Asgarian-Omran H.; Pourpak Z.; Sarrafnejad A.; Kardar G.A.; Shahrestani T.; Masoumi F.; Zare A.; Saghafi S.; Sarrafzadeh S.; Foster R.A.; Heath A.W.; Read R.C. B-cell-T-cell activation and interaction in common variable immunodeficiency 2010 Human Immunology
1465. Amirzargar A.; Shahram F.; Nikoopour E.; Rezaei N.; Saeedfar K.; Ziaei N.; Davatchi F. Proinflammatory cytokine gene polymorphisms in Behcet's disease 2010 European Cytokine Network
1466. Shamsian B.S.; Goudarzipour K.; Alavi S.; Jadali F.; Gharib A.; Aghakhani R.; Arzanian M.T.; Rezaei N. Langerhans Cell Histiocytosis in a Child with Non-Hodgkin Lymphoma 2010 Journal of Pediatric Hematology/Oncology
1467. Mohammadzadeh O.; Rezaei N.; Chatzis I. More insight into the pore-level physics of the solvent-aided SAGD (SA-SAGD) process for heavy oil and bitumen recovery 2012 Society of Petroleum Engineers - SPE Heavy Oil Conference Canada 2012
1468. Mohammadzadeh O.; Rezaei N.; Chatzis I. Pore-level investigation of heavy oil and bitumen recovery using hybrid SAGD process 2010 SPE - DOE Improved Oil Recovery Symposium Proceedings
1469. Salehi M.; Moradi S.; Chavoshzadeh Z.; Gorji F.A.; Khoramrooz Z.; Rezaei N. A Study of Home Characteristics in Children with Allergic Rhinitis and Asthma 2011 Acta Clinica Croatica
1470. Aghamohammadi A.; Imai K.; Moazzami K.; Abolhassani H.; Tabatabaeiyan M.; Parvaneh N.; Kalmarzi R.N.; Nakagawa N.; Oshima K.; Ohara O.; Nonoyama S.; Rezaei N. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome 2010 Journal of Investigational Allergology and Clinical Immunology
1471. Aghamohammadi A.; Bahrami A.; Mamishi S.; Mohammadi B.; Abolhassani H.; Parvaneh N.; Rezaei N. Impact of delayed diagnosis in children with primary antibody deficiencies 2011 Journal of Microbiology, Immunology and Infection
1472. Armin S.; Chavoshzadeh Z.; Rezaei N. Reply: Antiepileptic hypersensitivity syndrome and DRESS syndrome 2010 Turkish Journal of Pediatrics
1473. Rezaei N.; Mohammadzadeh O.; Parsaei R.; Chatzis I. The effect of reservoir wettability on the production characteristics of the VAPEX process 2010 Proceedings - SPE Symposium on Improved Oil Recovery
1474. Aghamohammadi A.; Rezaei N. Preface 2012 Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach
1475. Lashgary Z.; Khodadadi A.; Singh Y.; Houshmand S.M.; Mahjoubi F.; Sharma P.; Singh S.; Seyedin M.; Srivastava A.; Ataee M.; Mohammadi Z.S.; Rezaei N.; Bamezai R.N.K.; Sanati M.H. Y chromosome diversity among the Iranian religious groups: A reservoir of genetic variation 2011 Annals of Human Biology
1476. Rezaei N.; Aghamohammadi A. Guest Editorial: Hyper-IgE syndrome 2010 Journal of Postgraduate Medicine
1477. Aghamohammadi A.; Allahverdi A.; Abolhassani H.; Moazzami K.; Alizadeh H.; Gharagozlou M.; Kalantari N.; Sajedi V.; Shafiei A.; Parvaneh N.; Mohammadpour M.; Karimi N.; Sadaghiani M.S.; Rezaei N. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia 2010 Respirology
1478. Khanbabaee G.; Yeganeh M.H.; Tabatabaei S.A.; Khatami A.; Bazrafshan S.; Rezaei N. Langerhans cell histiocytosis with pulmonary involvement and unilateral pneumothorax 2010 Turkish Journal of Pediatrics
1479. Norouzi S.; Movahedi Z.; Mamishi S.; Monajemzadeh M.; Rezaei N. Disseminated BCG as a unique feature of an infant with severe combined immunodeficiency 2011 Turkish Journal of Pediatrics
1480. Khaledi M.; Rezaei N. Hereditary and sensory autonomic neuropathies 2012 Iranian Journal of Pediatrics
1481. Mahmoudi M.J.; Mahmoudi M.; Siassi F.; Shokri F.; Eshraghian M.R.; Zarnani A.H.; Chahardoli R.; Hedayat M.; Khoshnoodi J.; Nayeri H.; Rezaei N.; Saboor-Yaraghi A.-A. Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis 2011 Iranian Journal of Immunology
1482. Rezaei N.; Mohammadzadeh O.; Chatzis I. Improving the performance of vapor extraction of heavy oil and bitumen using the warm VAPEX process 2010 Society of Petroleum Engineers - Canadian Unconventional Resources and International Petroleum Conference 2010
1483. Aghamohammadi A.; Montazeri A.; Abolhassani H.; Saroukhani S.; Pourjabbar S.; Tavassoli M.; Darabi B.; Imanzadeh A.; Parvaneh N.; Rezaei N. Health-related quality of life in primary antibody deficiency 2011 Iranian Journal of Allergy, Asthma and Immunology
1484. Boztug K.; Rosenberg P.S.; Dorda M.; Banka S.; Moulton T.; Curtin J.; Rezaei N.; Corns J.; Innis J.W.; Avci Z.; Tran H.C.; Pellier I.; Pierani P.; Fruge R.; Parvaneh N.; Mamishi S.; Mody R.; Darbyshire P.; Motwani J.; Murray J.; Buchanan G.R.; Newman W.G.; Alter B.P.; Boxer L.A.; Donadieu J.; Welte K.; Klein C. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: Novel genotypes and phenotypic variability in severe congenital neutropenia 2012 Journal of Pediatrics
1485. Azizi E.; Massoud A.; Amirzargar A.A.; Mahmoudi M.; Soleimanifar N.; Rezaei N.; Jamshidi A.R.; Nikbin B.; Nicknam M.H. Association of CTLA4 gene polymorphism in iranian patients with ankylosing spondylitis 2010 Journal of Clinical Immunology
1486. Isaian A.; Bogdanova N.V.; Houshmand M.; Movahadi M.; Aghamohammadi A.; Rezaei N.; Atarod L.; Sadeghi-Shabestari M.; Tonekaboni S.H.; Chavoshzadeh Z.; Hassani S.M.S.; Mirfakhrai R.; Cheraghi T.; Kalantari N.; Ataei M.; Dork-Bousset T.; Sanati M.H. Erratum: BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia (Journal of Clinical Immunology DOI: 10.1007/s10875-009-9340-6) 2010 Journal of Clinical Immunology
1487. Hedayat M.; Netea M.G.; Rezaei N. Targeting of Toll-like receptors: A decade of progress in combating infectious diseases 2011 The Lancet Infectious Diseases
1488. Hedayat M.; Mahmoudi M.J.; Rose N.R.; Rezaei N. Proinflammatory cytokines in heart failure: Double-edged swords 2010 Heart Failure Reviews
1489. Mahmoudi M.; Siassi F.; Mahmoudi M.J.; Eshraghian M.R.; Zarnani A.H.; Rezaei N.; Hedayat M.; Shokri F.; Saboor-Yaraghi A.-A. Defective T-cell proliferation and IL-2 production in a subgroup of patients with coronary artery disease 2010 Iranian Journal of Allergy, Asthma and Immunology
1490. Ashrafi M.; Hosseini S.A.; Abolmaali S.; Biglari M.; Azizi R.; Farghadan M.; Samadian A.; Saghafi S.; Mombeini H.; Saladjegheh N.; Rezaei N.; Aghamohammadi A. Effect of anti-epileptic drugs on serum immunoglobulin levels in children 2010 Acta Neurologica Belgica
1491. Soleimanifar N.; Amirzargar A.A.; Mahmoudi M.; Pourfathollah A.A.; Azizi E.; Jamshidi A.R.; Rezaei N.; Tahoori M.T.; Bidad K.; Nikbin B.; Nicknam M.H. Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis 2011 Inflammation
1492. Salehzadeh M.; Aghamohammadi A.; Rezaei N. Evaluation of Immunoglobulin Levels and Infection Rate in Patients with Common Variable Immunodeficiency After Immunoglobulin Replacement Therapy 2010 Journal of Microbiology, Immunology and Infection
1493. Aghamohammadi A.; Abolhassani H.; Biglari M.; Abolmaali S.; Moazzami K.; Tabatabaeiyan M.; Asgarian-Omran H.; Parvaneh N.; Mirahmadian M.; Rezaei N. Analysis of switched memory b cells in patients with igA deficiency 2011 International Archives of Allergy and Immunology
1494. Moradi S.; Chavoshzadeh Z.; Izadyar M.; Mahjoub F.; Rezaei N. Angiocentric nasal T-cell lymphoma in a patient with idiopathic CD4+ lymphocytopenia 2009 Iranian Journal of Allergy, Asthma and Immunology
1495. Nicknam M.H.; Mahmoudi M.; Amirzargar A.A.; Jamshidi A.R.; Rezaei N.; Nikbin B. HLA-B27 subtypes and tumor necrosis factor α promoter region polymorphism in Iranian patients with ankylosing spondylitis 2009 European Cytokine Network
1496. Rezaei A.; Aghamohammadi A.; Moradinejad M.H.; Parvaneh N.; Rezaei N.; Seyedtabaei R.; Omran H.A.; Shahrestani T.; Amirzargar A.A. B-cell lineage study in patients with Juvenile idiopathic arthritis 2008 Iranian Journal of Pediatrics
1497. Yeganeh M.; Heidarzade M.; Pourpak Z.; Parvaneh N.; Rezaei N.; Gharagozlou M.; Movahedi M.; Shabestari M.S.; Mamishi S.; Aghamohammadi A.; Moin M. Severe combined immunodeficiency: A cohort of 40 patients 2008 Pediatric Allergy and Immunology
1498. Moin M.; Aghamohammadi A.; Kouhi A.; Tavassoli S.; Rezaei N.; Ghaffari S.-R.; Gharagozlou M.; Movahedi M.; Purpak Z.; MirSaeid Ghazi B.; Mahmoudi M.; Farhoudi A. Ataxia-Telangiectasia in Iran: Clinical and Laboratory Features of 104 Patients 2007 Pediatric Neurology
1499. Rezaei N.; Aghamohammadi A.; Moin M.; Pourpak Z.; Movahedi M.; Gharagozlou M.; Atarod L.; Ghazi B.M.; Isaeian A.; Mahmoudi M.; Abolmaali K.; Mansouri D.; Arshi S.; Tarash N.J.; Sherkat R.; Akbari H.; Amin R.; Alborzi A.; Kashef S.; Farid R.; Mohammadzadeh I.; Shabestari M.S.; Nabavi M.; Farhoudi A. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: Update from the Iranian primary immunodeficiency registry 2006 Journal of Clinical Immunology
1500. Atarod L.; Aghamohammadi A.; Moin M.; Kanegane H.; Rezaei N.; Kalantari K.R.; Amirzagar A.A.; Futatani T.; Miyawaki T. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy 2007 Iranian Journal of Allergy, Asthma and Immunology
1501. Mohammadi J.; Liu C.; Aghamohammadi A.; Bergbreiter A.; Du L.; Lu J.; Rezaei N.; Amirzargar A.A.; Moin M.; Salzer U.; Pan-Hammarström Q.; Hammarström L. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency 2009 Journal of Clinical Immunology
1502. Shabestari M.S.; Rezaei N. Asthma and allergic rhinitis in a patient with BTK deficiency 2008 Journal of Investigational Allergology and Clinical Immunology
1503. Rezaei N.; Aghamohammadi A.; Siadat S.D.; Moin M.; Pourpak Z.; Nejati M.; Ahmadi H.; Kamali S.; Norouzian D.; Tabaraei B.; Read R.C. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency 2008 Clinical and Vaccine Immunology
1504. Aghamohammadi A.; Rezaei N.; Gharagozlou M.; Ramyar A.; Mahjoub F.; Rezaei-Kalantari K.; Moin M. Hodgkin lymphoma in two siblings with common variable immunodeficiency 2007 Pediatric Hematology and Oncology
1505. Aghamohammadi A.; Moin M.; Karimi A.; Naraghi M.; Zandieh F.; Isaeian A.; Tahaei A.; Talaei-Khoei M.; Kouhi A.; Abdollahzade S.; Pouladi N.; Heidari G.; Amirzargar A.A.; Rezaei N.; Sazgar A.A. Immunologic evaluation of patients with recurrent ear, nose, and throat infections 2008 American Journal of Otolaryngology - Head and Neck Medicine and Surgery
1506. Rezaei N.; Amirzargar A.A.; Shakiba Y.; Mahmoudi M.; Moradi B.; Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency 2009 Clinical and Experimental Immunology
1507. Moin M.; Farhoudi A.; Movahedi M.; Rezaei N.; Pourpak Z.; Yeganeh M.; Gharagozlou M.; Mirsaeid Ghazi B.; Arshi S.; Mansouri D.; Sherkat R.; Kashef S.; Mahmoudi M.; Nabavi M.; Aghamohammadi A. The clinical and laboratory survey of Iranian patients with Hyper-IgE syndrome 2006 Scandinavian Journal of Infectious Diseases
1508. Shabestari M.S.; Maljaei S.H.; Baradaran R.; Barzegar M.; Hashemi F.; Mesri A.; Rezaei N. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran 2007 Journal of Clinical Immunology
1509. Isaian A.; Moin M.; Pourpak Z.; Rezaei N.; Aghamohammadi A.; Movahedi M.; Gharagozlou M.; Ghaffari J.; Zandieh F.; Mansouri M.; Farhoudi A. DNA banking of primary immunodeficiency disorders in Iran 2006 Iranian Journal of Allergy, Asthma and Immunology
1510. Mohammadi J.; Ramanujam R.; Jarefors S.; Rezaei N.; Aghamohammadi A.; Gregersen P.K.; Hammarström L. IgA deficiency and the MHC: Assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) Haplotype 2010 Journal of Clinical Immunology
1511. Ravanbakhsh M.; Sarafnejad A.; Aghamohammadi A.; Kardar G.A.; Omran H.A.; Atarod L.; Rezaei N.; Shahrestani T.; Hosseini M.; Moin M. CD40 ligand expression on stimulated T-helper lymphocytes in patients with common variable immunodeficiency 2007 Iranian Journal of Allergy, Asthma and Immunology
1512. Kheirandish M.; Siadat S.D.; Norouzian D.; Razavi M.R.; Aghasadeghi M.R.; Rezaei N.; Farazmand A.; Mobarakeh J.I.; Zangeneh M.; Moshiri A.; Sadat S.M.; Salmani A.S. Measurement of opsonophagocytic activity of antibodies specific to Neisseria meningitidis serogroup A capsular polysaccharide-serogroup B outer membrane vesicle conjugate in animal model 2009 Annals of Microbiology
1513. Rezaei N.; Chavoshzadeh Z.; Alaei O.R.; Sandrock I.; Klein C. Association of HAX1 deficiency with neurological disorder 2007 Neuropediatrics
1514. Tabatabaie P.; Aghamohammadi A.; Mamishi S.; Isaeian A.; Heidari G.; Abdollahzade S.; Pirouzi P.; Rezaei N.; Heidarnazhad H.; Ghazi B.M.; Yeganeh M.; Cheraghi T.; Abolhasani H.; Saghafi S.; Alizadeh H.; Anaraki M.R. Evaluation of humoral immune function in patients with bronchiectasis 2008 Iranian Journal of Allergy, Asthma and Immunology
1515. Rezaei N.; Aghamohammadi A.; Read R.C. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease 2008 Iranian Journal of Allergy, Asthma and Immunology
1516. Rezaei N.; Chatzis I. Incorporation of heat in the VAPEX process: Warm VAPEX 2007 Canadian International Petroleum Conference 2007, CIPC 2007
1517. Rezaei N.; Moin M.; Pourpak Z.; Ramyar A.; Izadyar M.; Chavoshzadeh Z.; Sherkat R.; Aghamohammadi A.; Yeganeh M.; Mahmoudi M.; Mahjoub F.; Germeshausen M.; Grudzien M.; Horwitz M.S.; Klein C.; Farhoudi A. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia 2007 Journal of Clinical Immunology
1518. Rezaei N.; Kordabadi H.; Elkamel A.; Jahanmiri A. An optimal extended Kalman filter designed by genetic algorithms 2009 Chemical Engineering Communications
1519. Armin S.; Chavoshzadeh Z.; Mohkam M.; Rezaei N. Antiepileptic hypersensitivity and DRESS syndrome due to phenytoin in two pediatric cases 2009 Turkish Journal of Pediatrics
1520. Rezaei A.A.; Shamsaei F.; Rezaei N. Personality characteristics in patients with migraine headaches 2006 Pakistan Journal of Medical Sciences
1521. Sadeghi-Shabestari M.; Vesal S.; Jabbarpour-Bonyadi M.; De Villatay J.P.; Fischer A.; Rezaei N. Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease 2009 Journal of Investigational Allergology and Clinical Immunology
1522. Mahdaviani S.A.; Rezaei N.; Moradi B.; Dorkhosh S.; Amirzargar A.A.; Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma 2009 Journal of Clinical Immunology
1523. Rezaei N. TNF-receptor-associated periodic syndrome (TRAPS): An autosomal dominant multisystem disorder 2006 Clinical Rheumatology
1524. Rezaei N.; Haji-Molla-Hoseini M.; Aghamohammadi A.; Pourfathollah A.A.; Moghtadaie M.; Pourpak Z. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications 2008 Journal of Clinical Immunology
1525. Nourizadeh M.; Aghamohammadi A.; Moazzeni S.M.; Mahdavi M.; Jalili A.; Rezaei N.; Hadjati J. Altered dendritic cell function in response to sera of common variable immunodeficiency patients 2007 Inflammation Research
1526. Fahimzad A.; Chavoshzadeh Z.; Abdollahpour H.; Klein C.; Rezaei N. Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 deficiency 2008 Journal of Investigational Allergology and Clinical Immunology
1527. Shamsian B.S.; Mansouri D.; Pourpak Z.; Rezaei N.; Chavoshzadeh Z.; Jadali F.; Gharib A.; Alavi S.; Eghbali A.; Arzanian M.T. Autosomal recessive chronic granulomatous disease, IgA deficiency and refractory autoimmune thrombocytopenia responding to anti-CD20 monoclonal antibody 2008 Iranian Journal of Allergy, Asthma and Immunology
1528. Vodjgani M.; Aghamohammadi A.; Samadi M.; Moin M.; Hadjati J.; Mirahmadian M.; Parvaneh N.; Salavati A.; Abdollahzade S.; Rezaei N.; Srrafnejad A. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications 2007 Journal of Investigational Allergology and Clinical Immunology
1529. Aghamohammadi A.; Foroughi F.; Rezaei N.; Dianat S.; Solgi G.; Amirzargar A.A. Mannose-binding lectin polymorphisms in common variable immunodeficiency 2009 Clinical and Experimental Medicine
1530. Shamsian B.S.; Rezaei N.; Arzanian M.T.; Alavi S.; Khojasteh O.; Eghbali A. Severe hypochromic microcytic anemia in a patient with congenital atransferrinemia 2009 Pediatric Hematology and Oncology
1531. Aghamohammadi A.; Fiorini M.; Moin M.; Parvaneh N.; Teimourian S.; Yeganeh M.; Goffi F.; Kanegane H.; Amirzargar A.A.; Pourpak Z.; Rezaei N.; Salavati A.; Pouladi N.; Abdollahzade S.; Notarangelo L.D.; Miyawaki T.; Plebani A. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia 2006 International Archives of Allergy and Immunology
1532. Rezaei N.; Pourpak Z.; Aghamohammadi A.; Farhoudi A.; Movahedi M.; Gharagozlou M.; MirSaeid Ghazi B.; Atarod L.; Abolmaali K.; Mahmoudi M.; Mansouri D.; Arshi S.; Tarash N.J.; Sherkat R.; Amin R.; Kashef S.; Hosseini R.F.; Mohammadzadeh I.; Shabestari M.S.; Nabavi M.; Moin M. Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry 2006 American Journal of Reproductive Immunology
1533. Ramyar A.; Shafiei M.; Rezaei N.; Asgarian-Omran H.; Esfahani S.A.; Moazzami K.; Sarafnejad A.; Aghamohammadi A. Cytologic phenotypes of B-cell acute lymphoblastic leukemia - A single center study 2009 Iranian Journal of Allergy, Asthma and Immunology
1534. Ghazi B.M.; Khalesi R.; Naseri M.; Salamati P.; Sotoudeh K.; Rezaei N. Sweat test in asthmatic children; a single center study 2006 Iranian Journal of Allergy, Asthma and Immunology
1535. Mahmoodi M.; Aghamohammadi A.; Rezaei N.; Lessan-Pezeshki M.; Pourmand G.; Mohagheghi M.-A.; Abdollahzade S.; Mousavi-Jarrahi A. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease 2009 European Cytokine Network
1536. Rezaei N.; Aghamohammadi A.; Shakiba Y.; Mahmoudi M.; Jalali A.; Moradi B.; Amirzargar A.A. Cytokine gene polymorphisms in common variable immunodeficiency 2009 International Archives of Allergy and Immunology
1537. Mahmoodi M.; Mir M.-R.; Daryaei P.; Harirchi I.; Rezaei N.; Mohagheghi M.-A.; Mousavi-Jarrahi A.; Nahavandian B.; Kavianpour M.; Jafari A. Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer 2008 European Cytokine Network
1538. James L.A.; Rezaei N.; Chatzis I. VAPEX, warm VAPEX and hybrid VAPEX - The state of enhanced oil recovery for in situ heavy oils in Canada 2008 Journal of Canadian Petroleum Technology
1539. Wintergerst U.; Rosenzweig S.D.; Abinun M.; Malech H.L.; Holland S.M.; Rezaei N. Phagocytes defects 2008 Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management
1540. Mamishi S.; Esfahani S.A.; Parvaneh N.; Diestelhorst J.; Rezaei N. Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency 2009 Journal of Investigational Allergology and Clinical Immunology
1541. Khodadad A.; Aghamohammadi A.; Parvaneh N.; Rezaei N.; Mahjoob F.; Bashashati M.; Movahedi M.; Fazlollahi M.R.; Zandieh F.; Roohi Z.; Abdollahzade S.; Salavati A.; Kouhi A.; Talebpour B.; Daryani N.E. Gastrointestinal manifestations in patients with common variable immunodeficiency 2007 Digestive Diseases and Sciences
1542. Dashti-Khavidaki S.; Aghamohammadi A.; Farshadi F.; Movahedi M.; Parvaneh N.; Pouladi N.; Moazzami K.; Cheraghi T.; Mahdaviani S.A.; Saghafi S.; Heydari G.; Abdollahzade S.; Rezaei N. Adverse reactions of prophylactic intravenous immunoglobulin: A 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases 2009 Journal of Investigational Allergology and Clinical Immunology
1543. Aghamohammadi A.; Cheraghi T.; Rezaei N.; Kanegane H.; Abdollahzede S.; Talaei-Khoei M.; Heidari G.; Zandieh F.; Moin M.; Miyawaki T. Neutropenia associated with X-linked agammaglobulinemia in an Iranian Referral Center 2009 Iranian Journal of Allergy, Asthma and Immunology
1544. Rezaei N.; Aghamohammadi A.; Siadat S.D.; Nejati M.; Ahmadi H.; Moin M.; Pourpak Z.; Kamali S.; Norouzian D.; Tabaraei B.; Read R.C. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies 2007 Vaccine
1545. Rezaei N.; Aghamohammadi A.; Notarangelo L.D. Preface 2008 Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management
1546. Ramyar A.; Aghamohammadi A.; Moazzami K.; Rezaei N.; Yeganeh M.; Cheraghi T.; Pouladi N.; Heydari G.; Abolhassani H.; Amirzargar A.A.; Parvaneh N.; Moin M. Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency 2008 Iranian Journal of Allergy, Asthma and Immunology
1547. Aghamohammadi A.; Moazzami K.; Rezaei N.; Karimi A.; Movahedi M.; Gharagozlou M.; Abdollahzade S.; Pouladi N.; Kouhi A.; Moin M. ENT manifestations in Iranian patients with primary antibody deficiencies 2008 Journal of Laryngology and Otology
1548. Boztug K.; Appaswamy G.; Ashikov A.; Schäffer A.A.; Salzer U.; Diestelhorst J.; Germeshausen M.; Brandes G.; Lee-Gossler J.; Noyan F.; Gatzke A.-K.; Minkov M.; Greil J.; Kratz C.; Petropoulou T.; Pellier I.; Bellanné-Chantelot C.; Rezaei N.; Mönkemöller K.; Irani-Hakimeh N.; Bakker H.; Gerardy-Schahn R.; Zeidler C.; Grimbacher B.; Welte K.; Klein C. A syndrome with congenital neutropenia and mutations in G6PC3 2009 New England Journal of Medicine
1549. Shakiba Y.; Mansouri K.; Arshadi D.; Rezaei N. Corneal neovascularization: Molecular events and therapeutic options 2009 Recent Patents on Inflammation and Allergy Drug Discovery
1550. Kashef S.; Mehdi Ghaedian M.; Rezaei N.; Karamizadeh Z.; Aghamohammadi A.; Durandy A.; Pan-Hammarstrom Q.; Hammarstrom L. Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency 2009 Journal of Investigational Allergology and Clinical Immunology
1551. Yeganeh M.; Henneke P.; Rezaei N.; Ehl S.; Thiel D.; Matamoros N.; Pietrogrande C.; Espanol T.; Litzman J.; Franco J.L.; Sanal O.; Kilic S.S.; Breborowicz A.; Plebani A.; Renner E.; Rothenfusser S.; Hawn T.R.; Woellner C.; Grimbacher B. Toll-like receptor stimulation induces higher TNF-α secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome 2008 International Archives of Allergy and Immunology
1552. Mohammadhoseiniakbari H.; Rezaei N.; Rezaei A.; Roshan S.K.; Honarbakhsh Y. Pattern of glomerulonephritis in Iran: A preliminary study and brief review 2009 Medical Science Monitor
1553. Rezaei N.; Aghamohammadi A.; Notarangelo L.D. Primary immunodeficiency diseases: Definition, diagnosis, and management 2008 Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management
1554. Aghamohammadi A.; Cheraghi T.; Gharagozlou M.; Movahedi M.; Rezaei N.; Yeganeh M.; Parvaneh N.; Abolhassani H.; Pourpak Z.; Moin M. IgA deficiency: Correlation between clinical and immunological phenotypes 2009 Journal of Clinical Immunology
1555. Fallahi G.; Bazvand F.; Eftekhari K.; Ahmadi F.; Ahmadi M.; Rezaei N. Neonatal giant cell hepatitis in an infant with cystic fibrosis 2009 Iranian Journal of Pediatrics
1556. Movahedi M.; Mahdaviani S.A.; Rezaei N.; Moradi B.; Dorkhosh S.; Amirzargar A.A. IL-10, TGF-β, IL-2, IL-12, and IFN-γ cytokine gene polymorphisms in asthma 2008 Journal of Asthma
1557. Fallahi G.H.; Khorasani E.N.; Mansouri F.; Rezaei N. The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease 2008 Allergy and Asthma Proceedings
1558. Amirzargar A.A.; Movahedi M.; Rezaei N.; Moradi B.; Dorkhosh S.; Mahloji M.; Mahdaviani S.A. Polymorphisms in IL4 and IL4RA confer susceptibility to asthma 2009 Journal of Investigational Allergology and Clinical Immunology
1559. Khazaei H.A.; Rezaei N.; Aghamohammadi A.; Amirzargar A.A.; Ghasemi K.M.; Mirimoghaddam I.; Nikbin B. Human leukocyte antigen profile of two ethnic groups in Southeast of Iran 2007 Iranian Journal of Allergy, Asthma and Immunology
1560. Tabatabaie P.; Fallahi G.-H.; Farahmand F.; Eftekhari K.; Ahmadi M.; Ahmadi F.; Bazvand F.; Rezaei N. Congenital choledochal cyst in an infant with cystic fibrosis 2009 Annals of Hepatology
1561. Rezaei N.; Bonilla F.A.; Sullivan K.E.; De Vries E.; Orange J.S. An introduction to primary immunodeficiency diseases 2008 Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management
1562. Klein C.; Grudzien M.; Appaswamy G.; Germeshausen M.; Sandrock I.; Schäffer A.A.; Rathinam C.; Boztug K.; Schwinzer B.; Rezaei N.; Bohn G.; Melin M.; Carlsson G.; Fadeel B.; Dahl N.; Palmblad J.; Henter J.-I.; Zeidler C.; Grimbacher B.; Welte K. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease) 2007 Nature Genetics
1563. Ahmadi F.; Ahmadi M.; Yaghmaei B.; Nejat F.; Rezaei N.; Mamishi S. Candida albicans meningitis in an infant with Noonan syndrome 2009 Brazilian Journal of Infectious Diseases
1564. Rezaei N.; Gavalas N.G.; Weetman A.P.; Kemp E.H. Autoimmunity as an aetiological factor in vitiligo 2007 Journal of the European Academy of Dermatology and Venereology
1565. Rezaei N.; Aghamohammadi A.; Ramyar A.; Pan-Hammarstrom Q.; Hammarstrom L. Severe congenital neutropenia or hyper-igm syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia 2008 International Archives of Allergy and Immunology
1566. Rezaei N.; Rahimpour M.R.; Khayatian A.; Jahanmiri A. A new hybrid approach in the estimation of end-states of a tubular plug-flow reactor by Kalman filter 2008 Chemical Engineering and Processing: Process Intensification
1567. Amirzargar A.A.; Rezaei N.; Jabbari H.; Danesh A.-A.; Khosravi F.; Hajabdolbaghi M.; Yalda A.; Nikbin B. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis 2006 European Cytokine Network
1568. Barkhordari E.; Rezaei N.; Ansaripour B.; Larki P.; Alighardashi M.; Ahmadi-Ashtiani H.R.; Mahmoudi M.; Keramati M.-R.; Habibollahi P.; Bashashati M.; Ebrahimi-Daryani N.; Amirzargar A.A. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome 2010 Journal of Clinical Immunology
1569. Germeshausen M.; Grudzien M.; Zeidler C.; Abdollahpour H.; Yetgin S.; Rezaei N.; Ballmaier M.; Grimbacher B.; Welte K.; Klein C. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations 2008 Blood
1570. Khorasani E.N.; Fallahi G.H.; Mansouri F.; Rezaei N. The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease (Allergy and Asthma Proceedings 29, (517-520)) 2008 Allergy and Asthma Proceedings
1571. Rezaei N.; Moazzami K.; Aghamohammadi A.; Klein C. Neutropenia and primary immunodeficiency diseases 2009 International Reviews of Immunology
1572. Ali Shokrgozar M.; Sarial S.; Amirzargar A.; Shokri F.; Rezaei N.; Arjang Z.; Radfar J.; Yousefi-Behzadi M.; Ali Sahraian M.; Lotfi J. IL-2, IFN-γ, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis 2009 Journal of Clinical Immunology
1573. Shams S.; Amirzargar A.A.; Yousefi M.; Rezaei N.; Solgi G.; Khosravi F.; Ansaripour B.; Moradi B.; Nikbin B. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris 2009 Journal of Clinical Immunology
1574. Niazi A.; Khazaei H.A.; Narouei B.; Moazzami K.; Rezaei N. Efficacy of hepatitis B vaccine amongst health-care workers of South-Eastern Iran 2009 Journal of Gastrointestinal and Liver Diseases
1575. Motamed F.; Aghamohammadi A.; Soltani M.; Mansouri M.; Rezaei N.; Teimourian S.; Pouladi N.; Abdollahzadeh S.; Parvaneh N. Evaluation of liver diseases in Iranian patients with primary antibody deficiencies 2009 Annals of Hepatology
1576. Aghamohammadi A.; Pouladi N.; Parvaneh N.; Yeganeh M.; Movahedi M.; Gharagolou M.; Pourpak Z.; Rezaei N.; Salavati A.; Abdollahzade S.; Moin M. Mortality and morbidity in common variable immunodeficiency 2007 Journal of Tropical Pediatrics
1577. Sadeghi-Shabestari M.; Rezaei N. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency 2009 International Journal of Infectious Diseases
1578. Kashef S.; Mehdi Ghaedian M.; Rezaei N.; Karamizadeh Z.; Aghamohammadi A.; Durandy A.; Pan-Hammarstrom Q.; Hammarstrom L. Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency (Journal of Investigational Allergology and Clinical Immunology (2009) 19, 3) 2009 Journal of Investigational Allergology and Clinical Immunology
1579. Safari M.; Rezaei N.; Hajilooi M.; Aghamohammadi A.; Pan-Hammarstrom Q.; Hammarstrom L. Onychomadesis in a patient with immunoglobulin class switch recombination deficiency 2008 Iranian Journal of Allergy, Asthma and Immunology
1580. Nourizadeh M.; Aghamohammadi A.; Moazzeni S.M.; Mahdavi M.; Rezaei N.; Hadjati J. High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency 2007 Iranian Journal of Allergy, Asthma and Immunology
1581. Aghamohammadi A.; Mohammadi J.; Parvaneh N.; Rezaei N.; Moin M.; Espanol T.; Hammarstrom L. Progression of selective IgA deficiency to common variable immunodeficiency 2008 International Archives of Allergy and Immunology
1582. Amirzargar A.A.; Naroueynejad M.; Khosravi F.; Dianat S.; Rezaei N.; Mytilineos J.; Nikbin B. Cytokine single nucleotide polymorphisms in Iranian populations 2008 European Cytokine Network
1583. Salipante S.J.; Benson K.F.; Luty J.; Hadavi V.; Kariminejad R.; Kariminejad M.H.; Rezaei N.; Horwitz M.S. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia 2007 Human Mutation
1584. Isaian A.; Bogdanova N.V.; Houshmand M.; Movahadi M.; Agamohammadi A.; Rezaei N.; Atarod L.; Sadeghi-Shabestari M.; Tonekaboni S.H.; Chavoshzadeh Z.; Hassani S.M.S.; Mirfakhrai R.; Cheraghi T.; Kalantari N.; Ataei M.; Dork-Bousset T.; Sanati M.H. BAK, BAX, and NBK/BIK Proapoptotic gene alterations in iranian patients with ataxia telangiectasia 2010 Journal of Clinical Immunology
1585. Aghamohammadi A.; Moin M.; Kouhi A.; Mohagheghi M.-A.; Shirazi A.; Rezaei N.; Tavassoli S.; Esfahani M.; Cheraghi T.; Dastan J.; Nersesian J.; Ghaffari S.R. Chromosomal radiosensitivity in patients with common variable immunodeficiency 2008 Immunobiology
1586. Rezaei N.; Aghamohammadi A.; Kardar G.A.; Nourizadeh M.; Pourpak Z. T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency 2008 Journal of Investigational Allergology and Clinical Immunology
1587. Aghamohammadi A.; Tavassoli M.; Abolhassani H.; Parvaneh N.; Moazzami K.; Allahverdi A.; Mahdaviani S.-A.; Atarod L.; Rezaei N. Infectious and non-infectious complications among undiagnosed patients with common variable immunodeficiency 2009 Iranian Journal of Pediatrics
1588. Azarang A.; Mahmoodi M.; Rajabalian S.; Shekari M.A.; Nosratabadi J.; Rezaei N. T-helper 1 and 2 serum cytokine assay in chronic opioid addicts 2007 European Cytokine Network
1589. Aghamohammadi A.; Parvaneh N.; Rezaei N. Editorial: Common variable immunodeficiency: A heterogeneous group needs further subclassification 2009 Expert Review of Clinical Immunology
1590. Fallahi G.-H.; Moazzami K.; Tabatabaeiyan M.; Zamani M.M.; Asgar-Shirazi M.; Najafi M.; Motamed F.; Farahmand F.; Khodad A.; Khatami G.-R.; Rezaei N. Clinical characteristics of Iranian pediatric patients with inflammatory bowel disease 2009 Acta Gastro-Enterologica Belgica
1591. Glocker E.-O.; Hennigs A.; Nabavi M.; Schäffer A.A.; Woellner C.; Salzer U.; Pfeifer D.; Veelken H.; Warnatz K.; Tahami F.; Jamal S.; Manguiat A.; Rezaei N.; Amirzargar A.A.; Plebani A.; Hannesschläger N.; Gross O.; Ruland J.; Grimbacher B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections 2009 New England Journal of Medicine
1592. Rezaei N.; Aghamohammadi A.; Mahmoudi M.; Shakiba Y.; Kardar G.A.; Mahmoudi M.; Moradi B.; Amirzargar A.A. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency 2010 Immunobiology
1593. Aghamohammadi A.; Parvaneh N.; Rezaei N.; Moazzami K.; Kashef S.; Abolhassani H.; Imanzadeh A.; Mohammadi J.; Hammarström L. Clinical and laboratory findings in Hyper-IgM syndrome with novel CD40L and AICDA mutations 2009 Journal of Clinical Immunology
1594. Amirzargar A.A.; Bagheri M.; Ghavamzadeh A.; Alimoghadam K.; Khosravi F.; Rezaei N.; Moheydin M.; Ansaripour B.; Moradi B.; Nikbin B. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia 2005 International Journal of Immunogenetics
1595. Aghamohammadi A.; Moein M.; Farhoudi A.; Pourpak Z.; Rezaei N.; Abolmaali K.; Movahedi M.; Gharagozlou M.; Ghazi B.M.S.; Mahmoudi M.; Mansouri D.; Arshi S.; Trash N.J.; Akbari H.; Sherkat R.; Hosayni R.F.; Hashemzadeh A.; Mohammadzadeh I.; Amin R.; Kashef S.; Alborzi A.; Karimi A.; Khazaei H. Primary immunodeficiency in Iran: First report of the national registry of PID in children and adults 2002 Journal of Clinical Immunology
1596. Rezaei N. Therapeutic targeting of pattern-recognition receptors 2006 International Immunopharmacology
1597. Fazlollahi M.R.; Aghamohammadi A.; Hosseini R.F.; Lotfi A.S.; Khoshdel A.; Farhoudi A.; Movahedi M.; Gharagozlou M.; Mozaffari H.; Zandieh F.; Mansouri M.; Ghaffari J.; Rezaei N. Study of α1-antitrypsin phenotypes frequencies in patients with primary antibody deficiency 2006 Iranian Journal of Allergy, Asthma and Immunology
1598. Fazlollahi M.R.; Farhoudi A.; Movahedi M.; Gharagozlou M.; Mohammadi K.; Rezaei N. Chronic Mucocutaneous Candidiasis; Report of three cases with different phenotypes 2005 Iranian Journal of Allergy, Asthma and Immunology
1599. Aghamohammadi A.; Moin M.; Farhoudi A.; Rezaei N.; Pourpak Z.; Movahedi M.; Gharagozlou M.; Nabavi M.; Shahrokhi A. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia 2004 FEMS Immunology and Medical Microbiology
1600. Almasi S.; Bashashati M.; Rezaei N.; Markazi-Moghaddam N. Brain metastasis from esophageal carcinoma 2004 Neurology India
1601. Farhoudi A.; Aghamohammadi A.; Moin M.; Rezaei N.; Pourpak Z.; Movahedi M.; Gharagozlou M.; Tahaei S.A.; Ghazi B.M.; Mahmoudi M.; Kouhi A.; Atarod L.; Ahmadiafshar A.; Bazargan N.; Isaeian A. Distribution of primary immunodeficiency disorders diagnosed in the Children's Medical Center in Iran 2005 Journal of Investigational Allergology and Clinical Immunology
1602. Aghamohammadi A.; Farhoudi A.; Moin M.; Rezaei N.; Kouhi A.; Pourpak Z.; Yaseri N.; Movahedi M.; Gharagozlou M.; Zandieh F.; Yazadni F.; Arshi S.; Mohammadzadeh I.; Ghazi B.M.; Mahmoudi M.; Tahaei S.; Isaeian A. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency 2005 Clinical and Diagnostic Laboratory Immunology
1603. Amirzargar A.A.; Yalda A.; Hajabolbaghi M.; Khosravi F.; Jabbari H.; Rezaei N.; Niknam M.H.; Ansari B.; Moradi B.; Nikbin B. The association of HLA-DRB, DQA1, DQB1 alleles and haplotype frequency in Iranian patients with pulmonary tuberculosis 2004 International Journal of Tuberculosis and Lung Disease
1604. Pourpak Z.; Aghamohammadi A.; Sedighipour L.; Farhoudi A.; Movahedi M.; Gharagozlou M.; Chavoshzadeh Z.; Jadid L.; Rezaei N.; Moin M. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency 2006 Journal of Microbiology, Immunology and Infection
1605. Gharagozlou M.; Ebrahimi F.A.; Farhoudi A.; Aghamohammadi A.; Bemanian M.-H.; Chavoshzadeh Z.; Heidarzadeh M.; Mehdizadeh M.; Moin M.; Movahedi M.; Nabavi M.; Pourpak Z.; Rezaei N. Pulmonary complications in primary hypogammaglobulinemia: A survey by high resolution CT scan 2006 Monaldi Archives for Chest Disease - Pulmonary Series
1606. Rezaei N.; Farhoudi A.; Pourpak Z.; Aghamohammadi A.; Moin M.; Movahedi M.; Gharagozlou M. Neutropenia in Iranian patients with primary immunodeficiency disorders 2005 Haematologica
1607. Esmaelzadeh S.; Rezaei N.; HajiAhmadi M. Normal uterine size in women of reproductive age in northern Islamic Republic of Iran 2004 Eastern Mediterranean Health Journal
1608. Aghamohammadi A.; Farhoudi A.; Nikzad M.; Moin M.; Pourpak Z.; Rezaei N.; Gharagozlou M.; Movahedi M.; Atarod L.; Ahmadiafshar A.; Bazargan N.; Hosseinpoor A.R. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency 2004 Annals of Allergy, Asthma and Immunology
1609. Moin M.; Rezaei N.; Yeganeh M. UNESCO chair in health education: A step toward public health improvement 2006 Iranian Journal of Public Health
1610. Amirzargar A.A.; Tabasi A.; Khosravi F.; Kheradvar A.; Rezaei N.; Naroueynejad M.; Ansaripour B.; Moradi B.; Nikbin B. Optic neuritis, multiple sclerosis and human leukocyte antigen: Results of a 4-year follow-up study 2005 European Journal of Neurology
1611. Rezaei N.; Farhoudi A.; Ramyar A.; Pourpak Z.; Aghamohammadi A.; Mohammadpour B.; Moin M.; Gharagozlou M.; Movahedi M.; Ghazi B.M.; Izadyar M.; Mahmoudi M. Congenital neutropenia and primary immunodeficiency disorders: A survey of 26 Iranian patients 2005 Journal of Pediatric Hematology/Oncology
1612. Khazaei H.-A.; Rezaei N.; Bagheri G.-R.; Moin A.-A. A six-year study of Vibrio cholerae in Southeastern Iran 2005 Japanese Journal of Infectious Diseases
1613. Khazaei H.A.; Rezaei N.; Bagheri G.R.; Dankoub M.A.; Shahryari K.; Tahai A.; Mahmoudi M. Epidemiology of tuberculosis in the southeastern Iran 2005 European Journal of Epidemiology
1614. Moin M.; Aghamohammadi A.; Farhoudi A.; Pourpak Z.; Rezaei N.; Movahedi M.; Gharagozlou M.; Ghazi B.M.S.; Zahed A.; Abolmaali K.; Mahmoudi M.; Emami L.; Bashashati M. X-Linked Agammaglobulinemia: A Survey of 33 Iranian Patients 2004 Immunological Investigations
1615. Hekmat M.; Taghipoor H.R.; Nobahar M.R.; Monfared M.B.; Tehrani M.M.M.; Arabnia M.K.; Hasantash S.A.; Zadeh A.-M.H.; Kachoueian N.; Foroughi M.; Rezaei N. Laparascopic cholecystectomy and open-heart surgery at the same time 2005 Journal of Cardiac Surgery
1616. Aghamohammadi A.; Parvaneh N.; Tirgari F.; Mahjoob F.; Movahedi M.; Gharagozlou M.; Mansouri M.; Kouhi A.; Rezaei N.; Webster D. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency 2006 Leukemia and Lymphoma
1617. Khazaei H.-A.; Rezaei N.; Bagheri G.-R.; Mahmoudi M.; Moin A.-A.; Dankoub M.-A.; Gazeran A. The epidemiology of Vibrio cholerae in Zabol city, Southeast of Iran 2005 Archives of Iranian Medicine
1618. Moin M.; Mahmoudi M.; Rezaei N. Scientific output of Iran at the threshold of the 21st century 2005 Scientometrics
1619. Farrokhi S.; Hojjat-Farsangi M.; Noohpisheh M.K.; Tahmasbi R.; Rezaei N. Assessment of the immune system in 55 Iranian patients with vitiligo 2005 Journal of the European Academy of Dermatology and Venereology
1620. Yegane R.-A.; Kheirollahi A.-R.; Bashashati M.; Rezaei N.; Tarrahi M.-J.; Khoshdel J.-A. The prevalence of penoscrotal abnormalities and inguinal hernia in elementary-school boys in the west of Iran 2005 International Journal of Urology
1621. Khazaei H.A.; Aghamohammadi A.; Rezaei N.; Nikbin B.; Khosravi M.A.; Mirimoghaddam I. Major histocompatibility complex class I and II antigens frequencies in Baloch ethnic group living in the southeast region of Iran 2004 Transplantation Proceedings
1622. Movahedi M.; Aghamohammadi A.; Rezaei N.; Shahnavaz N.; Jandaghi A.B.; Farhoudi A.; Pourpak Z.; Moin M.; Gharagozlou M.; Mansouri D. Chronic granulomatous disease: A clinical survey of 41 patients from the Iranian primary immunodeficiency registry 2004 International Archives of Allergy and Immunology
No items yet!
Founder
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-09
Managing Director
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-09
Founder
24-Feb-10
Founder
24-Feb-10